<?xml version="1.0" encoding="UTF-8"?>
<CodeSystem xmlns="http://hl7.org/fhir">
   <id value="WhoAtc"/>
   <url value="http://www.whocc.no/atc"/>
   <name value="WhoAtc"/>
   <title value="Anatomical Therapeutic Chemical (ATC) Classification"/>
   <status value="draft"/>
   <experimental value="true"/>
   <description value="Anatomical Therapeutic Chemical (ATC) Classification"/>
   <caseSensitive value="false"/>
   <content value="complete"/>
   <concept>
      <code value="QD07XB02"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN01"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19, RNA-based vaccine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19, RNA-basert vaksine"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AA01"/>
      <designation>
         <language value="en"/>
         <value value="Salmon pancreas disease virus (SPD)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laksepankreas sykdomsvirus (SPD)"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AK"/>
      <designation>
         <language value="en"/>
         <value value="Dihydroorotate dehydrogenase (DHODH) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydroorotatdehydrogenase (DHODH) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11D"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1, plain and in combination with vitamin B6 and B12"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1, inkl. kombinasjoner med B6 og B12"/>
      </designation>
   </concept>
   <concept>
      <code value="A11B"/>
      <designation>
         <language value="en"/>
         <value value="Multivitamins, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multivitaminer, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA03"/>
      <designation>
         <language value="en"/>
         <value value="Tocopherol (vit E)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tokoferol (Vit E)"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DX16"/>
      <designation>
         <language value="en"/>
         <value value="Nicorandil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikorandil"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA"/>
      <designation>
         <language value="en"/>
         <value value="Vinca alkaloids and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinkaalkaloider og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA05"/>
      <designation>
         <language value="en"/>
         <value value="Potassium clorazepate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumklorazepat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX62"/>
      <designation>
         <language value="en"/>
         <value value="Ivosidenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivosidenib"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA54"/>
      <designation>
         <language value="en"/>
         <value value="Cyclopentolate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklopentolat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Griseofulvin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Griseofulvin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA11"/>
      <designation>
         <language value="en"/>
         <value value="Norgestimate and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestimat og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD02"/>
      <designation>
         <language value="en"/>
         <value value="Ceftazidime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftazidim"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA12"/>
      <designation>
         <language value="en"/>
         <value value="Pravastatin, ezetimibe and fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pravastatin, ezetimib og fenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02AB"/>
      <designation>
         <language value="en"/>
         <value value="Glucocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukokortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA03"/>
      <designation>
         <language value="en"/>
         <value value="Canrenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanrenon"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CA02"/>
      <designation>
         <language value="en"/>
         <value value="Methylprednisolone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylprednisolon og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE04"/>
      <designation>
         <language value="en"/>
         <value value="Travoprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Travoprost"/>
      </designation>
   </concept>
   <concept>
      <code value="P02DA"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB51"/>
      <designation>
         <language value="en"/>
         <value value="Isoprenaline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoprenalin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AX04"/>
      <designation>
         <language value="en"/>
         <value value="Dermatan sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dermatansulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="QM03"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H02C"/>
      <designation>
         <language value="en"/>
         <value value="Antiadrenal preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibinyrebarkhormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA08"/>
      <designation>
         <language value="en"/>
         <value value="Isosorbide dinitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isosorbiddinitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QR05"/>
      <designation>
         <language value="en"/>
         <value value="Cough and cold preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hoste- og forkjølelsesmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XF03"/>
      <designation>
         <language value="en"/>
         <value value="Bexarotene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beksaroten"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX21"/>
      <designation>
         <language value="en"/>
         <value value="Brimonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brimonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CB16"/>
      <designation>
         <language value="en"/>
         <value value="Mannitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mannitol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Treosulfan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Treosulfan"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XA02"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX03"/>
      <designation>
         <language value="en"/>
         <value value="Voxelotor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vokselotor"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA01"/>
      <designation>
         <language value="en"/>
         <value value="Vinblastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinblastin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR01"/>
      <designation>
         <language value="en"/>
         <value value="Ampicillin and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ampicillin og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA03"/>
      <designation>
         <language value="en"/>
         <value value="Distigmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Distigmin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG51"/>
      <designation>
         <language value="en"/>
         <value value="Dihydralazine and diuretics, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydralazin og diuretika, kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AX14"/>
      <designation>
         <language value="en"/>
         <value value="Lactobacillus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laktobakterier"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Ipratropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipratropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01"/>
      <designation>
         <language value="en"/>
         <value value="Cardiac therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerteterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BD"/>
      <designation>
         <language value="en"/>
         <value value="Xanthine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xantinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BC"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory agents, non-steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske midler, ikke-steroide"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CB"/>
      <designation>
         <language value="en"/>
         <value value="Podophyllotoxin derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Podofyllotoksinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE53"/>
      <designation>
         <language value="en"/>
         <value value="Ketoprofen, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketoprofen, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA05"/>
      <designation>
         <language value="en"/>
         <value value="Calcium lactate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumlaktat"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA07"/>
      <designation>
         <language value="en"/>
         <value value="Sotalol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotalol"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH10"/>
      <designation>
         <language value="en"/>
         <value value="Lebrikizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lebrikizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Barbexaclone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbeksaklon"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09AX90"/>
      <designation>
         <language value="en"/>
         <value value="Equine stem cells"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stamceller fra hest"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AE01"/>
      <designation>
         <language value="en"/>
         <value value="Bordetella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bordetella"/>
      </designation>
   </concept>
   <concept>
      <code value="B02AB"/>
      <designation>
         <language value="en"/>
         <value value="Proteinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB07"/>
      <designation>
         <language value="en"/>
         <value value="Bisoprolol and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisoprolol og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA11"/>
      <designation>
         <language value="en"/>
         <value value="Miocamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Miokamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11EB"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex with vitamin C"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks med vitamin C"/>
      </designation>
   </concept>
   <concept>
      <code value="V08DA"/>
      <designation>
         <language value="en"/>
         <value value="Ultrasound contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kontrastmidler for ultralyd"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH"/>
      <designation>
         <language value="en"/>
         <value value="Coxibs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koksiber"/>
      </designation>
   </concept>
   <concept>
      <code value="B05AA06"/>
      <designation>
         <language value="en"/>
         <value value="Gelatin agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gelatinforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LK01"/>
      <designation>
         <language value="en"/>
         <value value="Veratrum and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Veratrum og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC04"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD"/>
      <designation>
         <language value="en"/>
         <value value="Measles vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslingvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs affecting bone structure and mineralization"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med effekt på benstruktur og mineralisering"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til injeksjon, middels eller lang virketid i kombinasjon med hurtigvirkende"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB04"/>
      <designation>
         <language value="en"/>
         <value value="Acebutolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acebutolol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlorambucil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorambucil"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF01"/>
      <designation>
         <language value="en"/>
         <value value="Rivaroxaban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rivaroksaban"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA03"/>
      <designation>
         <language value="en"/>
         <value value="Isradipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isradipin"/>
      </designation>
   </concept>
   <concept>
      <code value="P02B"/>
      <designation>
         <language value="en"/>
         <value value="Antitrematodals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot trematoder"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BF03"/>
      <designation>
         <language value="en"/>
         <value value="Mirogabalin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirogabalin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG"/>
      <designation>
         <language value="en"/>
         <value value="Aromatase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aromatasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BB"/>
      <designation>
         <language value="en"/>
         <value value="Sclerosing agents for local injection"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Skleroserende midler til lokal injeksjon"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AA09"/>
      <designation>
         <language value="en"/>
         <value value="Sargramostim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sargramostim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FA"/>
      <designation>
         <language value="en"/>
         <value value="CD20 (Clusters of differentitation 20) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="CD20 (Differensieringsantigen 20) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AB06"/>
      <designation>
         <language value="en"/>
         <value value="Senna glycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sennaglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="N07B"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in addictive disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved avhengighetslidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AC04"/>
      <designation>
         <language value="en"/>
         <value value="Pipotiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipotiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG11"/>
      <designation>
         <language value="en"/>
         <value value="Sodium lauryl sulfoacetate, incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumlaurylsulfoacetat, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D04A"/>
      <designation>
         <language value="en"/>
         <value value="Antipruritics, incl. antihistamines, anesthetics,  etc."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kløemidler, inkl. antihistaminer, anestetika, etc."/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="D02B"/>
      <designation>
         <language value="en"/>
         <value value="Protectives against UV-radiation"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beskyttelsesmidler ved UV-bestråling"/>
      </designation>
   </concept>
   <concept>
      <code value="QD04"/>
      <designation>
         <language value="en"/>
         <value value="Antipruritics, incl. antihistamines, anesthetics,  etc."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kløemidler, inkl. antihistaminer, anestetika, etc."/>
      </designation>
   </concept>
   <concept>
      <code value="D07XA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, weak, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, milde, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AX01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrogen peroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrogenperoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX04"/>
      <designation>
         <language value="en"/>
         <value value="Ipilimumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipilimumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD09"/>
      <designation>
         <language value="en"/>
         <value value="Fluanisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluanison"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AX03"/>
      <designation>
         <language value="en"/>
         <value value="Cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD06"/>
      <designation>
         <language value="en"/>
         <value value="Insulin degludec and insulin aspart"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin degludek og insulin aspart"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA05"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid gland preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoidea-kjertel midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA09"/>
      <designation>
         <language value="en"/>
         <value value="Trolnitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trolnitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC03"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="S01CA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FF"/>
      <designation>
         <language value="en"/>
         <value value="Lincosamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkosamider"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA12"/>
      <designation>
         <language value="en"/>
         <value value="Delapril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delapril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN04BC02"/>
      <designation>
         <language value="en"/>
         <value value="Pergolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pergolid"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective, and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, selektive, og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA09"/>
      <designation>
         <language value="en"/>
         <value value="Calcium citrate lysine complex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumsitratlysinkompleks"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC63"/>
      <designation>
         <language value="en"/>
         <value value="Clenbuterol and ambroxol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klenbuterol og ambroksol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna alkaloids, semisynthetic, quaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonnaalkaloider halvsyntetiske, kvartære ammonium forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AB"/>
      <designation>
         <language value="en"/>
         <value value="Milbemycins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Milbemyciner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FB"/>
      <designation>
         <language value="en"/>
         <value value="CD22 (Clusters of differentitation 22) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="CD22 (Differensieringsantigen 22) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AC04"/>
      <designation>
         <language value="en"/>
         <value value="Permethrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Permetrin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX06"/>
      <designation>
         <language value="en"/>
         <value value="Carvedilol and ivabradine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karvedilol og ivabradin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AG03"/>
      <designation>
         <language value="en"/>
         <value value="Flufenamic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flufenamsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB06"/>
      <designation>
         <language value="en"/>
         <value value="Thiosulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiosulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA11"/>
      <designation>
         <language value="en"/>
         <value value="Grepafloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Grepafloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BF03"/>
      <designation>
         <language value="en"/>
         <value value="Voglibose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Voglibose"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AA72"/>
      <designation>
         <language value="en"/>
         <value value="Quinine, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinin, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03HB01"/>
      <designation>
         <language value="en"/>
         <value value="Cyproterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyproteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonylureas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonyl urea"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB60"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon-alfa-2b, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon alfa-2b, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01C"/>
      <designation>
         <language value="en"/>
         <value value="Cardiac stimulants excl. cardiac glycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjertestimulerende midler ekskl. hjerteglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF04"/>
      <designation>
         <language value="en"/>
         <value value="Calcium levofolinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumlevofolinat"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AB"/>
      <designation>
         <language value="en"/>
         <value value="Peripherally acting antiobesity products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifert virkende midler mot fedme"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA06"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA06"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03BA"/>
      <designation>
         <language value="en"/>
         <value value="Glucocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukokortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA07"/>
      <designation>
         <language value="en"/>
         <value value="Ranitidine bismuth citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ranitidinvismutsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC05"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AC01"/>
      <designation>
         <language value="en"/>
         <value value="Pepsin and acid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pepsin og syremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AB02"/>
      <designation>
         <language value="en"/>
         <value value="Collagenase clostridium histolyticum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kollagenase klostridum histolyticum"/>
      </designation>
   </concept>
   <concept>
      <code value="V09G"/>
      <designation>
         <language value="en"/>
         <value value="Cardiovascular system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerte og kretsløp"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA14"/>
      <designation>
         <language value="en"/>
         <value value="Dydrogesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dydrogesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Benzydamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzydamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51RC25"/>
      <designation>
         <language value="en"/>
         <value value="Penethamate hydroiodide, combinations with other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penetamathydrojodid, kombinasjoner med andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XF"/>
      <designation>
         <language value="en"/>
         <value value="Retinoids for cancer treatment"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retinoider for kreftbehandling"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA15"/>
      <designation>
         <language value="en"/>
         <value value="Camazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kamazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53B"/>
      <designation>
         <language value="en"/>
         <value value="Ectoparasiticides for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ektoparasittmidler for systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FG02"/>
      <designation>
         <language value="en"/>
         <value value="Ramucirumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramucirumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C05A"/>
      <designation>
         <language value="en"/>
         <value value="Agents for treatment of hemorrhoids and anal fissures for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av hemoroider og anale fissurer til lokal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AB10"/>
      <designation>
         <language value="en"/>
         <value value="Staphylococcus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stafylokokkus"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE12"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX14"/>
      <designation>
         <language value="en"/>
         <value value="Tianeptine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tianeptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX07"/>
      <designation>
         <language value="en"/>
         <value value="Zofenopril and nebivolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zofenopril og nebivolol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB02"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (beef)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (storfe)"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CX99"/>
      <designation>
         <language value="en"/>
         <value value="Other mineral products, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse mineralmidler, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB12"/>
      <designation>
         <language value="en"/>
         <value value="Cidofovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cidofovir"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC04"/>
      <designation>
         <language value="en"/>
         <value value="Ethisterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etisteron"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF06"/>
      <designation>
         <language value="en"/>
         <value value="Iproclozide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iproklozid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA53"/>
      <designation>
         <language value="en"/>
         <value value="Famotidine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Famotidin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Framycetin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Framycetin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH"/>
      <designation>
         <language value="en"/>
         <value value="Dipeptidyl peptidase 4 (DPP-4) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dipepitidylpeptidase 4-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EK03"/>
      <designation>
         <language value="en"/>
         <value value="Tivozanib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tivozanib"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC11"/>
      <designation>
         <language value="en"/>
         <value value="Deltamethrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deltametrin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Etidronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etidronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AG02"/>
      <designation>
         <language value="en"/>
         <value value="Moclobemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moklobemid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Doxycycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksysyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB04"/>
      <designation>
         <language value="en"/>
         <value value="Dihydroxialumini sodium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydroksyaluminiumnatriumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB05"/>
      <designation>
         <language value="en"/>
         <value value="Fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BB02"/>
      <designation>
         <language value="en"/>
         <value value="Electrolytes with carbohydrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter med karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD11"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and linagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og linagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA06"/>
      <designation>
         <language value="en"/>
         <value value="Phenylephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylefrin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD01"/>
      <designation>
         <language value="en"/>
         <value value="Measles, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslinger, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51CE"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase sensitive penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamaseresistente penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB"/>
      <designation>
         <language value="en"/>
         <value value="Glucocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukokortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB04"/>
      <designation>
         <language value="en"/>
         <value value="Methylprednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylprednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC06"/>
      <designation>
         <language value="en"/>
         <value value="Diflucortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflukortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC"/>
      <designation>
         <language value="en"/>
         <value value="Platelet aggregation inhibitors excl. heparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hemmere av blodplateaggregasjonen, ekskl. heparin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA03"/>
      <designation>
         <language value="en"/>
         <value value="Promazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Promazin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD52"/>
      <designation>
         <language value="en"/>
         <value value="Promethazine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prometazin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH04"/>
      <designation>
         <language value="en"/>
         <value value="Belinostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belinostat"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AX01"/>
      <designation>
         <language value="en"/>
         <value value="Pilocarpine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pilokarpin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD"/>
      <designation>
         <language value="en"/>
         <value value="Iron in combination with folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern i kombinasjon med folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX"/>
      <designation>
         <language value="en"/>
         <value value="Other antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC03"/>
      <designation>
         <language value="en"/>
         <value value="Fludroxycortide and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fludroksykortid og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="B05CX"/>
      <designation>
         <language value="en"/>
         <value value="Other irrigating solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre skyllevæsker"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX01"/>
      <designation>
         <language value="en"/>
         <value value="Simvastatin and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simvastatin og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM02"/>
      <designation>
         <language value="en"/>
         <value value="Clomethiazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klometiazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB04"/>
      <designation>
         <language value="en"/>
         <value value="Cefazolin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX17"/>
      <designation>
         <language value="en"/>
         <value value="Ketotifen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketotifen"/>
      </designation>
   </concept>
   <concept>
      <code value="P02DA01"/>
      <designation>
         <language value="en"/>
         <value value="Niclosamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Niklosamid"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Isoflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isofluran"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA09"/>
      <designation>
         <language value="en"/>
         <value value="Vancomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vankomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DB01"/>
      <designation>
         <language value="en"/>
         <value value="Diltiazem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diltiazem"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BB51"/>
      <designation>
         <language value="en"/>
         <value value="Phenazone, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenazon, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB07"/>
      <designation>
         <language value="en"/>
         <value value="Ioversol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Joversol"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL03"/>
      <designation>
         <language value="en"/>
         <value value="Vilanterol and umeclidinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vilanterol og umeklidiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CB02"/>
      <designation>
         <language value="en"/>
         <value value="Octreotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oktreotid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF05"/>
      <designation>
         <language value="en"/>
         <value value="Iproniazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iproniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX09"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AD03"/>
      <designation>
         <language value="en"/>
         <value value="Aciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs), other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs), andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs), plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs), usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05"/>
      <designation>
         <language value="en"/>
         <value value="Blood substitutes and perfusion solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodsubstitutter og infusjonsløsninger ol."/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC"/>
      <designation>
         <language value="en"/>
         <value value="Somatropin and somatropin agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somatropin og somatropinagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Grass pollen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gresspollen"/>
      </designation>
   </concept>
   <concept>
      <code value="D11A"/>
      <designation>
         <language value="en"/>
         <value value="Other dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Doxycycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksysyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA05"/>
      <designation>
         <language value="en"/>
         <value value="Pentaerithrityl tetranitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentaeritrityltetranitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BB03"/>
      <designation>
         <language value="en"/>
         <value value="Trometamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trometamol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC52"/>
      <designation>
         <language value="en"/>
         <value value="Cefuroxime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefuroksim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB04"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ02"/>
      <designation>
         <language value="en"/>
         <value value="Liraglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Liraglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="M03CA01"/>
      <designation>
         <language value="en"/>
         <value value="Dantrolene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dantrolen"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA08"/>
      <designation>
         <language value="en"/>
         <value value="Dexetimide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksetimid"/>
      </designation>
   </concept>
   <concept>
      <code value="QC04"/>
      <designation>
         <language value="en"/>
         <value value="Peripheral vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifere kardilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC03"/>
      <designation>
         <language value="en"/>
         <value value="Chloropyramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorpyramin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AF01"/>
      <designation>
         <language value="en"/>
         <value value="Carbamazepine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbamazepin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB31"/>
      <designation>
         <language value="en"/>
         <value value="Prussian blue"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyanidblått"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX63"/>
      <designation>
         <language value="en"/>
         <value value="Nitrous oxide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dinitrogenoksid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Vasopressin (argipressin)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vasopressin (argipressin)"/>
      </designation>
   </concept>
   <concept>
      <code value="D05"/>
      <designation>
         <language value="en"/>
         <value value="Antipsoriatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antipsoriasismidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CA23"/>
      <designation>
         <language value="en"/>
         <value value="Penbutolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penbutolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AD01"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB13"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB13"/>
      <designation>
         <language value="en"/>
         <value value="Bevonium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bevon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD07"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and sitagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og sitagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX36"/>
      <designation>
         <language value="en"/>
         <value value="Oblimersen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oblimersen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03A"/>
      <designation>
         <language value="en"/>
         <value value="Hormonal contraceptives for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikonseptiva, hormoner, systemiske"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Avian infectious bursal (Gumboro) disease virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fuglebursalsykdomsvirus (Gumboro), infeksiøs"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC03"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB07"/>
      <designation>
         <language value="en"/>
         <value value="Cefatrizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefatrizin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AG06"/>
      <designation>
         <language value="en"/>
         <value value="Oxyclozanide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyklozanid"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX"/>
      <designation>
         <language value="en"/>
         <value value="Lipid modifying agents in combination with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lipidmodifiserende midler i kombinasjon med andre legemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB05"/>
      <designation>
         <language value="en"/>
         <value value="Enoxaparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enoksaparin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB09"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA03"/>
      <designation>
         <language value="en"/>
         <value value="Ethisterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etisteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX02"/>
      <designation>
         <language value="en"/>
         <value value="Levocabastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levokabastin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AA"/>
      <designation>
         <language value="en"/>
         <value value="Mineralocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mineralkortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AD"/>
      <designation>
         <language value="en"/>
         <value value="Phosphonic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfonsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R07"/>
      <designation>
         <language value="en"/>
         <value value="Other respiratory system products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på respirasjonssystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents against amoebiasis and other protozoal diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot amøbesykdommer og andre protozosykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC03"/>
      <designation>
         <language value="en"/>
         <value value="Cefamandole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefamandol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE51"/>
      <designation>
         <language value="en"/>
         <value value="Latanoprost and netarsudil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Latanoprost og netarsudil"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FG"/>
      <designation>
         <language value="en"/>
         <value value="VEGF/VEGFR (Vascular endothelial growth factor) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="VEGF/VEGFR (Vaskulær endotel vekstfaktor) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C03XA02"/>
      <designation>
         <language value="en"/>
         <value value="Conivaptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Konivaptan"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX05"/>
      <designation>
         <language value="en"/>
         <value value="Eltrombopag"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eltrombopag"/>
      </designation>
   </concept>
   <concept>
      <code value="C"/>
      <designation>
         <language value="en"/>
         <value value="Cardiovascular system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerte og kretsløp"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD"/>
      <designation>
         <language value="en"/>
         <value value="Calcitonin gene-related peptide (CGRP) antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsitonin-genrelatert peptid (CGRP) antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09AX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX13"/>
      <designation>
         <language value="en"/>
         <value value="Dimethyl sulfoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetylsulfoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA05"/>
      <designation>
         <language value="en"/>
         <value value="Propranolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propranolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="D07C"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LK"/>
      <designation>
         <language value="en"/>
         <value value="Alkaloids, excl. rauwolfia, in combination with diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkaloider, ekskl. rauwolfia, kombinasjoner med diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="V09CA"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD54"/>
      <designation>
         <language value="en"/>
         <value value="Measles, combinations with mumps, rubella and varicella, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslinger, kombinasjoner med kusma, rubella og varicella, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX31"/>
      <designation>
         <language value="en"/>
         <value value="Lenacapavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lenakapavir"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XD"/>
      <designation>
         <language value="en"/>
         <value value="Sensitizers used in photodynamic/radiation therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aktiverende midler til fotodynamisk- og stråleterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB09"/>
      <designation>
         <language value="en"/>
         <value value="Dibekacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dibekacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP01"/>
      <designation>
         <language value="en"/>
         <value value="Ribavirin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ribavirin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED07"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamerazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfamerazin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AB"/>
      <designation>
         <language value="en"/>
         <value value="Thyrotropin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyrotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AX01"/>
      <designation>
         <language value="en"/>
         <value value="Defibrotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Defibrotid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG04"/>
      <designation>
         <language value="en"/>
         <value value="Belimumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belimumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01CA01"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents and calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere og kalsiumkanalblokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA01"/>
      <designation>
         <language value="en"/>
         <value value="Verteporfin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Verteporfin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA09"/>
      <designation>
         <language value="en"/>
         <value value="Clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC"/>
      <designation>
         <language value="en"/>
         <value value="Triazole and tetrazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triazol- og tetrazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB04"/>
      <designation>
         <language value="en"/>
         <value value="Prilocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prilokain"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC14"/>
      <designation>
         <language value="en"/>
         <value value="Sarilumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sarilumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AR"/>
      <designation>
         <language value="en"/>
         <value value="Typhus (exanthematicus) vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Typhus (exanthermaticus) vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J06AA"/>
      <designation>
         <language value="en"/>
         <value value="Immune sera"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsera"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06A"/>
      <designation>
         <language value="en"/>
         <value value="Cat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katt"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC06"/>
      <designation>
         <language value="en"/>
         <value value="Thonzylamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tonzylamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09C"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II antagonists, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II antagonister, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX01"/>
      <designation>
         <language value="en"/>
         <value value="Minoxidil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Minoksidil"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX14"/>
      <designation>
         <language value="en"/>
         <value value="Histamine dihydrochloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Histamindihydroklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB01"/>
      <designation>
         <language value="en"/>
         <value value="Dydrogesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dydrogesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA08"/>
      <designation>
         <language value="en"/>
         <value value="Ethyl biscoumacetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etylbiskumacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC05"/>
      <designation>
         <language value="en"/>
         <value value="Lornoxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lornoksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA03"/>
      <designation>
         <language value="en"/>
         <value value="Norepinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noradrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC04"/>
      <designation>
         <language value="en"/>
         <value value="Sermorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sermorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AF02"/>
      <designation>
         <language value="en"/>
         <value value="Erythromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX14"/>
      <designation>
         <language value="en"/>
         <value value="Polatuzumab vedotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polatuzumabvedotin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE02"/>
      <designation>
         <language value="en"/>
         <value value="Ozanimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ozanimod"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA01"/>
      <designation>
         <language value="en"/>
         <value value="Erythropoietin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytropoietin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE09"/>
      <designation>
         <language value="en"/>
         <value value="Procaine benzylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokainbenzylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Trimetaphan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetafan"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX07"/>
      <designation>
         <language value="en"/>
         <value value="Sapropterin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sapropterin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD04"/>
      <designation>
         <language value="en"/>
         <value value="Canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundedistempervirus + hundeadenovirus + hundeparvovirus + hundeparainfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BX01"/>
      <designation>
         <language value="en"/>
         <value value="Tolcapone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolkapon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA03"/>
      <designation>
         <language value="en"/>
         <value value="Proxyphylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proksyfyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR09"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofovirdisoproksil, elvitegravir og kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AB02"/>
      <designation>
         <language value="en"/>
         <value value="Bethanechol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betanekol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01C"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory agents and antiinefectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske midler og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AC"/>
      <designation>
         <language value="en"/>
         <value value="Oxicams"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksikamer"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AA"/>
      <designation>
         <language value="en"/>
         <value value="Ethers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etere"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Neomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11EC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex with minerals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks med mineraler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BC10"/>
      <designation>
         <language value="en"/>
         <value value="Nepafenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nepafenak"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CB02"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB16"/>
      <designation>
         <language value="en"/>
         <value value="Remdesivir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Remdesivir"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CB05"/>
      <designation>
         <language value="en"/>
         <value value="Pasireotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pasireotid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX02"/>
      <designation>
         <language value="en"/>
         <value value="Repaglinide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Repaglinid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AE51"/>
      <designation>
         <language value="en"/>
         <value value="Cholera, combinations with typhoid vaccine, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolera, kombinasjoner med tyfoid vaksine, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA"/>
      <designation>
         <language value="en"/>
         <value value="H2-receptor antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="H2-reseptorantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BX03"/>
      <designation>
         <language value="en"/>
         <value value="Strontium ranelate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Strontiumranelat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD51"/>
      <designation>
         <language value="en"/>
         <value value="Cefotaxime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefotaksim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03BA01"/>
      <designation>
         <language value="en"/>
         <value value="Cyanocobalamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyanokobalamin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA07"/>
      <designation>
         <language value="en"/>
         <value value="Estrone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østron"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Triaziquone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triazikon"/>
      </designation>
   </concept>
   <concept>
      <code value="A04A"/>
      <designation>
         <language value="en"/>
         <value value="Antiemetics and antinauseants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AH03"/>
      <designation>
         <language value="en"/>
         <value value="Naloxegol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naloksegol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DF51"/>
      <designation>
         <language value="en"/>
         <value value="Aztreonam and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aztreonam og betalaktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF05"/>
      <designation>
         <language value="en"/>
         <value value="Flucloxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flukloksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF12"/>
      <designation>
         <language value="en"/>
         <value value="Clevudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klevudin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF07"/>
      <designation>
         <language value="en"/>
         <value value="Deucravacitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deukravacitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XE02"/>
      <designation>
         <language value="en"/>
         <value value="Nifurtoinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nifurtoinol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX09"/>
      <designation>
         <language value="en"/>
         <value value="Azatadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azatadin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX01"/>
      <designation>
         <language value="en"/>
         <value value="Tilidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tilidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AG04"/>
      <designation>
         <language value="en"/>
         <value value="Hydromorphone and antispasmodics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydromorfon og spasmolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA01"/>
      <designation>
         <language value="en"/>
         <value value="Reserpine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reserpin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC10"/>
      <designation>
         <language value="en"/>
         <value value="Carbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AC"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinsyre og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AD01"/>
      <designation>
         <language value="en"/>
         <value value="Brucella antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brucellaantigen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB02"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone butyrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortisonbutyrat"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA02"/>
      <designation>
         <language value="en"/>
         <value value="Dipivefrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dipivefrin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA04"/>
      <designation>
         <language value="en"/>
         <value value="Rauwolfia alkaloids, whole root"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider, hel rot"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA19"/>
      <designation>
         <language value="en"/>
         <value value="Calcium gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC25"/>
      <designation>
         <language value="en"/>
         <value value="Cangrelor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kangrelor"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BM01"/>
      <designation>
         <language value="en"/>
         <value value="Papillomavirus (human types 6, 11, 16, 18)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papillomavirus (human type 6,11,16,18)"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01FA95"/>
      <designation>
         <language value="en"/>
         <value value="Gamithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gamitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for local oral treatment"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til lokal behandling i munnen"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08A"/>
      <designation>
         <language value="en"/>
         <value value="Antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA12"/>
      <designation>
         <language value="en"/>
         <value value="Fluindione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluindion"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EC02"/>
      <designation>
         <language value="en"/>
         <value value="Dabrafenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dabrafenib"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AD"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics, local"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AC02"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC01"/>
      <designation>
         <language value="en"/>
         <value value="Triclabendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triklabendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AF01"/>
      <designation>
         <language value="en"/>
         <value value="Phoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Foksim"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH05"/>
      <designation>
         <language value="en"/>
         <value value="Dupilumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dupilumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA24"/>
      <designation>
         <language value="en"/>
         <value value="Bentazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bentazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC"/>
      <designation>
         <language value="en"/>
         <value value="Second-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre generasjon cefalosporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BE01"/>
      <designation>
         <language value="en"/>
         <value value="Buspirone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buspiron"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD13"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor X"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor X"/>
      </designation>
   </concept>
   <concept>
      <code value="J04B"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of lepra"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av lepra"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA09"/>
      <designation>
         <language value="en"/>
         <value value="Ofloxacin and ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ofloksacin og ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF03"/>
      <designation>
         <language value="en"/>
         <value value="Phenelzine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenelsin"/>
      </designation>
   </concept>
   <concept>
      <code value="V09GA01"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) sestamibi"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) sestamibi"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD03"/>
      <designation>
         <language value="en"/>
         <value value="Gemeprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemeprost"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA05"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN51AA01"/>
      <designation>
         <language value="en"/>
         <value value="Pentobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX12"/>
      <designation>
         <language value="en"/>
         <value value="Tafasitamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tafasitamab"/>
      </designation>
   </concept>
   <concept>
      <code value="QR05C"/>
      <designation>
         <language value="en"/>
         <value value="Expectorants, excl. combinations with cough suppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekspektorantia, ekskl. kombinasjoner med antitussiva"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD08"/>
      <designation>
         <language value="en"/>
         <value value="Cefixime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefiksim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB11"/>
      <designation>
         <language value="en"/>
         <value value="Pixantrone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piksantron"/>
      </designation>
   </concept>
   <concept>
      <code value="G04C"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in benign prostatic hypertrophy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot benign prostatahyperplasi"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AB"/>
      <designation>
         <language value="en"/>
         <value value="Alkyl sulfonates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkylsulfonater"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB07"/>
      <designation>
         <language value="en"/>
         <value value="Alglucosidase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alglukosidase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD30"/>
      <designation>
         <language value="en"/>
         <value value="Thrombin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trombin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EA02"/>
      <designation>
         <language value="en"/>
         <value value="Brodimoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brodimoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA05"/>
      <designation>
         <language value="en"/>
         <value value="Oxymetholone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksymetolon"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE03"/>
      <designation>
         <language value="en"/>
         <value value="Siponimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Siponimod"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BA"/>
      <designation>
         <language value="en"/>
         <value value="Acidifiers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Surgjørende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB05"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium acetoacetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumacetoacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA"/>
      <designation>
         <language value="en"/>
         <value value="Natural opium alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiumsalkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB05"/>
      <designation>
         <language value="en"/>
         <value value="Cimetropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cimetropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CR02"/>
      <designation>
         <language value="en"/>
         <value value="Amoxicillin and enzyme inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amoksicillin og enzymhemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01A"/>
      <designation>
         <language value="en"/>
         <value value="Anesthestics, general"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Generelle anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA"/>
      <designation>
         <language value="en"/>
         <value value="Other plain vitamin preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre usammensatte vitaminmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N06CA01"/>
      <designation>
         <language value="en"/>
         <value value="Amitriptyline and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amitriptylin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="B05ZB"/>
      <designation>
         <language value="en"/>
         <value value="Hemofiltrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hemofiltrasjonsvæsker"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for equidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for hest"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA06"/>
      <designation>
         <language value="en"/>
         <value value="Chlorotrianisene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortrianisen"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03XA"/>
      <designation>
         <language value="en"/>
         <value value="Antigonadotropins and similar agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antigonadotropiner og lignende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX67"/>
      <designation>
         <language value="en"/>
         <value value="Tagraxofusp"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tagraksofusp"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX03"/>
      <designation>
         <language value="en"/>
         <value value="Methotrexate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metotreksat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD05"/>
      <designation>
         <language value="en"/>
         <value value="Ibutilide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibutilid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX12"/>
      <designation>
         <language value="en"/>
         <value value="Terfenadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terfenadin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG"/>
      <designation>
         <language value="en"/>
         <value value="Enemas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klystermidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX17"/>
      <designation>
         <language value="en"/>
         <value value="Stiripentol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stiripentol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03H"/>
      <designation>
         <language value="en"/>
         <value value="Anti-androgens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiandrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics and chemoterapeutics for dermatological use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika og kjemoterapeutika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AX03"/>
      <designation>
         <language value="en"/>
         <value value="Ataluren"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ataluren"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA05"/>
      <designation>
         <language value="en"/>
         <value value="Glycopyrronium bromide and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykopyrroniumbromid og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Oxyphenonium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyfenon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01ED"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX07"/>
      <designation>
         <language value="en"/>
         <value value="Oliceridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oliceridin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02B"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB04"/>
      <designation>
         <language value="en"/>
         <value value="Kanamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AD"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, very potent (group IV)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, ekstra sterke (gruppe IV)"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH05"/>
      <designation>
         <language value="en"/>
         <value value="Other meningococcal polyvalent purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre meningokokk polyvalent renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM09"/>
      <designation>
         <language value="en"/>
         <value value="Valerianae radix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valerianae radix"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK12"/>
      <designation>
         <language value="en"/>
         <value value="Salmeterol and budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salmeterol og budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="QG51"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives and antiseptics for intrauterine use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika til intrauterin bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BF02"/>
      <designation>
         <language value="en"/>
         <value value="Miglitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Miglitol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX23"/>
      <designation>
         <language value="en"/>
         <value value="Brivaracetam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brivaracetam"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB03"/>
      <designation>
         <language value="en"/>
         <value value="Fluorometholone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorometolon og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="G04"/>
      <designation>
         <language value="en"/>
         <value value="Urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urologika"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07AC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent (group III)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke (gruppe III)"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC"/>
      <designation>
         <language value="en"/>
         <value value="Dopamine agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopaminagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AA14"/>
      <designation>
         <language value="en"/>
         <value value="Lipegfilgrastim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lipegfilgrastim"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH03"/>
      <designation>
         <language value="en"/>
         <value value="Saxagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saksagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB09"/>
      <designation>
         <language value="en"/>
         <value value="Iodixanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jodiksanol"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC27"/>
      <designation>
         <language value="en"/>
         <value value="Selexipag"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Seleksipag"/>
      </designation>
   </concept>
   <concept>
      <code value="A11A"/>
      <designation>
         <language value="en"/>
         <value value="Multivitamins, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multivitaminer, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX11"/>
      <designation>
         <language value="en"/>
         <value value="Tedizolid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tedizolid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BE01"/>
      <designation>
         <language value="en"/>
         <value value="Mumps, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kusma, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB02"/>
      <designation>
         <language value="en"/>
         <value value="Methylatropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylatropin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AG03"/>
      <designation>
         <language value="en"/>
         <value value="Pethidine and antispasmodics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Petidin og spasmolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="S02B"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BB01"/>
      <designation>
         <language value="en"/>
         <value value="Demoxytocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Demoksytocin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX01"/>
      <designation>
         <language value="en"/>
         <value value="Tioctic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioktinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA08"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrocodeine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrokodein"/>
      </designation>
   </concept>
   <concept>
      <code value="J01C"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactam antibacterials, penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktam antibakterielle midler, penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA01"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA54"/>
      <designation>
         <language value="en"/>
         <value value="Eprinomectin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eprinomektin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG02"/>
      <designation>
         <language value="en"/>
         <value value="Formestane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formestan"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX09"/>
      <designation>
         <language value="en"/>
         <value value="Mepolizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepolizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CC02"/>
      <designation>
         <language value="en"/>
         <value value="Cetrorelix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cetroreliks"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA14"/>
      <designation>
         <language value="en"/>
         <value value="Pinazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pinazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AE15"/>
      <designation>
         <language value="en"/>
         <value value="Terbinafine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbinafin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA"/>
      <designation>
         <language value="en"/>
         <value value="Ergot alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekalealkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB02"/>
      <designation>
         <language value="en"/>
         <value value="Dexchlorpheniramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksklorfeniramin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA02"/>
      <designation>
         <language value="en"/>
         <value value="Pyridoxine (vit B6)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyridoksin (vit B6)"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF08"/>
      <designation>
         <language value="en"/>
         <value value="Ritlecitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ritlecitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE"/>
      <designation>
         <language value="en"/>
         <value value="Protease inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD01"/>
      <designation>
         <language value="en"/>
         <value value="Niceritrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikeritrol"/>
      </designation>
   </concept>
   <concept>
      <code value="V10XX03"/>
      <designation>
         <language value="en"/>
         <value value="Radium (223Ra) dichloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Radium (223Ra) diklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Ketamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketamin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Nimorazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nimorazol"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Procaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokain"/>
      </designation>
   </concept>
   <concept>
      <code value="D03A"/>
      <designation>
         <language value="en"/>
         <value value="Cicatrizants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sårhelende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL11"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol, glycopyrronium bromide and budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol, glykopyrroniumbromid og budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BX01"/>
      <designation>
         <language value="en"/>
         <value value="Metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BG"/>
      <designation>
         <language value="en"/>
         <value value="Thiazolidinediones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazolidindioner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA04"/>
      <designation>
         <language value="en"/>
         <value value="Methoserpidine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoserpidin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD05"/>
      <designation>
         <language value="en"/>
         <value value="Eptinezumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eptinezumab"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE14"/>
      <designation>
         <language value="en"/>
         <value value="Ciclopirox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklopiroks"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB08"/>
      <designation>
         <language value="en"/>
         <value value="Celiprolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Celiprolol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA21"/>
      <designation>
         <language value="en"/>
         <value value="Mercaptamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Merkaptamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX17"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and ramipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og ramipril"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Somatropin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somatropin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL08"/>
      <designation>
         <language value="en"/>
         <value value="Lisocabtagene maraleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisokabtagenmaraleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05B"/>
      <designation>
         <language value="en"/>
         <value value="I.v. solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infusjonsløsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC04"/>
      <designation>
         <language value="en"/>
         <value value="Tolonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AE"/>
      <designation>
         <language value="en"/>
         <value value="Other antifungals for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre fungicider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX"/>
      <designation>
         <language value="en"/>
         <value value="Other protein kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre proteinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA"/>
      <designation>
         <language value="en"/>
         <value value="Paramagnetic contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paramagnetiske kontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG10"/>
      <designation>
         <language value="en"/>
         <value value="Inebilizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inebilizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA07"/>
      <designation>
         <language value="en"/>
         <value value="Nisoldipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nisoldipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A08A"/>
      <designation>
         <language value="en"/>
         <value value="Antiobesity preparations, excl. diet products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot fedme, ekskl. diettmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB07"/>
      <designation>
         <language value="en"/>
         <value value="Opinercept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opinercept"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AE03"/>
      <designation>
         <language value="en"/>
         <value value="Ketoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Otilonium bromide and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Otiloniumbromid og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA04"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03A"/>
      <designation>
         <language value="en"/>
         <value value="Antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC10"/>
      <designation>
         <language value="en"/>
         <value value="Mivacurium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mivakuriumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX03"/>
      <designation>
         <language value="en"/>
         <value value="BCG vaccine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="BCG vaksine"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB06"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD01"/>
      <designation>
         <language value="en"/>
         <value value="Erenumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erenumab"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC03"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR17"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine and tenofovir alafenamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin og tenofoviralafenamid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AG"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylbutylpiperidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylbutylpiperidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A16"/>
      <designation>
         <language value="en"/>
         <value value="Other alimentary tract and metabolism products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre fordøyelses- og stoffskiftemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N03A"/>
      <designation>
         <language value="en"/>
         <value value="Antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AL02"/>
      <designation>
         <language value="en"/>
         <value value="Feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + inactivated chlamydia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kattepanleukopenivirus / parvovirus + katterhinotrakeitittvirus + kattecalicivirus + klamydia, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BJ01"/>
      <designation>
         <language value="en"/>
         <value value="Rubella, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rubella, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DE"/>
      <designation>
         <language value="en"/>
         <value value="Fourth-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fjerde generasjon cefalasporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EE03"/>
      <designation>
         <language value="en"/>
         <value value="Binimetinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Binimetinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA17"/>
      <designation>
         <language value="en"/>
         <value value="Midodrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midodrin"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AB01"/>
      <designation>
         <language value="en"/>
         <value value="Hemin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hemin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BB02"/>
      <designation>
         <language value="en"/>
         <value value="Metamizole sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metamizolnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB24"/>
      <designation>
         <language value="en"/>
         <value value="Mavacamten"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mavakamten"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD11"/>
      <designation>
         <language value="en"/>
         <value value="Tenecteplase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenekteplase"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB11"/>
      <designation>
         <language value="en"/>
         <value value="Trimegestone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimegeston og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="A06A"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for constipation"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot forstoppelse"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE07"/>
      <designation>
         <language value="en"/>
         <value value="Clometocillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klometocillin"/>
      </designation>
   </concept>
   <concept>
      <code value="A"/>
      <designation>
         <language value="en"/>
         <value value="Alimentary tract and metabolism"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fordøyelsesorganer og stoffskifte"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxychloroquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksyklorokin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AL01"/>
      <designation>
         <language value="en"/>
         <value value="Pneumococcus, purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pneumokokk, renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC05"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Oxyphencyclimine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyfencyklimin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA30"/>
      <designation>
         <language value="en"/>
         <value value="Emepronium and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emepron og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX08"/>
      <designation>
         <language value="en"/>
         <value value="Darvadstrocel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darvadstrocel"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX22"/>
      <designation>
         <language value="en"/>
         <value value="Agomelatine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Agomelatin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB19"/>
      <designation>
         <language value="en"/>
         <value value="Timepidium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timepidiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Chlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD04"/>
      <designation>
         <language value="en"/>
         <value value="Chicken anaemia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kyllinganemi"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA"/>
      <designation>
         <language value="en"/>
         <value value="Nitrogen mustard analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sennepsgassanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX05"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril and bisoprolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril og bisoprolol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE"/>
      <designation>
         <language value="en"/>
         <value value="Indole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BX12"/>
      <designation>
         <language value="en"/>
         <value value="Bismuth subnitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vismut subnitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="R01B"/>
      <designation>
         <language value="en"/>
         <value value="Nasal  decongestants for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rhinologika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A14"/>
      <designation>
         <language value="en"/>
         <value value="Anabolic agents for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anabole midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX05"/>
      <designation>
         <language value="en"/>
         <value value="Pirfenidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pirfenidon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA"/>
      <designation>
         <language value="en"/>
         <value value="Penicillins with extended spectrum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicilliner med utvidet spekter"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA51"/>
      <designation>
         <language value="en"/>
         <value value="Cyanocobalamin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyanokobalamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CA03"/>
      <designation>
         <language value="en"/>
         <value value="Piretanide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piretanid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA11"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB04"/>
      <designation>
         <language value="en"/>
         <value value="Aurothioglucose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aurotioglukose"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DX12"/>
      <designation>
         <language value="en"/>
         <value value="Molsidomine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Molsidomin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antivirals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antivirale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA32"/>
      <designation>
         <language value="en"/>
         <value value="Apremilast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apremilast"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ordinary salt combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ordinære saltkombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC11"/>
      <designation>
         <language value="en"/>
         <value value="Tulobuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tulobuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BA05"/>
      <designation>
         <language value="en"/>
         <value value="Pralatrexate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pralatreksat"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02AA"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KD01"/>
      <designation>
         <language value="en"/>
         <value value="Ketanserin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketanserin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB05"/>
      <designation>
         <language value="en"/>
         <value value="Aclidinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aklidiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Demeclocycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Demeklosyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LN"/>
      <designation>
         <language value="en"/>
         <value value="Serotonin antagonists and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Serotonin antagonister og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlordiazepoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klordiazepoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CJ02"/>
      <designation>
         <language value="en"/>
         <value value="Protirelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protirelin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD"/>
      <designation>
         <language value="en"/>
         <value value="Enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01CB02"/>
      <designation>
         <language value="en"/>
         <value value="Erysipelothrix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erysipelotriks"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA51"/>
      <designation>
         <language value="en"/>
         <value value="Cimetidine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cimetidin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL02"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol and ipratropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol og ipratropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX18"/>
      <designation>
         <language value="en"/>
         <value value="Reboxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reboksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX05"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxycarbamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksykarbamid"/>
      </designation>
   </concept>
   <concept>
      <code value="D10A"/>
      <designation>
         <language value="en"/>
         <value value="Anti-acne preparations for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot akne til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC"/>
      <designation>
         <language value="en"/>
         <value value="Carbonic anhydrase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karboanhydrasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX10"/>
      <designation>
         <language value="en"/>
         <value value="Finasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Finasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Tubocurarine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tubokurarin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AI"/>
      <designation>
         <language value="en"/>
         <value value="Live viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levende virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX11"/>
      <designation>
         <language value="en"/>
         <value value="Quizartinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvizartinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX01"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AJ03"/>
      <designation>
         <language value="en"/>
         <value value="Cetylpyridinium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cetylpyridin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Policresulen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polikresulen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX10"/>
      <designation>
         <language value="en"/>
         <value value="Masoprocol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Masoprokol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BX02"/>
      <designation>
         <language value="en"/>
         <value value="Sucralfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sukralfat"/>
      </designation>
   </concept>
   <concept>
      <code value="N07CA02"/>
      <designation>
         <language value="en"/>
         <value value="Cinnarizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinnarizin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AC"/>
      <designation>
         <language value="en"/>
         <value value="Iron chelating agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jernbindende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AA13"/>
      <designation>
         <language value="en"/>
         <value value="Dimetindene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetinden"/>
      </designation>
   </concept>
   <concept>
      <code value="QR07AB"/>
      <designation>
         <language value="en"/>
         <value value="Respiratory stimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Respirasjonsstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC12"/>
      <designation>
         <language value="en"/>
         <value value="Salmeterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salmeterol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX01"/>
      <designation>
         <language value="en"/>
         <value value="Azathioprine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azatioprin"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD05"/>
      <designation>
         <language value="en"/>
         <value value="Sulprostone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulproston"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH03"/>
      <designation>
         <language value="en"/>
         <value value="Panobinostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Panobinostat"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK02"/>
      <designation>
         <language value="en"/>
         <value value="Canagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH02"/>
      <designation>
         <language value="en"/>
         <value value="Meropenem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meropenem"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CA02"/>
      <designation>
         <language value="en"/>
         <value value="Betacarotene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betakaroten"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB08"/>
      <designation>
         <language value="en"/>
         <value value="Tridihexethyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tridiheksetyl"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD07"/>
      <designation>
         <language value="en"/>
         <value value="Temazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE30"/>
      <designation>
         <language value="en"/>
         <value value="Nirmatrelvir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nirmatrelvir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA04"/>
      <designation>
         <language value="en"/>
         <value value="Nicomorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikomorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA55"/>
      <designation>
         <language value="en"/>
         <value value="Palonosetron combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palonosetron, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens and estrogens, fixed combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener og østrogener, faste kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03AB96"/>
      <designation>
         <language value="en"/>
         <value value="Ropinirole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ropinirol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA06"/>
      <designation>
         <language value="en"/>
         <value value="Rociverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rociverin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB13"/>
      <designation>
         <language value="en"/>
         <value value="Asfotase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Asfotase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB07"/>
      <designation>
         <language value="en"/>
         <value value="Umeclidinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Umeklidiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GA02"/>
      <designation>
         <language value="en"/>
         <value value="Tetryzoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetryzolin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EF01"/>
      <designation>
         <language value="en"/>
         <value value="Palbociclib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palbociklib"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA05"/>
      <designation>
         <language value="en"/>
         <value value="Ursodoxicoltaurine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ursodoksikoltaurin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01ED51"/>
      <designation>
         <language value="en"/>
         <value value="Timolol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timolol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D02A"/>
      <designation>
         <language value="en"/>
         <value value="Emollients and protectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bløtgjørende og hudbeskyttende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Mebeverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebeverin"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfur containing products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svovelholdige midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD"/>
      <designation>
         <language value="en"/>
         <value value="Prostaglandins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prostaglandiner"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD"/>
      <designation>
         <language value="en"/>
         <value value="Combinations for eradication of Helicobacter pylori"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner for eradikering av Helicobacter pylori"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB01"/>
      <designation>
         <language value="en"/>
         <value value="Metrizamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metrizamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06BA90"/>
      <designation>
         <language value="en"/>
         <value value="Formosulfathiazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formosulfatiazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AC03"/>
      <designation>
         <language value="en"/>
         <value value="Ethadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etadion"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE04"/>
      <designation>
         <language value="en"/>
         <value value="Insulin glargine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin glargin"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA02"/>
      <designation>
         <language value="en"/>
         <value value="Granisetron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Granisetron"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Interferon gamma"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon gamma"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC08"/>
      <designation>
         <language value="en"/>
         <value value="Vonoprazan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vonoprazan"/>
      </designation>
   </concept>
   <concept>
      <code value="H02CA02"/>
      <designation>
         <language value="en"/>
         <value value="Osilodrostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Osilodrostat"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DA90"/>
      <designation>
         <language value="en"/>
         <value value="Proligeston"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proligeston"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ16"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol and celecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol og celekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AA"/>
      <designation>
         <language value="en"/>
         <value value="Antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB04"/>
      <designation>
         <language value="en"/>
         <value value="Homatropine methylbromide and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Homatropinmetylbromid og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QG01"/>
      <designation>
         <language value="en"/>
         <value value="Gynecological antiinfectives and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika til gynekologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BC03"/>
      <designation>
         <language value="en"/>
         <value value="Bezlotoxumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bezlotoksumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE01"/>
      <designation>
         <language value="en"/>
         <value value="Fingolimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fingolimod"/>
      </designation>
   </concept>
   <concept>
      <code value="H01"/>
      <designation>
         <language value="en"/>
         <value value="Pituitary and hypothalamic hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofyse- og hypothalamushormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for canidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for hund"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA03"/>
      <designation>
         <language value="en"/>
         <value value="Nilotinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nilotinib"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD12"/>
      <designation>
         <language value="en"/>
         <value value="Lactitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laktitol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC02"/>
      <designation>
         <language value="en"/>
         <value value="Dienestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AB05"/>
      <designation>
         <language value="en"/>
         <value value="Lesinurad"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lesinurad"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX29"/>
      <designation>
         <language value="en"/>
         <value value="Fostemsavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fostemsavir"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02A"/>
      <designation>
         <language value="en"/>
         <value value="Uterotonics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Uterotonika"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA58"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrocodeine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrokodein, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE01"/>
      <designation>
         <language value="en"/>
         <value value="Buclizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buklizin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AG01"/>
      <designation>
         <language value="en"/>
         <value value="Etoglucid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etoglucid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DA"/>
      <designation>
         <language value="en"/>
         <value value="Actinomycines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aktinomyciner"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BB"/>
      <designation>
         <language value="en"/>
         <value value="Retinoids for treatment of psoriasis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retinoider til behandling av psoriasis"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BA02"/>
      <designation>
         <language value="en"/>
         <value value="Menadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Menadion"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CR"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of penicillins, incl. beta-lactamase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av penicilliner, inkludert beta-laktamasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA"/>
      <designation>
         <language value="en"/>
         <value value="Esters of aminobenzoic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminobenzosyreestre"/>
      </designation>
   </concept>
   <concept>
      <code value="L02A"/>
      <designation>
         <language value="en"/>
         <value value="Hormones and related agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hormoner og beslektede substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Diazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB21"/>
      <designation>
         <language value="en"/>
         <value value="Clocortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klokortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Ferric proteinsuccinylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferriproteinsuksinylat"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other general anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre generelle anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in diabetes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til diabetesbehandling"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX05"/>
      <designation>
         <language value="en"/>
         <value value="Trazodone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trazodon"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Fibrinogen, human"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fibrinogen, human"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)glukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC08"/>
      <designation>
         <language value="en"/>
         <value value="Canakinumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanakinumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB03"/>
      <designation>
         <language value="en"/>
         <value value="Tolbutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolbutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CA"/>
      <designation>
         <language value="en"/>
         <value value="Penicillins with extended spectrum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicilliner med utvidet spekter"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX09"/>
      <designation>
         <language value="en"/>
         <value value="Mupirocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mupirocin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX14"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin, amlodipine and perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin, amlodipin og perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA17"/>
      <designation>
         <language value="en"/>
         <value value="Bopindolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bopindolol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG01"/>
      <designation>
         <language value="en"/>
         <value value="Valproic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valproinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB12"/>
      <designation>
         <language value="en"/>
         <value value="Nebivolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nebivolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD10"/>
      <designation>
         <language value="en"/>
         <value value="Drotrecogin alfa (activated)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Drotrekogin alfa (aktivert)"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB03"/>
      <designation>
         <language value="en"/>
         <value value="Chlormadinone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klormadinon og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD03"/>
      <designation>
         <language value="en"/>
         <value value="Trastuzumab emtansine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trastuzumabemtansin"/>
      </designation>
   </concept>
   <concept>
      <code value="QWITHOUT"/>
      <designation>
         <language value="en"/>
         <value value="Non-relevance"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke relevant"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA11"/>
      <designation>
         <language value="en"/>
         <value value="Clomocycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klomosyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD09"/>
      <designation>
         <language value="en"/>
         <value value="Cefodizime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefodizim"/>
      </designation>
   </concept>
   <concept>
      <code value="C05CX03"/>
      <designation>
         <language value="en"/>
         <value value="Hippocastani semen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hippocastani semen"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Nystatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nystatin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA04"/>
      <designation>
         <language value="en"/>
         <value value="Ranibizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ranibizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="H03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Carbimazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbimazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB10"/>
      <designation>
         <language value="en"/>
         <value value="Trandolapril and verapamil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trandolapril og verapamil"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DB04"/>
      <designation>
         <language value="en"/>
         <value value="Theophylline and adrenergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllin og adrenergika"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA01"/>
      <designation>
         <language value="en"/>
         <value value="Captopril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaptopril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX06"/>
      <designation>
         <language value="en"/>
         <value value="Tapentadol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tapentadol"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03A"/>
      <designation>
         <language value="en"/>
         <value value="All other therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antipsoriatics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre psoriasismidler til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Estriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østriol"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX11"/>
      <designation>
         <language value="en"/>
         <value value="Sodium benzoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumbenzoat"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EC01"/>
      <designation>
         <language value="en"/>
         <value value="Sulfasalazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfasalazin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01CX04"/>
      <designation>
         <language value="en"/>
         <value value="Miltefosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Miltefosin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AJ"/>
      <designation>
         <language value="en"/>
         <value value="Quaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvartære ammoniumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA02"/>
      <designation>
         <language value="en"/>
         <value value="Potassium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CF"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine related drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinlignende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB05"/>
      <designation>
         <language value="en"/>
         <value value="Fluperolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluperolon"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC02"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA54"/>
      <designation>
         <language value="en"/>
         <value value="Clemastine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klemastin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AF01"/>
      <designation>
         <language value="en"/>
         <value value="Bordetella + canine parainfluenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bordetella + hundeparainfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE10"/>
      <designation>
         <language value="en"/>
         <value value="Indoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AC"/>
      <designation>
         <language value="en"/>
         <value value="Ethers of tropine or tropine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etere av tropin eller tropinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BA01"/>
      <designation>
         <language value="en"/>
         <value value="Silver sulfadiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sølvsulfadiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX15"/>
      <designation>
         <language value="en"/>
         <value value="Telotristat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telotristat"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Sodium feredetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumferedetat"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AX"/>
      <designation>
         <language value="en"/>
         <value value="Other ectoparasiticides for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre ektoparasittiske midler for topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX08"/>
      <designation>
         <language value="en"/>
         <value value="Tyrothricin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyrotricin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Methylphenobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylfenobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin D and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin D og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA17"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone and estradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron og østradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA08"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="G02B"/>
      <designation>
         <language value="en"/>
         <value value="Contraceptives for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikonseptiva, for topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC15"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC09"/>
      <designation>
         <language value="en"/>
         <value value="Budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="A11DA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ08"/>
      <designation>
         <language value="en"/>
         <value value="Codeine and ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein og ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX05"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and ivabradine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og ivabradin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE09"/>
      <designation>
         <language value="en"/>
         <value value="Vardenafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vardenafil"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AC"/>
      <designation>
         <language value="en"/>
         <value value="Antiallergic agents, excl. corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiallergiske midler, ekskl. kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA04"/>
      <designation>
         <language value="en"/>
         <value value="Procyclidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Procyklidin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK02"/>
      <designation>
         <language value="en"/>
         <value value="Niraparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Niraparib"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01XX"/>
      <designation>
         <language value="en"/>
         <value value="Other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM"/>
      <designation>
         <language value="en"/>
         <value value="Other hypnotics and sedatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hypnotika og sedativa"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA04"/>
      <designation>
         <language value="en"/>
         <value value="Terlipressin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terlipressin"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Crizanlizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Krizanlizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK07"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BG"/>
      <designation>
         <language value="en"/>
         <value value="Other analgesics and antipyretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre analgetika og antipyretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC04"/>
      <designation>
         <language value="en"/>
         <value value="Flecainide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flekainid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE56"/>
      <designation>
         <language value="en"/>
         <value value="Naproxen and misoprostol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naproksen og misoprostol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03B"/>
      <designation>
         <language value="en"/>
         <value value="Androgens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Androgener"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB04"/>
      <designation>
         <language value="en"/>
         <value value="Glibornuride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glibornurid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AB03"/>
      <designation>
         <language value="en"/>
         <value value="Aeromonas + moritella + vibrio"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aeromonas + moritella + vibrio"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AC"/>
      <designation>
         <language value="en"/>
         <value value="Ethylene imines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etyleniminer"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH91"/>
      <designation>
         <language value="en"/>
         <value value="Robenacoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Robenakoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="A01"/>
      <designation>
         <language value="en"/>
         <value value="Stomatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Munn- og tannmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="J07C"/>
      <designation>
         <language value="en"/>
         <value value="Bacterial and viral vaccines, combined"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterie- og virusvaksiner, kombinert"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA11"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="R05FA02"/>
      <designation>
         <language value="en"/>
         <value value="Opium derivatives and expectorants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiumsderivater og ekspektorantia"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AG"/>
      <designation>
         <language value="en"/>
         <value value="Opioids in combination with antispasmodics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioider i kombinasjoner med spasmolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC02"/>
      <designation>
         <language value="en"/>
         <value value="Desoximetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desoksymetason"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB14"/>
      <designation>
         <language value="en"/>
         <value value="Pipenzolate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipenzolon"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EC"/>
      <designation>
         <language value="en"/>
         <value value="Aminosalicylic acid and similar agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosalisylsyre og lignende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE06"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadiazine and tetroxoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadiazin og tetroksoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA01"/>
      <designation>
         <language value="en"/>
         <value value="Alfuzosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfuzosin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB03"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol and nifedipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol og nifedipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AA02"/>
      <designation>
         <language value="en"/>
         <value value="Multienzymes (lipase, protease etc.)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multienzymer (Lipase, Protease etc.)"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB03"/>
      <designation>
         <language value="en"/>
         <value value="Ioxaglic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Joksaglinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="G02"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC58"/>
      <designation>
         <language value="en"/>
         <value value="Decitabine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Decitabin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="S01J"/>
      <designation>
         <language value="en"/>
         <value value="Diagnostic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diagnostika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD07"/>
      <designation>
         <language value="en"/>
         <value value="Dronedarone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dronedaron"/>
      </designation>
   </concept>
   <concept>
      <code value="N07C"/>
      <designation>
         <language value="en"/>
         <value value="Antivertigo preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivertigomidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX06"/>
      <designation>
         <language value="en"/>
         <value value="Mandelic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mandelsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BF04"/>
      <designation>
         <language value="en"/>
         <value value="Poliomyelitis oral, bivalent, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poliomyelitt oral, bivalent, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QL"/>
      <designation>
         <language value="en"/>
         <value value="Antineoplastic and immunomodulating agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineoplastiske og immunmodulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX27"/>
      <designation>
         <language value="en"/>
         <value value="Arsenic trioxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Arsentrioksid"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA55"/>
      <designation>
         <language value="en"/>
         <value value="Nifedipine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nifedipin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D08"/>
      <designation>
         <language value="en"/>
         <value value="Antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE13"/>
      <designation>
         <language value="en"/>
         <value value="Ibuproxam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibuproksam"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DB"/>
      <designation>
         <language value="en"/>
         <value value="Hydrazinophthalazine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrazinoftalazinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="V06DD"/>
      <designation>
         <language value="en"/>
         <value value="Amino acids, incl. combinations with polypeptides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosyrer, inkl. kombinasjoner med polypeptider"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BC"/>
      <designation>
         <language value="en"/>
         <value value="Hepatitis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hepatittvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX21"/>
      <designation>
         <language value="en"/>
         <value value="Naxitamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naksitamab"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN03"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19, inactivated virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19, inaktivert virus"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AX05"/>
      <designation>
         <language value="en"/>
         <value value="Isopropanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isopropanol"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, weak (group I)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, milde (gruppe I)"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA30"/>
      <designation>
         <language value="en"/>
         <value value="Potassium (different salts in combination)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalium, ulike salter i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA17"/>
      <designation>
         <language value="en"/>
         <value value="Levamlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levamlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01BB"/>
      <designation>
         <language value="en"/>
         <value value="Oxytocin and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytocin og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX08"/>
      <designation>
         <language value="en"/>
         <value value="Rezafungin acetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rezafunginacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BC01"/>
      <designation>
         <language value="en"/>
         <value value="Cocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kokain"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC16"/>
      <designation>
         <language value="en"/>
         <value value="Procaterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokaterol"/>
      </designation>
   </concept>
   <concept>
      <code value="H02BX"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA"/>
      <designation>
         <language value="en"/>
         <value value="Bile acids and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gallesyrer og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CE02"/>
      <designation>
         <language value="en"/>
         <value value="Sodium selenite"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumselenitt"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna and derivatives in combination with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonna og derivater i kombinasjon med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC"/>
      <designation>
         <language value="en"/>
         <value value="Selective beta-2-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive beta-2-agonister"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA15"/>
      <designation>
         <language value="en"/>
         <value value="Chlormadinone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klormadinon og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA52"/>
      <designation>
         <language value="en"/>
         <value value="Tamsulosin and dutasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tamsulosin og dutasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL03"/>
      <designation>
         <language value="en"/>
         <value value="Axicabtagene ciloleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aksikabtagenciloleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG01"/>
      <designation>
         <language value="en"/>
         <value value="Nevirapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nevirapin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AF03"/>
      <designation>
         <language value="en"/>
         <value value="Thiopental"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiopental"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA08"/>
      <designation>
         <language value="en"/>
         <value value="Acetylcysteine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylcystein"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs) and calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs) og kalsiumkanal blokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Methyldopa (levorotatory)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldopa (venstredreiende)"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CC04"/>
      <designation>
         <language value="en"/>
         <value value="Linzagolix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linzagoliks"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX01"/>
      <designation>
         <language value="en"/>
         <value value="Smallpox vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koppevaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA14"/>
      <designation>
         <language value="en"/>
         <value value="Moxifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK04"/>
      <designation>
         <language value="en"/>
         <value value="Ertugliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ertugliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory and antirheumatic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske og antireumatiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED02"/>
      <designation>
         <language value="en"/>
         <value value="Ceritinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceritinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX66"/>
      <designation>
         <language value="en"/>
         <value value="Selinexor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selineksor"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB07"/>
      <designation>
         <language value="en"/>
         <value value="Ronifibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ronifibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA05"/>
      <designation>
         <language value="en"/>
         <value value="Trimebutine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimebutin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12"/>
      <designation>
         <language value="en"/>
         <value value="Mineral supplements"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mineraltilskudd"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA07"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and omega-3 fatty acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og omega-3 fettsyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA13"/>
      <designation>
         <language value="en"/>
         <value value="Norgestimate and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestimat og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC28"/>
      <designation>
         <language value="en"/>
         <value value="Limaprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Limaprost"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK04"/>
      <designation>
         <language value="en"/>
         <value value="Talazoparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talazoparib"/>
      </designation>
   </concept>
   <concept>
      <code value="H03BA"/>
      <designation>
         <language value="en"/>
         <value value="Thiouracils"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiouraciler"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DC"/>
      <designation>
         <language value="en"/>
         <value value="Pyrimidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrimidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX26"/>
      <designation>
         <language value="en"/>
         <value value="Mirvetuximab soravtansine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirvetuksimabsoravtansin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CB01"/>
      <designation>
         <language value="en"/>
         <value value="Finasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Finasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA03"/>
      <designation>
         <language value="en"/>
         <value value="Oxyphencyclimine and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyfencyklimin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Fosphenytoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfenytoin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX14"/>
      <designation>
         <language value="en"/>
         <value value="Iloperidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iloperidon"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other opioids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre opioider"/>
      </designation>
   </concept>
   <concept>
      <code value="V06DC01"/>
      <designation>
         <language value="en"/>
         <value value="Glucose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukose"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20CD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX11"/>
      <designation>
         <language value="en"/>
         <value value="Astemizole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Astemizol"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05XA05"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AX12"/>
      <designation>
         <language value="en"/>
         <value value="Glucosaminoglycan polysulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukosaminglykanpolysulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FY"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of monoclonal antibodies and antibody drug conjugates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av monoklonale antistoffer og antistoff-legemiddelkonjugater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD02"/>
      <designation>
         <language value="en"/>
         <value value="Docetaxel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Docetaksel"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC01"/>
      <designation>
         <language value="en"/>
         <value value="Allylestrenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allyløstrenol"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AX06"/>
      <designation>
         <language value="en"/>
         <value value="Mupirocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mupirocin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03B"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna and derivates, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonna og derivater, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX11"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin, amlodipine and perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin, amlodipin og perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AE"/>
      <designation>
         <language value="en"/>
         <value value="Iron in other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kombinasjoner med jern"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB10"/>
      <designation>
         <language value="en"/>
         <value value="Hexocyclium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksocyklum"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA10"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid-hepatitis A"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoid-hepatitt A"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AF02"/>
      <designation>
         <language value="en"/>
         <value value="Hexobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX02"/>
      <designation>
         <language value="en"/>
         <value value="Lysozyme"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lysosym"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Benzilone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzilon"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AC01"/>
      <designation>
         <language value="en"/>
         <value value="Ispaghula (psylla seeds)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ispaghula (loppefrø)"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09A"/>
      <designation>
         <language value="en"/>
         <value value="Pig"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svin"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AB"/>
      <designation>
         <language value="en"/>
         <value value="Preparations increasing uric acid excretion"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler som øker urinsyreutskillelsen"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA10"/>
      <designation>
         <language value="en"/>
         <value value="Rufloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rufloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC13"/>
      <designation>
         <language value="en"/>
         <value value="Clenbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klenbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="QM03BX"/>
      <designation>
         <language value="en"/>
         <value value="Other centrally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre sentralt virkende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BA02"/>
      <designation>
         <language value="en"/>
         <value value="Toremifene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toremifen"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ01"/>
      <designation>
         <language value="en"/>
         <value value="Eculizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekulizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG01"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B, purified antigen conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B, renset antigen konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF02"/>
      <designation>
         <language value="en"/>
         <value value="Pembrolizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pembrolizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AP03"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid, purified polysaccharide antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoid, renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AD01"/>
      <designation>
         <language value="en"/>
         <value value="Papaverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papaverin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC03"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (pork)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (svin)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX10"/>
      <designation>
         <language value="en"/>
         <value value="Olaratumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olaratumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BX03"/>
      <designation>
         <language value="en"/>
         <value value="Abiraterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abirateron"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51GA90"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrostreptomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrostreptomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03"/>
      <designation>
         <language value="en"/>
         <value value="Sex hormones and modulators of the genital system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kjønnshormoner og midler med effekt på genitalia"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CC02"/>
      <designation>
         <language value="en"/>
         <value value="Tienilic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tienilsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK09"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BA"/>
      <designation>
         <language value="en"/>
         <value value="Biguanides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biguanidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA17"/>
      <designation>
         <language value="en"/>
         <value value="Temocillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temocillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FY02"/>
      <designation>
         <language value="en"/>
         <value value="Nivolumab and relatlimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nivolumab og relatlimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX30"/>
      <designation>
         <language value="en"/>
         <value value="Sodium benzoate and sodium phenylacetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumbenzoat og fenylacetatnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA10"/>
      <designation>
         <language value="en"/>
         <value value="Norgestrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA02"/>
      <designation>
         <language value="en"/>
         <value value="Choline theophyllinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolinteofyllinat"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA"/>
      <designation>
         <language value="en"/>
         <value value="Centrally acting sympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sentralt virkende sympatomimetika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AG02"/>
      <designation>
         <language value="en"/>
         <value value="Pimozide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pimozid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC18"/>
      <designation>
         <language value="en"/>
         <value value="Risankizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risankizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX30"/>
      <designation>
         <language value="en"/>
         <value value="Beclamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beklamid"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF51"/>
      <designation>
         <language value="en"/>
         <value value="Rivaroxaban and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rivaroksaban og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AC01"/>
      <designation>
         <language value="en"/>
         <value value="Deferoxamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deferoksamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA01"/>
      <designation>
         <language value="en"/>
         <value value="Neostigmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neostigmin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB04"/>
      <designation>
         <language value="en"/>
         <value value="Osimertinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Osimertinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR24"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine, tenoforvir disoproxil and doravirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin, tenofovirdisoproksil og doravirin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB01"/>
      <designation>
         <language value="en"/>
         <value value="Sodium aurothiomalate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumaurotiomalat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL01"/>
      <designation>
         <language value="en"/>
         <value value="Fenoterol and ipratropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoterol og ipratropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AE01"/>
      <designation>
         <language value="en"/>
         <value value="Clonazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klonazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="C08GA"/>
      <designation>
         <language value="en"/>
         <value value="Calcium channel blockers and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumantagonister og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB04"/>
      <designation>
         <language value="en"/>
         <value value="Quinagolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinagolid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA03"/>
      <designation>
         <language value="en"/>
         <value value="Imipramine oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imipraminoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QB"/>
      <designation>
         <language value="en"/>
         <value value="Blood and blood forming organs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blod og bloddannende organer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX09"/>
      <designation>
         <language value="en"/>
         <value value="Daptomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daptomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52A"/>
      <designation>
         <language value="en"/>
         <value value="Anthelminitics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anthelmintika"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE57"/>
      <designation>
         <language value="en"/>
         <value value="Naproxen and diphenhydramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naproksen og difenhydramin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK01"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine and other drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin og andre midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Ketoconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketokonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="M01A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory and antirheumatic products, non-steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske og antireumatiske midler, ekskl. steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB02"/>
      <designation>
         <language value="en"/>
         <value value="Imiglucerase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imiglukerase"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA01"/>
      <designation>
         <language value="en"/>
         <value value="Tacrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Takrin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE07"/>
      <designation>
         <language value="en"/>
         <value value="Fosamprenavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosamprenavir"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CA"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropin-releasing hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropinfrisettende hormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC02"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA04"/>
      <designation>
         <language value="en"/>
         <value value="Enoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA01"/>
      <designation>
         <language value="en"/>
         <value value="Tobacco smoke"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tobakksrøyk"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX05"/>
      <designation>
         <language value="en"/>
         <value value="Pramlintide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pramlintid"/>
      </designation>
   </concept>
   <concept>
      <code value="H03A"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoideamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB52"/>
      <designation>
         <language value="en"/>
         <value value="Pethidine, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Petidin, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB51"/>
      <designation>
         <language value="en"/>
         <value value="Indometacin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indometacin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Digitalis leaves"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digitalisblad"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA06"/>
      <designation>
         <language value="en"/>
         <value value="Lanatoside C"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lanatosid C"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC23"/>
      <designation>
         <language value="en"/>
         <value value="Cilostazol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cilostazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD08"/>
      <designation>
         <language value="en"/>
         <value value="Canine parainfluenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundeparainfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB05"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="V10XX02"/>
      <designation>
         <language value="en"/>
         <value value="Ibritumomab tiuxetan (90Y)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibritumomabtiuksetan (90Y)"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AX09"/>
      <designation>
         <language value="en"/>
         <value value="Monepantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Monepantel"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01CA"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergic and dopaminergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenerge og dompaminerge midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL05"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and aclidinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og aklidiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD04"/>
      <designation>
         <language value="en"/>
         <value value="Oxybutynin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksybutynin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Lypressin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lypressin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC06"/>
      <designation>
         <language value="en"/>
         <value value="Estriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østriol"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB33"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxocobalamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksokobalamin"/>
      </designation>
   </concept>
   <concept>
      <code value="G01"/>
      <designation>
         <language value="en"/>
         <value value="Gynecological antiinfectives and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika til gynekologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A12C"/>
      <designation>
         <language value="en"/>
         <value value="Other mineral supplements"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre mineralmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA11"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous iodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)jodid"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CA03"/>
      <designation>
         <language value="en"/>
         <value value="Pindolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pindolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BG01"/>
      <designation>
         <language value="en"/>
         <value value="Troglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Troglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="B02A"/>
      <designation>
         <language value="en"/>
         <value value="Antifibrinolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antifibrinolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB12"/>
      <designation>
         <language value="en"/>
         <value value="Ceftezole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftezol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Pigeon paramyxovirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dueparamyksovirus"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC04"/>
      <designation>
         <language value="en"/>
         <value value="Lofexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lofeksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Chlormethine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klormetin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB06"/>
      <designation>
         <language value="en"/>
         <value value="Gestodene and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gestoden og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH52"/>
      <designation>
         <language value="en"/>
         <value value="Gemigliptin and rosuvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemigliptin og rosuvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51EA"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX16"/>
      <designation>
         <language value="en"/>
         <value value="Oportuzumab monatox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oportuzumab monatoks"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX26"/>
      <designation>
         <language value="en"/>
         <value value="Amenamevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amenamevir"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH05"/>
      <designation>
         <language value="en"/>
         <value value="Entinostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Entinostat"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, selektive"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CB"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin A and D in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin A og D i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51C"/>
      <designation>
         <language value="en"/>
         <value value="Classification"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klassifisering"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX29"/>
      <designation>
         <language value="en"/>
         <value value="Bilastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bilastin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BX02"/>
      <designation>
         <language value="en"/>
         <value value="Arterolane and piperaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Arterolan og piperakin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA13"/>
      <designation>
         <language value="en"/>
         <value value="Mebutizide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebutizid"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA53"/>
      <designation>
         <language value="en"/>
         <value value="Loperamide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loperamid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA01"/>
      <designation>
         <language value="en"/>
         <value value="Dihydroergotamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydroergotamin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX"/>
      <designation>
         <language value="en"/>
         <value value="Other immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA02"/>
      <designation>
         <language value="en"/>
         <value value="Darbepoetin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darbepoetin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="B05"/>
      <designation>
         <language value="en"/>
         <value value="Blood substitutes and perfusion solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodsubstitutter og infusjonsløsninger ol."/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD02"/>
      <designation>
         <language value="en"/>
         <value value="Trifluperidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trifluperidol"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA01"/>
      <designation>
         <language value="en"/>
         <value value="Potassium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AN01"/>
      <designation>
         <language value="en"/>
         <value value="Lithium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Litium"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA03"/>
      <designation>
         <language value="en"/>
         <value value="Trimazosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimazosin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CB"/>
      <designation>
         <language value="en"/>
         <value value="Somatostatin and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somatostatin og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AC01"/>
      <designation>
         <language value="en"/>
         <value value="Periciazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Periciazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA01"/>
      <designation>
         <language value="en"/>
         <value value="Ofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA08"/>
      <designation>
         <language value="en"/>
         <value value="Calcium glycerylphosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglyserylfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Diphenadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenadion"/>
      </designation>
   </concept>
   <concept>
      <code value="A12A"/>
      <designation>
         <language value="en"/>
         <value value="Calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="S01CB01"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA11"/>
      <designation>
         <language value="en"/>
         <value value="Indapamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indapamid"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC12"/>
      <designation>
         <language value="en"/>
         <value value="Bambuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bambuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA06"/>
      <designation>
         <language value="en"/>
         <value value="Brolucizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brolucizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA08"/>
      <designation>
         <language value="en"/>
         <value value="Heroin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heroin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB05"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BB71"/>
      <designation>
         <language value="en"/>
         <value value="Phenazone, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenazon, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AC90"/>
      <designation>
         <language value="en"/>
         <value value="Enilconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enilkonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlortetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA09"/>
      <designation>
         <language value="en"/>
         <value value="Textiles"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tekstiler"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE17"/>
      <designation>
         <language value="en"/>
         <value value="Dexketoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksketoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AF"/>
      <designation>
         <language value="en"/>
         <value value="Tetrahydropyrimidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrahydropyrimidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06"/>
      <designation>
         <language value="en"/>
         <value value="Antihistamines for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihistaminer til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AB02"/>
      <designation>
         <language value="en"/>
         <value value="Betaine hydrochloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betainhydroklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AL01"/>
      <designation>
         <language value="en"/>
         <value value="Bovine rotavirus + bovine coronavirus + escherichia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bovint rotavirus + bovint koronavirus + escherichia"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12C"/>
      <designation>
         <language value="en"/>
         <value value="Other mineral supplements"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre mineralmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54A"/>
      <designation>
         <language value="en"/>
         <value value="Macrocyclic lactones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrosykliske laktoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V04"/>
      <designation>
         <language value="en"/>
         <value value="Diagnostic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diagnostika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG05"/>
      <designation>
         <language value="en"/>
         <value value="Vedolizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vedolizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Tetracaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakain"/>
      </designation>
   </concept>
   <concept>
      <code value="G02A"/>
      <designation>
         <language value="en"/>
         <value value="Uterotonics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Uterotonika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL07"/>
      <designation>
         <language value="en"/>
         <value value="Levosulpiride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levosulpirid"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CA"/>
      <designation>
         <language value="en"/>
         <value value="Benzimidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzimidazol derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA07"/>
      <designation>
         <language value="en"/>
         <value value="Fluorometholone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorometolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA06"/>
      <designation>
         <language value="en"/>
         <value value="Trimipramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimipramin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07FA01"/>
      <designation>
         <language value="en"/>
         <value value="Lactic acid producing organisms"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melkesyreproduserende organismer"/>
      </designation>
   </concept>
   <concept>
      <code value="N06"/>
      <designation>
         <language value="en"/>
         <value value="Psychoanaleptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykoanaleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD08"/>
      <designation>
         <language value="en"/>
         <value value="Bismuth subcitrate, tetracycline and metronidazol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vismut subsitrat, tetrasyklin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX04"/>
      <designation>
         <language value="en"/>
         <value value="Simvastatin, acetylsalicylic acid and ramipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simvastatin, acetylsalisylsyre og ramipril"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AL01"/>
      <designation>
         <language value="en"/>
         <value value="Porcine parvovirus + erysipelothrix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svineparvovirus + erysipelothrix"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA06"/>
      <designation>
         <language value="en"/>
         <value value="Chlorphenoxamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorfenoksamin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE51"/>
      <designation>
         <language value="en"/>
         <value value="Ibuprofen, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibuprofen, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AX06"/>
      <designation>
         <language value="en"/>
         <value value="Potassium permanganate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumpermanganat"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CA01"/>
      <designation>
         <language value="en"/>
         <value value="Furosemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Furosemid"/>
      </designation>
   </concept>
   <concept>
      <code value="S03C"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FC01"/>
      <designation>
         <language value="en"/>
         <value value="Daratumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daratumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BX01"/>
      <designation>
         <language value="en"/>
         <value value="Halofuginone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halofuginon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF04"/>
      <designation>
         <language value="en"/>
         <value value="Avelumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avelumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA03"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH51"/>
      <designation>
         <language value="en"/>
         <value value="Fentanyl, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentanyl, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA31"/>
      <designation>
         <language value="en"/>
         <value value="Calcium pantothenate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumpantotenat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX07"/>
      <designation>
         <language value="en"/>
         <value value="Prothipendyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protipendyl"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB14"/>
      <designation>
         <language value="en"/>
         <value value="Protamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protamin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA24"/>
      <designation>
         <language value="en"/>
         <value value="Levonadifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonadifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC21"/>
      <designation>
         <language value="en"/>
         <value value="Ulobetasol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ulobetasol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD"/>
      <designation>
         <language value="en"/>
         <value value="Nitrosoureas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrosoureaforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX25"/>
      <designation>
         <language value="en"/>
         <value value="Mosunetuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mosunetuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BX04"/>
      <designation>
         <language value="en"/>
         <value value="Etelcalcetide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etelkalsetid"/>
      </designation>
   </concept>
   <concept>
      <code value="B05AA"/>
      <designation>
         <language value="en"/>
         <value value="Blood substitutes and plasma protein fractions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodsubstitutter og plasmaproteinfraksjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA13"/>
      <designation>
         <language value="en"/>
         <value value="Dirithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ15"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol and other non-opioid analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol og andre ikke-opioide analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03D"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs) and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs) og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA09"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone furoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikasonfuroat"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinsyre og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BX04"/>
      <designation>
         <language value="en"/>
         <value value="Denosumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Denosumab"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of levothyroxine and liothyronine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levotyroksin og liotyronin i kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX01"/>
      <designation>
         <language value="en"/>
         <value value="Moroxydine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moroksydin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX01"/>
      <designation>
         <language value="en"/>
         <value value="Indocyanine green"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indocyaningrønn"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX28"/>
      <designation>
         <language value="en"/>
         <value value="Bulevirtide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bulevirtid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA05"/>
      <designation>
         <language value="en"/>
         <value value="Polythiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polytiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA01"/>
      <designation>
         <language value="en"/>
         <value value="Cocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kokain"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XC"/>
      <designation>
         <language value="en"/>
         <value value="Selective estrogen receptor modulators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med selektiv østrogenreseptor modulerende effekt"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH95"/>
      <designation>
         <language value="en"/>
         <value value="Enflicoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enflikoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AF"/>
      <designation>
         <language value="en"/>
         <value value="Live bacterial and viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle og virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Fludrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fludrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB03"/>
      <designation>
         <language value="en"/>
         <value value="Tolmetin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolmetin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX21"/>
      <designation>
         <language value="en"/>
         <value value="Duloxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Duloksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Mercaptopurine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Merkaptopurin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11H"/>
      <designation>
         <language value="en"/>
         <value value="Other plain vitamin preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre usammensatte vitaminmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX01"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium hydroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumhydroksid"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BX02"/>
      <designation>
         <language value="en"/>
         <value value="Degarelix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Degareliks"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AX10"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Lomustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lomustin"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives and antiseptics for local oral treatment"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika til lokal behandling i munnen"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA09"/>
      <designation>
         <language value="en"/>
         <value value="Acefylline piperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acefyllinpiperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB"/>
      <designation>
         <language value="en"/>
         <value value="Nucleosides and nucleotides excl. reverse transcriptase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nukleosider og nukleotider ekskl. reverstranskriptase-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB06"/>
      <designation>
         <language value="en"/>
         <value value="Sertraline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sertralin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB14"/>
      <designation>
         <language value="en"/>
         <value value="Proglumetacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proglumetacin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM91"/>
      <designation>
         <language value="en"/>
         <value value="Medetomidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medetomidin"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX07"/>
      <designation>
         <language value="en"/>
         <value value="Gentamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gentamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BF02"/>
      <designation>
         <language value="en"/>
         <value value="Pregabalin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pregabalin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA04"/>
      <designation>
         <language value="en"/>
         <value value="Calcium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="QM"/>
      <designation>
         <language value="en"/>
         <value value="Musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muskler og skjelett"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA14"/>
      <designation>
         <language value="en"/>
         <value value="Sodium glycerophosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumglyserofosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB05"/>
      <designation>
         <language value="en"/>
         <value value="Betaxolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betaksolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA56"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06C"/>
      <designation>
         <language value="en"/>
         <value value="Psycholeptics and psychoanaleptics in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykoleptika og psykoanaleptika i kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA04"/>
      <designation>
         <language value="en"/>
         <value value="Nizatidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nizatidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06CA"/>
      <designation>
         <language value="en"/>
         <value value="Antidepressants in combination with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidepressiva i kombinasjon med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA02"/>
      <designation>
         <language value="en"/>
         <value value="Oxybuprocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksybuprokain"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD08"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikason"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC03"/>
      <designation>
         <language value="en"/>
         <value value="Zolmitriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zolmitriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA"/>
      <designation>
         <language value="en"/>
         <value value="Organic nitrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrater"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB58"/>
      <designation>
         <language value="en"/>
         <value value="Articaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artikain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD09"/>
      <designation>
         <language value="en"/>
         <value value="Avian infectious bursal disease virus (Gumboro disease)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fuglebursalsykdomsvirus (Gumboro), infeksiøs"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX72"/>
      <designation>
         <language value="en"/>
         <value value="Tazemetostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tazemetostat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB17"/>
      <designation>
         <language value="en"/>
         <value value="Ivabradine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivabradin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03GA"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA04"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02"/>
      <designation>
         <language value="en"/>
         <value value="Antihypertensives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihypertensiva"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AD02"/>
      <designation>
         <language value="en"/>
         <value value="Tacrolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Takrolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR06"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir disoproxil and efavirenz"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofovirdisoproksil og efavirenz"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Interferon alfa-2a"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon alfa-2a"/>
      </designation>
   </concept>
   <concept>
      <code value="S"/>
      <designation>
         <language value="en"/>
         <value value="Sensory organs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sanseorganer"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03AA"/>
      <designation>
         <language value="en"/>
         <value value="Barbiturates and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbiturater og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="S02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Boric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Borsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX17"/>
      <designation>
         <language value="en"/>
         <value value="Carfloglitazar"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karfloglitazar"/>
      </designation>
   </concept>
   <concept>
      <code value="QM05B"/>
      <designation>
         <language value="en"/>
         <value value="Drugs affecting bone structure and mineralization"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med effekt på benstruktur og mineralisering"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL04"/>
      <designation>
         <language value="en"/>
         <value value="Remoxipride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Remoksiprid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA05"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA13"/>
      <designation>
         <language value="en"/>
         <value value="Trovafloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trovafloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="D03"/>
      <designation>
         <language value="en"/>
         <value value="Preparations for treatment of wounds and ulcers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til sårbehandling"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA07"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)sulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BE03"/>
      <designation>
         <language value="en"/>
         <value value="Sarolaner"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sarolaner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD19"/>
      <designation>
         <language value="en"/>
         <value value="Linagliptin and empagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linagliptin og empagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL06"/>
      <designation>
         <language value="en"/>
         <value value="Veralipride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Veraliprid"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF"/>
      <designation>
         <language value="en"/>
         <value value="Direct factor Xa inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Direkte faktor Xa-inhibitorer"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AF01"/>
      <designation>
         <language value="en"/>
         <value value="Methohexital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoheksital"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB09"/>
      <designation>
         <language value="en"/>
         <value value="Butaperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butaperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA52"/>
      <designation>
         <language value="en"/>
         <value value="Donepezil and memantine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Donepezil og memantin"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Organo-heparinoid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Organo-heparinoid"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other emollients and protectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse bløtgjørende og hudbeskyttende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA09"/>
      <designation>
         <language value="en"/>
         <value value="Promestriene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Promestrien"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AC04"/>
      <designation>
         <language value="en"/>
         <value value="Colesevelam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolesevelam"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD06"/>
      <designation>
         <language value="en"/>
         <value value="Thiazinam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazinam"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC07"/>
      <designation>
         <language value="en"/>
         <value value="Guanoxabenz"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanoksabenz"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD04"/>
      <designation>
         <language value="en"/>
         <value value="Methdilazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metdilazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB10"/>
      <designation>
         <language value="en"/>
         <value value="Ribostamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ribostamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC05"/>
      <designation>
         <language value="en"/>
         <value value="Guanoclor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanoklor"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA02"/>
      <designation>
         <language value="en"/>
         <value value="Human menopausal gonadotrophin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Menopausegonadotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EC01"/>
      <designation>
         <language value="en"/>
         <value value="Vemurafenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vemurafenib"/>
      </designation>
   </concept>
   <concept>
      <code value="QL03AB"/>
      <designation>
         <language value="en"/>
         <value value="Interferons"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09CA07"/>
      <designation>
         <language value="en"/>
         <value value="Telmisartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telmisartan"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC01"/>
      <designation>
         <language value="en"/>
         <value value="Buprenorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buprenorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01A"/>
      <designation>
         <language value="en"/>
         <value value="Anterior pituitary lobe hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofyseforlapphormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA06"/>
      <designation>
         <language value="en"/>
         <value value="Eluxadoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eluksadolin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC01"/>
      <designation>
         <language value="en"/>
         <value value="Clonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Hydromorphone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydromorfon"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC01"/>
      <designation>
         <language value="en"/>
         <value value="Ergocalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ergokalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA08"/>
      <designation>
         <language value="en"/>
         <value value="Nitrendipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrendipin"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CF01"/>
      <designation>
         <language value="en"/>
         <value value="Ivermectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivermektin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Dicoumarol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dikumarol"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01FA"/>
      <designation>
         <language value="en"/>
         <value value="Macrolides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrolider"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AA"/>
      <designation>
         <language value="en"/>
         <value value="Enzyme preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX16"/>
      <designation>
         <language value="en"/>
         <value value="Plerixafor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pleriksafor"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Boric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Borsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BA10"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EB"/>
      <designation>
         <language value="en"/>
         <value value="High-ceiling diuretics and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="High-ceiling diuretika og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AG"/>
      <designation>
         <language value="en"/>
         <value value="Fenamates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenamater"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DX02"/>
      <designation>
         <language value="en"/>
         <value value="Ginkgo folium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ginkgo folium"/>
      </designation>
   </concept>
   <concept>
      <code value="A01A"/>
      <designation>
         <language value="en"/>
         <value value="Stomatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Munn- og tannmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA02"/>
      <designation>
         <language value="en"/>
         <value value="Imipramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imipramin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AE04"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BA"/>
      <designation>
         <language value="en"/>
         <value value="Psoralens for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psoralener til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB09"/>
      <designation>
         <language value="en"/>
         <value value="Cefradine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefradin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC06"/>
      <designation>
         <language value="en"/>
         <value value="Pipecuronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipekuroniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC01"/>
      <designation>
         <language value="en"/>
         <value value="Cytarabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cytarabin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB25"/>
      <designation>
         <language value="en"/>
         <value value="Olipudase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olipudase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB06"/>
      <designation>
         <language value="en"/>
         <value value="Carbutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA18"/>
      <designation>
         <language value="en"/>
         <value value="Pazufloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pazufloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX10"/>
      <designation>
         <language value="en"/>
         <value value="Benralizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benralizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BX04"/>
      <designation>
         <language value="en"/>
         <value value="Relugolix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Relugoliks"/>
      </designation>
   </concept>
   <concept>
      <code value="C07DB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective, thiazides and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, selektive, tiazider andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07"/>
      <designation>
         <language value="en"/>
         <value value="Vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AN01"/>
      <designation>
         <language value="en"/>
         <value value="Tuberculosis, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tuberkulose, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AD"/>
      <designation>
         <language value="en"/>
         <value value="Local anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM90"/>
      <designation>
         <language value="en"/>
         <value value="Detomidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Detomidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BX"/>
      <designation>
         <language value="en"/>
         <value value="Other local anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA04"/>
      <designation>
         <language value="en"/>
         <value value="Ammonium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ammoniumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA07"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KD"/>
      <designation>
         <language value="en"/>
         <value value="Serotonin antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Serotonin antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX08"/>
      <designation>
         <language value="en"/>
         <value value="Carbon monoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbonmonoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03A"/>
      <designation>
         <language value="en"/>
         <value value="Low-ceiling diuretics, thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Low-ceiling diuretika, tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX04"/>
      <designation>
         <language value="en"/>
         <value value="Neomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XD02"/>
      <designation>
         <language value="en"/>
         <value value="Tinidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tinidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA01"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX15"/>
      <designation>
         <language value="en"/>
         <value value="Xenon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xenon"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF04"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LE01"/>
      <designation>
         <language value="en"/>
         <value value="Prazosin and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazosin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG03"/>
      <designation>
         <language value="en"/>
         <value value="Efavirenz"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efavirenz"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AX10"/>
      <designation>
         <language value="en"/>
         <value value="Risdiplam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risdiplam"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BC"/>
      <designation>
         <language value="en"/>
         <value value="Local hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokale hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC15"/>
      <designation>
         <language value="en"/>
         <value value="Aloxiprin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aloksiprin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA19"/>
      <designation>
         <language value="en"/>
         <value value="Garenoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Garenoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE04"/>
      <designation>
         <language value="en"/>
         <value value="Azidocillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azidocillin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN"/>
      <designation>
         <language value="en"/>
         <value value="Nervous system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nervesystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB05"/>
      <designation>
         <language value="en"/>
         <value value="Paroxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paroksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CB03"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC01"/>
      <designation>
         <language value="en"/>
         <value value="Daclizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daklizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF08"/>
      <designation>
         <language value="en"/>
         <value value="Adefovir dipivoxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adefovirdipivoksil"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF03"/>
      <designation>
         <language value="en"/>
         <value value="Chlorprothixene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorprotiksen"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10A"/>
      <designation>
         <language value="en"/>
         <value value="Atlantic salmon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atlanterhavslaks"/>
      </designation>
   </concept>
   <concept>
      <code value="P02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Praziquantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazikvantel"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD03"/>
      <designation>
         <language value="en"/>
         <value value="Canine distemper virus + canine parvovirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundedistempervirus + hundeparvovirus"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BB03"/>
      <designation>
         <language value="en"/>
         <value value="Influenza, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Influensa, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antipruritics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kløemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC01"/>
      <designation>
         <language value="en"/>
         <value value="Mepyramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepyramin"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AA"/>
      <designation>
         <language value="en"/>
         <value value="Caries prophylactic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot karies"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD05"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor VII"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor VII"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AB"/>
      <designation>
         <language value="en"/>
         <value value="Enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK14"/>
      <designation>
         <language value="en"/>
         <value value="Indacaterol and mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indakaterol og mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA02"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB07"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium glycinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumglysinat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN05"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19, virus-like particles"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19, viruslignende partikler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AA04"/>
      <designation>
         <language value="en"/>
         <value value="Clomipramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klomipramin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03B"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B12 and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B12 og folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC12"/>
      <designation>
         <language value="en"/>
         <value value="Cefminox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefminoks"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AH09"/>
      <designation>
         <language value="en"/>
         <value value="Live feline rhinotracheitis virus + live feline panleucopenia virus / parvovirus + inactivated feline calicivirus antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus, levende + kattepanleukopenivirus / parvovirus, levende + kattecalicivirusantigen, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01"/>
      <designation>
         <language value="en"/>
         <value value="Antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB01"/>
      <designation>
         <language value="en"/>
         <value value="Isoprenaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoprenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA05"/>
      <designation>
         <language value="en"/>
         <value value="Roxadustat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Roksadustat"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sympatomiketika"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BA52"/>
      <designation>
         <language value="en"/>
         <value value="Carisoprodol, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karisoprodol, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="V06D"/>
      <designation>
         <language value="en"/>
         <value value="Other nutrients"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre nutrientia"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX28"/>
      <designation>
         <language value="en"/>
         <value value="Glofitamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glofitamab"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE05"/>
      <designation>
         <language value="en"/>
         <value value="Sucroferric oxyhydroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sukroferrioksihydroksid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA03"/>
      <designation>
         <language value="en"/>
         <value value="Metixene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metiksen"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AR01"/>
      <designation>
         <language value="en"/>
         <value value="Typhus exanthematicus, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Typhus exanthematicus, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="R05C"/>
      <designation>
         <language value="en"/>
         <value value="Expectorants, excl. combinations with cough suppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekspektorantia, ekskl. kombinasjoner med antitussiva"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB03"/>
      <designation>
         <language value="en"/>
         <value value="Alendronic acid and colecalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alendronsyre og kolekalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AF04"/>
      <designation>
         <language value="en"/>
         <value value="Eslicarbazepine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eslikarbazepin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BX53"/>
      <designation>
         <language value="en"/>
         <value value="Abiraterone and prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abirateron og prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N01B"/>
      <designation>
         <language value="en"/>
         <value value="Anesthestics, local"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA03"/>
      <designation>
         <language value="en"/>
         <value value="Cholic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP05"/>
      <designation>
         <language value="en"/>
         <value value="Simeprevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simeprevir"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC04"/>
      <designation>
         <language value="en"/>
         <value value="Dextropropoxyphene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstropropoksyfen"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD02"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous fumarate and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)fumarat og folinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE03"/>
      <designation>
         <language value="en"/>
         <value value="Bimatoprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bimatoprost"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AD02"/>
      <designation>
         <language value="en"/>
         <value value="Ulipristal"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ulipristal"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB08"/>
      <designation>
         <language value="en"/>
         <value value="Dienogest"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienogest"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AE01"/>
      <designation>
         <language value="en"/>
         <value value="Benzoyl peroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzoylperoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA"/>
      <designation>
         <language value="en"/>
         <value value="Avermectins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avermektiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03C"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika, midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="S01JA51"/>
      <designation>
         <language value="en"/>
         <value value="Fluorescein, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorescein, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX31"/>
      <designation>
         <language value="en"/>
         <value value="Quifenadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvifenadin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07AC16"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone aceponate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortisonaceponat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Alclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AB"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC20"/>
      <designation>
         <language value="en"/>
         <value value="Netakimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Netakimab"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC09"/>
      <designation>
         <language value="en"/>
         <value value="Lonapegsomatropin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lonapegsomatropin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Trimethadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetadion"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA57"/>
      <designation>
         <language value="en"/>
         <value value="Bietaserpine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bietaserpin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC08"/>
      <designation>
         <language value="en"/>
         <value value="Pirbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pirbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH01"/>
      <designation>
         <language value="en"/>
         <value value="Loxapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loksapin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX01"/>
      <designation>
         <language value="en"/>
         <value value="Tirilazad"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tirilazad"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XG02"/>
      <designation>
         <language value="en"/>
         <value value="Carfilzomib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karfilzomib"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB07"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC08"/>
      <designation>
         <language value="en"/>
         <value value="Loracarbef"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorakarbef"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR15"/>
      <designation>
         <language value="en"/>
         <value value="Atazanavir and cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atazanavir og kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX01"/>
      <designation>
         <language value="en"/>
         <value value="Guar gum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guargummi"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC21"/>
      <designation>
         <language value="en"/>
         <value value="Treprostinil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Treprostinil"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE02"/>
      <designation>
         <language value="en"/>
         <value value="Artemether"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemeter"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH05"/>
      <designation>
         <language value="en"/>
         <value value="Anileridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anileridin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX"/>
      <designation>
         <language value="en"/>
         <value value="Other blood glucose lowering drugs, excl. insulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre blodglukosesenkende midler, ekskl. insuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX01"/>
      <designation>
         <language value="en"/>
         <value value="Flucytosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flucytosin"/>
      </designation>
   </concept>
   <concept>
      <code value="R02A"/>
      <designation>
         <language value="en"/>
         <value value="Throat preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre utvortes midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB05"/>
      <designation>
         <language value="en"/>
         <value value="Insulin aspart"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin aspart"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR10"/>
      <designation>
         <language value="en"/>
         <value value="Lopinavir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lopinavir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX14"/>
      <designation>
         <language value="en"/>
         <value value="Esketamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Esketamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AC"/>
      <designation>
         <language value="en"/>
         <value value="Bile acid sequestrants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler som øker utskillelsen av gallesyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V06"/>
      <designation>
         <language value="en"/>
         <value value="General nutrients"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nutrientia"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA07"/>
      <designation>
         <language value="en"/>
         <value value="Theobromine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teobromin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB13"/>
      <designation>
         <language value="en"/>
         <value value="Talinolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talinolol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX10"/>
      <designation>
         <language value="en"/>
         <value value="Midostaurin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midostaurin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB08"/>
      <designation>
         <language value="en"/>
         <value value="Sevoflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sevofluran"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA11"/>
      <designation>
         <language value="en"/>
         <value value="Dimenhydrinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimenhydrinat"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG"/>
      <designation>
         <language value="en"/>
         <value value="Monoclonal antibodies"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Monoklonale antistoffer"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB17"/>
      <designation>
         <language value="en"/>
         <value value="Cortivazol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortivazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB01"/>
      <designation>
         <language value="en"/>
         <value value="Gefitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gefitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE08"/>
      <designation>
         <language value="en"/>
         <value value="Benzathine benzylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzatinbenzylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Deferiprone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deferipron"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM18"/>
      <designation>
         <language value="en"/>
         <value value="Dexmedetomidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksmedetomidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA03"/>
      <designation>
         <language value="en"/>
         <value value="Rivastigmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rivastigmin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA02"/>
      <designation>
         <language value="en"/>
         <value value="Dasatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dasatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D01B"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="M"/>
      <designation>
         <language value="en"/>
         <value value="Musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muskler og skjelett"/>
      </designation>
   </concept>
   <concept>
      <code value="C08G"/>
      <designation>
         <language value="en"/>
         <value value="Calcium channel blockers and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumantagonister og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C07F"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX02"/>
      <designation>
         <language value="en"/>
         <value value="Gemtuzumab ozogamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemtuzumabozogamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XA01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51RC"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactam antibacterials, penicillins, combinations with other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktam antibakterielle midler, penicilliner, i kombination med andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BG90"/>
      <designation>
         <language value="en"/>
         <value value="Frunevetmab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Frunevetmab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX05"/>
      <designation>
         <language value="en"/>
         <value value="Methenamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metenamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA01"/>
      <designation>
         <language value="en"/>
         <value value="Etilefrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etilefrin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04BX91"/>
      <designation>
         <language value="en"/>
         <value value="Phenylpropanolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylpropanolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BC"/>
      <designation>
         <language value="en"/>
         <value value="Xanthine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xantinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides and potassium in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider og kalium i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH04"/>
      <designation>
         <language value="en"/>
         <value value="Doripenem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doripenem"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB05"/>
      <designation>
         <language value="en"/>
         <value value="Tolazamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolazamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX14"/>
      <designation>
         <language value="en"/>
         <value value="Migalastat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Migalastat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL08"/>
      <designation>
         <language value="en"/>
         <value value="Vilanterol, umeclidinium bromide and fluticasone furoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vilanterol, umeklidiniumbromid og flutikasonfuroat"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA02"/>
      <designation>
         <language value="en"/>
         <value value="Felodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Felodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DC04"/>
      <designation>
         <language value="en"/>
         <value value="Ixabepilone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iksabepilon"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51FF02"/>
      <designation>
         <language value="en"/>
         <value value="Lincomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA57"/>
      <designation>
         <language value="en"/>
         <value value="Propatylnitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propatylnitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BB"/>
      <designation>
         <language value="en"/>
         <value value="Oxytocin and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytocin og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DE02"/>
      <designation>
         <language value="en"/>
         <value value="Cefpirome"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefpirom"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA02"/>
      <designation>
         <language value="en"/>
         <value value="Teriparatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teriparatid"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02AA13"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BA"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in nicotine dependence"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved nikotinavhengighet"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX77"/>
      <designation>
         <language value="en"/>
         <value value="Adagrasib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adagrasib"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AM"/>
      <designation>
         <language value="en"/>
         <value value="Antisera, immunoglobulin preparations, and antitoxins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antisera, immunoglobulinmidler og antitoksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC51"/>
      <designation>
         <language value="en"/>
         <value value="Buprenorphine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buprenorfin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03DB"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna and derivatives in combination with analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonna og derivater i kombinasjon med analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents against coccidiosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot koksidiose"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX75"/>
      <designation>
         <language value="en"/>
         <value value="Tebentafusp"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tebentafusp"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA08"/>
      <designation>
         <language value="en"/>
         <value value="Bromazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BC20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX09"/>
      <designation>
         <language value="en"/>
         <value value="Olopatadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olopatadin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AB52"/>
      <designation>
         <language value="en"/>
         <value value="Moxidectin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksidektin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D10"/>
      <designation>
         <language value="en"/>
         <value value="Anti-acne preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot akne"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, moderately potent, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, middels sterke, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KA"/>
      <designation>
         <language value="en"/>
         <value value="Alkaloids, excl. rauwolfia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkaloider, ekskl. rauwolfia"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA02"/>
      <designation>
         <language value="en"/>
         <value value="Eprosartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eprosartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC02"/>
      <designation>
         <language value="en"/>
         <value value="Icatibant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikatibant"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA06"/>
      <designation>
         <language value="en"/>
         <value value="Luspatercept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Luspatercept"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AA05"/>
      <designation>
         <language value="en"/>
         <value value="Equine rhinopneumonitis virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesterhinopneumonivirus"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Carbohydrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02AB"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AD01"/>
      <designation>
         <language value="en"/>
         <value value="Foscarnet"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Foskarnet"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Levothyroxine sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levotyroksinnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX99"/>
      <designation>
         <language value="en"/>
         <value value="Other general anesthetics, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre generelle anestetika, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AC03"/>
      <designation>
         <language value="en"/>
         <value value="Inositol nicotinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inositolnikotinat"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA08"/>
      <designation>
         <language value="en"/>
         <value value="Olmesartan medoxomil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olmesartanmedoksomil"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB12"/>
      <designation>
         <language value="en"/>
         <value value="Delapril and manidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delapril og manidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA13"/>
      <designation>
         <language value="en"/>
         <value value="Eravacycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eravasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA59"/>
      <designation>
         <language value="en"/>
         <value value="Doxylamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksylamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D09AB01"/>
      <designation>
         <language value="en"/>
         <value value="Zinc bandage without supplements"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkbandasjer uten tilsetninger"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BB03"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Heparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heparin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07CA03"/>
      <designation>
         <language value="en"/>
         <value value="Flunarizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flunarizin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DC02"/>
      <designation>
         <language value="en"/>
         <value value="Plicamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plikamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA51"/>
      <designation>
         <language value="en"/>
         <value value="Dihydroergotamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydroergotamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA03"/>
      <designation>
         <language value="en"/>
         <value value="Midecamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midekamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="S02BA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA56"/>
      <designation>
         <language value="en"/>
         <value value="Lorazepam, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorazepam, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX11"/>
      <designation>
         <language value="en"/>
         <value value="Mirtazapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirtazapin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07CA01"/>
      <designation>
         <language value="en"/>
         <value value="Betahistine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betahistin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD"/>
      <designation>
         <language value="en"/>
         <value value="Retinoids for topical use in acne"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retinoider til topikal behandling av akne"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA"/>
      <designation>
         <language value="en"/>
         <value value="Thiazides, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="D07A"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX03"/>
      <designation>
         <language value="en"/>
         <value value="Mianserin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mianserin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC04"/>
      <designation>
         <language value="en"/>
         <value value="Calcitriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsitriol"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BC09"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD07"/>
      <designation>
         <language value="en"/>
         <value value="Mequitazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mekvitazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA09"/>
      <designation>
         <language value="en"/>
         <value value="Atomoxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atomoksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB01"/>
      <designation>
         <language value="en"/>
         <value value="Flumetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetason"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX"/>
      <designation>
         <language value="en"/>
         <value value="Other systemic hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre systemiske hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AA"/>
      <designation>
         <language value="en"/>
         <value value="Alpha- and beta-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa- og betaagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="A11J"/>
      <designation>
         <language value="en"/>
         <value value="Other vitamin products, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre vitaminmidler, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01A"/>
      <designation>
         <language value="en"/>
         <value value="Alkylating agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkyleringsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03B"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for obstructive airway diseases, inhalants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler ved obstruktiv lungesykdom, til inhalasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA21"/>
      <designation>
         <language value="en"/>
         <value value="Sitafloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitafloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF03"/>
      <designation>
         <language value="en"/>
         <value value="Calcium folinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumfolinat"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01EX"/>
      <designation>
         <language value="en"/>
         <value value="Other protein kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre proteinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX12"/>
      <designation>
         <language value="en"/>
         <value value="Trientine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trientin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA01"/>
      <designation>
         <language value="en"/>
         <value value="Vancomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vankomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CB03"/>
      <designation>
         <language value="en"/>
         <value value="Zinc protein complex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sink/proteinkompleks"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC08"/>
      <designation>
         <language value="en"/>
         <value value="Decitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Decitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DF01"/>
      <designation>
         <language value="en"/>
         <value value="Aztreonam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aztreonam"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA08"/>
      <designation>
         <language value="en"/>
         <value value="Ciclesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA28"/>
      <designation>
         <language value="en"/>
         <value value="Vancomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vankomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA02BC01"/>
      <designation>
         <language value="en"/>
         <value value="Omeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC19"/>
      <designation>
         <language value="en"/>
         <value value="Olodaterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olodaterol"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01FF"/>
      <designation>
         <language value="en"/>
         <value value="Lincosamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkosamider"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03BA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B12 (cyanocobalamin and analogues)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B12  (cyanokobalamin og analoger)"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA06"/>
      <designation>
         <language value="en"/>
         <value value="Fencamfamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenkamfamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA07"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF04"/>
      <designation>
         <language value="en"/>
         <value value="Tiotixene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiotiksen"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AB01"/>
      <designation>
         <language value="en"/>
         <value value="Orlistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orlistat"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE02"/>
      <designation>
         <language value="en"/>
         <value value="Indinavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indinavir"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX03"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and acetylsalisylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QM03B"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants, centrally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sentralt virkende muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA"/>
      <designation>
         <language value="en"/>
         <value value="Calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="L04"/>
      <designation>
         <language value="en"/>
         <value value="Immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02CA"/>
      <designation>
         <language value="en"/>
         <value value="Anticorticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03D"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02CA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA01"/>
      <designation>
         <language value="en"/>
         <value value="Lovastatin and nicotinic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lovastatin og nikotinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AB02"/>
      <designation>
         <language value="en"/>
         <value value="Aeromonas + vibrio"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aeromonas + vibrio"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA02"/>
      <designation>
         <language value="en"/>
         <value value="Rescinnamine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reskinnamin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03AA"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyroideahormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AC"/>
      <designation>
         <language value="en"/>
         <value value="Synthetic antispasmodics, amides with tertiary amines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syntetiske spasmolytika, amider med tertiære aminer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE01"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamethoxazole and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametoksazol og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="B"/>
      <designation>
         <language value="en"/>
         <value value="Blood and blood forming organs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blod og bloddannende organer"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD09"/>
      <designation>
         <language value="en"/>
         <value value="Brotizolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brotizolam"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EB01"/>
      <designation>
         <language value="en"/>
         <value value="Cromoglicic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumkromoglikat"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX07"/>
      <designation>
         <language value="en"/>
         <value value="Enfuvirtide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enfuvirtid"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AD02"/>
      <designation>
         <language value="en"/>
         <value value="Phensuximide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fensuksimid"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH"/>
      <designation>
         <language value="en"/>
         <value value="Agents for dermatitis, excluding corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot dermatitt, ekskl. kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX92"/>
      <designation>
         <language value="en"/>
         <value value="Benzocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzokain"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AD"/>
      <designation>
         <language value="en"/>
         <value value="Emergency contraceptives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nødprevensjon"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AD"/>
      <designation>
         <language value="en"/>
         <value value="Benzomorphan derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzomorfanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="S02AA13"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01R"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD03"/>
      <designation>
         <language value="en"/>
         <value value="Melperone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melperon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA06"/>
      <designation>
         <language value="en"/>
         <value value="Cefepime and amikacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefepim og amikacin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA11"/>
      <designation>
         <language value="en"/>
         <value value="Tioclomarol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioklomarol"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB11"/>
      <designation>
         <language value="en"/>
         <value value="Acemetacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acemetacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AL02"/>
      <designation>
         <language value="en"/>
         <value value="Pneumococcus, purified polysaccharides antigen conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pneumokokk, renset polysakkarid antigen konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BC"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterial monoclonal antibodies"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle monoklonale antistoffer"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Interferon alfa natural"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naturlig interferon alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ07"/>
      <designation>
         <language value="en"/>
         <value value="Codeine and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AA"/>
      <designation>
         <language value="en"/>
         <value value="Preparations inhibiting uric acid production"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler som hemmer urinsyreproduksjonen"/>
      </designation>
   </concept>
   <concept>
      <code value="N07CA"/>
      <designation>
         <language value="en"/>
         <value value="Antivertigo preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivertigomidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CB"/>
      <designation>
         <language value="en"/>
         <value value="Zinc"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sink"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB06"/>
      <designation>
         <language value="en"/>
         <value value="Simfibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simfibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="A07D"/>
      <designation>
         <language value="en"/>
         <value value="Antipropulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peristaltikkhemmende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Digoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA12"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous sodium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)natriumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA53"/>
      <designation>
         <language value="en"/>
         <value value="Tamsulosin and solifenacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tamsulosin og solifenacin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX59"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstrometorfan, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA"/>
      <designation>
         <language value="en"/>
         <value value="Alimentary tract and metabolism"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fordøyelsesorganer og stoffskifte"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD51"/>
      <designation>
         <language value="en"/>
         <value value="Tretinoin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tretinoin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC07"/>
      <designation>
         <language value="en"/>
         <value value="Azacitidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azacitidin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB06"/>
      <designation>
         <language value="en"/>
         <value value="Chlormadinone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klormadinon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA04"/>
      <designation>
         <language value="en"/>
         <value value="Cyclopentolate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklopentolat"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC15"/>
      <designation>
         <language value="en"/>
         <value value="Beclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX12"/>
      <designation>
         <language value="en"/>
         <value value="Aripiprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aripiprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH10"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus A, purified polysaccharides antigen conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk A, renset polysakkarid antigen konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="C01D"/>
      <designation>
         <language value="en"/>
         <value value="Vasodilatators used in cardiac disease"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kardilaterende midler ved hjertesykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="G04B"/>
      <designation>
         <language value="en"/>
         <value value="Urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urologika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01"/>
      <designation>
         <language value="en"/>
         <value value="Antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ08"/>
      <designation>
         <language value="en"/>
         <value value="Iptacopan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iptakopan"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Cycloserine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cykloserin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AE02"/>
      <designation>
         <language value="en"/>
         <value value="Iron, multivitamins and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern, multivitaminer og folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX02"/>
      <designation>
         <language value="en"/>
         <value value="Ivacaftor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivakaftor"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DF02"/>
      <designation>
         <language value="en"/>
         <value value="Carumonam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Carumonam"/>
      </designation>
   </concept>
   <concept>
      <code value="QR05CB"/>
      <designation>
         <language value="en"/>
         <value value="Mucolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mucolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX26"/>
      <designation>
         <language value="en"/>
         <value value="Vortioxetin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vortioksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD03"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10BK90"/>
      <designation>
         <language value="en"/>
         <value value="Velagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Velagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB01"/>
      <designation>
         <language value="en"/>
         <value value="Practolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Praktolol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB03"/>
      <designation>
         <language value="en"/>
         <value value="Afelimomab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Afelimomab"/>
      </designation>
   </concept>
   <concept>
      <code value="WITHOUT"/>
      <designation>
         <language value="en"/>
         <value value="Non-relevance"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke relevant"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for pisces"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for fisk"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC11"/>
      <designation>
         <language value="en"/>
         <value value="Amcinonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amcinonid"/>
      </designation>
   </concept>
   <concept>
      <code value="QM05"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of bone diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av bensykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="V08DA05"/>
      <designation>
         <language value="en"/>
         <value value="Sulfur hexafluoride, phospholipid microspheres"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svovelheksafluorid, fosfolipidmikrosfærer"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AC08"/>
      <designation>
         <language value="en"/>
         <value value="Olopatadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olopatadin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EA02"/>
      <designation>
         <language value="en"/>
         <value value="Bepridil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bepridil"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AC01"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF02"/>
      <designation>
         <language value="en"/>
         <value value="Dexrazoxane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksrazoksan"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Tenoxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenoksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC14"/>
      <designation>
         <language value="en"/>
         <value value="Reproterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reproterol"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB14"/>
      <designation>
         <language value="en"/>
         <value value="Cepeginterferon alfa-2b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cepeginterferon alfa-2b"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB03"/>
      <designation>
         <language value="en"/>
         <value value="Bicalutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bikalutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB07"/>
      <designation>
         <language value="en"/>
         <value value="Flumequine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumekin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AE02"/>
      <designation>
         <language value="en"/>
         <value value="Bordetella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bordetella"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX14"/>
      <designation>
         <language value="en"/>
         <value value="Alirocumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alirokumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02AC04"/>
      <designation>
         <language value="en"/>
         <value value="Posaconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Posakonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BB"/>
      <designation>
         <language value="en"/>
         <value value="Oxazol, thiazine, and triazine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksazol-, tiazin- og triazinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AP"/>
      <designation>
         <language value="en"/>
         <value value="Live fungal vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA53"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxocobalamin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksokobalamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AB02"/>
      <designation>
         <language value="en"/>
         <value value="Bisacodyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisakodyl"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AC01"/>
      <designation>
         <language value="en"/>
         <value value="Aldesleukin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldesleukin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF02"/>
      <designation>
         <language value="en"/>
         <value value="Apixaban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apiksaban"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM04"/>
      <designation>
         <language value="en"/>
         <value value="Thioacetazone and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioacetazon og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB03"/>
      <designation>
         <language value="en"/>
         <value value="Agalsidase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Agalsidase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="B05A"/>
      <designation>
         <language value="en"/>
         <value value="Blood and related products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blod og plasmasubstitutter"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06AA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlortetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL10"/>
      <designation>
         <language value="en"/>
         <value value="Nadofaragene firadenovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nadofaragenfiradenovek"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AB05"/>
      <designation>
         <language value="en"/>
         <value value="Clostridium + pasteurella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klostridium + pasteurella"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE01"/>
      <designation>
         <language value="en"/>
         <value value="Ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB52"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and thiazides, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og tiazider, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA01"/>
      <designation>
         <language value="en"/>
         <value value="Amfetamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD08"/>
      <designation>
         <language value="en"/>
         <value value="Saruplase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saruplase"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB11"/>
      <designation>
         <language value="en"/>
         <value value="Poldine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poldon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD04"/>
      <designation>
         <language value="en"/>
         <value value="Cabazitaxel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabazitaksel"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BF03"/>
      <designation>
         <language value="en"/>
         <value value="Poliomyelitis, trivalent, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poliomyelitt, trivalent, inaktivert helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="L03A"/>
      <designation>
         <language value="en"/>
         <value value="Immunostimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AA01"/>
      <designation>
         <language value="en"/>
         <value value="Allopurinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allopurinol"/>
      </designation>
   </concept>
   <concept>
      <code value="S03BA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE04"/>
      <designation>
         <language value="en"/>
         <value value="Ponesimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ponesimod"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD53"/>
      <designation>
         <language value="en"/>
         <value value="Measles, combinations with rubella, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslinger, kombinasjoner med rubella, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Medazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QD04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG04"/>
      <designation>
         <language value="en"/>
         <value value="Letrozole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Letrozol"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AH01"/>
      <designation>
         <language value="en"/>
         <value value="Methylnaltrexone bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylnaltreksonbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA"/>
      <designation>
         <language value="en"/>
         <value value="Amino acids and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosyrer og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA04"/>
      <designation>
         <language value="en"/>
         <value value="Obeticholic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Obetikolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AJ"/>
      <designation>
         <language value="en"/>
         <value value="Integrase inhibitores"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Integrasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB09"/>
      <designation>
         <language value="en"/>
         <value value="Ubidecarenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ubidekarenon"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB01"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Saccharated iron oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferrioksidsakkarat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05CX02"/>
      <designation>
         <language value="en"/>
         <value value="Sorbitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sorbitol"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AD01"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11BA"/>
      <designation>
         <language value="en"/>
         <value value="Multivitamins, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multivitaminer, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02CA03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergics in combination with corticosteroides or other drugs, excl. anticholinergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika i kombinasjon med kortikosteroider eller andre midler, ekskl. antikolinergika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP09"/>
      <designation>
         <language value="en"/>
         <value value="Dasabuvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dasabuvir"/>
      </designation>
   </concept>
   <concept>
      <code value="B05DB"/>
      <designation>
         <language value="en"/>
         <value value="Hypertonic solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypertone løsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX03"/>
      <designation>
         <language value="en"/>
         <value value="Catumaxomab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katumaksomab"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA05"/>
      <designation>
         <language value="en"/>
         <value value="Deserpidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deserpidin"/>
      </designation>
   </concept>
   <concept>
      <code value="G02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Vaginal ring with progestogen and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vaginalring med progestogen og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QC04AD90"/>
      <designation>
         <language value="en"/>
         <value value="Propentofylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propentofyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DB"/>
      <designation>
         <language value="en"/>
         <value value="Other potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Mofebutazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mofebutazon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB05"/>
      <designation>
         <language value="en"/>
         <value value="Oxolinic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksolinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL07"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and glycopyrronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og glykopyrronbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE07"/>
      <designation>
         <language value="en"/>
         <value value="Dabigatran etexilate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dabigatran eteksilat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB"/>
      <designation>
         <language value="en"/>
         <value value="Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epidermal vekstfaktorreseptor (EGFR) tyrosinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA07"/>
      <designation>
         <language value="en"/>
         <value value="Noscapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noskapin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DX22"/>
      <designation>
         <language value="en"/>
         <value value="Vericiguat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Verisiguat"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB11"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon alfa-2a"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon alfa-2a"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE12"/>
      <designation>
         <language value="en"/>
         <value value="Oxaprozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksaprozin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Tamoxifen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tamoksifen"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB02"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and felodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og felodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BX"/>
      <designation>
         <language value="en"/>
         <value value="Other centrally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre sentralt virkende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF02"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate and mefloquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat og meflokin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB09"/>
      <designation>
         <language value="en"/>
         <value value="Etoperidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etoperidon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK01"/>
      <designation>
         <language value="en"/>
         <value value="Dapagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dapagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE10"/>
      <designation>
         <language value="en"/>
         <value value="Avanafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avanafil"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC11"/>
      <designation>
         <language value="en"/>
         <value value="Tulobuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tulobuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01L"/>
      <designation>
         <language value="en"/>
         <value value="Ocular vascular disorder agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved okulær vaskulær sykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD18"/>
      <designation>
         <language value="en"/>
         <value value="Cefteram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefteram"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC17"/>
      <designation>
         <language value="en"/>
         <value value="Tirofiban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tirofiban"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Phentolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01C"/>
      <designation>
         <language value="en"/>
         <value value="Hypothalamic hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypothalamushormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD05"/>
      <designation>
         <language value="en"/>
         <value value="Fibrinolysin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fibrinolysin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02C"/>
      <designation>
         <language value="en"/>
         <value value="Antiadrenal preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibinyrebarkhormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB18"/>
      <designation>
         <language value="en"/>
         <value value="Ranolazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ranolazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA09"/>
      <designation>
         <language value="en"/>
         <value value="Phenglutarimide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenglutarimid"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AC"/>
      <designation>
         <language value="en"/>
         <value value="Pyrethrines, incl. synthetic compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyretriner, inklusive syntetiske forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiallergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiallergiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB03"/>
      <designation>
         <language value="en"/>
         <value value="Lisinopril and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisinopril og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB02"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AX03"/>
      <designation>
         <language value="en"/>
         <value value="Cevimeline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cevimelin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03E"/>
      <designation>
         <language value="en"/>
         <value value="Diuretics and potassium-sparing agents in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diuretika i kombinasjoner med kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX05"/>
      <designation>
         <language value="en"/>
         <value value="Amifampridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amifampridin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Ferric sodium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferrinatriumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BB04"/>
      <designation>
         <language value="en"/>
         <value value="Hepatitis B immunoglobulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin mot hepatitt B"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX23"/>
      <designation>
         <language value="en"/>
         <value value="Pimethixene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pimetiksen"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AA"/>
      <designation>
         <language value="en"/>
         <value value="Softeners, emollients"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bløtgjørende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DC01"/>
      <designation>
         <language value="en"/>
         <value value="Bleomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bleomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC04"/>
      <designation>
         <language value="en"/>
         <value value="Beclometasone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beklometason og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA07"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-hepatitis B-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-hepatitt B-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB22"/>
      <designation>
         <language value="en"/>
         <value value="Avalglucosidase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avalglukosidase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BG01"/>
      <designation>
         <language value="en"/>
         <value value="Rabies, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabies, inaktivert, helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FB"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics excl. antiglaucoma preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sympatomimetika ekskl. antiglaukommidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N02"/>
      <designation>
         <language value="en"/>
         <value value="Analgetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AG01"/>
      <designation>
         <language value="en"/>
         <value value="Fluspirilene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluspirilen"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX05"/>
      <designation>
         <language value="en"/>
         <value value="Inosine pranobex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inosin pranobeks"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX15"/>
      <designation>
         <language value="en"/>
         <value value="Mifamurtide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mifamurtid"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC06"/>
      <designation>
         <language value="en"/>
         <value value="Calcifediol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsifediol"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AX25"/>
      <designation>
         <language value="en"/>
         <value value="Chondroitin sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kondroitinsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC06"/>
      <designation>
         <language value="en"/>
         <value value="Meloxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meloksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX01"/>
      <designation>
         <language value="en"/>
         <value value="Cromoglicic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumkromoglikat"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG"/>
      <designation>
         <language value="en"/>
         <value value="Hydrazinophthalazine derivatives and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrazinoftalazinderivater og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH07"/>
      <designation>
         <language value="en"/>
         <value value="Polmacoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polmakoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L"/>
      <designation>
         <language value="en"/>
         <value value="Antineoplastic and immunomodulating agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineoplastiske og immunmodulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AA10"/>
      <designation>
         <language value="en"/>
         <value value="Sibutramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sibutramin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01A"/>
      <designation>
         <language value="en"/>
         <value value="Cardiac glycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerteglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ03"/>
      <designation>
         <language value="en"/>
         <value value="Lixisenatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Liksisenatid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA"/>
      <designation>
         <language value="en"/>
         <value value="Tertiary amines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tertiære aminer"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX16"/>
      <designation>
         <language value="en"/>
         <value value="Inclisiran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inklisiran"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Econazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03A"/>
      <designation>
         <language value="en"/>
         <value value="Iron preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jernmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin K"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin K"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA40"/>
      <designation>
         <language value="en"/>
         <value value="Cladribine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kladribin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD12"/>
      <designation>
         <language value="en"/>
         <value value="Mirabegron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirabegron"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA51"/>
      <designation>
         <language value="en"/>
         <value value="Levothyroxine sodium and iodine compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levotyroksinnatrium og jodforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BA"/>
      <designation>
         <language value="en"/>
         <value value="Immunoglobulins, normal human"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin, normal human"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK"/>
      <designation>
         <language value="en"/>
         <value value="Poly (ADP-ribose) polymerase (PARP) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poly (ADP-ribose) polymerasehemmere (PARP)"/>
      </designation>
   </concept>
   <concept>
      <code value="H03B"/>
      <designation>
         <language value="en"/>
         <value value="Antithyroid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antithyreoideamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AX04"/>
      <designation>
         <language value="en"/>
         <value value="Dacarbazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dakarbazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB17"/>
      <designation>
         <language value="en"/>
         <value value="Sampeginterferon beta-1A"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sampeginterferon beta-1A"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA10"/>
      <designation>
         <language value="en"/>
         <value value="Bufylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bufyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DB01"/>
      <designation>
         <language value="en"/>
         <value value="Dihydralazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydralazin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XC05"/>
      <designation>
         <language value="en"/>
         <value value="Ospemifene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ospemifen"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB"/>
      <designation>
         <language value="en"/>
         <value value="Phenothiazines with piperazine structure"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiaziner med piperazinring i sidekjeden"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EN"/>
      <designation>
         <language value="en"/>
         <value value="Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fibroblast vekstfaktorreseptor (FGFR) tyrosinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ01"/>
      <designation>
         <language value="en"/>
         <value value="Exenatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eksenatid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AD01"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC05"/>
      <designation>
         <language value="en"/>
         <value value="Bezitramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bezitramid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51EX01"/>
      <designation>
         <language value="en"/>
         <value value="Imidocarb"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidocarb"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BG"/>
      <designation>
         <language value="en"/>
         <value value="Rabies vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabiesvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="H05A"/>
      <designation>
         <language value="en"/>
         <value value="Parathyroid hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parathyreoideahormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX18"/>
      <designation>
         <language value="en"/>
         <value value="Tiazofurine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazofurin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Indometacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indometacin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA02"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for acid related disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot syrerelaterte lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX21"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory preparations, non-steroids for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-steroide antiinflammatoriske midler til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="V06C"/>
      <designation>
         <language value="en"/>
         <value value="Infant formulas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barnedietter"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX05"/>
      <designation>
         <language value="en"/>
         <value value="Exagamglogene autotemcel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eksagamglogenautotemcel"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX23"/>
      <designation>
         <language value="en"/>
         <value value="Ibalizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibalizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP08"/>
      <designation>
         <language value="en"/>
         <value value="Sofosbuvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sofosbuvir"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AD01"/>
      <designation>
         <language value="en"/>
         <value value="Orf virus / contagious pustular dermatitis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orfvirus / pustuløs dermatitt, smittsom"/>
      </designation>
   </concept>
   <concept>
      <code value="QA04A"/>
      <designation>
         <language value="en"/>
         <value value="Antiemetics and antinauseants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB07"/>
      <designation>
         <language value="en"/>
         <value value="Fluprednidene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flupredniden"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA07"/>
      <designation>
         <language value="en"/>
         <value value="Risedronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risedronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA05"/>
      <designation>
         <language value="en"/>
         <value value="Oleandomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oleandomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB05"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril and felodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril og felodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX02"/>
      <designation>
         <language value="en"/>
         <value value="Riluzole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Riluzol"/>
      </designation>
   </concept>
   <concept>
      <code value="QD11A"/>
      <designation>
         <language value="en"/>
         <value value="Other dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Thyrotropin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyrotropin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD08"/>
      <designation>
         <language value="en"/>
         <value value="Uramustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Uramustin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX02"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril and bisoprolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril og bisoprolol"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB61"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon alfa-2a, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon alfa-2a, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Oxytocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytocin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA10"/>
      <designation>
         <language value="en"/>
         <value value="Azithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Primidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Primidon"/>
      </designation>
   </concept>
   <concept>
      <code value="V07AR"/>
      <designation>
         <language value="en"/>
         <value value="Sensitivity tests, discs and tablets"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Resistens tablett/lapp med antibiotika til konsentrasjonsbestemmelse"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD03"/>
      <designation>
         <language value="en"/>
         <value value="Bunaftine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bunaftin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BC01"/>
      <designation>
         <language value="en"/>
         <value value="Toltrazuril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toltrazuril"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA04"/>
      <designation>
         <language value="en"/>
         <value value="Galantamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galantamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Misoprostol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Misoprostol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM18"/>
      <designation>
         <language value="en"/>
         <value value="Dexmedetomidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksmedetomidin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD15"/>
      <designation>
         <language value="en"/>
         <value value="Macrogol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrogol"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC03"/>
      <designation>
         <language value="en"/>
         <value value="Terbutaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbutalin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AH"/>
      <designation>
         <language value="en"/>
         <value value="Opioid anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioidanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AB"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD03"/>
      <designation>
         <language value="en"/>
         <value value="Flunitrazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flunitrazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08"/>
      <designation>
         <language value="en"/>
         <value value="Antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD05"/>
      <designation>
         <language value="en"/>
         <value value="Pipamperone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipamperon"/>
      </designation>
   </concept>
   <concept>
      <code value="A02"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for acid related disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot syrerelaterte lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="S01K"/>
      <designation>
         <language value="en"/>
         <value value="Surgical aids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til bruk ved operasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA07"/>
      <designation>
         <language value="en"/>
         <value value="Sotalol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotalol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AA"/>
      <designation>
         <language value="en"/>
         <value value="Watersoluble, nephrotropic, high osmolar X-ray contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vannløselige, nefrotrope, høyosmolære røntgenkontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EA"/>
      <designation>
         <language value="en"/>
         <value value="Prostaglandins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prostaglandiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX22"/>
      <designation>
         <language value="en"/>
         <value value="Selpercatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selperkatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues for injection, long-acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til injeksjon, langtidsvirkende"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB05"/>
      <designation>
         <language value="en"/>
         <value value="Iopromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jopromid"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01RA"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H03"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid  therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoideaterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD01"/>
      <designation>
         <language value="en"/>
         <value value="Dinoprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dinoprost"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB01"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX15"/>
      <designation>
         <language value="en"/>
         <value value="Imeglimin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imeglimin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA16"/>
      <designation>
         <language value="en"/>
         <value value="Sulbenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulbenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA52"/>
      <designation>
         <language value="en"/>
         <value value="Reserpine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reserpin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase resistant penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamaseresistente penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CB"/>
      <designation>
         <language value="en"/>
         <value value="Mucolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mukolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD06"/>
      <designation>
         <language value="en"/>
         <value value="Glimepiride and pioglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glimepirid og pioglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="G03C"/>
      <designation>
         <language value="en"/>
         <value value="Estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03GA30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA"/>
      <designation>
         <language value="en"/>
         <value value="Antiarrhythmics, class Ia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiarytmika, klasse Ia"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX09"/>
      <designation>
         <language value="en"/>
         <value value="Glycerol phenylbutyrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyserolfenylbutyrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01CA01"/>
      <designation>
         <language value="en"/>
         <value value="Gonadorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD17"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and acarbose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og akarbose"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD"/>
      <designation>
         <language value="en"/>
         <value value="Blood coagulation factors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodkoagulasjonsfaktorer"/>
      </designation>
   </concept>
   <concept>
      <code value="C08D"/>
      <designation>
         <language value="en"/>
         <value value="Selective calcium channel blockers with direct cardiac effects"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive kalsiumantagonister med direkte virkning på hjertet"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03"/>
      <designation>
         <language value="en"/>
         <value value="Diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA03"/>
      <designation>
         <language value="en"/>
         <value value="Levodopa, decarboxylase inhibitor and COMT inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levodopa, dekarboksylasehemmer og COMT-hemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XB02"/>
      <designation>
         <language value="en"/>
         <value value="Ulipristal"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ulipristal"/>
      </designation>
   </concept>
   <concept>
      <code value="M01"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory and antirheumatic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske og antireumatiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AB18"/>
      <designation>
         <language value="en"/>
         <value value="Streptococcus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptokokk"/>
      </designation>
   </concept>
   <concept>
      <code value="C09XA53"/>
      <designation>
         <language value="en"/>
         <value value="Aliskiren and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aliskiren og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA06"/>
      <designation>
         <language value="en"/>
         <value value="Cerivastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cerivastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC01"/>
      <designation>
         <language value="en"/>
         <value value="C1-inhibitor, plasma derived"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="C1-hemmer, plasmaderivert"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE16"/>
      <designation>
         <language value="en"/>
         <value value="Ensitrelvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ensitrelvir"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, moderately potent, combinations with antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, middels sterke, kombinasjoner med antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD04"/>
      <designation>
         <language value="en"/>
         <value value="Ceftriaxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftriakson"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA09"/>
      <designation>
         <language value="en"/>
         <value value="Fosinopril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosinopril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA02"/>
      <designation>
         <language value="en"/>
         <value value="Quinethazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinetazon"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA12"/>
      <designation>
         <language value="en"/>
         <value value="Delapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delapril"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Disulfiram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Disulfiram"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BB02"/>
      <designation>
         <language value="en"/>
         <value value="Metamizole sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metamizolnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB02"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="QG01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiinfectives and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiinfektiva og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA"/>
      <designation>
         <language value="en"/>
         <value value="Antineovascularisation agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineovaskulariserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR16"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine and raltegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin og raltegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA11"/>
      <designation>
         <language value="en"/>
         <value value="Calcium pangamate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumpangamat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AF"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difterivaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB06"/>
      <designation>
         <language value="en"/>
         <value value="Clofarabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofarabin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Bendroflumethiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bendroflumetiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC04"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04A"/>
      <designation>
         <language value="en"/>
         <value value="Anticholinergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikolinergika"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA19"/>
      <designation>
         <language value="en"/>
         <value value="Amineptine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amineptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA08"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin and omega-3 fatty acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin og omega-3 fettsyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL03"/>
      <designation>
         <language value="en"/>
         <value value="Tiapride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiaprid"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC13"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Chloroform"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloroform"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB03"/>
      <designation>
         <language value="en"/>
         <value value="Fluprednidene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flupredniden"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX29"/>
      <designation>
         <language value="en"/>
         <value value="Denileukin diftitox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Denileukin diftitoks"/>
      </designation>
   </concept>
   <concept>
      <code value="N05C"/>
      <designation>
         <language value="en"/>
         <value value="Hypnotics and sedatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypnotika og sedativa"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AA"/>
      <designation>
         <language value="en"/>
         <value value="Quinoline derivatives and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolinderivater og relaterte substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EW13"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadoxine and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadoksin og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AP10"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid, combinations with paratyphi types"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoid, kombinasjoner med paratyfoide varianter"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA"/>
      <designation>
         <language value="en"/>
         <value value="Natural and semisynthetic estrogens, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naturlige og halvsyntetiske østrogener, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AC03"/>
      <designation>
         <language value="en"/>
         <value value="Selenium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selenforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XF01"/>
      <designation>
         <language value="en"/>
         <value value="Tretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxocobalamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksokobalamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB03"/>
      <designation>
         <language value="en"/>
         <value value="Indometacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indometacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09"/>
      <designation>
         <language value="en"/>
         <value value="Agents acting on the renin-angiotensin system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med virkning på renin-angiotensinsystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04B"/>
      <designation>
         <language value="en"/>
         <value value="Urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urologika"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AC07"/>
      <designation>
         <language value="en"/>
         <value value="Ciclonicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklonikat"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51E"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides and trimethoprim for intrammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider og trimetoprim for intramammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA04"/>
      <designation>
         <language value="en"/>
         <value value="Methylpropylpropanediol dinitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylpropylpropandioldinitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til dermatologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA"/>
      <designation>
         <language value="en"/>
         <value value="Vasopressin and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vasopressin og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA02"/>
      <designation>
         <language value="en"/>
         <value value="Levomepromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levomepromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA04"/>
      <designation>
         <language value="en"/>
         <value value="Chloroprocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorprokain"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AL01"/>
      <designation>
         <language value="en"/>
         <value value="Equine influenza virus + clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesteinfluensavirus + klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="B02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Tranexamic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Traneksamsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA30"/>
      <designation>
         <language value="en"/>
         <value value="Calcium laevulate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumlevulat"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Somatrem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somatrem"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Isopropamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isopropamid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA10"/>
      <designation>
         <language value="en"/>
         <value value="Mazaticol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mazatikol"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB02"/>
      <designation>
         <language value="en"/>
         <value value="Fluprednidene and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flupredniden og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BD01"/>
      <designation>
         <language value="en"/>
         <value value="Selegiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selegilin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA07"/>
      <designation>
         <language value="en"/>
         <value value="Metreleptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metreleptin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ03"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrocodeine and other non-opioid analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrokodein og andre ikke-opioide analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC05"/>
      <designation>
         <language value="en"/>
         <value value="Pramipexole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pramipeksol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BA"/>
      <designation>
         <language value="en"/>
         <value value="Encephalitis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Encefalittvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA56"/>
      <designation>
         <language value="en"/>
         <value value="Chlorphenoxamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorfenoksamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB12"/>
      <designation>
         <language value="en"/>
         <value value="Nomegestrol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nomegestrol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA06"/>
      <designation>
         <language value="en"/>
         <value value="Urapidil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urapidil"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09B"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB03"/>
      <designation>
         <language value="en"/>
         <value value="Orciprenaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orciprenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB03"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium clofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumklofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK08"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and beclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og beklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA51"/>
      <designation>
         <language value="en"/>
         <value value="Neomycin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neomycin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AB01"/>
      <designation>
         <language value="en"/>
         <value value="Doxapram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksapram"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BC06"/>
      <designation>
         <language value="en"/>
         <value value="Thrombin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trombin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ01"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrocodeine and paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrokodein og paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AB06"/>
      <designation>
         <language value="en"/>
         <value value="Tetracaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakain"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Etynodiol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etynodiol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Ditazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ditazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB13"/>
      <designation>
         <language value="en"/>
         <value value="Mycoplasma"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mykoplasma"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BD01"/>
      <designation>
         <language value="en"/>
         <value value="Pyrimethamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrimetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CB01"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin A concentrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin-A-konsentrat"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA06"/>
      <designation>
         <language value="en"/>
         <value value="Candesartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kandesartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BE"/>
      <designation>
         <language value="en"/>
         <value value="Mumps vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kusmavaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE07"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamerazine and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfamerazin og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA52"/>
      <designation>
         <language value="en"/>
         <value value="Glyceryl trinitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyseryltrinitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05A"/>
      <designation>
         <language value="en"/>
         <value value="Direct acting antivirals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Direktevirkende antivirale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for dermatological use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til dermatologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB04"/>
      <designation>
         <language value="en"/>
         <value value="Prochlorperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proklorperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC03"/>
      <designation>
         <language value="en"/>
         <value value="Tegafur"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tegafur"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AX01"/>
      <designation>
         <language value="en"/>
         <value value="Pegvisomant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pegvisomant"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX"/>
      <designation>
         <language value="en"/>
         <value value="Other respiratory system products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på respirasjonssystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX27"/>
      <designation>
         <language value="en"/>
         <value value="Epcoritamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epkoritamab"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX05"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and acetylsalisylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB"/>
      <designation>
         <language value="en"/>
         <value value="Interferons"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC01"/>
      <designation>
         <language value="en"/>
         <value value="Fluconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flukonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53"/>
      <designation>
         <language value="en"/>
         <value value="Ectoparasiticides, insecticides og repellents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ektoparasittmidler og insektmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB"/>
      <designation>
         <language value="en"/>
         <value value="Selective serotonin reuptake inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive serotoninreopptakshemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BL01"/>
      <designation>
         <language value="en"/>
         <value value="Yellow fever, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gulfeber, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Phenylbutazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylbutazon"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AG03"/>
      <designation>
         <language value="en"/>
         <value value="Penfluridol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penfluridol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EE01"/>
      <designation>
         <language value="en"/>
         <value value="Trametinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trametinib"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DA"/>
      <designation>
         <language value="en"/>
         <value value="Pregnen (4) derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pregnen (4) derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB07"/>
      <designation>
         <language value="en"/>
         <value value="Acetophenazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acefenazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CE02"/>
      <designation>
         <language value="en"/>
         <value value="Irinotecan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Irinotekan"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX"/>
      <designation>
         <language value="en"/>
         <value value="Other diagnostic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre diagnostika"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX06"/>
      <designation>
         <language value="en"/>
         <value value="Roflumilast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Roflumilast"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX08"/>
      <designation>
         <language value="en"/>
         <value value="Avatrombopag"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avatrombopag"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DA"/>
      <designation>
         <language value="en"/>
         <value value="Phenylalkylamine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylalkylaminderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AX01"/>
      <designation>
         <language value="en"/>
         <value value="Flurbiprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flurbiprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC03"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX27"/>
      <designation>
         <language value="en"/>
         <value value="Esketamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Esketamin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Flunisolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flunisolid"/>
      </designation>
   </concept>
   <concept>
      <code value="QD11AH90"/>
      <designation>
         <language value="en"/>
         <value value="Oclacitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oklacitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK06"/>
      <designation>
         <language value="en"/>
         <value value="Pamiparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pamiparib"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05A"/>
      <designation>
         <language value="en"/>
         <value value="Antipsychotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antipsykotika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03XA"/>
      <designation>
         <language value="en"/>
         <value value="Vasopressin antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vasopressinantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC01"/>
      <designation>
         <language value="en"/>
         <value value="Acetazolamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetazolamid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05B"/>
      <designation>
         <language value="en"/>
         <value value="Drugs affecting bone structure and mineralization"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med effekt på benstruktur og mineralisering"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC05"/>
      <designation>
         <language value="en"/>
         <value value="Diethylstilbestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dietylstilbøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01D"/>
      <designation>
         <language value="en"/>
         <value value="Other beta-lactam antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre beta-laktam antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC07"/>
      <designation>
         <language value="en"/>
         <value value="Apomorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apomorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD01"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AN"/>
      <designation>
         <language value="en"/>
         <value value="Tuberculosis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tuberkulose vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA09"/>
      <designation>
         <language value="en"/>
         <value value="Rolitetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rolitetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX06"/>
      <designation>
         <language value="en"/>
         <value value="Nefazodone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nefazodon"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB52"/>
      <designation>
         <language value="en"/>
         <value value="Phenytoin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenytoin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC03"/>
      <designation>
         <language value="en"/>
         <value value="Propafenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propafenon"/>
      </designation>
   </concept>
   <concept>
      <code value="S03CA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CD"/>
      <designation>
         <language value="en"/>
         <value value="Tests for pituitary function"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til undersøkelse av hypofysefunksjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Procainamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokainamid"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA54"/>
      <designation>
         <language value="en"/>
         <value value="Tamsulosin and tadalafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tamsulosin og tadalafil"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AF"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues, for inhalation"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til inhalasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocodone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokodon"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB01"/>
      <designation>
         <language value="en"/>
         <value value="Bromocriptine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromokriptin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA04"/>
      <designation>
         <language value="en"/>
         <value value="Phenprocoumon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenprokumon"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CB02"/>
      <designation>
         <language value="en"/>
         <value value="Dutasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dutasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51CA02"/>
      <designation>
         <language value="en"/>
         <value value="Ronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB12"/>
      <designation>
         <language value="en"/>
         <value value="Rimexolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rimeksolon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB08"/>
      <designation>
         <language value="en"/>
         <value value="Gliquidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gliquidon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA15"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05AD"/>
      <designation>
         <language value="en"/>
         <value value="Butyrophenone derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butyrofenonderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XD04"/>
      <designation>
         <language value="en"/>
         <value value="Aminolevulinic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminolevulinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XE03"/>
      <designation>
         <language value="en"/>
         <value value="Furazidin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Furazidin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC19"/>
      <designation>
         <language value="en"/>
         <value value="Beraprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beraprost"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11JA"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of vitamins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL10"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and tiotropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og tiotropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL06"/>
      <designation>
         <language value="en"/>
         <value value="Olodaterol and tiotropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olodaterol og tiotropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB05"/>
      <designation>
         <language value="en"/>
         <value value="Neomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA"/>
      <designation>
         <language value="en"/>
         <value value="HMG CoA reductase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="HMG-CoA-reduktasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03FA01"/>
      <designation>
         <language value="en"/>
         <value value="Metoclopramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoklopramid"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02A"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EH01"/>
      <designation>
         <language value="en"/>
         <value value="Lapatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lapatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="G02BA"/>
      <designation>
         <language value="en"/>
         <value value="Intrauterine contraceptives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Intrauterine antikonseptiva"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AG"/>
      <designation>
         <language value="en"/>
         <value value="Barbiturates in combination with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbiturater i kombinasjon med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD06"/>
      <designation>
         <language value="en"/>
         <value value="Von Willebrand factor and coagulation factor VIII in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Von Willebrand faktor og  koagulasjonsfaktor VIII i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AF03"/>
      <designation>
         <language value="en"/>
         <value value="Rufinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rufinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Tetracosactide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakosaktid"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG"/>
      <designation>
         <language value="en"/>
         <value value="Non-nucleoside reverse transcriptase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-nukleosid reverstranskriptasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB07"/>
      <designation>
         <language value="en"/>
         <value value="Alaproclate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alaproklat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ09"/>
      <designation>
         <language value="en"/>
         <value value="Codeine and other non-opioid analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein og andre ikke-opioide analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BG10"/>
      <designation>
         <language value="en"/>
         <value value="Cannabinoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cannabinoider"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA04"/>
      <designation>
         <language value="en"/>
         <value value="Riboflavin (vit B2)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Riboflavin (Vit B2)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX13"/>
      <designation>
         <language value="en"/>
         <value value="Gilteritinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gilteritinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AH01"/>
      <designation>
         <language value="en"/>
         <value value="Zanamivir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zanamivir"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02A"/>
      <designation>
         <language value="en"/>
         <value value="Antimycotics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimykotika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED09"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfamazon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX02"/>
      <designation>
         <language value="en"/>
         <value value="Xibornol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xibornol"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of hyperkalemia and hyperphosphatemia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot hyperkalemi og hyperfosfatemi"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX15"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin and perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin og perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BC51"/>
      <designation>
         <language value="en"/>
         <value value="Toltrazuril, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toltrazuril, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA07"/>
      <designation>
         <language value="en"/>
         <value value="Amphotericin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfotericin B"/>
      </designation>
   </concept>
   <concept>
      <code value="B02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Aprotinin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aprotinin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AD"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA09"/>
      <designation>
         <language value="en"/>
         <value value="Desogestrel and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desogestrel og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA05"/>
      <designation>
         <language value="en"/>
         <value value="Mecobalamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mekobalamin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE02"/>
      <designation>
         <language value="en"/>
         <value value="Sevelamer"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sevelamer"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AF"/>
      <designation>
         <language value="en"/>
         <value value="Morphinan derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfinanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07X"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD01"/>
      <designation>
         <language value="en"/>
         <value value="Trastuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trastuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE10"/>
      <designation>
         <language value="en"/>
         <value value="Benzathine phenoxymethylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzatinfenoksymetylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Capsaicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Capsaicin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06A"/>
      <designation>
         <language value="en"/>
         <value value="Antihistamines for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihistaminer til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB"/>
      <designation>
         <language value="en"/>
         <value value="Gold preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gullmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BJ"/>
      <designation>
         <language value="en"/>
         <value value="Rubella vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rubellavaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02CA01"/>
      <designation>
         <language value="en"/>
         <value value="Trilostane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trilostan"/>
      </designation>
   </concept>
   <concept>
      <code value="J06A"/>
      <designation>
         <language value="en"/>
         <value value="Immune sera"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsera"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DG01"/>
      <designation>
         <language value="en"/>
         <value value="Pinacidil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pinacidil"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB08"/>
      <designation>
         <language value="en"/>
         <value value="Sulfathiourea"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfatiourea"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC04"/>
      <designation>
         <language value="en"/>
         <value value="Ropinirole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ropinirol"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA08"/>
      <designation>
         <language value="en"/>
         <value value="Sodium acetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ09"/>
      <designation>
         <language value="en"/>
         <value value="Danicopan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Danikopan"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CM"/>
      <designation>
         <language value="en"/>
         <value value="Tests for fertility disturbances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til undersøkelse av fertilitetsforstyrrelser"/>
      </designation>
   </concept>
   <concept>
      <code value="H"/>
      <designation>
         <language value="en"/>
         <value value="Systemic hormonal preparations excl. sex hormones and insulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hormoner til systemisk bruk, ekskl. kjønnshormoner og insulin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FG01"/>
      <designation>
         <language value="en"/>
         <value value="Pristinamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pristinamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA08"/>
      <designation>
         <language value="en"/>
         <value value="Prednimustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednimustin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB"/>
      <designation>
         <language value="en"/>
         <value value="Fibrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fibrater"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AC51"/>
      <designation>
         <language value="en"/>
         <value value="Isoniazid, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoniazid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BB03"/>
      <designation>
         <language value="en"/>
         <value value="Mepivacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepivakain"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01XQ"/>
      <designation>
         <language value="en"/>
         <value value="Pleuromutilins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pleuromutiliner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA58"/>
      <designation>
         <language value="en"/>
         <value value="Isosorbide dinitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isosorbiddinitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC04"/>
      <designation>
         <language value="en"/>
         <value value="Permethrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Permetrin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB34"/>
      <designation>
         <language value="en"/>
         <value value="Fomepizole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fomepizol"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF08"/>
      <designation>
         <language value="en"/>
         <value value="Artemisinin and naphthoquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemisinin og naftokin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09D"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs), combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs), kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AA"/>
      <designation>
         <language value="en"/>
         <value value="Lung surfactants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lungesurfaktanter"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DA"/>
      <designation>
         <language value="en"/>
         <value value="Pregnen (4) derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pregnen (4) derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB10"/>
      <designation>
         <language value="en"/>
         <value value="Imiquimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imiquimod"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AN"/>
      <designation>
         <language value="en"/>
         <value value="Lithium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Litium"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX12"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin, Acetylsalisylsyre and Perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin, Acetylsalisylsyre og Perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA04"/>
      <designation>
         <language value="en"/>
         <value value="Theophylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03"/>
      <designation>
         <language value="en"/>
         <value value="All other therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CB03"/>
      <designation>
         <language value="en"/>
         <value value="Methallenestril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metallenøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX04"/>
      <designation>
         <language value="en"/>
         <value value="Phenindamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenindamin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX11"/>
      <designation>
         <language value="en"/>
         <value value="Tezepelumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tezepelumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK"/>
      <designation>
         <language value="en"/>
         <value value="Sodium-glucose co-transporter 2 (SGLT2) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumglukose-kotransportør 2 (SLGT2)-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents for treatment of hemorrhoids and anal fissures for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre topikale midler for behandling mot hemorrider og analfissurer"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA22"/>
      <designation>
         <language value="en"/>
         <value value="Cloxazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloksazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="V08B"/>
      <designation>
         <language value="en"/>
         <value value="X-ray contrast media, non-iodinated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Røntgenkontrastmidler, uten jod"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA"/>
      <designation>
         <language value="en"/>
         <value value="Synthetic anticholinergics, esters with tertiary amino group"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syntetiske antikolinergika, estre med en tertiær aminogruppe"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA07"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF02"/>
      <designation>
         <language value="en"/>
         <value value="Baricitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Baricitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX19"/>
      <designation>
         <language value="en"/>
         <value value="Sabatolimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sabatolimab"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoideahormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA02"/>
      <designation>
         <language value="en"/>
         <value value="Sodium bicarbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumhydrogenkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01CA24"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA20"/>
      <designation>
         <language value="en"/>
         <value value="Organic nitrates in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrater i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CX"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51E"/>
      <designation>
         <language value="en"/>
         <value value="Agents against babesiosis and theileriosis - optional classification"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot babesiosis og theileriosis - valgfri klassifisering"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD15"/>
      <designation>
         <language value="en"/>
         <value value="Valoctocogene roxaparvovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valoktokogenroksaparvovek"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other opioids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre opioider"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02AX99"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AB"/>
      <designation>
         <language value="en"/>
         <value value="Ethers chemically close to antihistamines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etere, kjemisk nærstående antihistaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BB"/>
      <designation>
         <language value="en"/>
         <value value="Prostaglandins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prostaglandiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LC01"/>
      <designation>
         <language value="en"/>
         <value value="Clonidine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klonidin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CB02"/>
      <designation>
         <language value="en"/>
         <value value="Teniposide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teniposid"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02AA11"/>
      <designation>
         <language value="en"/>
         <value value="Polymyxin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polymyksin B"/>
      </designation>
   </concept>
   <concept>
      <code value="R01BA51"/>
      <designation>
         <language value="en"/>
         <value value="Phenylpropanolamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylpropanolamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA11"/>
      <designation>
         <language value="en"/>
         <value value="Spirapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spirapril"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AB"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AC02"/>
      <designation>
         <language value="en"/>
         <value value="Thioridazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioridazin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC08"/>
      <designation>
         <language value="en"/>
         <value value="Fazadinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fazadiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BE01"/>
      <designation>
         <language value="en"/>
         <value value="Paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD18"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and gemigliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og gemigliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ13"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol and paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol og paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG02"/>
      <designation>
         <language value="en"/>
         <value value="Hydralazine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydralazin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Filgrastim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Filgrastim"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AX09"/>
      <designation>
         <language value="en"/>
         <value value="Onasemnogene abeparvovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Onasemnogenabeparvovek"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX24"/>
      <designation>
         <language value="en"/>
         <value value="Tecovirimat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tekovirimat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BF"/>
      <designation>
         <language value="en"/>
         <value value="Poliomyelitis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poliomyelittvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA04"/>
      <designation>
         <language value="en"/>
         <value value="Urofollitropin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urofollitropin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE03"/>
      <designation>
         <language value="en"/>
         <value value="Sertindole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sertindol"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BB"/>
      <designation>
         <language value="en"/>
         <value value="Folic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Folsyre og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AA13"/>
      <designation>
         <language value="en"/>
         <value value="Pegfilgrastim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pegfilgrastim"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB06"/>
      <designation>
         <language value="en"/>
         <value value="Iotrolan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jotrolan"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AG"/>
      <designation>
         <language value="en"/>
         <value value="Fenamates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenamater"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues for injection, fast-acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til injeksjon, hurtigvirkende"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04"/>
      <designation>
         <language value="en"/>
         <value value="Urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urologika"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX12"/>
      <designation>
         <language value="en"/>
         <value value="Lomitapide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lomitapid"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA01"/>
      <designation>
         <language value="en"/>
         <value value="Parathyroid gland extract"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parathyreoideakjertel ekstrakt"/>
      </designation>
   </concept>
   <concept>
      <code value="G02BB"/>
      <designation>
         <language value="en"/>
         <value value="Intravaginal contraceptives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Intravaginale antikonseptiva"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX26"/>
      <designation>
         <language value="en"/>
         <value value="Fexofenadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Feksofenadin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01CA93"/>
      <designation>
         <language value="en"/>
         <value value="Deslorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deslorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD01"/>
      <designation>
         <language value="en"/>
         <value value="Carmustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karmustin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX05"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and nebivolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og nebivolol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AB02"/>
      <designation>
         <language value="en"/>
         <value value="Moxidectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksidektin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antithrombotic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antitrombotiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC11"/>
      <designation>
         <language value="en"/>
         <value value="Iloprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iloprost"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC04"/>
      <designation>
         <language value="en"/>
         <value value="Atracurium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atrakurium"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Amino(diphenylhydantoin) valeric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminodifenylhydantoinvaleriansyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB"/>
      <designation>
         <language value="en"/>
         <value value="Hydantoin derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydantoinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA12"/>
      <designation>
         <language value="en"/>
         <value value="Zinc chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BC11"/>
      <designation>
         <language value="en"/>
         <value value="Bromfenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromfenak"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD13"/>
      <designation>
         <language value="en"/>
         <value value="Sodium sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC01"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC02"/>
      <designation>
         <language value="en"/>
         <value value="Fluorouracil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorouracil"/>
      </designation>
   </concept>
   <concept>
      <code value="A05"/>
      <designation>
         <language value="en"/>
         <value value="Bile and liver therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galle- og leverterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA01"/>
      <designation>
         <language value="en"/>
         <value value="Beclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA08"/>
      <designation>
         <language value="en"/>
         <value value="Carbinoxamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbinoksamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD05"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinyl alcohol (pyridylcarbinol)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinylalkohol (pyridylkarbinol)"/>
      </designation>
   </concept>
   <concept>
      <code value="B03"/>
      <designation>
         <language value="en"/>
         <value value="Antianemic preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot anemi"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XD07"/>
      <designation>
         <language value="en"/>
         <value value="Padeliporfin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Padeliporfin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AC01"/>
      <designation>
         <language value="en"/>
         <value value="Benzatropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benztropin"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IX12"/>
      <designation>
         <language value="en"/>
         <value value="Fluciclovine (18F)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluciklovin (18F)"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA04"/>
      <designation>
         <language value="en"/>
         <value value="Irbesartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Irbesartan"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB08"/>
      <designation>
         <language value="en"/>
         <value value="Thioproperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioproperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10B"/>
      <designation>
         <language value="en"/>
         <value value="Anti-acne preparations for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til systemisk behandling av akne"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CE"/>
      <designation>
         <language value="en"/>
         <value value="Selenium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selen"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA08"/>
      <designation>
         <language value="en"/>
         <value value="Dibenzepin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dibenzepin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA09"/>
      <designation>
         <language value="en"/>
         <value value="Metaraminol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metaraminol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AC"/>
      <designation>
         <language value="en"/>
         <value value="Anthrax vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antraksvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="M03A"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants, peripherally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifert virkende muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX04"/>
      <designation>
         <language value="en"/>
         <value value="Nitisinone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitisinon"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CA02"/>
      <designation>
         <language value="en"/>
         <value value="Oxprenolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksprenolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CX"/>
      <designation>
         <language value="en"/>
         <value value="Other selective calcium channel blockers with mainly vascular effects"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre selektive kalsiumantagonister med primært vaskulær virkning"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA02"/>
      <designation>
         <language value="en"/>
         <value value="Diphenhydramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenhydramin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD15"/>
      <designation>
         <language value="en"/>
         <value value="Nimetazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nimetazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB"/>
      <designation>
         <language value="en"/>
         <value value="Bisphosphonates, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisfosfonater, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01FA94"/>
      <designation>
         <language value="en"/>
         <value value="Tulathromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tulatromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA04"/>
      <designation>
         <language value="en"/>
         <value value="Nicardipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikardipin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA53"/>
      <designation>
         <language value="en"/>
         <value value="Estradiol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østradiol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BC03"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortolone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortolon og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Etanercept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etanercept"/>
      </designation>
   </concept>
   <concept>
      <code value="QL04"/>
      <designation>
         <language value="en"/>
         <value value="Immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EC"/>
      <designation>
         <language value="en"/>
         <value value="Intermediate-acting sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider med middels lang virketid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA52"/>
      <designation>
         <language value="en"/>
         <value value="Diphenhydramine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenhydramin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ"/>
      <designation>
         <language value="en"/>
         <value value="Complement inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Komplementhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB08"/>
      <designation>
         <language value="en"/>
         <value value="Galsulfase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galsulfase"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX15"/>
      <designation>
         <language value="en"/>
         <value value="Bempedoic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bempedoinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AA02"/>
      <designation>
         <language value="en"/>
         <value value="Sodium aminosalicylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosalisylatnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA14"/>
      <designation>
         <language value="en"/>
         <value value="Melitracen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melitracen"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11C"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin A and D, incl. combinations of the two"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin A og D, inkl. A og D i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB13"/>
      <designation>
         <language value="en"/>
         <value value="Oxametacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksametacin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX20"/>
      <designation>
         <language value="en"/>
         <value value="Tremelimumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tremelimumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DA02"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF09"/>
      <designation>
         <language value="en"/>
         <value value="Glucarpidase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukarpidase"/>
      </designation>
   </concept>
   <concept>
      <code value="QD04A"/>
      <designation>
         <language value="en"/>
         <value value="Antipruritics, incl. antihistamines, anesthetics,  etc."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kløemidler, inkl. antihistaminer, anestetika, etc."/>
      </designation>
   </concept>
   <concept>
      <code value="C09XA52"/>
      <designation>
         <language value="en"/>
         <value value="Aliskiren and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aliskiren og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB07"/>
      <designation>
         <language value="en"/>
         <value value="Risedronic acid and colecalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risedronsyre og kolekalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AA"/>
      <designation>
         <language value="en"/>
         <value value="Centrally acting antiobesity products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sentralt virkende midler mot fedme"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI02"/>
      <designation>
         <language value="en"/>
         <value value="Ceftaroline fosamil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftarolin fosamil"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB09"/>
      <designation>
         <language value="en"/>
         <value value="Ibandronic acid and colecalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibandronsyre og kolekalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF06"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate and pyronaridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat og pyronaridin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB06"/>
      <designation>
         <language value="en"/>
         <value value="Dexbrompheniramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksbromfeniramin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LX"/>
      <designation>
         <language value="en"/>
         <value value="Other antihypertensives and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antihypertensiva og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04C"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in benign prostatic hypertrophy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot benign prostatahyperplasi"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA04"/>
      <designation>
         <language value="en"/>
         <value value="Antithymocyte immunoglobulin (rabbit)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitymocyttimmunglobulin (kanin)"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC07"/>
      <designation>
         <language value="en"/>
         <value value="Norgestrienone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestrienon"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG01"/>
      <designation>
         <language value="en"/>
         <value value="Dihydralazine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydralazin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BG04"/>
      <designation>
         <language value="en"/>
         <value value="Lobeglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lobeglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF"/>
      <designation>
         <language value="en"/>
         <value value="Monoamine oxidase inhibitors, non-selective"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="MAO-hemmere, uselektive"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX15"/>
      <designation>
         <language value="en"/>
         <value value="Rifamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD02"/>
      <designation>
         <language value="en"/>
         <value value="Pertuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pertuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C03"/>
      <designation>
         <language value="en"/>
         <value value="Diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA05"/>
      <designation>
         <language value="en"/>
         <value value="Tasosartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tasosartan"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA06"/>
      <designation>
         <language value="en"/>
         <value value="Norfloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norfloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD02"/>
      <designation>
         <language value="en"/>
         <value value="Nitrazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX04"/>
      <designation>
         <language value="en"/>
         <value value="Bisoprolol and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisoprolol og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC09"/>
      <designation>
         <language value="en"/>
         <value value="Tegoprazan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tegoprazan"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB19"/>
      <designation>
         <language value="en"/>
         <value value="Physostigmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fysostigmin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC07"/>
      <designation>
         <language value="en"/>
         <value value="Conjugated estrogens and bazedoxifene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Konjugerte østrogener og bazedoksifen"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CD"/>
      <designation>
         <language value="en"/>
         <value value="Fluoride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorid"/>
      </designation>
   </concept>
   <concept>
      <code value="A07BB"/>
      <designation>
         <language value="en"/>
         <value value="Bismuth preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vismutmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA05"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA07"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="V08BA"/>
      <designation>
         <language value="en"/>
         <value value="Barium sulfate containing X-ray contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bariumsulfatholdige røntgenkontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01MA95"/>
      <designation>
         <language value="en"/>
         <value value="Orbifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orbifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE09"/>
      <designation>
         <language value="en"/>
         <value value="Patiromer calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Patiromerkalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL06"/>
      <designation>
         <language value="en"/>
         <value value="Brexucabtagene autoleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Breksukabtagenautoleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BC30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07AA03"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED"/>
      <designation>
         <language value="en"/>
         <value value="Anaplastic lymphoma kinase (ALK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anaplastisk lymfomkinasehemmere (ALK)"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA13"/>
      <designation>
         <language value="en"/>
         <value value="Fenquizone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenkvison"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA06"/>
      <designation>
         <language value="en"/>
         <value value="Amodiaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amodiakin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CC01"/>
      <designation>
         <language value="en"/>
         <value value="Chloral hydrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloralhydrat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD06"/>
      <designation>
         <language value="en"/>
         <value value="Tedisamil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tedisamil"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Melphalan flufenamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melfalanflufenamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CB01"/>
      <designation>
         <language value="en"/>
         <value value="Zinc sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinksulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA52"/>
      <designation>
         <language value="en"/>
         <value value="Morphine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01B"/>
      <designation>
         <language value="en"/>
         <value value="Anesthestics, local"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA51"/>
      <designation>
         <language value="en"/>
         <value value="Potassium chloride, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumklorid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AA03"/>
      <designation>
         <language value="en"/>
         <value value="Febuxostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Febuksostat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB07"/>
      <designation>
         <language value="en"/>
         <value value="Sulfathiazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfatiazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C07B"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents and thiazider"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="A11E"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="P02BX"/>
      <designation>
         <language value="en"/>
         <value value="Other antitrematodal agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot trematoder"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX25"/>
      <designation>
         <language value="en"/>
         <value value="Hyperici herba"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyperici herba"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AC"/>
      <designation>
         <language value="en"/>
         <value value="Antracen derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antracenderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA16"/>
      <designation>
         <language value="en"/>
         <value value="Dienogest and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienogest og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD26"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and lobeglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og lobeglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC04"/>
      <designation>
         <language value="en"/>
         <value value="Brinzolamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brinzolamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AA11"/>
      <designation>
         <language value="en"/>
         <value value="Equine rhinopneumonitis virus + equine abortion virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesterhinopneumonivirus + hesteabortvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC55"/>
      <designation>
         <language value="en"/>
         <value value="Colecalciferol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolekalsiferol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB05"/>
      <designation>
         <language value="en"/>
         <value value="Irbesartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Irbesartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QR"/>
      <designation>
         <language value="en"/>
         <value value="Respiratory system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Respirasjonsorganer"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE56"/>
      <designation>
         <language value="en"/>
         <value value="Insulin degludec and liraglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin degludek og liraglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX13"/>
      <designation>
         <language value="en"/>
         <value value="Enfortumab vedotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enfortumabvedotin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BD"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, very potent, combinations with antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, ekstra sterke, kombinasjoner med antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AD09"/>
      <designation>
         <language value="en"/>
         <value value="Ganciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ganciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="QL04AD"/>
      <designation>
         <language value="en"/>
         <value value="Calcineurin inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsineurinhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX02"/>
      <designation>
         <language value="en"/>
         <value value="Pravastatin and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pravastatin og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC"/>
      <designation>
         <language value="en"/>
         <value value="Pyrimidine analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrimidinanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD02"/>
      <designation>
         <language value="en"/>
         <value value="Magaldrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magaldrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10AC03"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (pork)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (svin)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Melphalan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melfalan"/>
      </designation>
   </concept>
   <concept>
      <code value="B05AA01"/>
      <designation>
         <language value="en"/>
         <value value="Albumin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Albumin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB05"/>
      <designation>
         <language value="en"/>
         <value value="Flumetasone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetason og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, weak, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, milde, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BC02"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA13"/>
      <designation>
         <language value="en"/>
         <value value="Halazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01XA18"/>
      <designation>
         <language value="en"/>
         <value value="Ciclosporin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklosporin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01H"/>
      <designation>
         <language value="en"/>
         <value value="Local anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Pyridostigmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyridostigmin"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05BB01"/>
      <designation>
         <language value="en"/>
         <value value="Electrolytes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Electrolytes"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AB01"/>
      <designation>
         <language value="en"/>
         <value value="Glutamic acid hydrochloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glutaminsyrehydroklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AE51"/>
      <designation>
         <language value="en"/>
         <value value="Carbamide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbamid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AG"/>
      <designation>
         <language value="en"/>
         <value value="Alpha and beta blocking agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa- og betablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA"/>
      <designation>
         <language value="en"/>
         <value value="Glycopeptide antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykopeptid antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V03A"/>
      <designation>
         <language value="en"/>
         <value value="All other therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A07"/>
      <designation>
         <language value="en"/>
         <value value="Antidiarrheals, intestinal antiinflammatory/antiinfective agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidiarroika, tarmantiseptika og antiinflammatoriske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR13"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine, abacavir and dolutegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin, abakavir og dolutegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AA03"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA02"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-pertussis-poliomyelitis-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-kikhoste-poliomyelitt-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="S02AA14"/>
      <designation>
         <language value="en"/>
         <value value="Gentamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gentamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XJ"/>
      <designation>
         <language value="en"/>
         <value value="Hedgehog pathway inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hedgehog-signalvei hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AA03"/>
      <designation>
         <language value="en"/>
         <value value="Porcine influenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svineinfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AE"/>
      <designation>
         <language value="en"/>
         <value value="Propionic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propionsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AC10"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR05"/>
      <designation>
         <language value="en"/>
         <value value="Piperacillin and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piperacillin og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX10"/>
      <designation>
         <language value="en"/>
         <value value="Maribavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Maribavir"/>
      </designation>
   </concept>
   <concept>
      <code value="C02K"/>
      <designation>
         <language value="en"/>
         <value value="Other antihypertensives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antihypertensiva"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX32"/>
      <designation>
         <language value="en"/>
         <value value="Elranatamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elranatamab"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AD03"/>
      <designation>
         <language value="en"/>
         <value value="Benzocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzokain"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE10"/>
      <designation>
         <language value="en"/>
         <value value="Sodium zirconium cyclosilicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumsirkoniumsyklosilikat"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB06"/>
      <designation>
         <language value="en"/>
         <value value="Trichlormethiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triklormetiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA04"/>
      <designation>
         <language value="en"/>
         <value value="Clemastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klemastin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02"/>
      <designation>
         <language value="en"/>
         <value value="Antimycotics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimykotika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB04"/>
      <designation>
         <language value="en"/>
         <value value="Cladribine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kladribin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD02"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (beef)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (storfe)"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01XA"/>
      <designation>
         <language value="en"/>
         <value value="Other ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AD"/>
      <designation>
         <language value="en"/>
         <value value="Thiocarbamide derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiokarbamidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA13"/>
      <designation>
         <language value="en"/>
         <value value="Norelgestromin and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norelgestromin og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CB"/>
      <designation>
         <language value="en"/>
         <value value="Tests for fat absorption"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til undersøkelse av fettabsorbsjon"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA05"/>
      <designation>
         <language value="en"/>
         <value value="Palopegteriparatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palopegteriparatid"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CA03"/>
      <designation>
         <language value="en"/>
         <value value="Guaifenesin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guaifenesin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Butylscopolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butylskopolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07A"/>
      <designation>
         <language value="en"/>
         <value value="Bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterievaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX01"/>
      <designation>
         <language value="en"/>
         <value value="Edrecolomab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Edrekolomab"/>
      </designation>
   </concept>
   <concept>
      <code value="J04BA02"/>
      <designation>
         <language value="en"/>
         <value value="Dapsone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dapson"/>
      </designation>
   </concept>
   <concept>
      <code value="A07F"/>
      <designation>
         <language value="en"/>
         <value value="Antidiarrheal microorganisms"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidiarroiske mikroorganismer"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR22"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir alafenamide, darunavir and cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofoviralafenamid, darunavir og kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AR02"/>
      <designation>
         <language value="en"/>
         <value value="Avian tuberculin PPD"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fugletuberkulin PPD"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX08"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA03"/>
      <designation>
         <language value="en"/>
         <value value="Lisinopril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisinopril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="P02"/>
      <designation>
         <language value="en"/>
         <value value="Anthelminitics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anthelmintika"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterials for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA07"/>
      <designation>
         <language value="en"/>
         <value value="Telmisartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telmisartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FA01"/>
      <designation>
         <language value="en"/>
         <value value="Rituximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rituksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AF"/>
      <designation>
         <language value="en"/>
         <value value="Morphinan derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfinanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BX03"/>
      <designation>
         <language value="en"/>
         <value value="Piracetam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piracetam"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AX"/>
      <designation>
         <language value="en"/>
         <value value="Calcium, combinations with vitamin D and/or other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium, kombinasjoner med vitamin D og/eller andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09AX99"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BE05"/>
      <designation>
         <language value="en"/>
         <value value="Propacetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propacetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BB"/>
      <designation>
         <language value="en"/>
         <value value="Pyrazolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrazoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA06"/>
      <designation>
         <language value="en"/>
         <value value="Quinbolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinbolon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FY01"/>
      <designation>
         <language value="en"/>
         <value value="Pertuzumab and trastuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pertuzumab og trastuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB02"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamethizole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametizol"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XX02"/>
      <designation>
         <language value="en"/>
         <value value="Trometamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trometamol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG14"/>
      <designation>
         <language value="en"/>
         <value value="Ublituximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ublituksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A09A"/>
      <designation>
         <language value="en"/>
         <value value="Digestives, incl. enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digestiva, inkl.enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XJ03"/>
      <designation>
         <language value="en"/>
         <value value="Glasdegib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glasdegib"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01E"/>
      <designation>
         <language value="en"/>
         <value value="Protein kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM05"/>
      <designation>
         <language value="en"/>
         <value value="Scopolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Skopolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01FF01"/>
      <designation>
         <language value="en"/>
         <value value="Clindamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klindamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AA"/>
      <designation>
         <language value="en"/>
         <value value="Curare alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kurarealkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA"/>
      <designation>
         <language value="en"/>
         <value value="Fluoroquinolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorokinoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BK03"/>
      <designation>
         <language value="en"/>
         <value value="Zoster. purified antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zoster, renset antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04CX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs used in benign prostatic hypertrophy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot benign prostatahyperplasi"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04BX"/>
      <designation>
         <language value="en"/>
         <value value="Other urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre urologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA09"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-haemophilus influenzae B-kikhoste-poliomyelitt-tetanus-hepatitt B"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BE02"/>
      <designation>
         <language value="en"/>
         <value value="Fluralaner"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluralaner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EL01"/>
      <designation>
         <language value="en"/>
         <value value="Ibrutinibq"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibrutinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01E"/>
      <designation>
         <language value="en"/>
         <value value="Pigeon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Due"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FC"/>
      <designation>
         <language value="en"/>
         <value value="CD38 (Clusters of differentitation 38) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="CD38 (Differensieringsantigen 38) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AA51"/>
      <designation>
         <language value="en"/>
         <value value="Allopurinol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allopurinol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB07"/>
      <designation>
         <language value="en"/>
         <value value="Nelarabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nelarabin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE02"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadiazine and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadiazin og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX"/>
      <designation>
         <language value="en"/>
         <value value="Other nervous system drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på nervesystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AC02"/>
      <designation>
         <language value="en"/>
         <value value="Calcium silicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumsilikat"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB03"/>
      <designation>
         <language value="en"/>
         <value value="Clopamide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klopamid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB07"/>
      <designation>
         <language value="en"/>
         <value value="Clofenamide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofenamid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="QI08"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for leporidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for hare"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EK"/>
      <designation>
         <language value="en"/>
         <value value="Vascular endothelial growth factor receptor (VEGFR)-tyrosine kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vaskulær endotel vekstfaktorreseptor (VEGFR) tyrosinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA01"/>
      <designation>
         <language value="en"/>
         <value value="Losartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Losartan"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB08"/>
      <designation>
         <language value="en"/>
         <value value="Pirarubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pirarubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AE03"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GA01"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06B"/>
      <designation>
         <language value="en"/>
         <value value="Chemotherapeutics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kjemoterapeutika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EW10"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadiazine and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadiazin og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED03"/>
      <designation>
         <language value="en"/>
         <value value="Alectinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alektinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA06"/>
      <designation>
         <language value="en"/>
         <value value="Emamectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emamektin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11DB"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1 in combination with vitamin B6 and/or vitamin B12"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1 i kombinasjoner med vitamin B6 og/eller vitamin B12"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC04"/>
      <designation>
         <language value="en"/>
         <value value="Diflucortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflukortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB03"/>
      <designation>
         <language value="en"/>
         <value value="Gentamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gentamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesium"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC03"/>
      <designation>
         <language value="en"/>
         <value value="Terbutaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbutalin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE04"/>
      <designation>
         <language value="en"/>
         <value value="Calcium acetate and magnesium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumacetat og magnesiumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="N07X"/>
      <designation>
         <language value="en"/>
         <value value="Other nervous system drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på nervesystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA03"/>
      <designation>
         <language value="en"/>
         <value value="Doramectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doramektin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BA52"/>
      <designation>
         <language value="en"/>
         <value value="Procaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Clotrimazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klotrimazol"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB04"/>
      <designation>
         <language value="en"/>
         <value value="Risedronic acid, calcium and colecalciferol, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risedronsyre, kalsium og kolekalsiferol, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="M02A"/>
      <designation>
         <language value="en"/>
         <value value="Topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topikale midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC25"/>
      <designation>
         <language value="en"/>
         <value value="Levilimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levilimab"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BA02"/>
      <designation>
         <language value="en"/>
         <value value="Carisoprodol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karisoprodol"/>
      </designation>
   </concept>
   <concept>
      <code value="P"/>
      <designation>
         <language value="en"/>
         <value value="Antiparasitic products, insecticides and repellents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiparasitære midler, insekticider og insektmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in diabetes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til diabetesbehandling"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX"/>
      <designation>
         <language value="en"/>
         <value value="Other monoclonal antibodies and antibody drug conjugates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre monoklonale antistoffer og antistoff-legemiddelkonjugater"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01"/>
      <designation>
         <language value="en"/>
         <value value="Ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EX01"/>
      <designation>
         <language value="en"/>
         <value value="Lidoflazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidoflazin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AH01"/>
      <designation>
         <language value="en"/>
         <value value="Chlorothiazide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortiazid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB16"/>
      <designation>
         <language value="en"/>
         <value value="(2-benzhydryloxyethyl)diethyl-methylammonium iodide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="(2-benzhydryloksyetyl)dietylmetylammonium jodid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA27"/>
      <designation>
         <language value="en"/>
         <value value="Droxidopa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Droksidopa"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA16"/>
      <designation>
         <language value="en"/>
         <value value="Cardioplegia solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kardioplegiløsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA27"/>
      <designation>
         <language value="en"/>
         <value value="Voretigene neparvovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Voretigenneparvovek"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB06"/>
      <designation>
         <language value="en"/>
         <value value="Terguride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tergurid"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA02"/>
      <designation>
         <language value="en"/>
         <value value="Enalapril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enalapril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA04"/>
      <designation>
         <language value="en"/>
         <value value="Eprinomectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eprinomektin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE"/>
      <designation>
         <language value="en"/>
         <value value="Sphingosine 1-phosphate (S1P) receptor modulators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sfingosin-1-fosfat (S1P) reseptormodulatorer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XC01"/>
      <designation>
         <language value="en"/>
         <value value="Fusidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fusidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Calcitonin (salmon synthetic)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laksekalsitonin, syntetisk"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA27"/>
      <designation>
         <language value="en"/>
         <value value="Cloranolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloranolol"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CD01"/>
      <designation>
         <language value="en"/>
         <value value="Metyrapone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyrapon"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA09"/>
      <designation>
         <language value="en"/>
         <value value="Syrosingopine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syrosingopin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AP"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoidvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA05AX90"/>
      <designation>
         <language value="en"/>
         <value value="Menbutone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Menbuton"/>
      </designation>
   </concept>
   <concept>
      <code value="QA04"/>
      <designation>
         <language value="en"/>
         <value value="Antiemetics and antinauseants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC07"/>
      <designation>
         <language value="en"/>
         <value value="Doxacurium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksakuriumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QC08"/>
      <designation>
         <language value="en"/>
         <value value="Calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA03"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-rubella-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-rubella-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="QC05BA"/>
      <designation>
         <language value="en"/>
         <value value="Heparins or heparinoids for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hepariner eller heparinoider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD62"/>
      <designation>
         <language value="en"/>
         <value value="Cefoperazone and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefoperazon og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="C05CA"/>
      <designation>
         <language value="en"/>
         <value value="Bioflavonoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bioflavonoider"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA07"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylpyraline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylpyralin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CH02"/>
      <designation>
         <language value="en"/>
         <value value="Indigo carmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indigokarmin"/>
      </designation>
   </concept>
   <concept>
      <code value="A09"/>
      <designation>
         <language value="en"/>
         <value value="Digestives, incl. enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digestiva, inkl.enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB09"/>
      <designation>
         <language value="en"/>
         <value value="Fimasartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fimasartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08A"/>
      <designation>
         <language value="en"/>
         <value value="Antiseptics and disinfectants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiseptika og desinfiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC10"/>
      <designation>
         <language value="en"/>
         <value value="Indobufen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indobufen"/>
      </designation>
   </concept>
   <concept>
      <code value="A07A"/>
      <designation>
         <language value="en"/>
         <value value="Intestinal antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tarmantiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC15"/>
      <designation>
         <language value="en"/>
         <value value="Sirukumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sirukumab"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BB"/>
      <designation>
         <language value="en"/>
         <value value="Solutions affecting the electrolyte balance"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Løsninger med effekt på elektrolyttbalansen"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA11"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-haemophilus influenzae B-kikhoste-tetanus-hepatitt B"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Glycerol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyserol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Camylofin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kamylofin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BC01"/>
      <designation>
         <language value="en"/>
         <value value="Glymidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glymidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC02"/>
      <designation>
         <language value="en"/>
         <value value="Naratriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naratriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BX03"/>
      <designation>
         <language value="en"/>
         <value value="Phenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenol"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BD05"/>
      <designation>
         <language value="en"/>
         <value value="Sotrovimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotrovimab"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AX"/>
      <designation>
         <language value="en"/>
         <value value="Other peripheral vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre perifere kardilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Corticotropin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD06"/>
      <designation>
         <language value="en"/>
         <value value="Latamoxef"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Latamoksef"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ethyl esters of iodised fatty acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etylestre av joderte fettsyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens and estrogens, fixed combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener og østrogener, faste kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG12"/>
      <designation>
         <language value="en"/>
         <value value="Ofatumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ofatumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C09XA54"/>
      <designation>
         <language value="en"/>
         <value value="Aliskiren, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aliskiren, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other ectoparasiticides, incl. scabicides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre ektoparasittmidler, inkl. skabbmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX23"/>
      <designation>
         <language value="en"/>
         <value value="Mitotane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitotan"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX06"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril, bisoprolol, amlodipine and indapamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril, bisoprolol, amlodipin og indapamid"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Dimercaprol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimerkaprol"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB05"/>
      <designation>
         <language value="en"/>
         <value value="Aurotioprol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aurotioprol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA04"/>
      <designation>
         <language value="en"/>
         <value value="Vinorelbine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinorelbin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG16"/>
      <designation>
         <language value="en"/>
         <value value="Rozanolixizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rozanoliksizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA07"/>
      <designation>
         <language value="en"/>
         <value value="Lutropin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lutropin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA53"/>
      <designation>
         <language value="en"/>
         <value value="Hydromorphone and naloxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydromorfon og nalokson"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GA52"/>
      <designation>
         <language value="en"/>
         <value value="Tetryzoline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetryzolin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA"/>
      <designation>
         <language value="en"/>
         <value value="Other plain vitamin preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre usammensatte vitaminmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BD01"/>
      <designation>
         <language value="en"/>
         <value value="Theobromine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teobromin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AC04"/>
      <designation>
         <language value="en"/>
         <value value="Antazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51F"/>
      <designation>
         <language value="en"/>
         <value value="Macrolides and lincosamides for intramammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrolider og linkosamider for intramammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX08"/>
      <designation>
         <language value="en"/>
         <value value="Teduglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teduglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergic and dopaminergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenerge og dopaminerge midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BJ51"/>
      <designation>
         <language value="en"/>
         <value value="Rubella, combinations with mumps, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rubella, kombinert med kusma, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="A11GA01"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vit C)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Askorbinsyre (vit C)"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CG01"/>
      <designation>
         <language value="en"/>
         <value value="Sulbactam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulbaktam"/>
      </designation>
   </concept>
   <concept>
      <code value="N05B"/>
      <designation>
         <language value="en"/>
         <value value="Anxiolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anksiolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE01"/>
      <designation>
         <language value="en"/>
         <value value="Benzylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB01"/>
      <designation>
         <language value="en"/>
         <value value="Rosoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX07"/>
      <designation>
         <language value="en"/>
         <value value="Cabozantinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabozantinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA"/>
      <designation>
         <language value="en"/>
         <value value="Tetracyclines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasykliner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BA04"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE"/>
      <designation>
         <language value="en"/>
         <value value="Prostaglandin analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prostaglandinanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02"/>
      <designation>
         <language value="en"/>
         <value value="Antihemorrhagics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihemoragika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AX01"/>
      <designation>
         <language value="en"/>
         <value value="Mitobronitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitobronitol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX52"/>
      <designation>
         <language value="en"/>
         <value value="Ambrisentan and tadalafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ambrisentan og tadalafil"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01E"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB01"/>
      <designation>
         <language value="en"/>
         <value value="Clobetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klobetason"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX22"/>
      <designation>
         <language value="en"/>
         <value value="Ebastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ebastin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CE99"/>
      <designation>
         <language value="en"/>
         <value value="Selenium, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selen, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC03"/>
      <designation>
         <language value="en"/>
         <value value="Dorzolamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dorzolamid"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CA51"/>
      <designation>
         <language value="en"/>
         <value value="Mebendazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebendazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA03"/>
      <designation>
         <language value="en"/>
         <value value="Pravastatin and fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pravastatin og fenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR02"/>
      <designation>
         <language value="en"/>
         <value value="Amoxicillin and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amoksicillin og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BG07"/>
      <designation>
         <language value="en"/>
         <value value="Cibenzoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cibenzolin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AE04"/>
      <designation>
         <language value="en"/>
         <value value="Triptorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triptorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="V08A"/>
      <designation>
         <language value="en"/>
         <value value="X-ray contrast media, iodinated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Røntgenkontrastmidler, med jod"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX24"/>
      <designation>
         <language value="en"/>
         <value value="Pegaspargase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pegaspargase"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA04"/>
      <designation>
         <language value="en"/>
         <value value="Altizide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Altizid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA01"/>
      <designation>
         <language value="en"/>
         <value value="Losartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Losartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE02"/>
      <designation>
         <language value="en"/>
         <value value="Methylrosaniline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylrosanilin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AC03"/>
      <designation>
         <language value="en"/>
         <value value="Deferasirox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deferasiroks"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA01"/>
      <designation>
         <language value="en"/>
         <value value="Desipramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desipramin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED06"/>
      <designation>
         <language value="en"/>
         <value value="Sulfaperin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfaperin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA01"/>
      <designation>
         <language value="en"/>
         <value value="Atropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atropin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR50"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ17"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone and paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon og paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AB03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrochloric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saltsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="S02"/>
      <designation>
         <language value="en"/>
         <value value="Otologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Øremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AJ51"/>
      <designation>
         <language value="en"/>
         <value value="Pertussis, inactivated, whole cell, combinations with toxoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kikhoste, inaktivert, helcelle, kombinasjoner med toksoider"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BA"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="V07A"/>
      <designation>
         <language value="en"/>
         <value value="All other non-therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre ikke-terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03CC13"/>
      <designation>
         <language value="en"/>
         <value value="Clenbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klenbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE15"/>
      <designation>
         <language value="en"/>
         <value value="Terbinafine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbinafin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC56"/>
      <designation>
         <language value="en"/>
         <value value="Meloxicam, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meloksikam, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA55"/>
      <designation>
         <language value="en"/>
         <value value="Aminophylline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllinetylendiamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07X"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GA01"/>
      <designation>
         <language value="en"/>
         <value value="Naphazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nafazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AA"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB05"/>
      <designation>
         <language value="en"/>
         <value value="Metergoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metergolin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA06"/>
      <designation>
         <language value="en"/>
         <value value="Roxatidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Roksatidin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB09"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC"/>
      <designation>
         <language value="en"/>
         <value value="Benzimidazoles and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzimidazoler og relaterte substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BF01"/>
      <designation>
         <language value="en"/>
         <value value="Acarbose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Akarbose"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX59"/>
      <designation>
         <language value="en"/>
         <value value="Enasidenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enasidenib"/>
      </designation>
   </concept>
   <concept>
      <code value="A11AA"/>
      <designation>
         <language value="en"/>
         <value value="Multivitamins with minerals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multivitaminer med mineraler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CE02"/>
      <designation>
         <language value="en"/>
         <value value="Phenoxymethylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoksymetylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05B"/>
      <designation>
         <language value="en"/>
         <value value="I.v. solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infusjonsløsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH02"/>
      <designation>
         <language value="en"/>
         <value value="Other meningococcal monovalent purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre meningokokk monovalent, renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA12"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE10"/>
      <designation>
         <language value="en"/>
         <value value="Darunavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darunavir"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Procaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokain"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Fusidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fusidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB02"/>
      <designation>
         <language value="en"/>
         <value value="Zimeldine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zimeldin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XA"/>
      <designation>
         <language value="en"/>
         <value value="Antigonadotropins and similar agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antigonadotropiner og lignende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CB02"/>
      <designation>
         <language value="en"/>
         <value value="Diethylstilbestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dietylstilbøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10AC"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues for injection, intermediate-acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til injeksjon, middels lang virketid"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA08"/>
      <designation>
         <language value="en"/>
         <value value="Tocofersolan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tokofersolan"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Azelastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azelastin"/>
      </designation>
   </concept>
   <concept>
      <code value="H04AA01"/>
      <designation>
         <language value="en"/>
         <value value="Glucagon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukagon"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX13"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin, perindopril and indapamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin, perindopril og indapamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX03"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX58"/>
      <designation>
         <language value="en"/>
         <value value="Epacadostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epakadostat"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AD01"/>
      <designation>
         <language value="en"/>
         <value value="Protionamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protionamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA03"/>
      <designation>
         <language value="en"/>
         <value value="Tocopherol (vit E)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tokoferol (vit E)"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA05"/>
      <designation>
         <language value="en"/>
         <value value="Ipidacrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipidakrin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BB01"/>
      <designation>
         <language value="en"/>
         <value value="Proguanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proguanil"/>
      </designation>
   </concept>
   <concept>
      <code value="S02A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CF"/>
      <designation>
         <language value="en"/>
         <value value="Avermectines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avermektiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA05"/>
      <designation>
         <language value="en"/>
         <value value="Selamectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selamektin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA10"/>
      <designation>
         <language value="en"/>
         <value value="Mezlocillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mezlocillin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CB04"/>
      <designation>
         <language value="en"/>
         <value value="Moxestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksestrol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03BB"/>
      <designation>
         <language value="en"/>
         <value value="5-androstanon (3) derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="5-androstanon (3) derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other general anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre generelle anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BH01"/>
      <designation>
         <language value="en"/>
         <value value="Rota virus, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rotavirus, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QG51AA01"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05BA"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA05"/>
      <designation>
         <language value="en"/>
         <value value="Aflibercept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aflibercept"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE05"/>
      <designation>
         <language value="en"/>
         <value value="Amprenavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amprenavir"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AC"/>
      <designation>
         <language value="en"/>
         <value value="Bulk-forming laxatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Volumøkende laksantia"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Ketoconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketokonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA22"/>
      <designation>
         <language value="en"/>
         <value value="Abetimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abetimus"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA19"/>
      <designation>
         <language value="en"/>
         <value value="Aspoxicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aspoksicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX21"/>
      <designation>
         <language value="en"/>
         <value value="Tepotinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tepotinib"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Phytomenadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fytomenadion"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA03"/>
      <designation>
         <language value="en"/>
         <value value="Epitizide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epitizid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06"/>
      <designation>
         <language value="en"/>
         <value value="Psychoanaleptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykoanaleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AG02"/>
      <designation>
         <language value="en"/>
         <value value="Povidone-iodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Povidon, jodert"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA"/>
      <designation>
         <language value="en"/>
         <value value="Synthetic anticholinergic agents in combination with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syntetiske antikolinergika i kombinasjon med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA12"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin and ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin og ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX05"/>
      <designation>
         <language value="en"/>
         <value value="Bacitracin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bacitracin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB07"/>
      <designation>
         <language value="en"/>
         <value value="Desflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desfluran"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE15"/>
      <designation>
         <language value="en"/>
         <value value="Flunoxaprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flunoksaprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of rauwolfia alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider i blanding"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP51"/>
      <designation>
         <language value="en"/>
         <value value="Sofosbuvir and ledipasvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sofosbuvir og ledipasvir"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD"/>
      <designation>
         <language value="en"/>
         <value value="Phenothiazine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiazinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AA"/>
      <designation>
         <language value="en"/>
         <value value="Butylpyrazolidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butylpyrazolidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX19"/>
      <designation>
         <language value="en"/>
         <value value="Carisbamate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karisbamat"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB09"/>
      <designation>
         <language value="en"/>
         <value value="Ropivacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ropivakain"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE52"/>
      <designation>
         <language value="en"/>
         <value value="Naproxen and esomeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naproksen og esomeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AB51"/>
      <designation>
         <language value="en"/>
         <value value="Milbemycin oxime, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Milbemycinoksim, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA02"/>
      <designation>
         <language value="en"/>
         <value value="Eprosartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eprosartan"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CD"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, very potent, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, ekstra sterke, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BH02"/>
      <designation>
         <language value="en"/>
         <value value="Rota virus, pentavalent, live, reassorted"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rotavirus, femverdig, levende, assorterte"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03A"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoideamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA09"/>
      <designation>
         <language value="en"/>
         <value value="Sparfloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sparfloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD15"/>
      <designation>
         <language value="en"/>
         <value value="Vonoprazan, amoxicillin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vonoprazan, amoksicillin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB03"/>
      <designation>
         <language value="en"/>
         <value value="Cabergoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabergolin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03"/>
      <designation>
         <language value="en"/>
         <value value="All other therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA02"/>
      <designation>
         <language value="en"/>
         <value value="Biperiden"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biperiden"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EB"/>
      <designation>
         <language value="en"/>
         <value value="Antiallergic agents, excl. corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiallergiske midler, ekskl. kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BA01"/>
      <designation>
         <language value="en"/>
         <value value="Nicotine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotin"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BA03"/>
      <designation>
         <language value="en"/>
         <value value="Mafenide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mafenid"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BA01"/>
      <designation>
         <language value="en"/>
         <value value="Immunoglobulins, normal human, for extravascular adm."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin, normal human, til ekstravaskulær adm"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX19"/>
      <designation>
         <language value="en"/>
         <value value="Tilorone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiloron"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX05"/>
      <designation>
         <language value="en"/>
         <value value="Micafungin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikafungin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA15"/>
      <designation>
         <language value="en"/>
         <value value="Zofenopril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zofenopril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA51"/>
      <designation>
         <language value="en"/>
         <value value="Quinidine, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinidin, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB55"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenac, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenak, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01E"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB07"/>
      <designation>
         <language value="en"/>
         <value value="Chondroitin sulfate-iron complex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kondroitinsulfat-jern kompleks"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC30"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium (different salts in combination)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesium, blanding av salter"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD06"/>
      <designation>
         <language value="en"/>
         <value value="Lormetazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lormetazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB04"/>
      <designation>
         <language value="en"/>
         <value value="Insulin lispro"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin lispro"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA04"/>
      <designation>
         <language value="en"/>
         <value value="Mercaptamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Merkaptamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE05"/>
      <designation>
         <language value="en"/>
         <value value="Insulin detemir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin detemir"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AE"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropin releasing hormone analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropinfrigjørende hormonanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB01"/>
      <designation>
         <language value="en"/>
         <value value="Brompheniramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromfeniramin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA07"/>
      <designation>
         <language value="en"/>
         <value value="Cyclopenthiazide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklopentiazid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CJ"/>
      <designation>
         <language value="en"/>
         <value value="Tests for thyreoidea function"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til påvisning av thyreoidale lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07CC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA08"/>
      <designation>
         <language value="en"/>
         <value value="Vadadustat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vadadustat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB15"/>
      <designation>
         <language value="en"/>
         <value value="Trimetazidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetazidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QR07A"/>
      <designation>
         <language value="en"/>
         <value value="Other respiratory system products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på respirasjonssystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03CC"/>
      <designation>
         <language value="en"/>
         <value value="Selective beta-2-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive beta-2-agonister"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX09"/>
      <designation>
         <language value="en"/>
         <value value="Diroximel fumarate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diroksimelfumarat"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AD03"/>
      <designation>
         <language value="en"/>
         <value value="Feline rhinotracheitis virus + feline calicivirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus + kattekalicivirus"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX18"/>
      <designation>
         <language value="en"/>
         <value value="Dorzagliatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dorzagliatin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF03"/>
      <designation>
         <language value="en"/>
         <value value="Upadacitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Upadacitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CB02"/>
      <designation>
         <language value="en"/>
         <value value="Diethylcarbamazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dietylkarbamazin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA01"/>
      <designation>
         <language value="en"/>
         <value value="Prazosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazosin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA01"/>
      <designation>
         <language value="en"/>
         <value value="Potassium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX15"/>
      <designation>
         <language value="en"/>
         <value value="Belantamab mafodotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belantamabmafodotin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XF02"/>
      <designation>
         <language value="en"/>
         <value value="Alitretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alitretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EX05"/>
      <designation>
         <language value="en"/>
         <value value="Netarsudil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Netarsudil"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC11"/>
      <designation>
         <language value="en"/>
         <value value="Ceforanide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceforanid"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB01"/>
      <designation>
         <language value="en"/>
         <value value="Aciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB13"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon beta-1a"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon beta-1a"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC05"/>
      <designation>
         <language value="en"/>
         <value value="Almotriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Almotriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="C07DB01"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol, thiazides and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol, tiazider og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA06"/>
      <designation>
         <language value="en"/>
         <value value="Timolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AC01"/>
      <designation>
         <language value="en"/>
         <value value="Anthrax antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antraksantigen"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC16"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone aceponate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortisonaceponat"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Algeldrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Algeldrat"/>
      </designation>
   </concept>
   <concept>
      <code value="C05"/>
      <designation>
         <language value="en"/>
         <value value="Vasoprotectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vasoprotektorer"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BG"/>
      <designation>
         <language value="en"/>
         <value value="Other antiarrhythmics, class I and III"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiarytmika, klasse I og III"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AX01"/>
      <designation>
         <language value="en"/>
         <value value="Nabumetone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nabumeton"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC04"/>
      <designation>
         <language value="en"/>
         <value value="Droxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Droksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Amino acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA01"/>
      <designation>
         <language value="en"/>
         <value value="Morphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BX"/>
      <designation>
         <language value="en"/>
         <value value="Other psychostimulants and nootropics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre psykostimulantia og nootropika"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB"/>
      <designation>
         <language value="en"/>
         <value value="Substituted alkylamines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkylaminer, substituerte"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA10"/>
      <designation>
         <language value="en"/>
         <value value="Nortriptyline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nortriptylin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA08"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B and hepatitis B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B og hepatitt B"/>
      </designation>
   </concept>
   <concept>
      <code value="G02C"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA03"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D06A"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA10"/>
      <designation>
         <language value="en"/>
         <value value="Gadoxetic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadoksetsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG73"/>
      <designation>
         <language value="en"/>
         <value value="Picodralazine and diuretics, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pikodralazin og diuretika, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C05C"/>
      <designation>
         <language value="en"/>
         <value value="Capillary stabilizing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kapillærstabiliserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD08"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and vildagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og vildagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX04"/>
      <designation>
         <language value="en"/>
         <value value="Tacalcitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Takalcitol"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01A"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD12"/>
      <designation>
         <language value="en"/>
         <value value="Aprepitant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aprepitant"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA11"/>
      <designation>
         <language value="en"/>
         <value value="Manidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Manidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium peroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumperoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="J04"/>
      <designation>
         <language value="en"/>
         <value value="Antimycobacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimykobakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG01"/>
      <designation>
         <language value="en"/>
         <value value="Muromonab-CD3"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muromonab-CD3"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD24"/>
      <designation>
         <language value="en"/>
         <value value="Sitagliptin and ertugliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitagliptin og ertugliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="J04BA"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of lepra"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av lepra"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AC"/>
      <designation>
         <language value="en"/>
         <value value="Hydrazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrazider"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX07"/>
      <designation>
         <language value="en"/>
         <value value="Lonidamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lonidamin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB"/>
      <designation>
         <language value="en"/>
         <value value="Iron trivalent, oral preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern III-verdig, orale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB06"/>
      <designation>
         <language value="en"/>
         <value value="Enalapril and nitrendipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enalapril og nitrendipin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE02"/>
      <designation>
         <language value="en"/>
         <value value="Molindone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Molindon"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA08"/>
      <designation>
         <language value="en"/>
         <value value="Choriogonadotropin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koriongonadotropin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EE04"/>
      <designation>
         <language value="en"/>
         <value value="Selumetinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selumetinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens and estrogens, sequential preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener og østrogener, sekvensmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA02"/>
      <designation>
         <language value="en"/>
         <value value="Clodronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klodronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD13"/>
      <designation>
         <language value="en"/>
         <value value="Cefpodoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefpodoksim"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA02"/>
      <designation>
         <language value="en"/>
         <value value="Pyridoxine (vit B6)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyridoksin (Vit B6)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XY"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD03"/>
      <designation>
         <language value="en"/>
         <value value="Adapalene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adapalen"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FB01"/>
      <designation>
         <language value="en"/>
         <value value="Phenylephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylefrin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01M"/>
      <designation>
         <language value="en"/>
         <value value="Quinolone antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolon, antibakterielle"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH93"/>
      <designation>
         <language value="en"/>
         <value value="Cimicoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cimikoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC05"/>
      <designation>
         <language value="en"/>
         <value value="Febantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Febantel"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD05"/>
      <designation>
         <language value="en"/>
         <value value="Budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EL03"/>
      <designation>
         <language value="en"/>
         <value value="Zanubrutinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zanubrutinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09"/>
      <designation>
         <language value="en"/>
         <value value="Agents acting on the renin-angiotensin system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med virkning på renin-angiotensinsystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD04"/>
      <designation>
         <language value="en"/>
         <value value="Trastuzumab deruxtecan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trastuzumabderukstekan"/>
      </designation>
   </concept>
   <concept>
      <code value="N01A"/>
      <designation>
         <language value="en"/>
         <value value="Anesthestics, general"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Generelle anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01X"/>
      <designation>
         <language value="en"/>
         <value value="Other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB05"/>
      <designation>
         <language value="en"/>
         <value value="Pheniramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Feniramin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01BA"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA04"/>
      <designation>
         <language value="en"/>
         <value value="Melevodopa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melevodopa"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AE"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AF"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives for treatment of acne"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva til behandling av akne"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB09"/>
      <designation>
         <language value="en"/>
         <value value="Gliclazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gliklazid"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Halothane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halotan"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BB01"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxyzine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksyzin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN51"/>
      <designation>
         <language value="en"/>
         <value value="Products for animal euthanasia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avlivningsmidler for dyr"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE04"/>
      <designation>
         <language value="en"/>
         <value value="Yohimbin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Johimbin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AM52"/>
      <designation>
         <language value="en"/>
         <value value="Tetanus toxoid, combinations with tetanus immunoglobulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetanustoksoid, kombinasjoner med tetanus immunglobulin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05A"/>
      <designation>
         <language value="en"/>
         <value value="Antipsychotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antipsykotika"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD04"/>
      <designation>
         <language value="en"/>
         <value value="Flunisolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flunisolid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX03"/>
      <designation>
         <language value="en"/>
         <value value="Altretamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Altretamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01CA90"/>
      <designation>
         <language value="en"/>
         <value value="Buserelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buserelin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA02"/>
      <designation>
         <language value="en"/>
         <value value="Ranitidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ranitidin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD14"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and repaglinide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og repaglinid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA16"/>
      <designation>
         <language value="en"/>
         <value value="Nordazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nordazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01AA90"/>
      <designation>
         <language value="en"/>
         <value value="Cloxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EN04"/>
      <designation>
         <language value="en"/>
         <value value="Futibatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Futibatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA51"/>
      <designation>
         <language value="en"/>
         <value value="Neostigmine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neostigmin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC14"/>
      <designation>
         <language value="en"/>
         <value value="Flomoxef"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flomoksef"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XX"/>
      <designation>
         <language value="en"/>
         <value value="Other sex hormones and modulators of the genital system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kjønnshormoner og midler med effekt på genitalia"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA04"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium hydroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumhydroksid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EB01"/>
      <designation>
         <language value="en"/>
         <value value="Pilocarpine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pilokarpin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA11"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin and tinidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin og tinidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE55"/>
      <designation>
         <language value="en"/>
         <value value="Meclozine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meklozin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R05FA01"/>
      <designation>
         <language value="en"/>
         <value value="Opium derivatives and mucolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiumsderivater og mukolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB05"/>
      <designation>
         <language value="en"/>
         <value value="Apalutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apalutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB12"/>
      <designation>
         <language value="en"/>
         <value value="Nebivolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nebivolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX17"/>
      <designation>
         <language value="en"/>
         <value value="Enisamium iodide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enisamiumjodid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC08"/>
      <designation>
         <language value="en"/>
         <value value="Etonogestrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etonogestrel"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB07"/>
      <designation>
         <language value="en"/>
         <value value="Actinobacillus/haemophilus vaccine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Actinobacillus/haemofilus vaksine"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB54"/>
      <designation>
         <language value="en"/>
         <value value="Prilocaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prilokain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AA"/>
      <designation>
         <language value="en"/>
         <value value="Antihistamines for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihistaminer til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF07"/>
      <designation>
         <language value="en"/>
         <value value="Artemisinin and piperaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemisinin og piperakin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XX01"/>
      <designation>
         <language value="en"/>
         <value value="Prasterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prasteron"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC09"/>
      <designation>
         <language value="en"/>
         <value value="Rocuronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rokuroniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02"/>
      <designation>
         <language value="en"/>
         <value value="Analgetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01A"/>
      <designation>
         <language value="en"/>
         <value value="Domestic fowl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fjærkre"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LF"/>
      <designation>
         <language value="en"/>
         <value value="Guanidine derivatives and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanidinderivater og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CE01"/>
      <designation>
         <language value="en"/>
         <value value="Levamisole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levamisol"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB03"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01X"/>
      <designation>
         <language value="en"/>
         <value value="Other ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FA02"/>
      <designation>
         <language value="en"/>
         <value value="Ofatumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ofatumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC06"/>
      <designation>
         <language value="en"/>
         <value value="Dexlansoprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekslansoprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD04"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor IX"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor IX"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11GA"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vitamin C), plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Askorbinsyre (vitamin C), usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01CB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC06"/>
      <designation>
         <language value="en"/>
         <value value="Oteseconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Otesekonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA02"/>
      <designation>
         <language value="en"/>
         <value value="Indoramin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indoramin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB10"/>
      <designation>
         <language value="en"/>
         <value value="Velaglucerase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Velaglukerase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="QI08A"/>
      <designation>
         <language value="en"/>
         <value value="Rabbit"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD23"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and ertugliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og ertugliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Carboquone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbokon"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BB"/>
      <designation>
         <language value="en"/>
         <value value="Pyrazolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrazoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XC01"/>
      <designation>
         <language value="en"/>
         <value value="Raloxifene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Raloksifen"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX32"/>
      <designation>
         <language value="en"/>
         <value value="Sequifenadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekvifenadin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AN01"/>
      <designation>
         <language value="en"/>
         <value value="Oxygen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksygen"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX19"/>
      <designation>
         <language value="en"/>
         <value value="Azelastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azelastin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX08"/>
      <designation>
         <language value="en"/>
         <value value="Elotuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elotuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AX02"/>
      <designation>
         <language value="en"/>
         <value value="Phenoxybenzamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoksybenzamin"/>
      </designation>
   </concept>
   <concept>
      <code value="P03"/>
      <designation>
         <language value="en"/>
         <value value="Ectoparasiticides incl. scabicides, insecticides og repellents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ektoparasittmidler, inkl. skabbmidler og insektmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BA02"/>
      <designation>
         <language value="en"/>
         <value value="Metformin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE"/>
      <designation>
         <language value="en"/>
         <value value="Propionic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propionsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA30"/>
      <designation>
         <language value="en"/>
         <value value="Piperidolate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piperidolat"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AD"/>
      <designation>
         <language value="en"/>
         <value value="Succinimide derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Suksinimidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC04"/>
      <designation>
         <language value="en"/>
         <value value="Posaconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Posakonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA34"/>
      <designation>
         <language value="en"/>
         <value value="Propantheline and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propantelin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA12"/>
      <designation>
         <language value="en"/>
         <value value="Drospirenone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Drospirenon og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AF"/>
      <designation>
         <language value="en"/>
         <value value="Barbiturates, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbiturater, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED03"/>
      <designation>
         <language value="en"/>
         <value value="Sulfametomidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametomidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06BA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA06"/>
      <designation>
         <language value="en"/>
         <value value="Cigar"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sigar"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC54"/>
      <designation>
         <language value="en"/>
         <value value="Rabeprazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabeprazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA09"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous aspartate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)aspartat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX13"/>
      <designation>
         <language value="en"/>
         <value value="Paliperidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paliperidon"/>
      </designation>
   </concept>
   <concept>
      <code value="J06AA03"/>
      <designation>
         <language value="en"/>
         <value value="Snake venom antiserum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Slangegiftantiserum"/>
      </designation>
   </concept>
   <concept>
      <code value="QR02A"/>
      <designation>
         <language value="en"/>
         <value value="Throat preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AX99"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX06"/>
      <designation>
         <language value="en"/>
         <value value="Benfluorex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benfluoreks"/>
      </designation>
   </concept>
   <concept>
      <code value="M09"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD16"/>
      <designation>
         <language value="en"/>
         <value value="Etranacogene dezaparvovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etranakogendezaparvovek"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA11"/>
      <designation>
         <language value="en"/>
         <value value="Yogurt"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Yoghurt"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX29"/>
      <designation>
         <language value="en"/>
         <value value="Talquetamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talkvetamab"/>
      </designation>
   </concept>
   <concept>
      <code value="N03"/>
      <designation>
         <language value="en"/>
         <value value="Antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC05"/>
      <designation>
         <language value="en"/>
         <value value="Cefotetan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefotetan"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BG07"/>
      <designation>
         <language value="en"/>
         <value value="Flupirtine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flupirtin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BA"/>
      <designation>
         <language value="en"/>
         <value value="Folic acid analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Folsyreanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DA01"/>
      <designation>
         <language value="en"/>
         <value value="Verapamil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Verapamil"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11DA01"/>
      <designation>
         <language value="en"/>
         <value value="Thiamine (vit B1)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamin (Vit B1)"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA08"/>
      <designation>
         <language value="en"/>
         <value value="Lafutidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lafutidin"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB08"/>
      <designation>
         <language value="en"/>
         <value value="Iopentol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jopentol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AX01"/>
      <designation>
         <language value="en"/>
         <value value="Leptospira vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leptospiravaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CE01"/>
      <designation>
         <language value="en"/>
         <value value="Topotecan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topotekan"/>
      </designation>
   </concept>
   <concept>
      <code value="N06CA02"/>
      <designation>
         <language value="en"/>
         <value value="Melitracen and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melitracen og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA07"/>
      <designation>
         <language value="en"/>
         <value value="Adinazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adinazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE04"/>
      <designation>
         <language value="en"/>
         <value value="Ziprasidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ziprasidon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD27"/>
      <designation>
         <language value="en"/>
         <value value="Metformin, linagliptin and empagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin, linagliptin og empagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC01"/>
      <designation>
         <language value="en"/>
         <value value="Omeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA05"/>
      <designation>
         <language value="en"/>
         <value value="Triflupromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triflupromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AA"/>
      <designation>
         <language value="en"/>
         <value value="Aminosalicylic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosalisylsyre og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AJ02"/>
      <designation>
         <language value="en"/>
         <value value="Pertussis, purified antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kikhoste, renset antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX69"/>
      <designation>
         <language value="en"/>
         <value value="Lurbinectedin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lurbinektedin"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX01"/>
      <designation>
         <language value="en"/>
         <value value="Fumaric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fumarsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DX01"/>
      <designation>
         <language value="en"/>
         <value value="Memantine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Memantin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD54"/>
      <designation>
         <language value="en"/>
         <value value="Ceftriaxone, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftriakson, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01E"/>
      <designation>
         <language value="en"/>
         <value value="Protein kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX10"/>
      <designation>
         <language value="en"/>
         <value value="Mosapramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mosapramin"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CX01"/>
      <designation>
         <language value="en"/>
         <value value="Atosiban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atosiban"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AB01"/>
      <designation>
         <language value="en"/>
         <value value="Milbemycin oxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Milbemycinoksim"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03D"/>
      <designation>
         <language value="en"/>
         <value value="Antispasmodics in combination with analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spasmolytika i kombinasjon med analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LC51"/>
      <designation>
         <language value="en"/>
         <value value="Clonidine and diuretics, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klonidin og diuretika inkl. andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CX"/>
      <designation>
         <language value="en"/>
         <value value="Other mineral products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse mineralmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C02L"/>
      <designation>
         <language value="en"/>
         <value value="Antihypertensives and diuretics in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihypertensiva og diuretika i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="B01A"/>
      <designation>
         <language value="en"/>
         <value value="Antithrombotic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitrombotiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcal vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokkvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BB03"/>
      <designation>
         <language value="en"/>
         <value value="Tocainide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tokainid"/>
      </designation>
   </concept>
   <concept>
      <code value="C05CX"/>
      <designation>
         <language value="en"/>
         <value value="Other capillary stabilizing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kapillærstabiliserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01ED02"/>
      <designation>
         <language value="en"/>
         <value value="Betaxolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betaksolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BC01"/>
      <designation>
         <language value="en"/>
         <value value="Hepatitis B, purified antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hepatitt B, renset antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN02"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19, viral vector, non-replicating"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19, viral vektor, ikke-replikerende"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB12"/>
      <designation>
         <language value="en"/>
         <value value="Elosulfase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elosulfase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GB02"/>
      <designation>
         <language value="en"/>
         <value value="Clomifene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klomifen"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of various lipid modifying agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av ulike lipidmodifiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX41"/>
      <designation>
         <language value="en"/>
         <value value="Eribulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eribulin"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02A"/>
      <designation>
         <language value="en"/>
         <value value="Topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topikale midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BB52"/>
      <designation>
         <language value="en"/>
         <value value="Chloroquine and proguanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorokin og proguanil"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD10"/>
      <designation>
         <language value="en"/>
         <value value="Von Willebrand factor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Von Willebrand faktor"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE04"/>
      <designation>
         <language value="en"/>
         <value value="Melagatran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melagatran"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL09"/>
      <designation>
         <language value="en"/>
         <value value="Tabelecleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tabelekleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA02"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides, combinations with other antibacterials (excl. trimethoprim)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, kombinasjoner med andre antibakterielle midler ekskl. trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB04"/>
      <designation>
         <language value="en"/>
         <value value="Adalimumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adalimumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC06"/>
      <designation>
         <language value="en"/>
         <value value="Guanazodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanazodin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC05"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinonide and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinonid og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D01A"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX14"/>
      <designation>
         <language value="en"/>
         <value value="Dapoxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dapoksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE06"/>
      <designation>
         <language value="en"/>
         <value value="Colestilan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolestilan"/>
      </designation>
   </concept>
   <concept>
      <code value="N02B"/>
      <designation>
         <language value="en"/>
         <value value="Other analgesics and antipyretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre analgetika og antipyretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01F"/>
      <designation>
         <language value="en"/>
         <value value="Macrolides, lincosamides and streptogramins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrolider, linkosamider og streptograminer"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01X"/>
      <designation>
         <language value="en"/>
         <value value="Other ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC24"/>
      <designation>
         <language value="en"/>
         <value value="Mirikizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirikizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S03"/>
      <designation>
         <language value="en"/>
         <value value="Ophthalmological and otological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Øye-og øremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB06"/>
      <designation>
         <language value="en"/>
         <value value="Darolutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darolutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA02"/>
      <designation>
         <language value="en"/>
         <value value="Opium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opium"/>
      </designation>
   </concept>
   <concept>
      <code value="A11C"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin A and D, incl. combinations of the two"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin A og D, inkl. A og D i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF01"/>
      <designation>
         <language value="en"/>
         <value value="Tofacitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tofacitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA06"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous succinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)suksinat"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB02"/>
      <designation>
         <language value="en"/>
         <value value="Iohexol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Joheksol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01C"/>
      <designation>
         <language value="en"/>
         <value value="Turkey"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalkun"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA06"/>
      <designation>
         <language value="en"/>
         <value value="Candesartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kandesartan"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX24"/>
      <designation>
         <language value="en"/>
         <value value="Teclistamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teklistamab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA13"/>
      <designation>
         <language value="en"/>
         <value value="Fusidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fusidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CX90"/>
      <designation>
         <language value="en"/>
         <value value="Denaverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Denaverin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF07"/>
      <designation>
         <language value="en"/>
         <value value="Dostarlimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dostarlimab"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BB51"/>
      <designation>
         <language value="en"/>
         <value value="Proguanil and atovaquone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proguanil og atovakvon"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD02"/>
      <designation>
         <language value="en"/>
         <value value="Dinoprostone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dinoproston"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AX13"/>
      <designation>
         <language value="en"/>
         <value value="Silicones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Silikonforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxyprogesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksyprogesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CX01"/>
      <designation>
         <language value="en"/>
         <value value="Tibolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tibolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CX04"/>
      <designation>
         <language value="en"/>
         <value value="Clomethiazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klometiazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AB01"/>
      <designation>
         <language value="en"/>
         <value value="Nandrolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nandrolon"/>
      </designation>
   </concept>
   <concept>
      <code value="C01B"/>
      <designation>
         <language value="en"/>
         <value value="Antiarrhythmics, class I and III"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiarytmika, klasse I og III"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterials for intrammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle midler for intramammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EC01"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamethoxazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametoksazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07AC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE05"/>
      <designation>
         <language value="en"/>
         <value value="Tafluprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tafluprost"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB06"/>
      <designation>
         <language value="en"/>
         <value value="Bevantolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bevantolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BB01"/>
      <designation>
         <language value="en"/>
         <value value="Amantadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amantadin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB07"/>
      <designation>
         <language value="en"/>
         <value value="Netilmicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Netilmicin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11AA03"/>
      <designation>
         <language value="en"/>
         <value value="Multivitamins and other minerals, incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Multivitaminer og andre mineraler inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA01"/>
      <designation>
         <language value="en"/>
         <value value="Diazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA"/>
      <designation>
         <language value="en"/>
         <value value="BCR-ABL tyrosine kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="BCR-ABL tyrosinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD15"/>
      <designation>
         <language value="en"/>
         <value value="Cefdinir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefdinir"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL05"/>
      <designation>
         <language value="en"/>
         <value value="Ciltacabtagene autoleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciltakabtagenautoleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AD04"/>
      <designation>
         <language value="en"/>
         <value value="Cinchocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinkokain"/>
      </designation>
   </concept>
   <concept>
      <code value="A05A"/>
      <designation>
         <language value="en"/>
         <value value="Bile therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galleterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA"/>
      <designation>
         <language value="en"/>
         <value value="Iron bivalent, oral preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern II-verdig, orale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C10"/>
      <designation>
         <language value="en"/>
         <value value="Lipid modifying agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lipidmodifiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AX03"/>
      <designation>
         <language value="en"/>
         <value value="Other preparations, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Reserpine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reserpin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Avian encephalomyelitis virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fugleencefalomyelittvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA03"/>
      <designation>
         <language value="en"/>
         <value value="Tropisetron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tropisetron"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA04"/>
      <designation>
         <language value="en"/>
         <value value="Fluvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XB01"/>
      <designation>
         <language value="en"/>
         <value value="Arginine hydrochloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Argininhydroklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB13"/>
      <designation>
         <language value="en"/>
         <value value="Bekanamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bekanamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX11"/>
      <designation>
         <language value="en"/>
         <value value="Sodium oxybate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumoksybat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC06"/>
      <designation>
         <language value="en"/>
         <value value="Cefonicide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefonicid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA04"/>
      <designation>
         <language value="en"/>
         <value value="Alendronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alendronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CE"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase sensitive penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamaseømfintlige penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH03"/>
      <designation>
         <language value="en"/>
         <value value="Valdecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valdekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AX09"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA05"/>
      <designation>
         <language value="en"/>
         <value value="Aminophylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllinetylendiamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BC03"/>
      <designation>
         <language value="en"/>
         <value value="Teflubenzuron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teflubenzuron"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB04"/>
      <designation>
         <language value="en"/>
         <value value="Sulfapyridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfapyridin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF05"/>
      <designation>
         <language value="en"/>
         <value value="Atezolizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atezolizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA01"/>
      <designation>
         <language value="en"/>
         <value value="Neomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AA03"/>
      <designation>
         <language value="en"/>
         <value value="Hyaluronidase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyaluronidase"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlortetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XB01"/>
      <designation>
         <language value="en"/>
         <value value="Procarbazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokarbazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB"/>
      <designation>
         <language value="en"/>
         <value value="Anthracyclines and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antracykliner og lignende substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM02"/>
      <designation>
         <language value="en"/>
         <value value="Rifampicin and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifampicin og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA13"/>
      <designation>
         <language value="en"/>
         <value value="Ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC05"/>
      <designation>
         <language value="en"/>
         <value value="Ticlopidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiklopidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AH01"/>
      <designation>
         <language value="en"/>
         <value value="Fentanyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentanyl"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF08"/>
      <designation>
         <language value="en"/>
         <value value="Palifermin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palifermin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA61"/>
      <designation>
         <language value="en"/>
         <value value="Dimenhydrinate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimenhydrinat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB54"/>
      <designation>
         <language value="en"/>
         <value value="Mephenytoin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mefenytoin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V01"/>
      <designation>
         <language value="en"/>
         <value value="Allergens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allergener"/>
      </designation>
   </concept>
   <concept>
      <code value="A16A"/>
      <designation>
         <language value="en"/>
         <value value="Other alimentary tract and metabolism products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre fordøyelses- og stoffskiftemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A11JC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamins, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitaminer, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA55"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone and naloxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon og nalokson"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Cimetidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cimetidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AG03"/>
      <designation>
         <language value="en"/>
         <value value="Toloxatone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toloksaton"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX24"/>
      <designation>
         <language value="en"/>
         <value value="Epinastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epinastin"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AA54"/>
      <designation>
         <language value="en"/>
         <value value="Disulfiram, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Disulfiram, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA53"/>
      <designation>
         <language value="en"/>
         <value value="Tetracaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A07CA"/>
      <designation>
         <language value="en"/>
         <value value="Oral rehydration salt formulations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter med karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="R05"/>
      <designation>
         <language value="en"/>
         <value value="Cough and cold preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hoste- og forkjølelsesmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB"/>
      <designation>
         <language value="en"/>
         <value value="Antidotes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot forgiftninger"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CX06"/>
      <designation>
         <language value="en"/>
         <value value="Fezolinetant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fezolinetant"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB03"/>
      <designation>
         <language value="en"/>
         <value value="Perphenazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perfenazin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02AD"/>
      <designation>
         <language value="en"/>
         <value value="Prostaglandins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prostaglandiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX02"/>
      <designation>
         <language value="en"/>
         <value value="Sotalol and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotalol og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AE07"/>
      <designation>
         <language value="en"/>
         <value value="Moxifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA02B"/>
      <designation>
         <language value="en"/>
         <value value="Reflux disease (GORD)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reflukslidelse (GERD)"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA07"/>
      <designation>
         <language value="en"/>
         <value value="Chlorproethazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorproetazin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA03"/>
      <designation>
         <language value="en"/>
         <value value="Sodium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC74"/>
      <designation>
         <language value="en"/>
         <value value="Dextropropoxyphene, comb. with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstropropoksyfen, kombinasjoner med psykolelptika"/>
      </designation>
   </concept>
   <concept>
      <code value="V09C"/>
      <designation>
         <language value="en"/>
         <value value="Renal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nyrer og urinveier"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EG"/>
      <designation>
         <language value="en"/>
         <value value="Mammalian target of rapamycin (mTOR) kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="(mTOR) kinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX06"/>
      <designation>
         <language value="en"/>
         <value value="Anidulafungin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anidulafungin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE04"/>
      <designation>
         <language value="en"/>
         <value value="Artemotil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemotil"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02AA03"/>
      <designation>
         <language value="en"/>
         <value value="Desoxycortone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desoksykorton"/>
      </designation>
   </concept>
   <concept>
      <code value="D09AB"/>
      <designation>
         <language value="en"/>
         <value value="Zinc bandages"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkbandasjer"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC51"/>
      <designation>
         <language value="en"/>
         <value value="Omeprazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omeprasol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA"/>
      <designation>
         <language value="en"/>
         <value value="Rauwolfia alkaloids and diuretics in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider og diuretika i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA11"/>
      <designation>
         <language value="en"/>
         <value value="Bornaprine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bornaprin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB08"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AJ02"/>
      <designation>
         <language value="en"/>
         <value value="Elvitegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elvitegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="H03BB"/>
      <designation>
         <language value="en"/>
         <value value="Sulfur-containing imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svovelholdige imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CC01"/>
      <designation>
         <language value="en"/>
         <value value="Demecolcine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Demekolcin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19 vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19-vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB03"/>
      <designation>
         <language value="en"/>
         <value value="Flumetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetason"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AM01"/>
      <designation>
         <language value="en"/>
         <value value="Tetanus toxoid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetanustoksoid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01D"/>
      <designation>
         <language value="en"/>
         <value value="Cytotoxic antibiotics and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cytotoksiske antibiotika og lignende substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antimycotics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antimykotika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK13"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol and beclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol og beklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other throat preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre halsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AG09"/>
      <designation>
         <language value="en"/>
         <value value="Closantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klosantel"/>
      </designation>
   </concept>
   <concept>
      <code value="D03AX03"/>
      <designation>
         <language value="en"/>
         <value value="Dexpanthenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekspantenol"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB07"/>
      <designation>
         <language value="en"/>
         <value value="Prednisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednison"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK03"/>
      <designation>
         <language value="en"/>
         <value value="Empagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Empagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG"/>
      <designation>
         <language value="en"/>
         <value value="Genito urinary system and sex hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urogenitalsystem og kjønnshormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA01"/>
      <designation>
         <language value="en"/>
         <value value="Isopropamide and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isopropamid og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB"/>
      <designation>
         <language value="en"/>
         <value value="Anti-androgens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiandrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA09"/>
      <designation>
         <language value="en"/>
         <value value="Clobetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klobetason"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX13"/>
      <designation>
         <language value="en"/>
         <value value="Nitrous oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dinitrogenoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB14"/>
      <designation>
         <language value="en"/>
         <value value="Valganciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valganciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AC"/>
      <designation>
         <language value="en"/>
         <value value="Iron, parenteral preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern, injeksjonsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB04"/>
      <designation>
         <language value="en"/>
         <value value="Acebutolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acebutolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC17"/>
      <designation>
         <language value="en"/>
         <value value="Bitolterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bitolterol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA14"/>
      <designation>
         <language value="en"/>
         <value value="Flurithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA12"/>
      <designation>
         <language value="en"/>
         <value value="Naproxen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naproksen"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CD08"/>
      <designation>
         <language value="en"/>
         <value value="Midazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD04"/>
      <designation>
         <language value="en"/>
         <value value="Moperone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moperon"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AD51"/>
      <designation>
         <language value="en"/>
         <value value="Pentazocine and naloxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentazocin og nalokson"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Diethyl ether"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dietyleter"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD06"/>
      <designation>
         <language value="en"/>
         <value value="Misoprostol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Misoprostol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC02"/>
      <designation>
         <language value="en"/>
         <value value="Cefuroxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefuroksim"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC05"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium aspartate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumaspartat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD08"/>
      <designation>
         <language value="en"/>
         <value value="Midazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="C03D"/>
      <designation>
         <language value="en"/>
         <value value="Aldosterone antagonists and other potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldosteronantagonister og andre kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX08"/>
      <designation>
         <language value="en"/>
         <value value="Tafamidis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tafamidis"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07CC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AG03"/>
      <designation>
         <language value="en"/>
         <value value="Iodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jod"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD09"/>
      <designation>
         <language value="en"/>
         <value value="Ancrod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ankrod"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB08"/>
      <designation>
         <language value="en"/>
         <value value="Desonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desonid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB08"/>
      <designation>
         <language value="en"/>
         <value value="Dienogest and estradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienogest og østradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AP02"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoid, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AB03"/>
      <designation>
         <language value="en"/>
         <value value="Mannosulfan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mannosulfan"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Phenindione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenindion"/>
      </designation>
   </concept>
   <concept>
      <code value="H04"/>
      <designation>
         <language value="en"/>
         <value value="Pancreatic hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pankreashormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA01"/>
      <designation>
         <language value="en"/>
         <value value="Calcium phosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EA01"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AH"/>
      <designation>
         <language value="en"/>
         <value value="Mammalian target of rapamycin (mTOR) kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="(mTOR) kinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA17"/>
      <designation>
         <language value="en"/>
         <value value="Fludiazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fludiazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA08"/>
      <designation>
         <language value="en"/>
         <value value="Prajmaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prajmalin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD09"/>
      <designation>
         <language value="en"/>
         <value value="Pioglitazone and alogliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pioglitazon og alogliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG08"/>
      <designation>
         <language value="en"/>
         <value value="Ocrelizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Okrelizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX32"/>
      <designation>
         <language value="en"/>
         <value value="Ivacaftor, tezacaftor and elexacaftor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivakaftor, tezakaftor og eleksakaftor"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX14"/>
      <designation>
         <language value="en"/>
         <value value="Ozenoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ozenoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, moderately potent (group II)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, middels sterke (gruppe II)"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX"/>
      <designation>
         <language value="en"/>
         <value value="Various alimentary tract and metabolism products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre fordøyelses- og stoffskiftemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BX"/>
      <designation>
         <language value="en"/>
         <value value="Other chemotherapeutics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kjemoterapeutika"/>
      </designation>
   </concept>
   <concept>
      <code value="V10"/>
      <designation>
         <language value="en"/>
         <value value="Therapeutic radiopharmaceuticals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Radiofarmaka til terapeutisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA12"/>
      <designation>
         <language value="en"/>
         <value value="Fidaxomicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fidaksomicin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Testosterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Testosteron"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LL01"/>
      <designation>
         <language value="en"/>
         <value value="Pargyline and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pargylin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA04"/>
      <designation>
         <language value="en"/>
         <value value="Riboflavin (vit B2)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Riboflavin (vit B2)"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA07"/>
      <designation>
         <language value="en"/>
         <value value="Calcium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AC"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole and triazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazol- og triazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD07"/>
      <designation>
         <language value="en"/>
         <value value="Ceftizoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftizoksim"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ"/>
      <designation>
         <language value="en"/>
         <value value="Opioids in combination with non-opioid analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioider i kombinasjon med ikke-opioide analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD"/>
      <designation>
         <language value="en"/>
         <value value="Third-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tredje generasjon cefalosporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="P01CX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents against leishmaniasis and trypanosomiasis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot leishmaniasis og trypanosomiasis"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AA01"/>
      <designation>
         <language value="en"/>
         <value value="Diatrizoic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diatrizoinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Imatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA10"/>
      <designation>
         <language value="en"/>
         <value value="Bempedoic acid and ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bempedoinsyre og ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CX"/>
      <designation>
         <language value="en"/>
         <value value="Other estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre østrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX16"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and fimasartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og fimasartan"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01AA06"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA01"/>
      <designation>
         <language value="en"/>
         <value value="Levodopa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levodopa"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BC04"/>
      <designation>
         <language value="en"/>
         <value value="Diflucortolone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflukortolon og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF04"/>
      <designation>
         <language value="en"/>
         <value value="Tranylcypromine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tranylcypromin"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Hachimycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hakimycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DG"/>
      <designation>
         <language value="en"/>
         <value value="Guanidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BG01"/>
      <designation>
         <language value="en"/>
         <value value="Labetalol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Labetalol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA14"/>
      <designation>
         <language value="en"/>
         <value value="Metampicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metampicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11DB"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1 in combination with vitamin B6 and/or vitamin B12"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1 i kombinasjoner med vitamin B6 og/eller vitamin B12"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot ulcus og gastroøsofageal reflukssykdom (GORD)"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA04"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B and poliomyelitis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B og poliomyelitt"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XE51"/>
      <designation>
         <language value="en"/>
         <value value="Nitrofurantoin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrofurantoin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA16"/>
      <designation>
         <language value="en"/>
         <value value="Cefixime and azithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefiksim og azitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA01"/>
      <designation>
         <language value="en"/>
         <value value="Cyanocobalamin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyanokobalamin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AC01"/>
      <designation>
         <language value="en"/>
         <value value="Dibrompropamidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dibrompropamidin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07B"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, combinations with antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, kombinasjoner med antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA"/>
      <designation>
         <language value="en"/>
         <value value="Non-selective monoamine reuptake inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-selektive monoaminreopptakshemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX06"/>
      <designation>
         <language value="en"/>
         <value value="Hexaminolevulinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksaminolevulinat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC03"/>
      <designation>
         <language value="en"/>
         <value value="Piritramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piritramid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA01"/>
      <designation>
         <language value="en"/>
         <value value="Chorionic gonadotrophin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koriongonadotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AG"/>
      <designation>
         <language value="en"/>
         <value value="Organic acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Organiske syrer"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX15"/>
      <designation>
         <language value="en"/>
         <value value="Pentosan polysulfate sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentosanpolysulfatnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01B"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA12"/>
      <designation>
         <language value="en"/>
         <value value="Gadopiclenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadopiklenol"/>
      </designation>
   </concept>
   <concept>
      <code value="D05B"/>
      <designation>
         <language value="en"/>
         <value value="Antipsoriatics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antipsoriasismidler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX44"/>
      <designation>
         <language value="en"/>
         <value value="Aflibercept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aflibercept"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B12 (cyanocobalamin and analogues)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B12  (cyanokobalamin og analoger)"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD14"/>
      <designation>
         <language value="en"/>
         <value value="Vonoprazan, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vonoprazan, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DA04"/>
      <designation>
         <language value="en"/>
         <value value="Progesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC03"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA08"/>
      <designation>
         <language value="en"/>
         <value value="Metolazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metolazon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC05"/>
      <designation>
         <language value="en"/>
         <value value="Rimiterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rimiterol"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF03"/>
      <designation>
         <language value="en"/>
         <value value="Edoxaban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Edoksaban"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR12"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine and tenofovir disoproxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin og tenofovirdisoproksil"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CF01"/>
      <designation>
         <language value="en"/>
         <value value="Zopiclone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zopiklon"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05B"/>
      <designation>
         <language value="en"/>
         <value value="Anxiolytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anksiolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA"/>
      <designation>
         <language value="en"/>
         <value value="Serotonin (5HT3) antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Serotonin (5HT3)-antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AK01"/>
      <designation>
         <language value="en"/>
         <value value="Leflunomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leflunomid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CX91"/>
      <designation>
         <language value="en"/>
         <value value="Butafosfan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butafosfan"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC02"/>
      <designation>
         <language value="en"/>
         <value value="Guanethidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanetidin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD"/>
      <designation>
         <language value="en"/>
         <value value="Antiarrhythmics, class III"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiarytmika, klasse III"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DA"/>
      <designation>
         <language value="en"/>
         <value value="Thiazide derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD07"/>
      <designation>
         <language value="en"/>
         <value value="Reteplase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reteplase"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA05"/>
      <designation>
         <language value="en"/>
         <value value="Oritavancin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oritavancin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA02"/>
      <designation>
         <language value="en"/>
         <value value="Calcium glubionate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglubionat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC06"/>
      <designation>
         <language value="en"/>
         <value value="Eletriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eletriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Methocarbamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metokarbamol"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AB"/>
      <designation>
         <language value="en"/>
         <value value="Contact laxatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kontaktlaksantia"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BX01"/>
      <designation>
         <language value="en"/>
         <value value="Baclofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Baklofen"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AH02"/>
      <designation>
         <language value="en"/>
         <value value="Hydroflumethiazide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroflumetiazid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EC02"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02A"/>
      <designation>
         <language value="en"/>
         <value value="Opioids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioider"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiinflammatory and antirheumatic agents, non-steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiinflammatoriske og antireumatiske midler, ikke-steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA04"/>
      <designation>
         <language value="en"/>
         <value value="Dalbavancin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dalbavancin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA04"/>
      <designation>
         <language value="en"/>
         <value value="Dopamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopamin"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB02"/>
      <designation>
         <language value="en"/>
         <value value="Risedronic acid and calcium, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risedronsyre og kalsium, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG05"/>
      <designation>
         <language value="en"/>
         <value value="Progabide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progabid"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE01"/>
      <designation>
         <language value="en"/>
         <value value="Polystyrene sulfonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polystyrensulfonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA13"/>
      <designation>
         <language value="en"/>
         <value value="Eritrityl tetranitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytritoltetranitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX02"/>
      <designation>
         <language value="en"/>
         <value value="Betibeglogene autotemcel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betibeglogenautotemcel"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC08"/>
      <designation>
         <language value="en"/>
         <value value="Encainide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enkainid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE14"/>
      <designation>
         <language value="en"/>
         <value value="Dexibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EE02"/>
      <designation>
         <language value="en"/>
         <value value="Cobimetinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kobimetinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA06"/>
      <designation>
         <language value="en"/>
         <value value="Methoserpidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoserpidin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA04"/>
      <designation>
         <language value="en"/>
         <value value="Progesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD10"/>
      <designation>
         <language value="en"/>
         <value value="Quazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AE"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA13"/>
      <designation>
         <language value="en"/>
         <value value="Calcium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH03"/>
      <designation>
         <language value="en"/>
         <value value="Ertapenem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ertapenem"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BE51"/>
      <designation>
         <language value="en"/>
         <value value="Paracetamol, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paracetamol, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA07"/>
      <designation>
         <language value="en"/>
         <value value="Cyclopenthiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklopentiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AH"/>
      <designation>
         <language value="en"/>
         <value value="Antacids with sodium bicarbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antacida med natriumhydrogenkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF06"/>
      <designation>
         <language value="en"/>
         <value value="Cemiplimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cemiplimab"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BB01"/>
      <designation>
         <language value="en"/>
         <value value="Flumetasone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetason og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AD02"/>
      <designation>
         <language value="en"/>
         <value value="Phenazocine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenazocin"/>
      </designation>
   </concept>
   <concept>
      <code value="C04"/>
      <designation>
         <language value="en"/>
         <value value="Peripheral vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifere kardilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BE"/>
      <designation>
         <language value="en"/>
         <value value="Azaspirodecanedione derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azaspirodekandionderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA06"/>
      <designation>
         <language value="en"/>
         <value value="Roxithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Roksitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD01"/>
      <designation>
         <language value="en"/>
         <value value="Paclitaxel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paklitaksel"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CE03"/>
      <designation>
         <language value="en"/>
         <value value="Etirinotecan pegol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etirinotekan pegol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE04"/>
      <designation>
         <language value="en"/>
         <value value="Chlorcyclizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorcyklizin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Methyldopa (racemic)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldopa (rasemisk)"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02AC"/>
      <designation>
         <language value="en"/>
         <value value="Preparations with salicylic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med innhold av salisyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC03"/>
      <designation>
         <language value="en"/>
         <value value="Levacetylmethadol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levacetylmetadol"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01CE"/>
      <designation>
         <language value="en"/>
         <value value="Phosphodiesterase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfodiesterasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="H05"/>
      <designation>
         <language value="en"/>
         <value value="Calcium homeostasis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium homøostase"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA06"/>
      <designation>
         <language value="en"/>
         <value value="Etynodiol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etynodiol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other nasal preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler til bruk i nesen"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA10"/>
      <designation>
         <language value="en"/>
         <value value="Gestodene and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gestoden og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Methylergometrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylergometrin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AG02"/>
      <designation>
         <language value="en"/>
         <value value="Tolfenamic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolfenamsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Chlorothiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AB"/>
      <designation>
         <language value="en"/>
         <value value="Selective serotonin reuptake inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive serotoninreopptakshemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA10"/>
      <designation>
         <language value="en"/>
         <value value="Colistin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolistin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA01"/>
      <designation>
         <language value="en"/>
         <value value="Alprenolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alprenolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD05"/>
      <designation>
         <language value="en"/>
         <value value="Cefmenoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefmenoksim"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC05"/>
      <designation>
         <language value="en"/>
         <value value="Mecasermin rinfabate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mekaserminrinfabat"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AB04"/>
      <designation>
         <language value="en"/>
         <value value="Citric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CA01"/>
      <designation>
         <language value="en"/>
         <value value="Mebendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A07B"/>
      <designation>
         <language value="en"/>
         <value value="Intestinal adsorbents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tarmadsorpsjonsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA02"/>
      <designation>
         <language value="en"/>
         <value value="Vincristine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinkristin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA"/>
      <designation>
         <language value="en"/>
         <value value="Alpha-adrenoreceptor antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD07"/>
      <designation>
         <language value="en"/>
         <value value="Atogepant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atogepant"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AG01"/>
      <designation>
         <language value="en"/>
         <value value="Morphine and antispasmodics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfin og spasmolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01RA01"/>
      <designation>
         <language value="en"/>
         <value value="Penicillins, combinations with other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicilliner, kombinasjoner med andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L03"/>
      <designation>
         <language value="en"/>
         <value value="Immunostimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR14"/>
      <designation>
         <language value="en"/>
         <value value="Darunavir and cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darunavir og kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB12"/>
      <designation>
         <language value="en"/>
         <value value="Clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AG"/>
      <designation>
         <language value="en"/>
         <value value="Iodine products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jodmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A07FA02"/>
      <designation>
         <language value="en"/>
         <value value="Saccharomyces boulardii"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saccharomyces boulardii"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AC03"/>
      <designation>
         <language value="en"/>
         <value value="Colextran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolekstran"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA08"/>
      <designation>
         <language value="en"/>
         <value value="Diphemanil and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difemanil og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AD"/>
      <designation>
         <language value="en"/>
         <value value="Brucellosis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brucellosisvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01EA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF11"/>
      <designation>
         <language value="en"/>
         <value value="Telbivudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telbivudin"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AA90"/>
      <designation>
         <language value="en"/>
         <value value="Suxibuzone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Suksibuzon"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX10"/>
      <designation>
         <language value="en"/>
         <value value="Propofol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propofol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KA01"/>
      <designation>
         <language value="en"/>
         <value value="Veratrum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Veratrum"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA08"/>
      <designation>
         <language value="en"/>
         <value value="Tetracycline and oleandomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasyklin og oleandomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="P02C"/>
      <designation>
         <language value="en"/>
         <value value="Antinematodal agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot nematoder"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Cyclophosphamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syklofosfamid"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL09"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol, glycopyrronium bromide and beclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol, glykopyrroniumbromid og beklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AA01"/>
      <designation>
         <language value="en"/>
         <value value="Liquid paraffin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flytende parafin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR03"/>
      <designation>
         <language value="en"/>
         <value value="Ticarcillin and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tikarcillin og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Chloramphenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloramfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="P03AX01"/>
      <designation>
         <language value="en"/>
         <value value="Benzyl benzoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzylbenzoat"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AA01"/>
      <designation>
         <language value="en"/>
         <value value="Aminosalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX07"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin, amlodipine and lisinopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin, amlodipin og lisinopril"/>
      </designation>
   </concept>
   <concept>
      <code value="V07"/>
      <designation>
         <language value="en"/>
         <value value="All other non-therapeutic products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alle andre ikke-terapeutiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01"/>
      <designation>
         <language value="en"/>
         <value value="Ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK02"/>
      <designation>
         <language value="en"/>
         <value value="Ethambutol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etambutol"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AJ04"/>
      <designation>
         <language value="en"/>
         <value value="Cabotegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabotegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB11"/>
      <designation>
         <language value="en"/>
         <value value="Prednylidene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednyliden"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB02"/>
      <designation>
         <language value="en"/>
         <value value="Olmesartan medoxomil and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olmesartanmedoksomil og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD03"/>
      <designation>
         <language value="en"/>
         <value value="Anistreplase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anistreplase"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC08"/>
      <designation>
         <language value="en"/>
         <value value="Lasmiditan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lasmiditan"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AH"/>
      <designation>
         <language value="en"/>
         <value value="Neuraminidase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neuraminidasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A11ED"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex with anabolic steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks med anabole steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB03"/>
      <designation>
         <language value="en"/>
         <value value="Afatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Afatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX21"/>
      <designation>
         <language value="en"/>
         <value value="Tritoqualine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tritokvalin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX13"/>
      <designation>
         <language value="en"/>
         <value value="Loratadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loratadin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, non-selective, and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, ikke-selektive, og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX02"/>
      <designation>
         <language value="en"/>
         <value value="Ebola vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ebolavaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiinfectives and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiinfektiva og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BK"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD13"/>
      <designation>
         <language value="en"/>
         <value value="Apadamtase alfa and cinaxadamtase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apadamtase alfa og cinaksadamtase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE05"/>
      <designation>
         <language value="en"/>
         <value value="Ximelagatran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ximelagatran"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF02"/>
      <designation>
         <language value="en"/>
         <value value="Clopenthixol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klopentiksol"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CX01"/>
      <designation>
         <language value="en"/>
         <value value="Pizotifen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pizotifen"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Chlortetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX04"/>
      <designation>
         <language value="en"/>
         <value value="Macitentan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Macitentan"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD02"/>
      <designation>
         <language value="en"/>
         <value value="Promethazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prometazin"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Feather"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fjær"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Carbohydrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC02"/>
      <designation>
         <language value="en"/>
         <value value="Oxfendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksfendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB05"/>
      <designation>
         <language value="en"/>
         <value value="Trichloroethylene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trikloretylen"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE02"/>
      <designation>
         <language value="en"/>
         <value value="Papaverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papaverin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX01"/>
      <designation>
         <language value="en"/>
         <value value="Bosentan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bosentan"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XB"/>
      <designation>
         <language value="en"/>
         <value value="Amino acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX06"/>
      <designation>
         <language value="en"/>
         <value value="Emedastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emedastin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN51A"/>
      <designation>
         <language value="en"/>
         <value value="Products for animal euthanasia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avlivningsmidler for dyr"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB03"/>
      <designation>
         <language value="en"/>
         <value value="Atropine and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atropin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB04"/>
      <designation>
         <language value="en"/>
         <value value="Dalteparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dalteparin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA08"/>
      <designation>
         <language value="en"/>
         <value value="Bamifylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bamifyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE11"/>
      <designation>
         <language value="en"/>
         <value value="Tiaprofenic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiaprofensyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AH"/>
      <designation>
         <language value="en"/>
         <value value="Peripheral opioid receptor antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifere opioidreseptor antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX03"/>
      <designation>
         <language value="en"/>
         <value value="Pazopanib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pazopanib"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XA01"/>
      <designation>
         <language value="en"/>
         <value value="Danazol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Danazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ05AB"/>
      <designation>
         <language value="en"/>
         <value value="Nucleosides and nucleotides excl. reverse transcriptase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nukleosider og nukleotider ekskl. reverstranskriptase-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB01"/>
      <designation>
         <language value="en"/>
         <value value="Tobramycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tobramycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AD02"/>
      <designation>
         <language value="en"/>
         <value value="Equine influenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesteinfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="A11GA"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vitamin C), plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Askorbinsyre (vitamin C), usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC05"/>
      <designation>
         <language value="en"/>
         <value value="Isavuconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isavukonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R02"/>
      <designation>
         <language value="en"/>
         <value value="Throat preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC52"/>
      <designation>
         <language value="en"/>
         <value value="Histapyrrodine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Histapyrrodin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EG02"/>
      <designation>
         <language value="en"/>
         <value value="Everolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Everolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC04"/>
      <designation>
         <language value="en"/>
         <value value="Rabeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10XX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs used in diabetes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler brukt i forbindelse med diabetes"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA"/>
      <designation>
         <language value="en"/>
         <value value="Butylpyrazolidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butylpyrazolidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BD03"/>
      <designation>
         <language value="en"/>
         <value value="Safinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Safinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01CA96"/>
      <designation>
         <language value="en"/>
         <value value="Salmon gonadotropin releasing hormone analogue"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laksegonadotropin frigjørende hormonanalog"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BD03"/>
      <designation>
         <language value="en"/>
         <value value="Tixagevimab and cilgavimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiksagevimab og cilgavimab"/>
      </designation>
   </concept>
   <concept>
      <code value="QL04A"/>
      <designation>
         <language value="en"/>
         <value value="Immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA12"/>
      <designation>
         <language value="en"/>
         <value value="Mepyramine theophyllinacetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepyramin teofyllinacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CA01"/>
      <designation>
         <language value="en"/>
         <value value="Sodium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA15"/>
      <designation>
         <language value="en"/>
         <value value="Omadacycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omadasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Ipecacuanha"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipekakuanharot"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL01"/>
      <designation>
         <language value="en"/>
         <value value="Sulpiride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulpirid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA05"/>
      <designation>
         <language value="en"/>
         <value value="Polyplatillen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polyplatillen"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC02"/>
      <designation>
         <language value="en"/>
         <value value="Pergolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pergolid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA06"/>
      <designation>
         <language value="en"/>
         <value value="Mycophenolic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mykofenolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA04"/>
      <designation>
         <language value="en"/>
         <value value="Mould fungus and yeast fungus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muggsopp og gjærsopp"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB13"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XB01"/>
      <designation>
         <language value="en"/>
         <value value="Colistin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolistin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX12"/>
      <designation>
         <language value="en"/>
         <value value="Bupropion"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bupropion"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AB02"/>
      <designation>
         <language value="en"/>
         <value value="Ethylestrenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etyløstrenol"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AB"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics, combinations excl. corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika, kombinasjoner ekskl. kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD29"/>
      <designation>
         <language value="en"/>
         <value value="Sitagliptin and dapagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitagliptin og dapagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="QS"/>
      <designation>
         <language value="en"/>
         <value value="Sensory organs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sanseorganer"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA13"/>
      <designation>
         <language value="en"/>
         <value value="Armodafinil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Armodafinil"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA02"/>
      <designation>
         <language value="en"/>
         <value value="Isoprenaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoprenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LE"/>
      <designation>
         <language value="en"/>
         <value value="Alpha-adrenoreceptor antagonists and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfablokkere og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB06"/>
      <designation>
         <language value="en"/>
         <value value="Idarubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idarubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX07"/>
      <designation>
         <language value="en"/>
         <value value="Roflumilast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Roflumilast"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03"/>
      <designation>
         <language value="en"/>
         <value value="Antianemic preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot anemi"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA05"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikason"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD08"/>
      <designation>
         <language value="en"/>
         <value value="Solifenacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Solifenacin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CB01"/>
      <designation>
         <language value="en"/>
         <value value="Acetylcysteine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylcystein"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XB04"/>
      <designation>
         <language value="en"/>
         <value value="Fluorometholone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorometolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA23"/>
      <designation>
         <language value="en"/>
         <value value="Delafloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delafloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC53"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA01"/>
      <designation>
         <language value="en"/>
         <value value="Levocarnitine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levokarnitin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB07"/>
      <designation>
         <language value="en"/>
         <value value="Bisoprolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisoprolol"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CC"/>
      <designation>
         <language value="en"/>
         <value value="Anti-gonadotropin-releasing hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antigonadotropinfrisettende hormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA02"/>
      <designation>
         <language value="en"/>
         <value value="Gadoteric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadotersyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EL02"/>
      <designation>
         <language value="en"/>
         <value value="Acalabrutinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Akalabrutinib"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XB01"/>
      <designation>
         <language value="en"/>
         <value value="Mifepristone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mifepriston"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of drugs for treatment of tuberculosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av tuberkulose, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CE"/>
      <designation>
         <language value="en"/>
         <value value="Phosphodiesterase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfodiesterasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM03"/>
      <designation>
         <language value="en"/>
         <value value="Ethambutol and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etambutol og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA13"/>
      <designation>
         <language value="en"/>
         <value value="Hydroquinidie"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokinidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CX"/>
      <designation>
         <language value="en"/>
         <value value="Hypnotics and sedatives in combination, excl. barbiturates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypnotika og sedativa i kombinasjon, ekskl. barbiturater"/>
      </designation>
   </concept>
   <concept>
      <code value="A10XA01"/>
      <designation>
         <language value="en"/>
         <value value="Tolrestat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolrestat"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD11"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG"/>
      <designation>
         <language value="en"/>
         <value value="Fatty acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fettsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB08"/>
      <designation>
         <language value="en"/>
         <value value="Articaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artikain"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC05"/>
      <designation>
         <language value="en"/>
         <value value="Levomethadone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levometadon"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AX92"/>
      <designation>
         <language value="en"/>
         <value value="Grapiprant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Grapiprant"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD02"/>
      <designation>
         <language value="en"/>
         <value value="Galcanezumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galkanezumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC55"/>
      <designation>
         <language value="en"/>
         <value value="Flumethrin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetrin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM99"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiinflammatory and antirheumatic agents, non-steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiinflammatoriske og antireumatiske midler, ikke-steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA70"/>
      <designation>
         <language value="en"/>
         <value value="Organic nitrates in combination with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrater i kombinasjon med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09BX"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD09"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, clarithromycin and tinidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, klaritromycin og tinidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA05"/>
      <designation>
         <language value="en"/>
         <value value="Temafloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temafloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors and calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere og kalsiumantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="A07C"/>
      <designation>
         <language value="en"/>
         <value value="Electrolytes with carbohydrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter med karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB03"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadimidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadimidin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR02"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine and abacavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin og abakavir"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH06"/>
      <designation>
         <language value="en"/>
         <value value="Remifentanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Remifentanil"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA09"/>
      <designation>
         <language value="en"/>
         <value value="Norethandrolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretandrolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QG52X"/>
      <designation>
         <language value="en"/>
         <value value="Various products for teats and udder"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse midler for spener og jur"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XG"/>
      <designation>
         <language value="en"/>
         <value value="Proteasome inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteasomhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="A06"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for constipation"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot forstoppelse"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB"/>
      <designation>
         <language value="en"/>
         <value value="Thiazides and potassium in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazider og kalium i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BB"/>
      <designation>
         <language value="en"/>
         <value value="Adamantane derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adamantanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BF01"/>
      <designation>
         <language value="en"/>
         <value value="Poliomyelitis oral, monovalent live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poliomyelitt oral, monovalent, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="C07EA"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, non-selective, and vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, ikke-selektive, og vasodilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03AX90"/>
      <designation>
         <language value="en"/>
         <value value="Imepitoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imepitoin"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02C"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC06"/>
      <designation>
         <language value="en"/>
         <value value="Rilmenidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rilmenidin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX03"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF04"/>
      <designation>
         <language value="en"/>
         <value value="Oxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA08"/>
      <designation>
         <language value="en"/>
         <value value="Kanamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA08"/>
      <designation>
         <language value="en"/>
         <value value="Zoledronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zoledronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BB"/>
      <designation>
         <language value="en"/>
         <value value="Biguanides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biguanider"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BA03"/>
      <designation>
         <language value="en"/>
         <value value="Encephalitis, Japanese, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Japansk encefalitt, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB09"/>
      <designation>
         <language value="en"/>
         <value value="Lonazolac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lonazolak"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BB02"/>
      <designation>
         <language value="en"/>
         <value value="Tetanus immunoglobulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin mot stivkrampe"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Levothyroxine sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levotyroksinnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BX02"/>
      <designation>
         <language value="en"/>
         <value value="Amprolium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amprolium"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX58"/>
      <designation>
         <language value="en"/>
         <value value="Pyrrobutamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrrobutamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB08"/>
      <designation>
         <language value="en"/>
         <value value="Cefapirin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefapirin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB37"/>
      <designation>
         <language value="en"/>
         <value value="Idarucizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idarusizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AF"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD01"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor IX, II, VII and X in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor IX, II, VII og X i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="J02A"/>
      <designation>
         <language value="en"/>
         <value value="Antimycotics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimykotika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J06B"/>
      <designation>
         <language value="en"/>
         <value value="Immunoglobulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC16"/>
      <designation>
         <language value="en"/>
         <value value="Eptifibatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eptifibatid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD12"/>
      <designation>
         <language value="en"/>
         <value value="Doxefazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksefazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CA04"/>
      <designation>
         <language value="en"/>
         <value value="Amoxicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amoksicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BG01"/>
      <designation>
         <language value="en"/>
         <value value="Moracizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moracizin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB04"/>
      <designation>
         <language value="en"/>
         <value value="Pipemidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipemidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QC01CE90"/>
      <designation>
         <language value="en"/>
         <value value="Pimobendane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pimobendan"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF01"/>
      <designation>
         <language value="en"/>
         <value value="Nivolumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nivolumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA13"/>
      <designation>
         <language value="en"/>
         <value value="Iprindole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iprindol"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE05"/>
      <designation>
         <language value="en"/>
         <value value="Artenimol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artenimol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED04"/>
      <designation>
         <language value="en"/>
         <value value="Sulfametoxydiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametoksydiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC13"/>
      <designation>
         <language value="en"/>
         <value value="Ixekizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iksekizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC03"/>
      <designation>
         <language value="en"/>
         <value value="Anakinra"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anakinra"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BX13"/>
      <designation>
         <language value="en"/>
         <value value="Idebenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idebenon"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AM01"/>
      <designation>
         <language value="en"/>
         <value value="Clostridium antiserum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klostridiumantiserum"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AX03"/>
      <designation>
         <language value="en"/>
         <value value="Dimethyl sulfoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetylsulfoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BG03"/>
      <designation>
         <language value="en"/>
         <value value="Pioglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pioglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03CA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="G02BA03"/>
      <designation>
         <language value="en"/>
         <value value="Plastic IUD with progestogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plastspiraler med progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB"/>
      <designation>
         <language value="en"/>
         <value value="Phenylpiperidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylpiperidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D06"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics and chemoterapeutics for dermatological use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika og kjemoterapeutika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD14"/>
      <designation>
         <language value="en"/>
         <value value="Remimazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Remimazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC09"/>
      <designation>
         <language value="en"/>
         <value value="Tretoquinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tretokinol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB05"/>
      <designation>
         <language value="en"/>
         <value value="Sulfafurazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfafurazol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA18"/>
      <designation>
         <language value="en"/>
         <value value="Ciclosporin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklosporin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Hyoscyamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyoscyamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AG"/>
      <designation>
         <language value="en"/>
         <value value="Phenol derivatives, incl. salicylanilides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenolderivater, inklusive salicylanilider"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EB02"/>
      <designation>
         <language value="en"/>
         <value value="Carbachol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbakolin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA06"/>
      <designation>
         <language value="en"/>
         <value value="Chlortalidone and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortalidon og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AB03"/>
      <designation>
         <language value="en"/>
         <value value="Ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03CA01"/>
      <designation>
         <language value="en"/>
         <value value="Furosemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Furosemid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BX06"/>
      <designation>
         <language value="en"/>
         <value value="Romosozumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Romosozumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C09X"/>
      <designation>
         <language value="en"/>
         <value value="Other agents acting on the renin-angiotensin system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på renin-angiotensin systemet"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CB01"/>
      <designation>
         <language value="en"/>
         <value value="Dienestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KB01"/>
      <designation>
         <language value="en"/>
         <value value="Metirosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metirosin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH05"/>
      <designation>
         <language value="en"/>
         <value value="Asenapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Asenapin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DX"/>
      <designation>
         <language value="en"/>
         <value value="Other progestogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre progestogener"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC31"/>
      <designation>
         <language value="en"/>
         <value value="Methylestrenolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyløstrenolon"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB"/>
      <designation>
         <language value="en"/>
         <value value="Amides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amider"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AD02"/>
      <designation>
         <language value="en"/>
         <value value="Halcinonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halcinonid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB06"/>
      <designation>
         <language value="en"/>
         <value value="Alendronic acid and alfacalcidol, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alendronsyre og kolekalsiferol, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AA03"/>
      <designation>
         <language value="en"/>
         <value value="Calcium aminosalicylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosalylkalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AC05"/>
      <designation>
         <language value="en"/>
         <value value="Tiropramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiropramid"/>
      </designation>
   </concept>
   <concept>
      <code value="C09C"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II receptor blockers (ARBs), plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II reseptorblokkere (ARBs), usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DA51"/>
      <designation>
         <language value="en"/>
         <value value="Verapamil, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Verapamil, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX09"/>
      <designation>
         <language value="en"/>
         <value value="Lamotrigine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamotrigin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG04"/>
      <designation>
         <language value="en"/>
         <value value="Etravirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etravirin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Desmopressin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desmopressin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02D"/>
      <designation>
         <language value="en"/>
         <value value="Arteriolar smooth muscle, agents acting on"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihypertensiva med virkning på arteriolær glatt muskel"/>
      </designation>
   </concept>
   <concept>
      <code value="C09A"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CF02"/>
      <designation>
         <language value="en"/>
         <value value="Zolpidem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zolpidem"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB06"/>
      <designation>
         <language value="en"/>
         <value value="Sulfanilamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfanilamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA08"/>
      <designation>
         <language value="en"/>
         <value value="Metildigoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldigoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AG01"/>
      <designation>
         <language value="en"/>
         <value value="Formic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Maursyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Rabies virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabies virus"/>
      </designation>
   </concept>
   <concept>
      <code value="QC04AD"/>
      <designation>
         <language value="en"/>
         <value value="Purine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Purinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QM05BA"/>
      <designation>
         <language value="en"/>
         <value value="Bisphosphonates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisfosfonater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01F"/>
      <designation>
         <language value="en"/>
         <value value="Monoclonal antibodies and antibody drug conjugates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Monoklonale antistoffer og antistoff-legemiddelkonjugater"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL04"/>
      <designation>
         <language value="en"/>
         <value value="Indacaterol and glycopyrronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indakaterol og glykopyrroniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="V06DB"/>
      <designation>
         <language value="en"/>
         <value value="Fat/carbohydrates/proteins/minerals/vitamins, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fett, karbohydrater, proteiner, mineraler, vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Acetic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eddiksyre"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Primaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Primakin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB03"/>
      <designation>
         <language value="en"/>
         <value value="Cefalotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefalotin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA05"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AB"/>
      <designation>
         <language value="en"/>
         <value value="Imidazoline derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA12"/>
      <designation>
         <language value="en"/>
         <value value="Doxepin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksepin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA08"/>
      <designation>
         <language value="en"/>
         <value value="Cilazapril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cilazapril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01XX04"/>
      <designation>
         <language value="en"/>
         <value value="Spectinomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spektinomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Mecamylamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mekamylamin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB10"/>
      <designation>
         <language value="en"/>
         <value value="Levobupivacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levobupivakain"/>
      </designation>
   </concept>
   <concept>
      <code value="A10XA"/>
      <designation>
         <language value="en"/>
         <value value="Aldose reductase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldose reduktase hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AF02"/>
      <designation>
         <language value="en"/>
         <value value="Pyrantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrantel"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH03"/>
      <designation>
         <language value="en"/>
         <value value="Sufentanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sufentanil"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AX65"/>
      <designation>
         <language value="en"/>
         <value value="Fipronil, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fipronil, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF04"/>
      <designation>
         <language value="en"/>
         <value value="Stavudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stavudin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05AA"/>
      <designation>
         <language value="en"/>
         <value value="Phenothiazines with aliphatic side-chain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiaziner med alifatisk sidekjede"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB02"/>
      <designation>
         <language value="en"/>
         <value value="Nilutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nilutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AX02"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA05"/>
      <designation>
         <language value="en"/>
         <value value="Niperotidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Niperotidin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA"/>
      <designation>
         <language value="en"/>
         <value value="Low-ceiling diuretics and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Low-ceiling diuretika og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA08"/>
      <designation>
         <language value="en"/>
         <value value="Fenozolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenozolon"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CB53"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol and other diuretics, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol og andre diuretika, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AB"/>
      <designation>
         <language value="en"/>
         <value value="Methyldopa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldopa"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC13"/>
      <designation>
         <language value="en"/>
         <value value="Cefbuperazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefbuperazon"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CD"/>
      <designation>
         <language value="en"/>
         <value value="Pyrazolone derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrazolonderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01DD91"/>
      <designation>
         <language value="en"/>
         <value value="Cefovecin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefovecin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AD03"/>
      <designation>
         <language value="en"/>
         <value value="Mesuximide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mesuksimid"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AE01"/>
      <designation>
         <language value="en"/>
         <value value="Glyceryl trinitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyseryltrinitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA51"/>
      <designation>
         <language value="en"/>
         <value value="Ivermectin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivermektin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for bovidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for kvegdyr"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA05"/>
      <designation>
         <language value="en"/>
         <value value="Polymyxin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polymyksin B"/>
      </designation>
   </concept>
   <concept>
      <code value="C08"/>
      <designation>
         <language value="en"/>
         <value value="Calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX10"/>
      <designation>
         <language value="en"/>
         <value value="Felbamate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Felbamat"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BA01"/>
      <designation>
         <language value="en"/>
         <value value="Atropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atropin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE16"/>
      <designation>
         <language value="en"/>
         <value value="Alminoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alminoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BB"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in alcohol dependence"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved alkoholavhengighet"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL01"/>
      <designation>
         <language value="en"/>
         <value value="Sitimagene ceradenovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitimagenceradenovek"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK05"/>
      <designation>
         <language value="en"/>
         <value value="Ipragliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipragliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK02"/>
      <designation>
         <language value="en"/>
         <value value="Isoprenaline and other drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoprenalin og andre midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LG03"/>
      <designation>
         <language value="en"/>
         <value value="Picodralazine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pikodralazin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH01"/>
      <designation>
         <language value="en"/>
         <value value="Fentanyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentanyl"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AX17"/>
      <designation>
         <language value="en"/>
         <value value="Imidacloprid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidakloprid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA16"/>
      <designation>
         <language value="en"/>
         <value value="Trimegestone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimegeston og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AF01"/>
      <designation>
         <language value="en"/>
         <value value="Clindamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klindamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC06"/>
      <designation>
         <language value="en"/>
         <value value="Etynodiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etynodiol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AX15"/>
      <designation>
         <language value="en"/>
         <value value="Fipronil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fipronil"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA19"/>
      <designation>
         <language value="en"/>
         <value value="Etizolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etizolam"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CF04"/>
      <designation>
         <language value="en"/>
         <value value="Eszopiclone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eszopiklon"/>
      </designation>
   </concept>
   <concept>
      <code value="S02BA07"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD01"/>
      <designation>
         <language value="en"/>
         <value value="Haloperidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haloperidol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA22"/>
      <designation>
         <language value="en"/>
         <value value="Tosufloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tosufloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA09"/>
      <designation>
         <language value="en"/>
         <value value="Gitoformate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gitoformat"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05XA"/>
      <designation>
         <language value="en"/>
         <value value="Electrolyte solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD11"/>
      <designation>
         <language value="en"/>
         <value value="Cefpiramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefpiramid"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB07"/>
      <designation>
         <language value="en"/>
         <value value="Bisoprolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisoprolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX04"/>
      <designation>
         <language value="en"/>
         <value value="Mannitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mannitol"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CB02"/>
      <designation>
         <language value="en"/>
         <value value="Zinc gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG06"/>
      <designation>
         <language value="en"/>
         <value value="Alemtuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alemtuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE03"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (pork)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (svin)"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX15"/>
      <designation>
         <language value="en"/>
         <value value="Zonisamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zonisamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C10A"/>
      <designation>
         <language value="en"/>
         <value value="Lipid modifying agents, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lipidmodifiserende midler, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD01"/>
      <designation>
         <language value="en"/>
         <value value="Canine parvovirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundeparvovirus"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA51"/>
      <designation>
         <language value="en"/>
         <value value="Amlodipine and celecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amlodipin og celekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="C09XA"/>
      <designation>
         <language value="en"/>
         <value value="Renin-inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reninhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD58"/>
      <designation>
         <language value="en"/>
         <value value="Cefixime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefiksim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="QC08CA"/>
      <designation>
         <language value="en"/>
         <value value="Dihydropyridine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydropyridinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB15"/>
      <designation>
         <language value="en"/>
         <value value="Ketorolac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketorolak"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA03"/>
      <designation>
         <language value="en"/>
         <value value="Apraclonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apraklonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AA"/>
      <designation>
         <language value="en"/>
         <value value="Tetracycline and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasyklin og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DB"/>
      <designation>
         <language value="en"/>
         <value value="Benzothiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzotiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD52"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinic acid, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinsyre, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA10"/>
      <designation>
         <language value="en"/>
         <value value="Fenetylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenetyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE01"/>
      <designation>
         <language value="en"/>
         <value value="Saquinavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sakinavir"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA13"/>
      <designation>
         <language value="en"/>
         <value value="Moexipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moeksipril"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC09"/>
      <designation>
         <language value="en"/>
         <value value="Ethacizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etacizin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB06"/>
      <designation>
         <language value="en"/>
         <value value="Glycopyrronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykopyrroniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CD01"/>
      <designation>
         <language value="en"/>
         <value value="Clobetasol and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klobetasol og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51CF02"/>
      <designation>
         <language value="en"/>
         <value value="Cloxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EF02"/>
      <designation>
         <language value="en"/>
         <value value="Ribociclib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ribosiklib"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BC01"/>
      <designation>
         <language value="en"/>
         <value value="Quinine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA51"/>
      <designation>
         <language value="en"/>
         <value value="Reserpine and diuretics, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reserpin og diuretika, kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BE"/>
      <designation>
         <language value="en"/>
         <value value="Isoxazolines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoksazoliner"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA23"/>
      <designation>
         <language value="en"/>
         <value value="Penbutolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penbutolol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03HB"/>
      <designation>
         <language value="en"/>
         <value value="Antiandrogens and estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiandrogener og østrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA55"/>
      <designation>
         <language value="en"/>
         <value value="Pentaerithrityl tetranitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentaeritrityltetranitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX02"/>
      <designation>
         <language value="en"/>
         <value value="Ambrisentan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ambrisentan"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX02"/>
      <designation>
         <language value="en"/>
         <value value="Sorafenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sorafenib"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antidepressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antidepressiva"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE07"/>
      <designation>
         <language value="en"/>
         <value value="Insulin icodec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin ikodek"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Glucosamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukosamin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD06"/>
      <designation>
         <language value="en"/>
         <value value="Rimegepant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rimegepant"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX17"/>
      <designation>
         <language value="en"/>
         <value value="Sacituzumab govitecan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sacituzumabgovitekan"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BK01"/>
      <designation>
         <language value="en"/>
         <value value="Varicella, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varicella, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FE01"/>
      <designation>
         <language value="en"/>
         <value value="Cetuximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cetuksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE06"/>
      <designation>
         <language value="en"/>
         <value value="Insulin degludec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin degludek"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AX02"/>
      <designation>
         <language value="en"/>
         <value value="Propionibacterium acnes, inactivated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propionibacterium acnes, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51CF"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase resistant penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamaseresistente penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA01"/>
      <designation>
         <language value="en"/>
         <value value="Rescinnamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reskinnamin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC04"/>
      <designation>
         <language value="en"/>
         <value value="Rilonacept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rilonacept"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA08"/>
      <designation>
         <language value="en"/>
         <value value="Oxandrolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksandrolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AE"/>
      <designation>
         <language value="en"/>
         <value value="Oripavine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oripavinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA04"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB"/>
      <designation>
         <language value="en"/>
         <value value="Enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AX"/>
      <designation>
         <language value="en"/>
         <value value="Other bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre bakterievaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD02"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX05"/>
      <designation>
         <language value="en"/>
         <value value="Tazarotene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tazaroten"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51D"/>
      <designation>
         <language value="en"/>
         <value value="Agents against Leishmaniosis and trypanosomosis - optional"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot leishmaniosis og trypanosomosis - valgfritt"/>
      </designation>
   </concept>
   <concept>
      <code value="J07XA"/>
      <designation>
         <language value="en"/>
         <value value="Parasitic vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parasittvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA03"/>
      <designation>
         <language value="en"/>
         <value value="Telavancin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telavancin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BD"/>
      <designation>
         <language value="en"/>
         <value value="Monoamine oxidase B inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="MAO-hemmere, type B"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX06"/>
      <designation>
         <language value="en"/>
         <value value="Dinutuximab beta"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dinutuksimab beta"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB06"/>
      <designation>
         <language value="en"/>
         <value value="Trifluoperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trifluoperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB05"/>
      <designation>
         <language value="en"/>
         <value value="Thiopropazate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiopropazat"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA07"/>
      <designation>
         <language value="en"/>
         <value value="Prasterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prasteron"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC03"/>
      <designation>
         <language value="en"/>
         <value value="Alfacalcidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfakalsidol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX10"/>
      <designation>
         <language value="en"/>
         <value value="Bacitracin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bacitracin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02"/>
      <designation>
         <language value="en"/>
         <value value="Topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topikale midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD51"/>
      <designation>
         <language value="en"/>
         <value value="Measles, combinations with mumps, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslinger, kombinasjoner med kusma, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA12"/>
      <designation>
         <language value="en"/>
         <value value="Levofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA01"/>
      <designation>
         <language value="en"/>
         <value value="Penicillins, combinations with other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicilliner, kombinasjoner med andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB54"/>
      <designation>
         <language value="en"/>
         <value value="Chlorphenamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorfenamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB53"/>
      <designation>
         <language value="en"/>
         <value value="Mepivacaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepivakain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DA01"/>
      <designation>
         <language value="en"/>
         <value value="Dactinomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daktinomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC55"/>
      <designation>
         <language value="en"/>
         <value value="Febantel, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Febantel, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR18"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofoviralafenamid, elvitegravir og kobicistat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA02"/>
      <designation>
         <language value="en"/>
         <value value="Pivampicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pivampicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB05"/>
      <designation>
         <language value="en"/>
         <value value="Zorubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zorubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD11AH"/>
      <designation>
         <language value="en"/>
         <value value="Agents for dermatitis, excluding corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot dermatitt, ekskl. kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XB02"/>
      <designation>
         <language value="en"/>
         <value value="Alanyl glutamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alanylglutamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09AA07"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EM03"/>
      <designation>
         <language value="en"/>
         <value value="Alpelisib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alpelisib"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AH"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of hypoglycemia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot hypoglykemi"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD11"/>
      <designation>
         <language value="en"/>
         <value value="Loprazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loprazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DE51"/>
      <designation>
         <language value="en"/>
         <value value="Cefepime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefepim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE06"/>
      <designation>
         <language value="en"/>
         <value value="Bivalirudin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bivalirudin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE"/>
      <designation>
         <language value="en"/>
         <value value="Artemisinin and derivatives, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemisinin og derivater, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB12"/>
      <designation>
         <language value="en"/>
         <value value="Mepenzolate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepenzolat"/>
      </designation>
   </concept>
   <concept>
      <code value="H02CA"/>
      <designation>
         <language value="en"/>
         <value value="Anticorticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CB03"/>
      <designation>
         <language value="en"/>
         <value value="Lanreotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lanreotid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA07"/>
      <designation>
         <language value="en"/>
         <value value="Clofenamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofenamid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA15"/>
      <designation>
         <language value="en"/>
         <value value="Dexmethylphenidate and serdexmethylphenidate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksmetylfenidat og serdeksmetylfenidat"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CG01"/>
      <designation>
         <language value="en"/>
         <value value="Labetalol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Labetalol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AD"/>
      <designation>
         <language value="en"/>
         <value value="Calcineurin inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsineurinhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ05A"/>
      <designation>
         <language value="en"/>
         <value value="Direct acting antivirals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Direktevirkende antivirale midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK04"/>
      <designation>
         <language value="en"/>
         <value value="Morinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="S01JA"/>
      <designation>
         <language value="en"/>
         <value value="Colouring agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fargestoffer"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BF"/>
      <designation>
         <language value="en"/>
         <value value="Gabapentinoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gabapentinoider"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA03"/>
      <designation>
         <language value="en"/>
         <value value="Estradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BB04"/>
      <designation>
         <language value="en"/>
         <value value="Influenza, virus like particles"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Influensa, viruslignende partikler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF02"/>
      <designation>
         <language value="en"/>
         <value value="Cloxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF01"/>
      <designation>
         <language value="en"/>
         <value value="Flupentixol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flupentiksol"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Natural phospholipids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naturlige fosfolipider"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB03"/>
      <designation>
         <language value="en"/>
         <value value="Tioguanine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioguanin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF"/>
      <designation>
         <language value="en"/>
         <value value="Detoxifying agents for antineoplastic treatment"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler som motvirker toksisitet av antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens and estrogens, sequential preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener og østrogener, sekvensmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA"/>
      <designation>
         <language value="en"/>
         <value value="Barbiturates and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbiturater og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH51"/>
      <designation>
         <language value="en"/>
         <value value="Imipenem and cilastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imipenem og cilastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05BB"/>
      <designation>
         <language value="en"/>
         <value value="Solutions affecting the electrolyte balance"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Løsninger med effekt på elektrolyttbalansen"/>
      </designation>
   </concept>
   <concept>
      <code value="C07EB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective, and vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, selektive, og vasodilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB10"/>
      <designation>
         <language value="en"/>
         <value value="Fentiazac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiazak"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Interferon alfacon-1"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon alfakon-1"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR19"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir alafenamide and rilpivirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofoviralafenamid og rilpivirin"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AA"/>
      <designation>
         <language value="en"/>
         <value value="Quinine and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinin og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX06"/>
      <designation>
         <language value="en"/>
         <value value="Emicizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emicizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Tinidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tinidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="B06A"/>
      <designation>
         <language value="en"/>
         <value value="Other hematological agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hematologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB03"/>
      <designation>
         <language value="en"/>
         <value value="Rifamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51EX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents against babesiosis and theileriosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot babesiose og teileriose"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AC02"/>
      <designation>
         <language value="en"/>
         <value value="Colestipol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolestipol"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03GA99"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropins, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropiner, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A11G"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vitamin C), incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin C, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B06"/>
      <designation>
         <language value="en"/>
         <value value="Other hematological agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hematologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AM"/>
      <designation>
         <language value="en"/>
         <value value="Tetanus vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetanusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA51"/>
      <designation>
         <language value="en"/>
         <value value="Alfuzosin and finasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfuzosin og finasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB06"/>
      <designation>
         <language value="en"/>
         <value value="Aloglutamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aloglutamol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX05"/>
      <designation>
         <language value="en"/>
         <value value="Regorafenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Regorafenib"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP52"/>
      <designation>
         <language value="en"/>
         <value value="Dasabuvir, ombitasvir, paritaprevir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dasabuvir, ombitasvir, paritaprevir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="J01B"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Mecasermin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mekasermin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AN05"/>
      <designation>
         <language value="en"/>
         <value value="Medical air"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinsk luft"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Ketamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA06"/>
      <designation>
         <language value="en"/>
         <value value="Pyridoxal phosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyridoksalfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="G03HA01"/>
      <designation>
         <language value="en"/>
         <value value="Cyproterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyproteron"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF09"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51GA"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomyciner"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA09"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og fenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA12"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-kikhoste-poliomyelitt-tetanus-hepatitt B"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BA03"/>
      <designation>
         <language value="en"/>
         <value value="Famotidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Famotidin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA07"/>
      <designation>
         <language value="en"/>
         <value value="Itopride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Itoprid"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BB01"/>
      <designation>
         <language value="en"/>
         <value value="Anti-D (rh) immunoglobulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin mot rh-immunisering"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG03"/>
      <designation>
         <language value="en"/>
         <value value="Natalizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natalizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA56"/>
      <designation>
         <language value="en"/>
         <value value="Tropicamide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tropikamid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Phenylpropanolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylpropanolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Quinidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinidin"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IA09"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) tilmanocept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) tilmanocept"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB"/>
      <designation>
         <language value="en"/>
         <value value="Non-selective beta-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-selektive betaagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="QA05A"/>
      <designation>
         <language value="en"/>
         <value value="Bile therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galleterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB10"/>
      <designation>
         <language value="en"/>
         <value value="Cefacetrile"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefacetril"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX18"/>
      <designation>
         <language value="en"/>
         <value value="Amivantamab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amivantamab"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AD"/>
      <designation>
         <language value="en"/>
         <value value="Non-watersoluble X-ray contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-vannløselige røntgenkontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03F"/>
      <designation>
         <language value="en"/>
         <value value="Progestogens and estrogens in combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progestogener og østrogener i kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI04"/>
      <designation>
         <language value="en"/>
         <value value="Cefiderocol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefiderokol"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD12"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone furoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikasonfuroat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA18"/>
      <designation>
         <language value="en"/>
         <value value="Ethyl loflazepate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etylloflazepat"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA11"/>
      <designation>
         <language value="en"/>
         <value value="Prazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC02"/>
      <designation>
         <language value="en"/>
         <value value="Fluclorolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluklorolon"/>
      </designation>
   </concept>
   <concept>
      <code value="R07A"/>
      <designation>
         <language value="en"/>
         <value value="Other respiratory system products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på respirasjonssystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AB04"/>
      <designation>
         <language value="en"/>
         <value value="Yersinia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Yersinia"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other immunologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre immunologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A05B"/>
      <designation>
         <language value="en"/>
         <value value="Liver therapy, lipotropics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leverterapi, lipotropika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BA04"/>
      <designation>
         <language value="en"/>
         <value value="Sodium salicylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumsalisylat"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Chloroquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorokin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI03"/>
      <designation>
         <language value="en"/>
         <value value="Faropenem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Faropenem"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of penicillins, incl. beta-lactamase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av penicilliner, inkludert beta-laktamasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA09"/>
      <designation>
         <language value="en"/>
         <value value="Azilsartan medoxomil and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azilsartanmedoksomil og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D05A"/>
      <designation>
         <language value="en"/>
         <value value="Antipsoriatics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antipsoriasismidler til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK05"/>
      <designation>
         <language value="en"/>
         <value value="Veliparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Veliparib"/>
      </designation>
   </concept>
   <concept>
      <code value="D02"/>
      <designation>
         <language value="en"/>
         <value value="Emollients and protectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bløtgjørende og hudbeskyttende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB18"/>
      <designation>
         <language value="en"/>
         <value value="Vamorolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vamorolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01X"/>
      <designation>
         <language value="en"/>
         <value value="Other antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH06"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus B, outer membrane vesicle vaccine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk B, yttermembran vesikkel vaksine"/>
      </designation>
   </concept>
   <concept>
      <code value="QD"/>
      <designation>
         <language value="en"/>
         <value value="Dermatologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AB"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anestetika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX02"/>
      <designation>
         <language value="en"/>
         <value value="Chloramphenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloramfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BE"/>
      <designation>
         <language value="en"/>
         <value value="Anilides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anilider"/>
      </designation>
   </concept>
   <concept>
      <code value="D01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Terbinafine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbinafin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP54"/>
      <designation>
         <language value="en"/>
         <value value="Elbasvir and grazoprevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elbasvir og grazoprevir"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BX51"/>
      <designation>
         <language value="en"/>
         <value value="Fumaric acid derivatives, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fumarsyrederivater, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA57"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylpyraline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylpyralin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B05AA05"/>
      <designation>
         <language value="en"/>
         <value value="Dextran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstran"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA09"/>
      <designation>
         <language value="en"/>
         <value value="Gadobutrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadobutrol"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX10"/>
      <designation>
         <language value="en"/>
         <value value="Eliglustat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eliglustat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX51"/>
      <designation>
         <language value="en"/>
         <value value="Tilidine and naloxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tilidin og nalokson"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE08"/>
      <designation>
         <language value="en"/>
         <value value="Atazanavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atazanavir"/>
      </designation>
   </concept>
   <concept>
      <code value="S01KA01"/>
      <designation>
         <language value="en"/>
         <value value="Hyaluronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyaluronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="M04A"/>
      <designation>
         <language value="en"/>
         <value value="Antigout preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Giktmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A07E"/>
      <designation>
         <language value="en"/>
         <value value="Intestinal antiinflammatory agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske midler ved tarmlidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC"/>
      <designation>
         <language value="en"/>
         <value value="Estrogens, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østrogener, kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB03"/>
      <designation>
         <language value="en"/>
         <value value="Methylscopolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylskopolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA04"/>
      <designation>
         <language value="en"/>
         <value value="Dolasetron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dolasetron"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BX04"/>
      <designation>
         <language value="en"/>
         <value value="Capsaicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Capsaicin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BA01"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase sensitive penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamaseømfintlige penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB11"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA02"/>
      <designation>
         <language value="en"/>
         <value value="Enalapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enalapril"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX10"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and valsartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og valsartan"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CA03"/>
      <designation>
         <language value="en"/>
         <value value="Albendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Albendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10A"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BB05"/>
      <designation>
         <language value="en"/>
         <value value="Nalmefene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nalmefen"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB14"/>
      <designation>
         <language value="en"/>
         <value value="Sebelipase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sebelipase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AX15"/>
      <designation>
         <language value="en"/>
         <value value="Propamidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propamidin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous amino acid complex and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)aminosyrekompleks og folinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA08"/>
      <designation>
         <language value="en"/>
         <value value="Dihexyverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diheksyverin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA51"/>
      <designation>
         <language value="en"/>
         <value value="Diprophylline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diprofyllin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R01"/>
      <designation>
         <language value="en"/>
         <value value="Nasal preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rhinologika"/>
      </designation>
   </concept>
   <concept>
      <code value="B02B"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin K and other hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin K og andre hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07B"/>
      <designation>
         <language value="en"/>
         <value value="Viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="M03B"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants, centrally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sentralt virkende muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AD07"/>
      <designation>
         <language value="en"/>
         <value value="Bovine respiratory syncytial virus + bovine parainfluenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bovint respiratorisk syncytialvirus + bovint parainfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA06"/>
      <designation>
         <language value="en"/>
         <value value="Lorazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA04"/>
      <designation>
         <language value="en"/>
         <value value="Eplerenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eplerenon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX12"/>
      <designation>
         <language value="en"/>
         <value value="Lefamulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lefamulin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB06"/>
      <designation>
         <language value="en"/>
         <value value="Penciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AD11"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD08"/>
      <designation>
         <language value="en"/>
         <value value="Droperidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Droperidol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LB"/>
      <designation>
         <language value="en"/>
         <value value="Methyldopa and diuretics in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldopa og diuretika i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB08"/>
      <designation>
         <language value="en"/>
         <value value="Ferric acetyl transferrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferriacetyltransferrin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03C"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika, midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA07"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="QR07"/>
      <designation>
         <language value="en"/>
         <value value="Other respiratory system products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på respirasjonssystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX30"/>
      <designation>
         <language value="en"/>
         <value value="Ivacaftor and lumacaftor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivakaftor og lumakaftor"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA10"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA04AD90"/>
      <designation>
         <language value="en"/>
         <value value="Maropitant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Maropitant"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AD04"/>
      <designation>
         <language value="en"/>
         <value value="Bovine respiratory syncytial virus (BRSV)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bovint respiratorisk syncytialvirus (BRSV)"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX18"/>
      <designation>
         <language value="en"/>
         <value value="Letermovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Letermovir"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB08"/>
      <designation>
         <language value="en"/>
         <value value="Reviparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reviparin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LC"/>
      <designation>
         <language value="en"/>
         <value value="Imidazoline receptor agonists in combination with diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolinreseptoragonister kombinasjoner med diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB11"/>
      <designation>
         <language value="en"/>
         <value value="Glisoxepide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glisoksepid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for ovidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for okse"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BG02"/>
      <designation>
         <language value="en"/>
         <value value="Rosiglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosiglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01G"/>
      <designation>
         <language value="en"/>
         <value value="Decongestants and antiallergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karkontraherende og antiallergiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH03"/>
      <designation>
         <language value="en"/>
         <value value="Olanzapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olanzapin"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AA05"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01MA90"/>
      <designation>
         <language value="en"/>
         <value value="Enrofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enrofloksasin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB08"/>
      <designation>
         <language value="en"/>
         <value value="Methyclothiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyklotiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA04"/>
      <designation>
         <language value="en"/>
         <value value="Spiramycin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spiramycin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC04"/>
      <designation>
         <language value="en"/>
         <value value="Cefaclor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefaklor"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrochlorothiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroklortiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AG02"/>
      <designation>
         <language value="en"/>
         <value value="Ketobemidone and antispasmodics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketobemidon og spasmolytika"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC08"/>
      <designation>
         <language value="en"/>
         <value value="Somatrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somatrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH02"/>
      <designation>
         <language value="en"/>
         <value value="Pimecrolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pimecrolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="QC08C"/>
      <designation>
         <language value="en"/>
         <value value="Selective calcium channel blockers with mainly vascular effects"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive kalsiumantagonister med primært vaskulær virkning"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA09"/>
      <designation>
         <language value="en"/>
         <value value="Doxylamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksylamin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Ferric hydroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferrihydroksid"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AC02"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA05"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin and ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin og ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE03"/>
      <designation>
         <language value="en"/>
         <value value="Sildenafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sildenafil"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC"/>
      <designation>
         <language value="en"/>
         <value value="Interleukin inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interleukinhemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM01"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycin and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomycin og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XD03"/>
      <designation>
         <language value="en"/>
         <value value="Methyl aminolevulinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylaminolevulinat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA"/>
      <designation>
         <language value="en"/>
         <value value="Macrolides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrolider"/>
      </designation>
   </concept>
   <concept>
      <code value="QC08CA01"/>
      <designation>
         <language value="en"/>
         <value value="Amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC07"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium levulinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumlevulinat"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA51"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="H01B"/>
      <designation>
         <language value="en"/>
         <value value="Posterior pituitary lobe hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofysebaklapphormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX08"/>
      <designation>
         <language value="en"/>
         <value value="Pyrrobutamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrrobutamin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AF52"/>
      <designation>
         <language value="en"/>
         <value value="Erythromycin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytromycin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD02"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor VIII"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor VIII"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE06"/>
      <designation>
         <language value="en"/>
         <value value="Oxatomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksatomid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH04"/>
      <designation>
         <language value="en"/>
         <value value="Quetiapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvetiapin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA25"/>
      <designation>
         <language value="en"/>
         <value value="Lascufloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laskufloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FE02"/>
      <designation>
         <language value="en"/>
         <value value="Panitumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Panitumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX07"/>
      <designation>
         <language value="en"/>
         <value value="Dimethyl fumarate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetylfumarat"/>
      </designation>
   </concept>
   <concept>
      <code value="QA14AB"/>
      <designation>
         <language value="en"/>
         <value value="Estren derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Estrenderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QL04AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ciclosporin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklosporin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH06"/>
      <designation>
         <language value="en"/>
         <value value="Clotiapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klotiapin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA09"/>
      <designation>
         <language value="en"/>
         <value value="Corifollitropin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Korifollitropin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LL"/>
      <designation>
         <language value="en"/>
         <value value="MAO inhibitors and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="MAO-hemmere og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX09"/>
      <designation>
         <language value="en"/>
         <value value="Patent blue"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Patentblått"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AE91"/>
      <designation>
         <language value="en"/>
         <value value="Carprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA13"/>
      <designation>
         <language value="en"/>
         <value value="Lercanidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lerkanidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AG90"/>
      <designation>
         <language value="en"/>
         <value value="Flunixin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluniksin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AF01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB"/>
      <designation>
         <language value="en"/>
         <value value="First-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Første generasjon cefalosporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF02"/>
      <designation>
         <language value="en"/>
         <value value="Didanosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Didanosin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX11"/>
      <designation>
         <language value="en"/>
         <value value="Pitolisant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pitolisant"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD"/>
      <designation>
         <language value="en"/>
         <value value="HER2 (Human epidermal growth factor receptor 2) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="HER2 (Epidermal vekstfaktorreseptor 2, human) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04CX90"/>
      <designation>
         <language value="en"/>
         <value value="Osaterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Osateron"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BC01"/>
      <designation>
         <language value="en"/>
         <value value="Mersalyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mersalyl"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA02"/>
      <designation>
         <language value="en"/>
         <value value="Levodopa and decarboxylase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levodopa og dekarboksylasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AB"/>
      <designation>
         <language value="en"/>
         <value value="Choline derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA05"/>
      <designation>
         <language value="en"/>
         <value value="Propranolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propranolol"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Heparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heparin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA06"/>
      <designation>
         <language value="en"/>
         <value value="Bacampicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakampicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE08"/>
      <designation>
         <language value="en"/>
         <value value="Tadalafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tadalafil"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BC02"/>
      <designation>
         <language value="en"/>
         <value value="Mefloquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meflokin"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX03"/>
      <designation>
         <language value="en"/>
         <value value="Calcitriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsitriol"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB02"/>
      <designation>
         <language value="en"/>
         <value value="Bezafibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bezafibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AA01"/>
      <designation>
         <language value="en"/>
         <value value="Methylprednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylprednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AX90"/>
      <designation>
         <language value="en"/>
         <value value="Pentosan polysulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentosanpolysulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB04"/>
      <designation>
         <language value="en"/>
         <value value="Gemfibrozil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemfibrozil"/>
      </designation>
   </concept>
   <concept>
      <code value="QN04"/>
      <designation>
         <language value="en"/>
         <value value="Anti-parkinson drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiparkinsonmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CX04"/>
      <designation>
         <language value="en"/>
         <value value="Cimicifugae rhizoma"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klaseormedruerot"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE04"/>
      <designation>
         <language value="en"/>
         <value value="Nelfinavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nelfinavir"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AE03"/>
      <designation>
         <language value="en"/>
         <value value="Goserelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Goserelin"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AD02"/>
      <designation>
         <language value="en"/>
         <value value="Methoxsalen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoksalen"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD07"/>
      <designation>
         <language value="en"/>
         <value value="Tolterodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolterodin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03BB"/>
      <designation>
         <language value="en"/>
         <value value="Sulfur-containing imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svovelholdige imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L02"/>
      <designation>
         <language value="en"/>
         <value value="Endocrine therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Endokrin terapi"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB10"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon alfa-2b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon alfa-2b"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA09"/>
      <designation>
         <language value="en"/>
         <value value="Cyclothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklotiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX05"/>
      <designation>
         <language value="en"/>
         <value value="Omalizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omalizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01E"/>
      <designation>
         <language value="en"/>
         <value value="Antiglaucoma preparations and miotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glaukommidler og miotika"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB52"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Disopyramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Disopyramid"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AC52"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CA12"/>
      <designation>
         <language value="en"/>
         <value value="Hederae helicis folium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eføyblad"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB13"/>
      <designation>
         <language value="en"/>
         <value value="Obidoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Obidoksim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XJ01"/>
      <designation>
         <language value="en"/>
         <value value="Vismodegib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vismodegib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA09"/>
      <designation>
         <language value="en"/>
         <value value="Bendamustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bendamustin"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE07"/>
      <designation>
         <language value="en"/>
         <value value="Calcium acetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="P01"/>
      <designation>
         <language value="en"/>
         <value value="Antiprotozoals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protozomidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX07"/>
      <designation>
         <language value="en"/>
         <value value="Ibrexafungerp"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibreksafungerp"/>
      </designation>
   </concept>
   <concept>
      <code value="QL03AB90"/>
      <designation>
         <language value="en"/>
         <value value="Interferon omega, feline origin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon omega, katteopprinnelse"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC06"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortolone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortolon og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH02"/>
      <designation>
         <language value="en"/>
         <value value="Clozapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klozapin"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09BA07"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BX"/>
      <designation>
         <language value="en"/>
         <value value="Other antipsoriatics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antipsoriasismidler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="S02C"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BA02"/>
      <designation>
         <language value="en"/>
         <value value="Fat emulsions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fettemulsjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK06"/>
      <designation>
         <language value="en"/>
         <value value="Salmeterol and fluticasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salmeterol og flutikason"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Sulindac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulindak"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB06"/>
      <designation>
         <language value="en"/>
         <value value="Fluorometholone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorometolon"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AN"/>
      <designation>
         <language value="en"/>
         <value value="Medical gases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinske gasser"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC"/>
      <designation>
         <language value="en"/>
         <value value="Selective serotonin (5HT1) agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive serotonin (5HT1) agonister"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IX09"/>
      <designation>
         <language value="en"/>
         <value value="Gallium (68Ga) edotreotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gallium (68Ga) edotreotid"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA05"/>
      <designation>
         <language value="en"/>
         <value value="Tiludronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiludronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB15"/>
      <designation>
         <language value="en"/>
         <value value="Naloxone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nalokson"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CC01"/>
      <designation>
         <language value="en"/>
         <value value="Ganirelix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ganireliks"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03AB95"/>
      <designation>
         <language value="en"/>
         <value value="Apomorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apomorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11CC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin D and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin D og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB08"/>
      <designation>
         <language value="en"/>
         <value value="Zoledronic acid, calcium and colecalciferol, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zoledronsyre, kalsium og kolekalsiferol, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB11"/>
      <designation>
         <language value="en"/>
         <value value="Valaciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valaciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AG01"/>
      <designation>
         <language value="en"/>
         <value value="Mefenamic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mefenamsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB10"/>
      <designation>
         <language value="en"/>
         <value value="Iomeprol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jomeprol"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA08"/>
      <designation>
         <language value="en"/>
         <value value="Methyclothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyklotiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA05"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium silicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumsilikat"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP57"/>
      <designation>
         <language value="en"/>
         <value value="Glecaprevir and pibrentasvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glekaprevir og pibrentasvir"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA05"/>
      <designation>
         <language value="en"/>
         <value value="Potassium gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BA"/>
      <designation>
         <language value="en"/>
         <value value="Heparins or heparinoids for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hepariner eller heparinoider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AX01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrochlorothiazide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroklortiazid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antibiotics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibiotika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA17"/>
      <designation>
         <language value="en"/>
         <value value="Amoxapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amoksapin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB01"/>
      <designation>
         <language value="en"/>
         <value value="Bupivacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bupivakain"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AC01"/>
      <designation>
         <language value="en"/>
         <value value="Paramethadione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parametadion"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BA03"/>
      <designation>
         <language value="en"/>
         <value value="Varenicline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vareniklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB21"/>
      <designation>
         <language value="en"/>
         <value value="Regadenoson"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Regadenoson"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Nadroparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nadroparin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04"/>
      <designation>
         <language value="en"/>
         <value value="Anti-parkinson drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiparkinsonmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG03"/>
      <designation>
         <language value="en"/>
         <value value="Anastrozole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anastrozol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA09"/>
      <designation>
         <language value="en"/>
         <value value="Azlocillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azlocillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB12"/>
      <designation>
         <language value="en"/>
         <value value="Pemafibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pemafibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Torasemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Torasemid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB08"/>
      <designation>
         <language value="en"/>
         <value value="Nemonoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nemonoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD10"/>
      <designation>
         <language value="en"/>
         <value value="Dronabinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dronabinol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC"/>
      <designation>
         <language value="en"/>
         <value value="Guanidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC02"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrotachysterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrotakysterol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC02"/>
      <designation>
         <language value="en"/>
         <value value="Guanfacine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanfacin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC01"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB10"/>
      <designation>
         <language value="en"/>
         <value value="Tinzaparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tinzaparin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH53"/>
      <designation>
         <language value="en"/>
         <value value="Olanzapine and samidorphan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olanzapin og samidorfan"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF03"/>
      <designation>
         <language value="en"/>
         <value value="Zalcitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zalcitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA11"/>
      <designation>
         <language value="en"/>
         <value value="Rifaximin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifaksimin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC10"/>
      <designation>
         <language value="en"/>
         <value value="Secukinumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekukinumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02"/>
      <designation>
         <language value="en"/>
         <value value="Otologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Øremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA11"/>
      <designation>
         <language value="en"/>
         <value value="Doxofylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksofyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01B"/>
      <designation>
         <language value="en"/>
         <value value="Antimetabolites"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimetabolitter"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA04"/>
      <designation>
         <language value="en"/>
         <value value="Silodosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Silodosin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01BA"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC09"/>
      <designation>
         <language value="en"/>
         <value value="Desogestrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desogestrel"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR28"/>
      <designation>
         <language value="en"/>
         <value value="Stavudine and lamivudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stavudin og lamivudin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LX01"/>
      <designation>
         <language value="en"/>
         <value value="Pinacidil and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pinacidil og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA15"/>
      <designation>
         <language value="en"/>
         <value value="Zofenopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zofenopril"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD51"/>
      <designation>
         <language value="en"/>
         <value value="Scopolamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Skopolamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD10"/>
      <designation>
         <language value="en"/>
         <value value="Darifenacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darifenacin"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AA"/>
      <designation>
         <language value="en"/>
         <value value="Enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH"/>
      <designation>
         <language value="en"/>
         <value value="Histone deacetylase (HDAC) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Histondeacetylasehemmere (HDAC)"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL"/>
      <designation>
         <language value="en"/>
         <value value="Benzamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzamider"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG10"/>
      <designation>
         <language value="en"/>
         <value value="Docusate sodium, incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dokusatnatrium, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH05"/>
      <designation>
         <language value="en"/>
         <value value="Biapenem"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biapenem"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC54"/>
      <designation>
         <language value="en"/>
         <value value="Permethrin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Permetrin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC06"/>
      <designation>
         <language value="en"/>
         <value value="Diamorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diamorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01C"/>
      <designation>
         <language value="en"/>
         <value value="Spesific antirheumatic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spesifikke antireumatiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02B"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA07"/>
      <designation>
         <language value="en"/>
         <value value="Josamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Josamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA05"/>
      <designation>
         <language value="en"/>
         <value value="Follitropin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Follitropin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB10"/>
      <designation>
         <language value="en"/>
         <value value="Escitalopram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escitalopram"/>
      </designation>
   </concept>
   <concept>
      <code value="D01"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for dermatological use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til dermatologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA06"/>
      <designation>
         <language value="en"/>
         <value value="Nimodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nimodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03CA"/>
      <designation>
         <language value="en"/>
         <value value="Natural and semisynthetic estrogens, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naturlige og halvsyntetiske østrogener, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX07"/>
      <designation>
         <language value="en"/>
         <value value="Tapinarof"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tapinarof"/>
      </designation>
   </concept>
   <concept>
      <code value="R03"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DB03"/>
      <designation>
         <language value="en"/>
         <value value="Endralazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Endralazin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Mesterolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mesterolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05AA04"/>
      <designation>
         <language value="en"/>
         <value value="Acepromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acepromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC59"/>
      <designation>
         <language value="en"/>
         <value value="Trifluridine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trifluridin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DC03"/>
      <designation>
         <language value="en"/>
         <value value="Montelukast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Montelukast"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA59"/>
      <designation>
         <language value="en"/>
         <value value="Codeine, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A03F"/>
      <designation>
         <language value="en"/>
         <value value="Propulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Motilitetsregulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB13"/>
      <designation>
         <language value="en"/>
         <value value="Deflazacort"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deflazakort"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK07"/>
      <designation>
         <language value="en"/>
         <value value="Thioacetazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioacetazon"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51CA"/>
      <designation>
         <language value="en"/>
         <value value="Nitroimidazole derivatives against amoebiosis and histomonosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitroimidazolderivater mot amøbiose og histomonose"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03BB02"/>
      <designation>
         <language value="en"/>
         <value value="Thiamazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA"/>
      <designation>
         <language value="en"/>
         <value value="Selective immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB01"/>
      <designation>
         <language value="en"/>
         <value value="Sulfaisodimidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfaisodimidin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ04"/>
      <designation>
         <language value="en"/>
         <value value="Sutimlimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sutimlimab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA03"/>
      <designation>
         <language value="en"/>
         <value value="Oxaliplatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksaliplatin"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AB"/>
      <designation>
         <language value="en"/>
         <value value="Ergot alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekalealkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AX05"/>
      <designation>
         <language value="en"/>
         <value value="Prucalopride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prukaloprid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BB02"/>
      <designation>
         <language value="en"/>
         <value value="Influenza, inactivated, split virus or surface antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Influensa, inaktivert, splitvirus eller overflateantigen"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CF03"/>
      <designation>
         <language value="en"/>
         <value value="Zaleplon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zaleplon"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CD01"/>
      <designation>
         <language value="en"/>
         <value value="Muzolimine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Muzolimin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX01"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril, amlodipine and indapamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril, amlodipin og indapamid"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CA10"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB03"/>
      <designation>
         <language value="en"/>
         <value value="Medrogestone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medrogeston"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC15"/>
      <designation>
         <language value="en"/>
         <value value="Reproterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reproterol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL"/>
      <designation>
         <language value="en"/>
         <value value="Antineoplastic cell and gene therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antineoplastisk celle- og genterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM08"/>
      <designation>
         <language value="en"/>
         <value value="Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoniazid, sulfametoksazol, trimetoprim og pyridoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11GA01"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vit C)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Askorbinsyre (vit C)"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB02"/>
      <designation>
         <language value="en"/>
         <value value="Cefaloridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefaloridin"/>
      </designation>
   </concept>
   <concept>
      <code value="M09AX07"/>
      <designation>
         <language value="en"/>
         <value value="Nusinersen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nusinersen"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BB04"/>
      <designation>
         <language value="en"/>
         <value value="Naltrexone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naltrekson"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA10"/>
      <designation>
         <language value="en"/>
         <value value="Nilvadipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nilvadipin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA11"/>
      <designation>
         <language value="en"/>
         <value value="Dexmethylphenidate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksmetylfenidat"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DB01"/>
      <designation>
         <language value="en"/>
         <value value="Amiloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amilorid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX08"/>
      <designation>
         <language value="en"/>
         <value value="Pentostatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentostatin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX11"/>
      <designation>
         <language value="en"/>
         <value value="Zotepine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zotepin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AK02"/>
      <designation>
         <language value="en"/>
         <value value="Teriflunomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teriflunomid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA13"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-haemophilus influenzae B-kikhoste-tetanus-hepatitt B-meningokokk A+C"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC11"/>
      <designation>
         <language value="en"/>
         <value value="Siltuximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Siltuksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA03"/>
      <designation>
         <language value="en"/>
         <value value="Deserpidine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deserpidin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD04"/>
      <designation>
         <language value="en"/>
         <value value="Dofetilide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dofetilid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Clofezone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofezon"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA19"/>
      <designation>
         <language value="en"/>
         <value value="Bupranolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bupranolol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AX15"/>
      <designation>
         <language value="en"/>
         <value value="Menthae piperitae aetheroleum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peppermynteolje"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10B"/>
      <designation>
         <language value="en"/>
         <value value="Blood glucose lowering drugs, excl. insulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodglukosesenkende midler, ekskl. insuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="A02A"/>
      <designation>
         <language value="en"/>
         <value value="Antacids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antacida"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03AX91"/>
      <designation>
         <language value="en"/>
         <value value="Potassium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX17"/>
      <designation>
         <language value="en"/>
         <value value="Pimavanserin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pimavanserin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB14"/>
      <designation>
         <language value="en"/>
         <value value="Cloprednol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloprednol"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG06"/>
      <designation>
         <language value="en"/>
         <value value="Doravirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doravirin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)karbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA01"/>
      <designation>
         <language value="en"/>
         <value value="Captopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaptopril"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH04"/>
      <designation>
         <language value="en"/>
         <value value="Alogliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alogliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX"/>
      <designation>
         <language value="en"/>
         <value value="Other viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre virusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC03"/>
      <designation>
         <language value="en"/>
         <value value="Voriconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vorikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54"/>
      <designation>
         <language value="en"/>
         <value value="Endectocides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Endektosider"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AD"/>
      <designation>
         <language value="en"/>
         <value value="Organic acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Organiske syrer"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01XX"/>
      <designation>
         <language value="en"/>
         <value value="Other antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XD01"/>
      <designation>
         <language value="en"/>
         <value value="Metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF06"/>
      <designation>
         <language value="en"/>
         <value value="Abacavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abakavir"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BA03"/>
      <designation>
         <language value="en"/>
         <value value="Buformin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buformin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EA"/>
      <designation>
         <language value="en"/>
         <value value="Phenylalkylamine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylalkylaminderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB06"/>
      <designation>
         <language value="en"/>
         <value value="Enviomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enviomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CD03"/>
      <designation>
         <language value="en"/>
         <value value="Fremanezumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fremanezumab"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB51"/>
      <designation>
         <language value="en"/>
         <value value="Bupivacaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bupivakain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE06"/>
      <designation>
         <language value="en"/>
         <value value="Benoxaprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benoksaprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA06"/>
      <designation>
         <language value="en"/>
         <value value="Betaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betain"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA01"/>
      <designation>
         <language value="en"/>
         <value value="Chlorpromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorpromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA"/>
      <designation>
         <language value="en"/>
         <value value="Propulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Motilitetsregulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiglaucoma preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre glaukommidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N06A"/>
      <designation>
         <language value="en"/>
         <value value="Antidepressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidepressiva"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CA01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10X"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs used in diabetes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler brukt i forbindelse med diabetes"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antihistamines for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antihistaminer til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CD01"/>
      <designation>
         <language value="en"/>
         <value value="Sodium fluoride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumfluorid"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC"/>
      <designation>
         <language value="en"/>
         <value value="Other quaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kvartære ammoniumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB16"/>
      <designation>
         <language value="en"/>
         <value value="Aceclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aceklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA09"/>
      <designation>
         <language value="en"/>
         <value value="Amitriptyline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amitriptylin"/>
      </designation>
   </concept>
   <concept>
      <code value="A14A"/>
      <designation>
         <language value="en"/>
         <value value="Anabolic steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anabole steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="G03"/>
      <designation>
         <language value="en"/>
         <value value="Sex hormones and modulators of the genital system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kjønnshormoner og midler med effekt på genitalia"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylpropylamine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylpropylaminderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AB01"/>
      <designation>
         <language value="en"/>
         <value value="Busulfan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Busulfan"/>
      </designation>
   </concept>
   <concept>
      <code value="QL03A"/>
      <designation>
         <language value="en"/>
         <value value="Immunostimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA04"/>
      <designation>
         <language value="en"/>
         <value value="Lymecycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lymesyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other muscle relaxants, peripherally acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre perifert virkende muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF03"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate and amodiaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat og amodiakin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AE03"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA11"/>
      <designation>
         <language value="en"/>
         <value value="Oxymorphone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksymorfon"/>
      </designation>
   </concept>
   <concept>
      <code value="R05F"/>
      <designation>
         <language value="en"/>
         <value value="Cough suppressants and expectorants, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitussiva og ekspektorantia, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B05C"/>
      <designation>
         <language value="en"/>
         <value value="Irrigating solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Skyllevæsker"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF10"/>
      <designation>
         <language value="en"/>
         <value value="Entecavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Entekavir"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB06"/>
      <designation>
         <language value="en"/>
         <value value="Losartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Losartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01CA"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropin-releasing hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropinfrisettende hormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA05"/>
      <designation>
         <language value="en"/>
         <value value="Methylnortestosterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylnortestosteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX02"/>
      <designation>
         <language value="en"/>
         <value value="Cyproheptadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyproheptadin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KC"/>
      <designation>
         <language value="en"/>
         <value value="MAO inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="MAO-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AD07"/>
      <designation>
         <language value="en"/>
         <value value="Feline leukaemia recombinant live canarypox virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katteleukemi, canarykoppervirus, rekombinant, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX78"/>
      <designation>
         <language value="en"/>
         <value value="Navitoclax"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Navitoklaks"/>
      </designation>
   </concept>
   <concept>
      <code value="R"/>
      <designation>
         <language value="en"/>
         <value value="Respiratory system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Respirasjonsorganer"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA06"/>
      <designation>
         <language value="en"/>
         <value value="Ibandronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibandronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N02A"/>
      <designation>
         <language value="en"/>
         <value value="Opioids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioider"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AB"/>
      <designation>
         <language value="en"/>
         <value value="Heme products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hemprodukter"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AC"/>
      <designation>
         <language value="en"/>
         <value value="Interleukins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interleukiner"/>
      </designation>
   </concept>
   <concept>
      <code value="M09A"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA21"/>
      <designation>
         <language value="en"/>
         <value value="Clotiazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klotiazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB"/>
      <designation>
         <language value="en"/>
         <value value="Other cardiac preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler for hjerteterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA"/>
      <designation>
         <language value="en"/>
         <value value="Aminoalkyl ethers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminoalkyletere"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX06"/>
      <designation>
         <language value="en"/>
         <value value="Miglustat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Miglustat"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AD04"/>
      <designation>
         <language value="en"/>
         <value value="Feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kattepanleukopenivirus / parvovirus + katterhinotrakeitittvirus  + kattekalicivirus"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CM06"/>
      <designation>
         <language value="en"/>
         <value value="Propiomazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propiomazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF02"/>
      <designation>
         <language value="en"/>
         <value value="Nialamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nialamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB06"/>
      <designation>
         <language value="en"/>
         <value value="Homatropine methylbromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Homatropinmetylbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA07"/>
      <designation>
         <language value="en"/>
         <value value="Lofepramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lofepramin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA05"/>
      <designation>
         <language value="en"/>
         <value value="Carglumic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kargluminsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EC02"/>
      <designation>
         <language value="en"/>
         <value value="Mesalazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mesalazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AA01"/>
      <designation>
         <language value="en"/>
         <value value="Phentermine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentermin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA"/>
      <designation>
         <language value="en"/>
         <value value="Digitalis glycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digitalisglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD12"/>
      <designation>
         <language value="en"/>
         <value value="Protein C"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protein C"/>
      </designation>
   </concept>
   <concept>
      <code value="L02B"/>
      <designation>
         <language value="en"/>
         <value value="Hormone antagonists and related agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hormonantagonister og beslektede substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR25"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine and dolutegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin og dolutegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="C03X"/>
      <designation>
         <language value="en"/>
         <value value="Other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CK01"/>
      <designation>
         <language value="en"/>
         <value value="Secretin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekretin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE05"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadimidine and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadimidin og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC53"/>
      <designation>
         <language value="en"/>
         <value value="Tegafur, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tegafur, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA11"/>
      <designation>
         <language value="en"/>
         <value value="Animals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dyr"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03GA01"/>
      <designation>
         <language value="en"/>
         <value value="Chorionic gonadotrophin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koriongonadotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC"/>
      <designation>
         <language value="en"/>
         <value value="Antiarrhythmics, class Ic"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiarytmika, klasse Ic"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC02"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (beef)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (storfe)"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR23"/>
      <designation>
         <language value="en"/>
         <value value="Atazanavir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atazanavir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF03"/>
      <designation>
         <language value="en"/>
         <value value="Meticillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meticillin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AC52"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Alteplase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alteplase"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AX02"/>
      <designation>
         <language value="en"/>
         <value value="Pipobroman"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipobroman"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03B"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna and derivates, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonna og derivater, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF09"/>
      <designation>
         <language value="en"/>
         <value value="Tislelizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tislelizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AX18"/>
      <designation>
         <language value="en"/>
         <value value="Povidone-iodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Povidon, jodert"/>
      </designation>
   </concept>
   <concept>
      <code value="QR05CB01"/>
      <designation>
         <language value="en"/>
         <value value="Acetylcysteine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylcystein"/>
      </designation>
   </concept>
   <concept>
      <code value="R05D"/>
      <designation>
         <language value="en"/>
         <value value="Cough suppressants, excl. combinations with expectorants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitussiva, ekskl. kombinasjoner med ekspektorantia"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03AB90"/>
      <designation>
         <language value="en"/>
         <value value="Atipamezole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atipamezol"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BB01"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA06"/>
      <designation>
         <language value="en"/>
         <value value="Tropicamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tropikamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DD01"/>
      <designation>
         <language value="en"/>
         <value value="Nitroprusside"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitroprussid"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA07"/>
      <designation>
         <language value="en"/>
         <value value="Azithromycin, fluconazole and secnidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azitromycin, flukonazol og seknidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AE"/>
      <designation>
         <language value="en"/>
         <value value="Peroxides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peroksider"/>
      </designation>
   </concept>
   <concept>
      <code value="QC05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Heparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heparin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC22"/>
      <designation>
         <language value="en"/>
         <value value="Spesolimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spesolimab"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03DA"/>
      <designation>
         <language value="en"/>
         <value value="Aldosterone antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldosteronantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB12"/>
      <designation>
         <language value="en"/>
         <value value="Bemiparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bemiparin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD21"/>
      <designation>
         <language value="en"/>
         <value value="Saxagliptin and dapagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saksagliptin og dapagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CA02"/>
      <designation>
         <language value="en"/>
         <value value="Bumetanide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bumetanid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20CD01"/>
      <designation>
         <language value="en"/>
         <value value="Mink distemper virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Minkdistempervirus"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BA02"/>
      <designation>
         <language value="en"/>
         <value value="Encephalitis, Japanese, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Japansk encefalitt, inaktivert helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD16"/>
      <designation>
         <language value="en"/>
         <value value="Cefditoren"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefditoren"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AJ01"/>
      <designation>
         <language value="en"/>
         <value value="Pertussis, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kikhoste, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA08"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous tartrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)tartrat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD04"/>
      <designation>
         <language value="en"/>
         <value value="Streptozocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptozocin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA12"/>
      <designation>
         <language value="en"/>
         <value value="Tropatepine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tropatepin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KB"/>
      <designation>
         <language value="en"/>
         <value value="Tyrosine hydroxylase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyrosinhydroksylasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="P02D"/>
      <designation>
         <language value="en"/>
         <value value="Anticestodals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot cestoder"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KN"/>
      <designation>
         <language value="en"/>
         <value value="Other antihypertensives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antihypertensiva"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AX"/>
      <designation>
         <language value="en"/>
         <value value="Other topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre topikale midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BB04"/>
      <designation>
         <language value="en"/>
         <value value="Sodium tetradecyl sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumtetradekylsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK06"/>
      <designation>
         <language value="en"/>
         <value value="Delamanid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delamanid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB"/>
      <designation>
         <language value="en"/>
         <value value="Other quinolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kinoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF11"/>
      <designation>
         <language value="en"/>
         <value value="Sugemalimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sugemalimab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA06"/>
      <designation>
         <language value="en"/>
         <value value="Ifosfamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ifosfamid"/>
      </designation>
   </concept>
   <concept>
      <code value="P01A"/>
      <designation>
         <language value="en"/>
         <value value="Agents against amoebiasis and other protozoal diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av amøbesykdommer og andre protozosykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BC"/>
      <designation>
         <language value="en"/>
         <value value="Solutions producing osmotic diuresis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Løsninger for fremkalling av osmotisk diurese"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CC"/>
      <designation>
         <language value="en"/>
         <value value="Colchicine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolkisinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA01"/>
      <designation>
         <language value="en"/>
         <value value="Androstanolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Androstanolon"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CL"/>
      <designation>
         <language value="en"/>
         <value value="Tests for allergic diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til allergidiagnostikk"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in opioid dependence"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved opioidavhengighet"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA08"/>
      <designation>
         <language value="en"/>
         <value value="Olmesartan medoxomil and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olmesartanmedoksomil og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AA"/>
      <designation>
         <language value="en"/>
         <value value="Tars"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tjærer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA11"/>
      <designation>
         <language value="en"/>
         <value value="Mecillinam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mecillinam"/>
      </designation>
   </concept>
   <concept>
      <code value="C02C"/>
      <designation>
         <language value="en"/>
         <value value="Antiadrenergic agents, peripherally acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiadrenergika, perifert virkende"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA06"/>
      <designation>
         <language value="en"/>
         <value value="Quinapril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinapril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Bendroflumethiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bendroflumetiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE03"/>
      <designation>
         <language value="en"/>
         <value value="Cyclizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syklizin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AE01"/>
      <designation>
         <language value="en"/>
         <value value="Iron, vitamin B12 and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern, B12 og folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB"/>
      <designation>
         <language value="en"/>
         <value value="Anticholinergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikolinergika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EB02"/>
      <designation>
         <language value="en"/>
         <value value="Bumetanide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bumetanid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03X"/>
      <designation>
         <language value="en"/>
         <value value="Other sex hormones and modulators of the genital system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kjønnshormoner og midler med effekt på genitalia"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AG"/>
      <designation>
         <language value="en"/>
         <value value="Monoamine oxidase A inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="MAO-hemmere, type A"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EA03"/>
      <designation>
         <language value="en"/>
         <value value="Prednisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednison"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BE01"/>
      <designation>
         <language value="en"/>
         <value value="Afoxolaner"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Afoksolaner"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AC05"/>
      <designation>
         <language value="en"/>
         <value value="Dequalinium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekvalin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA"/>
      <designation>
         <language value="en"/>
         <value value="Other antianemic preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot anemi"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA01"/>
      <designation>
         <language value="en"/>
         <value value="Amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD04"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium nicotinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumnikotinat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE09"/>
      <designation>
         <language value="en"/>
         <value value="Flurbiprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flurbiprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="M04"/>
      <designation>
         <language value="en"/>
         <value value="Antigout preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Giktmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB02"/>
      <designation>
         <language value="en"/>
         <value value="Rifampicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifampicin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA08"/>
      <designation>
         <language value="en"/>
         <value value="Fleroxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fleroksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC10"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA06"/>
      <designation>
         <language value="en"/>
         <value value="Paromomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paromomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB10"/>
      <designation>
         <language value="en"/>
         <value value="Metahexamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metaheksamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA14AB01"/>
      <designation>
         <language value="en"/>
         <value value="Nandrolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nandrolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QR02"/>
      <designation>
         <language value="en"/>
         <value value="Throat preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC05"/>
      <designation>
         <language value="en"/>
         <value value="Ustekinumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ustekinumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX03"/>
      <designation>
         <language value="en"/>
         <value value="Nateglinide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nateglinid"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03DA01"/>
      <designation>
         <language value="en"/>
         <value value="Spironolactone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spironolakton"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XY01"/>
      <designation>
         <language value="en"/>
         <value value="Cytarabine and daunorubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cytarabin og daunorubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI01"/>
      <designation>
         <language value="en"/>
         <value value="Ceftobiprole medocaril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftobiprolmedokaril"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB21"/>
      <designation>
         <language value="en"/>
         <value value="Potassium iodide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumjodid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH01"/>
      <designation>
         <language value="en"/>
         <value value="Celecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Celekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA12"/>
      <designation>
         <language value="en"/>
         <value value="Piperacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piperacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BX"/>
      <designation>
         <language value="en"/>
         <value value="Other antimalarials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre malariamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Ketobemidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketobemidon"/>
      </designation>
   </concept>
   <concept>
      <code value="H02A"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX06"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin, acetylsalicylic acid and ramipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin, acetylsalisylsyre og ramipril"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA12"/>
      <designation>
         <language value="en"/>
         <value value="Yogurt"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jogurt"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ06"/>
      <designation>
         <language value="en"/>
         <value value="Semaglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Semaglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FE"/>
      <designation>
         <language value="en"/>
         <value value="EGFR (Epidermal growth factor receptor) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="EGFR (Epidermal vekstfaktorreseptor) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EJ01"/>
      <designation>
         <language value="en"/>
         <value value="Ruxolitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ruksolitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE54"/>
      <designation>
         <language value="en"/>
         <value value="Insulin glargine and lixisenatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin glargin og liksisenatid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AK"/>
      <designation>
         <language value="en"/>
         <value value="Plague vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pestvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB09"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD17"/>
      <designation>
         <language value="en"/>
         <value value="Cefcapene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefkapen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF03"/>
      <designation>
         <language value="en"/>
         <value value="Durvalumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Durvalumab"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD03"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous sulfate and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)sulfat og folinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01DD90"/>
      <designation>
         <language value="en"/>
         <value value="Ceftiofur"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftiofur"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH92"/>
      <designation>
         <language value="en"/>
         <value value="Mavacoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mavakobsib"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02AA"/>
      <designation>
         <language value="en"/>
         <value value="Mineralocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mineralkortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH02"/>
      <designation>
         <language value="en"/>
         <value value="Alfentanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfentanil"/>
      </designation>
   </concept>
   <concept>
      <code value="QR07AB01"/>
      <designation>
         <language value="en"/>
         <value value="Doxapram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksapram"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Nystatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nystatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01B"/>
      <designation>
         <language value="en"/>
         <value value="Posterior pituitary lobe hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofysebaklapphormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="B05CB"/>
      <designation>
         <language value="en"/>
         <value value="Salt solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saltløsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA05"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK05"/>
      <designation>
         <language value="en"/>
         <value value="Reproterol and sodium cromoglicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reproterol og natriumkromoglikat"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC14"/>
      <designation>
         <language value="en"/>
         <value value="Methylprednisolone aceponate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylprednisolon aceponat"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA"/>
      <designation>
         <language value="en"/>
         <value value="Antipropulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peristaltikkhemmende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB17"/>
      <designation>
         <language value="en"/>
         <value value="Tiemonium iodide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiemoniumjodid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB14"/>
      <designation>
         <language value="en"/>
         <value value="Plazomicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plazomicin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA15"/>
      <designation>
         <language value="en"/>
         <value value="Benidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB06"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AG"/>
      <designation>
         <language value="en"/>
         <value value="Epoxides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epoksider"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BB"/>
      <designation>
         <language value="en"/>
         <value value="Amides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amider"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Etanautine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etanautin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01C"/>
      <designation>
         <language value="en"/>
         <value value="Agents against leishmaniasis and trypanosomiasis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot leishmaniasis og trypanosomiasis"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="A05BA"/>
      <designation>
         <language value="en"/>
         <value value="Liver therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leverterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EF"/>
      <designation>
         <language value="en"/>
         <value value="Cyclin-dependent kinases (CDK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklinavhengige kinasehemmere (CDK)"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AB03"/>
      <designation>
         <language value="en"/>
         <value value="Fluoxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluoksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA01"/>
      <designation>
         <language value="en"/>
         <value value="Ethylmorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etylmorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BG11"/>
      <designation>
         <language value="en"/>
         <value value="Vernakalant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vernakalant"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CC01"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QG51A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives and antiseptics for intrauterine use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika til intrauterin bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BA"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin A, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin A, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="B05CB02"/>
      <designation>
         <language value="en"/>
         <value value="Sodium citrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA09"/>
      <designation>
         <language value="en"/>
         <value value="Pipenzolate and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pipenzolat og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AE05"/>
      <designation>
         <language value="en"/>
         <value value="Etrasimod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etrasimod"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB06"/>
      <designation>
         <language value="en"/>
         <value value="Otilonium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Otiloniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="D03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other cicatrizants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse sårhelende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AG"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of hypercalcemia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot hyperkalsemi"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX07"/>
      <designation>
         <language value="en"/>
         <value value="Blinatumomab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blinatumomab"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BA01"/>
      <designation>
         <language value="en"/>
         <value value="Ammonium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ammoniumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB18"/>
      <designation>
         <language value="en"/>
         <value value="Lawsonia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lawsoni"/>
      </designation>
   </concept>
   <concept>
      <code value="QG04BX90"/>
      <designation>
         <language value="en"/>
         <value value="Ephedrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efedrin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG15"/>
      <designation>
         <language value="en"/>
         <value value="Divozilimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Divozilimab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Thiamphenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GA02"/>
      <designation>
         <language value="en"/>
         <value value="Streptoduocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptoduocin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BB01"/>
      <designation>
         <language value="en"/>
         <value value="Influenza, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Influensa, inaktivert, helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA06"/>
      <designation>
         <language value="en"/>
         <value value="Cyamemazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyamemazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA10"/>
      <designation>
         <language value="en"/>
         <value value="Papaveretum"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papaveretum"/>
      </designation>
   </concept>
   <concept>
      <code value="H04A"/>
      <designation>
         <language value="en"/>
         <value value="Glycogenolytic hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykogenolytisk hormon"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BC"/>
      <designation>
         <language value="en"/>
         <value value="Esters of benzoic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzosyreestre"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB53"/>
      <designation>
         <language value="en"/>
         <value value="Aciclovir, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aciklovir, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BM02"/>
      <designation>
         <language value="en"/>
         <value value="Papillomavirus (human types 16, 18)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papillomavirus (human type 16,18)"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA03"/>
      <designation>
         <language value="en"/>
         <value value="Pindolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pindolol"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BA"/>
      <designation>
         <language value="en"/>
         <value value="Calcitonin preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsitoninmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED08"/>
      <designation>
         <language value="en"/>
         <value value="Sulfaphenazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfafenazol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA18"/>
      <designation>
         <language value="en"/>
         <value value="Polymyxin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polymyksin B"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EB01"/>
      <designation>
         <language value="en"/>
         <value value="Furosemide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Furosemid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB03"/>
      <designation>
         <language value="en"/>
         <value value="Dimetindene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetinden"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB31"/>
      <designation>
         <language value="en"/>
         <value value="Hyoscyamine and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyoscyamin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Cycloguanil embonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cykloguanilembonat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX09"/>
      <designation>
         <language value="en"/>
         <value value="Nintedanib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nintedanib"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB01"/>
      <designation>
         <language value="en"/>
         <value value="Methylscopolamine and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylskopolamin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10BK"/>
      <designation>
         <language value="en"/>
         <value value="Sodium-glucose co-transporter 2 (SGLT2) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumglukose-kotransportør 2 (SLGT2)-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DB02"/>
      <designation>
         <language value="en"/>
         <value value="Triamterene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamteren"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA31"/>
      <designation>
         <language value="en"/>
         <value value="Electrolytes in combination with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter i kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA09"/>
      <designation>
         <language value="en"/>
         <value value="Difemerine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difemerin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51CE09"/>
      <designation>
         <language value="en"/>
         <value value="Procaine penicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokainpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BA51"/>
      <designation>
         <language value="en"/>
         <value value="Acetylsalicylic acid, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylsalisylsyre, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BX05"/>
      <designation>
         <language value="en"/>
         <value value="Bismuth subcitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vismutsubsitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BD"/>
      <designation>
         <language value="en"/>
         <value value="Antiviral monoclonal antibodies"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale monoklonale antistoffer"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX02"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB01"/>
      <designation>
         <language value="en"/>
         <value value="Cefalexin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefaleksin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD04"/>
      <designation>
         <language value="en"/>
         <value value="Urokinase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urokinase"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB03"/>
      <designation>
         <language value="en"/>
         <value value="Aciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Metacycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD02"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AG05"/>
      <designation>
         <language value="en"/>
         <value value="Sodium phosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB02"/>
      <designation>
         <language value="en"/>
         <value value="Infliximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infliksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ciclosporin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklosporin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BB04"/>
      <designation>
         <language value="en"/>
         <value value="Fentonium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentonium"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA08"/>
      <designation>
         <language value="en"/>
         <value value="Rauwolfia alkaloids, whole root and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider, hel rot og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA14"/>
      <designation>
         <language value="en"/>
         <value value="Norfloxacin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norfloksacin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02CA91"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="R03A"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergics, inhalants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika, midler til inhalasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB07"/>
      <designation>
         <language value="en"/>
         <value value="Candesartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kandesartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AE"/>
      <designation>
         <language value="en"/>
         <value value="Cholera vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koleravaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Suxamethonium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Suksametonium"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR01"/>
      <designation>
         <language value="en"/>
         <value value="Zidovudine and lamivudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zidovudin og lamivudin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA10"/>
      <designation>
         <language value="en"/>
         <value value="Ketoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA55"/>
      <designation>
         <language value="en"/>
         <value value="Doxazosin and finasteride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksazosin og finasterid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AA07"/>
      <designation>
         <language value="en"/>
         <value value="Porcine circovirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Svinecirkovirus"/>
      </designation>
   </concept>
   <concept>
      <code value="D01BA"/>
      <designation>
         <language value="en"/>
         <value value="Antifungals for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fungicider til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX04"/>
      <designation>
         <language value="en"/>
         <value value="Romiplostim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Romiplostim"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF01"/>
      <designation>
         <language value="en"/>
         <value value="Metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BB03"/>
      <designation>
         <language value="en"/>
         <value value="Acamprosate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Akamprosat"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03XB"/>
      <designation>
         <language value="en"/>
         <value value="Progesterone receptor modulators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progesteron reseptormodulatorer"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FB12"/>
      <designation>
         <language value="en"/>
         <value value="Nebivolol and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nebivolol og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX55"/>
      <designation>
         <language value="en"/>
         <value value="Tazarotene and ulobetasol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tazaroten og ulobetasol"/>
      </designation>
   </concept>
   <concept>
      <code value="QV03AB"/>
      <designation>
         <language value="en"/>
         <value value="Antidotes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot forgiftninger"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB07"/>
      <designation>
         <language value="en"/>
         <value value="Mitoxantrone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitoksantron"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BB02"/>
      <designation>
         <language value="en"/>
         <value value="Acitretin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acitretin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX16"/>
      <designation>
         <language value="en"/>
         <value value="Tirzepatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tirzepatid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX07"/>
      <designation>
         <language value="en"/>
         <value value="Triprolidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triprolidin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CK"/>
      <designation>
         <language value="en"/>
         <value value="Tests for pancreatic function"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til pankreasfunksjonsprøver"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC56"/>
      <designation>
         <language value="en"/>
         <value value="Acetylsalicylic acid, combinations with proton pump inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylsalisylsyre, kombinasjoner med protonpumpehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03G"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropins and other ovulation stimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropiner og andre ovulasjonsstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG02"/>
      <designation>
         <language value="en"/>
         <value value="Bisacodyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisakodyl"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AA"/>
      <designation>
         <language value="en"/>
         <value value="Colony stimulating factors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolonistimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IX14"/>
      <designation>
         <language value="en"/>
         <value value="Gallium (68Ga) gozetotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gallium (68Ga) gozetotide"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK03"/>
      <designation>
         <language value="en"/>
         <value value="Terizidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terizidon"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA05"/>
      <designation>
         <language value="en"/>
         <value value="Sodium edetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumedetat"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX04"/>
      <designation>
         <language value="en"/>
         <value value="Dengue virus vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Denguevirusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AB"/>
      <designation>
         <language value="en"/>
         <value value="Halogenated hydrocarbons"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halogenerte hydrokarboner"/>
      </designation>
   </concept>
   <concept>
      <code value="V08C"/>
      <designation>
         <language value="en"/>
         <value value="Magnetic resonance imaging contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kontrastmidler for magnettomografi"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ07"/>
      <designation>
         <language value="en"/>
         <value value="Crovalimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Krovalimab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AE"/>
      <designation>
         <language value="en"/>
         <value value="Fluoroquinolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorokinoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD04"/>
      <designation>
         <language value="en"/>
         <value value="Insulin lispro"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin lispro"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA16"/>
      <designation>
         <language value="en"/>
         <value value="Imidapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidapril"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA03"/>
      <designation>
         <language value="en"/>
         <value value="Metamfetamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metamfetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for functional gastrointestinal disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot funksjonelle gastrointestinale lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01A"/>
      <designation>
         <language value="en"/>
         <value value="Tetracyclines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasykliner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM93"/>
      <designation>
         <language value="en"/>
         <value value="Romifidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Romifidin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX05"/>
      <designation>
         <language value="en"/>
         <value value="Antazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA"/>
      <designation>
         <language value="en"/>
         <value value="Potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF04"/>
      <designation>
         <language value="en"/>
         <value value="Filgotinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Filgotinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01X"/>
      <designation>
         <language value="en"/>
         <value value="Other antineoplastic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antineoplastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD13"/>
      <designation>
         <language value="en"/>
         <value value="Cinolazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinolazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="L01C"/>
      <designation>
         <language value="en"/>
         <value value="Plant alkaloids and other natural products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plantealkaloider og andre naturprodukter"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EM01"/>
      <designation>
         <language value="en"/>
         <value value="Idelalisib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idelalisib"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB04"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortin"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA20"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BL"/>
      <designation>
         <language value="en"/>
         <value value="Yellow fever vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gulfebervaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AB03"/>
      <designation>
         <language value="en"/>
         <value value="Oxabolone cipionate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksaboloncipionat"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BX02"/>
      <designation>
         <language value="en"/>
         <value value="Entacapone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Entakapon"/>
      </designation>
   </concept>
   <concept>
      <code value="V09CA03"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) mertiatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) mertiatid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF06"/>
      <designation>
         <language value="en"/>
         <value value="Peficitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peficitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX52"/>
      <designation>
         <language value="en"/>
         <value value="Venetoclax"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Venetoklaks"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC18"/>
      <designation>
         <language value="en"/>
         <value value="Triflusal"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triflusal"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA02"/>
      <designation>
         <language value="en"/>
         <value value="Ergotamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ergotamin"/>
      </designation>
   </concept>
   <concept>
      <code value="V10XX04"/>
      <designation>
         <language value="en"/>
         <value value="Lutetium (177Lu) oxodotreotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lutetium (177Lu) oksodotreotid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE03"/>
      <designation>
         <language value="en"/>
         <value value="Sulfametrole and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametrol og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids acting locally"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider med lokal virkning"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Piroxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piroksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11CC05"/>
      <designation>
         <language value="en"/>
         <value value="Colecalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolekalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AA04"/>
      <designation>
         <language value="en"/>
         <value value="Tetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AB04"/>
      <designation>
         <language value="en"/>
         <value value="Borrelia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Borrelia"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA06"/>
      <designation>
         <language value="en"/>
         <value value="Quinapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinapril"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AK01"/>
      <designation>
         <language value="en"/>
         <value value="Plague, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pest, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA04"/>
      <designation>
         <language value="en"/>
         <value value="Oxazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC13"/>
      <designation>
         <language value="en"/>
         <value value="Abcixmab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abciksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC06"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX16"/>
      <designation>
         <language value="en"/>
         <value value="Eflornithine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eflornitin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CA91"/>
      <designation>
         <language value="en"/>
         <value value="Clenbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klenbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA14"/>
      <designation>
         <language value="en"/>
         <value value="Isosorbide mononitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isosorbidmononitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED01"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadimethoxine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadimetoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="G"/>
      <designation>
         <language value="en"/>
         <value value="Genito urinary system and sex hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Urogenitalsystem og kjønnshormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA07"/>
      <designation>
         <language value="en"/>
         <value value="Modafinil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Modafinil"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA02"/>
      <designation>
         <language value="en"/>
         <value value="Ursodeoxycholic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ursodeoksykolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB04"/>
      <designation>
         <language value="en"/>
         <value value="Tiotropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiotropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AG03"/>
      <designation>
         <language value="en"/>
         <value value="Oxalic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksalsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A05AA01"/>
      <designation>
         <language value="en"/>
         <value value="Chenodeoxycholic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kenodeoksykolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX21"/>
      <designation>
         <language value="en"/>
         <value value="Retigabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retigabin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA01"/>
      <designation>
         <language value="en"/>
         <value value="Diprophylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diprofyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE07"/>
      <designation>
         <language value="en"/>
         <value value="Suprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Suprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="S01KA"/>
      <designation>
         <language value="en"/>
         <value value="Viscoelastic substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Viskoelastiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA82"/>
      <designation>
         <language value="en"/>
         <value value="Clorexolone, comb. with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloreksolon, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA27"/>
      <designation>
         <language value="en"/>
         <value value="Cefuoxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefuroksim"/>
      </designation>
   </concept>
   <concept>
      <code value="S01CB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids/antiinfectives/mydriatics in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider/antiinfektiva/mydriatika i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DC01"/>
      <designation>
         <language value="en"/>
         <value value="Zafirlukast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zafirlukast"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Flowers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blomster"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03"/>
      <designation>
         <language value="en"/>
         <value value="Thyroid  therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Thyreoideaterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01XQ01"/>
      <designation>
         <language value="en"/>
         <value value="Tiamulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamulin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA16"/>
      <designation>
         <language value="en"/>
         <value value="Dosulepin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dosulepin"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01AA13"/>
      <designation>
         <language value="en"/>
         <value value="Fusidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fusidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A10B"/>
      <designation>
         <language value="en"/>
         <value value="Blood glucose lowering drugs, excl. insulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Blodglukosesenkende midler, ekskl. insuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD14"/>
      <designation>
         <language value="en"/>
         <value value="Susoctocog alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Susoktokog alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG07"/>
      <designation>
         <language value="en"/>
         <value value="Begelomab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Begelomab"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA04"/>
      <designation>
         <language value="en"/>
         <value value="Metenolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metenolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA07"/>
      <designation>
         <language value="en"/>
         <value value="Epicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA18"/>
      <designation>
         <language value="en"/>
         <value value="Hetacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hetacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC04"/>
      <designation>
         <language value="en"/>
         <value value="Conestat alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Konestat alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole and triazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazol- og triazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ03"/>
      <designation>
         <language value="en"/>
         <value value="Pegcetacoplan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pegcetakoplan"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB06"/>
      <designation>
         <language value="en"/>
         <value value="Interferon alfa-n1"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon alfa-n1"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF13"/>
      <designation>
         <language value="en"/>
         <value value="Toripalimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toripalimab"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH"/>
      <designation>
         <language value="en"/>
         <value value="Coxibs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koksiber"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG54"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenza B, combinations with meningococcus C,Y, conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenza B, kombinasjoner med meningococcus C,Y, konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB08"/>
      <designation>
         <language value="en"/>
         <value value="Dydrogesterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dydrogesteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC05"/>
      <designation>
         <language value="en"/>
         <value value="Gemcitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemcitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BX05"/>
      <designation>
         <language value="en"/>
         <value value="Burosumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Burosumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CX"/>
      <designation>
         <language value="en"/>
         <value value="Other high-ceiling diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre high-ceiling diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC04"/>
      <designation>
         <language value="en"/>
         <value value="Tripelennamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tripelennamin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX06"/>
      <designation>
         <language value="en"/>
         <value value="Pleconaril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plekonaril"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EC"/>
      <designation>
         <language value="en"/>
         <value value="B-Raf serine-threonine kinase (BRAF) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="B-Raf serin-treoninkinasehemmere (BRAF)"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03FA"/>
      <designation>
         <language value="en"/>
         <value value="Propulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Motilitetsregulerende midle"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD58"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikason, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03XA01"/>
      <designation>
         <language value="en"/>
         <value value="Tolvaptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tolvaptan"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BB"/>
      <designation>
         <language value="en"/>
         <value value="Influenza vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Influensavaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA02"/>
      <designation>
         <language value="en"/>
         <value value="Glyceryl trinitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyseryltrinitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB03"/>
      <designation>
         <language value="en"/>
         <value value="Fentanyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentanyl"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC04"/>
      <designation>
         <language value="en"/>
         <value value="Rizatriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rizatriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AF"/>
      <designation>
         <language value="en"/>
         <value value="Wart and anti-corn preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vorte- og hudetsende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AB17"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia + staphylococcus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia + stafylokokker"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA52"/>
      <designation>
         <language value="en"/>
         <value value="Ergotamine, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ergotamin, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA01"/>
      <designation>
         <language value="en"/>
         <value value="Bromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX18"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB08"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia + clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia + klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD11"/>
      <designation>
         <language value="en"/>
         <value value="Catridecacog"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katridekakog"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF10"/>
      <designation>
         <language value="en"/>
         <value value="Retifanlimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retifanlimab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX04"/>
      <designation>
         <language value="en"/>
         <value value="Spectinomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spektinomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals for treatment of HCV infections"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler til behandling av HCV infeksjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BB52"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G01A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives and antisetics, excl. combinations with corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva og antiseptika, ekskl. kombinasjoner med kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE02"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (beef)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (storfe)"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AX24"/>
      <designation>
         <language value="en"/>
         <value value="Dicyclanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dicyklanil"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CD"/>
      <designation>
         <language value="en"/>
         <value value="Benzodiazepine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzodiazepinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J04BA01"/>
      <designation>
         <language value="en"/>
         <value value="Clofazimine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofazimin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA30"/>
      <designation>
         <language value="en"/>
         <value value="Ambenonium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ambenonium"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CX"/>
      <designation>
         <language value="en"/>
         <value value="Other cardiac stimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hjertestimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AC"/>
      <designation>
         <language value="en"/>
         <value value="Calcium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AE"/>
      <designation>
         <language value="en"/>
         <value value="Live bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BB"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylmethane derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylmetanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AP01"/>
      <designation>
         <language value="en"/>
         <value value="Typhoid, oral, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tyfoid, oral, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07A"/>
      <designation>
         <language value="en"/>
         <value value="Dog"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hund"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CX"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB05"/>
      <designation>
         <language value="en"/>
         <value value="Alendronic acid, calcium and colecalciferol, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alendronsyre, kalsium og kolekalsiferol, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03XA91"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropin releasing factor analogue, conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropinfrigjørende hormonanaloger, konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="S03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="J07XA01"/>
      <designation>
         <language value="en"/>
         <value value="Malaria vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Malariavaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF01"/>
      <designation>
         <language value="en"/>
         <value value="Dicloxacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dikloksacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AE"/>
      <designation>
         <language value="en"/>
         <value value="Live bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="N07"/>
      <designation>
         <language value="en"/>
         <value value="Other nervous system drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler med virkning på nervesystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Xylometazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xylometazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AC"/>
      <designation>
         <language value="en"/>
         <value value="Biguanides and amidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biguanider og amidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AB08"/>
      <designation>
         <language value="en"/>
         <value value="Sevoflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sevofluran"/>
      </designation>
   </concept>
   <concept>
      <code value="A03A"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for functional gastrointestinal disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot funksjonelle gastrointestinale lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC54"/>
      <designation>
         <language value="en"/>
         <value value="Dextropropoxyphene, comb. excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstropropoksyfen, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="D09"/>
      <designation>
         <language value="en"/>
         <value value="Medicated dressings"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinsk forbindingsmateriale"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX15"/>
      <designation>
         <language value="en"/>
         <value value="Mebhydrolin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebhydrolin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AF01"/>
      <designation>
         <language value="en"/>
         <value value="Butorphanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butorfanol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EE"/>
      <designation>
         <language value="en"/>
         <value value="Mitogen-activated protein kinase (MEK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitogenaktiverte proteinkinasehemmere (MEK)"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01AA"/>
      <designation>
         <language value="en"/>
         <value value="Tetracyclines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasykliner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, moderately potent, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, middels sterke, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR05"/>
      <designation>
         <language value="en"/>
         <value value="Zidovudine, lamivudine and nevirapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zidovudin, lamivudin og nevirapin"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02BA03"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB31"/>
      <designation>
         <language value="en"/>
         <value value="Acetohexamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetoheksamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB02"/>
      <designation>
         <language value="en"/>
         <value value="Nalidixic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nalidiksinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A11D"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1, plain and in combination with vitamin B6 and B12"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1, inkl. kombinasjoner med B6 og B12"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ04"/>
      <designation>
         <language value="en"/>
         <value value="Albiglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Albiglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AC"/>
      <designation>
         <language value="en"/>
         <value value="Oxicams"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksikamer"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CA17"/>
      <designation>
         <language value="en"/>
         <value value="Bopindolol and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bopindolol og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD12"/>
      <designation>
         <language value="en"/>
         <value value="Pioglitazone and sitagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pioglitazon og sitagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AA"/>
      <designation>
         <language value="en"/>
         <value value="ACTH"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACTH"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA07"/>
      <designation>
         <language value="en"/>
         <value value="Foslevodopa and decarboxylase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Foslevodopa og dekarboksylasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB09"/>
      <designation>
         <language value="en"/>
         <value value="Danaparoid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Danaparoid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA05"/>
      <designation>
         <language value="en"/>
         <value value="Melevodopa and decarboxylase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melevodopa og dekarboksylasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="N06B"/>
      <designation>
         <language value="en"/>
         <value value="Psychostimulants, agents used for ADHD and nootropics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykostimulantia, midler ved ADHD og nootropika"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CA"/>
      <designation>
         <language value="en"/>
         <value value="Expectorants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekspektorantia"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC01"/>
      <designation>
         <language value="en"/>
         <value value="Bromocriptine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromokriptin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD05"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and pioglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og pioglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB"/>
      <designation>
         <language value="en"/>
         <value value="Pregnadien derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pregnadienderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA13"/>
      <designation>
         <language value="en"/>
         <value value="Prenalterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prenalterol"/>
      </designation>
   </concept>
   <concept>
      <code value="S03B"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX73"/>
      <designation>
         <language value="en"/>
         <value value="Sotorasib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotorasib"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM96"/>
      <designation>
         <language value="en"/>
         <value value="Tasipimidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tasipimidin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC10"/>
      <designation>
         <language value="en"/>
         <value value="Drospirenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Drospirenon"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB02"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia"/>
      </designation>
   </concept>
   <concept>
      <code value="S02AA"/>
      <designation>
         <language value="en"/>
         <value value="Antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX52"/>
      <designation>
         <language value="en"/>
         <value value="Calcipotriol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsipotriol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AJ"/>
      <designation>
         <language value="en"/>
         <value value="Pertussis vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kikhostevaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AJ03"/>
      <designation>
         <language value="en"/>
         <value value="Dolutegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dolutegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR20"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir alafenamide and bictegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofoviralafenamid og biktegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX57"/>
      <designation>
         <language value="en"/>
         <value value="Plitidepsin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Plitidepsin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ05AB16"/>
      <designation>
         <language value="en"/>
         <value value="Remdesivir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Remdesivir"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA30"/>
      <designation>
         <language value="en"/>
         <value value="Metharbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BC02"/>
      <designation>
         <language value="en"/>
         <value value="Hepatitis A, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hepatitt A, inaktivert, helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA55"/>
      <designation>
         <language value="en"/>
         <value value="Selamectin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selamektin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA"/>
      <designation>
         <language value="en"/>
         <value value="Glucocorticoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukokortikoider"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC01"/>
      <designation>
         <language value="en"/>
         <value value="Pancuronium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pankuronium"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB07"/>
      <designation>
         <language value="en"/>
         <value value="Chlormadinone and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klormadinon og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA03"/>
      <designation>
         <language value="en"/>
         <value value="Parathyroid hormone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parathyreoideahormon"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX21"/>
      <designation>
         <language value="en"/>
         <value value="Elapegademase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elapegademase"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB11"/>
      <designation>
         <language value="en"/>
         <value value="S-atenolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="S-atenolol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB12"/>
      <designation>
         <language value="en"/>
         <value value="Glimepiride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glimepirid"/>
      </designation>
   </concept>
   <concept>
      <code value="QC04A"/>
      <designation>
         <language value="en"/>
         <value value="Peripheral vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifere kardilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AL01"/>
      <designation>
         <language value="en"/>
         <value value="Silver nitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sølvnitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CC"/>
      <designation>
         <language value="en"/>
         <value value="Penicillamine and similar agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicillamin og lignende substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AD02"/>
      <designation>
         <language value="en"/>
         <value value="Trifluridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trifluridin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX74"/>
      <designation>
         <language value="en"/>
         <value value="Belzutifan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belzutifan"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AC06"/>
      <designation>
         <language value="en"/>
         <value value="Meloxicam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meloksikam"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AX11"/>
      <designation>
         <language value="en"/>
         <value value="Nitazoxanide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitazoksanid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AE30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE"/>
      <designation>
         <language value="en"/>
         <value value="Piperazine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piperazinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CB01"/>
      <designation>
         <language value="en"/>
         <value value="Furosemide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Furosemid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GA"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomyciner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XC01"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EL"/>
      <designation>
         <language value="en"/>
         <value value="Bruton's tyrosine kinase (BTK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brutons tyrosinkinasehemmere (BTK)"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA09"/>
      <designation>
         <language value="en"/>
         <value value="Azilsartan medoxomil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azilsartanmedoksomil"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB"/>
      <designation>
         <language value="en"/>
         <value value="Synthetic anticholinergics, quaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syntetiske antikolinergika, kvartære ammoniumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA57"/>
      <designation>
         <language value="en"/>
         <value value="Conjugated estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Konjugerte østrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA02"/>
      <designation>
         <language value="en"/>
         <value value="Lovastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lovastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA03"/>
      <designation>
         <language value="en"/>
         <value value="Metandienone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metandienon"/>
      </designation>
   </concept>
   <concept>
      <code value="C08GA01"/>
      <designation>
         <language value="en"/>
         <value value="Nifedipine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nifedipin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EX"/>
      <designation>
         <language value="en"/>
         <value value="Other non-selective calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre ikke-selektive kalsiumantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AE01"/>
      <designation>
         <language value="en"/>
         <value value="Buprenorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buprenorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC05"/>
      <designation>
         <language value="en"/>
         <value value="Fluocortolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluokortolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BC"/>
      <designation>
         <language value="en"/>
         <value value="Chitin synthesisinhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kitinsyntesehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="V07AY"/>
      <designation>
         <language value="en"/>
         <value value="Other non-therapeutic auxiliary products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre ikke-terapeutiske hjelpeprodukter"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC09"/>
      <designation>
         <language value="en"/>
         <value value="Briakinumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Briakinumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51RV"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antibacterials and other substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antibakterielle midler og andre substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AL04"/>
      <designation>
         <language value="en"/>
         <value value="Bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bovint parainfluensavirus + bovint respiratorisk syncytialvirus + pasteurella"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Oxytocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytocin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02BA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonium derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfoniumderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QC"/>
      <designation>
         <language value="en"/>
         <value value="Cardiovascular system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerte og kretsløp"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD11"/>
      <designation>
         <language value="en"/>
         <value value="Pantoprazole, amoxicillin, clarithromycin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pantoprazol, amoksicillin, klaritromycin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QH"/>
      <designation>
         <language value="en"/>
         <value value="Systemic hormonal preparations excl. sex hormones and insulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hormoner til systemisk bruk, ekskl. kjønnshormoner og insulin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE04"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamoxole and trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfamoksol og trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX16"/>
      <designation>
         <language value="en"/>
         <value value="Mitoguazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitoguazon"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB04"/>
      <designation>
         <language value="en"/>
         <value value="Telmisartan and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telmisartan og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA04"/>
      <designation>
         <language value="en"/>
         <value value="Methylphenidate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylfenidat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA03"/>
      <designation>
         <language value="en"/>
         <value value="Carbenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM05"/>
      <designation>
         <language value="en"/>
         <value value="Rifampicin, pyrazinamide and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifampicin, pyrazinamid og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB07"/>
      <designation>
         <language value="en"/>
         <value value="Cyclopenthiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklopentiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05"/>
      <designation>
         <language value="en"/>
         <value value="Psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB05"/>
      <designation>
         <language value="en"/>
         <value value="Paramethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parametason"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BB04"/>
      <designation>
         <language value="en"/>
         <value value="Aprindine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aprindin"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AA01"/>
      <designation>
         <language value="en"/>
         <value value="Amphotericin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfotericin B"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB02"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other immunostimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre immunstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG03"/>
      <designation>
         <language value="en"/>
         <value value="Aminobutyric acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminobutyrsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="H03C"/>
      <designation>
         <language value="en"/>
         <value value="Iodine therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jodterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="A11DA01"/>
      <designation>
         <language value="en"/>
         <value value="Thiamine (vit B1)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamin (Vit B1)"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BC03"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA04"/>
      <designation>
         <language value="en"/>
         <value value="Bosutinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bosutinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CE02"/>
      <designation>
         <language value="en"/>
         <value value="Milrinone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Milrinon"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX03"/>
      <designation>
         <language value="en"/>
         <value value="Dezocine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dezocin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CB02"/>
      <designation>
         <language value="en"/>
         <value value="Bromhexine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromheksin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA04"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA04"/>
      <designation>
         <language value="en"/>
         <value value="Codeine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein"/>
      </designation>
   </concept>
   <concept>
      <code value="V08"/>
      <designation>
         <language value="en"/>
         <value value="Contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B05DA"/>
      <designation>
         <language value="en"/>
         <value value="Isotonic solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isotone løsninger"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Mephenytoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mefenytoin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EB"/>
      <designation>
         <language value="en"/>
         <value value="Parasympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parasympatomimetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB11"/>
      <designation>
         <language value="en"/>
         <value value="Cefroxadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefroksadin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX13"/>
      <designation>
         <language value="en"/>
         <value value="Pheneturide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Feneturid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CX01"/>
      <designation>
         <language value="en"/>
         <value value="Etozolin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etozolin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA05"/>
      <designation>
         <language value="en"/>
         <value value="Levofloxacin and ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levofloksacin og ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB56"/>
      <designation>
         <language value="en"/>
         <value value="Dexbrompheniramine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksbromfeniramin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Nystatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nystatin"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AC"/>
      <designation>
         <language value="en"/>
         <value value="Medicated shampoos"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinske sjampoer"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD01"/>
      <designation>
         <language value="en"/>
         <value value="Alimemazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alimemazin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, non-selective"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, ikke-selektive"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DC03"/>
      <designation>
         <language value="en"/>
         <value value="Mitomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="D03BA"/>
      <designation>
         <language value="en"/>
         <value value="Proteolytic enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proteolytiske enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BA"/>
      <designation>
         <language value="en"/>
         <value value="Carbamic acid esters"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbaminsyreestre"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC06"/>
      <designation>
         <language value="en"/>
         <value value="Berotralstat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Berotralstat"/>
      </designation>
   </concept>
   <concept>
      <code value="S03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA14"/>
      <designation>
         <language value="en"/>
         <value value="Cilnidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cilnidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC01"/>
      <designation>
         <language value="en"/>
         <value value="Dextromoramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstromoramid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX80"/>
      <designation>
         <language value="en"/>
         <value value="Imetelstat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imetelstat"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals for treatment of HIV infections, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler til behandling av HIV infeksjoner, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA16"/>
      <designation>
         <language value="en"/>
         <value value="Solithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Solitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="P03A"/>
      <designation>
         <language value="en"/>
         <value value="Ectoparasiticides, incl. scabicides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ektoparasittmidler, inkl. skabbmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD06"/>
      <designation>
         <language value="en"/>
         <value value="Margetuximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Margetuksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ05"/>
      <designation>
         <language value="en"/>
         <value value="Dulaglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dulaglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL11"/>
      <designation>
         <language value="en"/>
         <value value="Lifileucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lifileucel"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA09"/>
      <designation>
         <language value="en"/>
         <value value="Dextromethorphan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekstrometorfan"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB10"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BX02"/>
      <designation>
         <language value="en"/>
         <value value="Paricalcitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parikalsitol"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CE"/>
      <designation>
         <language value="en"/>
         <value value="Imidazothiazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazotiazol derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AC"/>
      <designation>
         <language value="en"/>
         <value value="Preparations with no effect on uric acid metabolism"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler uten virkning på urinsyreomsetningen"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB08"/>
      <designation>
         <language value="en"/>
         <value value="Fluvoxamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluvoksamin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC05"/>
      <designation>
         <language value="en"/>
         <value value="Hexoprenaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksoprenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AF17"/>
      <designation>
         <language value="en"/>
         <value value="Azamethiphos"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azametifos"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Ipratropium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ipratropiumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA07"/>
      <designation>
         <language value="en"/>
         <value value="Tafenoquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tafenokin"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX24"/>
      <designation>
         <language value="en"/>
         <value value="Deoxycholic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deoksykolsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11G"/>
      <designation>
         <language value="en"/>
         <value value="Ascorbic acid (vitamin C), incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin C, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02A"/>
      <designation>
         <language value="en"/>
         <value value="Antiadrenergic agents, centrally acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiadrenergika, sentralt virkende"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB02"/>
      <designation>
         <language value="en"/>
         <value value="Metoprolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoprolol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CA01"/>
      <designation>
         <language value="en"/>
         <value value="Ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KC01"/>
      <designation>
         <language value="en"/>
         <value value="Pargyline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pargylin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BA03"/>
      <designation>
         <language value="en"/>
         <value value="Fulvestrant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fulvestrant"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH56"/>
      <designation>
         <language value="en"/>
         <value value="Imipenem, cilastatin and relebactam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imipenem, cilastatin og relebaktam"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD"/>
      <designation>
         <language value="en"/>
         <value value="Other antiemetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB04"/>
      <designation>
         <language value="en"/>
         <value value="Chlortalidone and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortalidon og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01M"/>
      <designation>
         <language value="en"/>
         <value value="Quinolone antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolon, antibakterielle"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EH02"/>
      <designation>
         <language value="en"/>
         <value value="Neratinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Neratinib"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AC"/>
      <designation>
         <language value="en"/>
         <value value="Oxazolidine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksazolidinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB07"/>
      <designation>
         <language value="en"/>
         <value value="Promegestone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Promegeston"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09A"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC22"/>
      <designation>
         <language value="en"/>
         <value value="Prasugrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prasugrel"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07C"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, combinations with antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, kombinasjoner med antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D04AB02"/>
      <designation>
         <language value="en"/>
         <value value="Cinchocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinkokain"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA08"/>
      <designation>
         <language value="en"/>
         <value value="Minocycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Minosyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CB02"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna total alkaloids and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonnakombinasjoner og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA10"/>
      <designation>
         <language value="en"/>
         <value value="Fimasartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fimasartan"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF12"/>
      <designation>
         <language value="en"/>
         <value value="Serplulimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Serplulimab"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AL04"/>
      <designation>
         <language value="en"/>
         <value value="Infectious pancreatic necrosis (IPN) virus + infectious salmon anaemia (ISA) virus + aeromonas + moritella + vibrio"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infeksiøs pankreasnekrose-virus (IPN) + infeksøs lakseanemivirus (ISA) + aeromonas + moritella + vibrio"/>
      </designation>
   </concept>
   <concept>
      <code value="S01LA09"/>
      <designation>
         <language value="en"/>
         <value value="Faricimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Faricimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA03"/>
      <designation>
         <language value="en"/>
         <value value="Loperamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loperamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CA"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics, labour repressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sympatomimetika, fødselsutsettende"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11EA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA01"/>
      <designation>
         <language value="en"/>
         <value value="Gadopentetic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadopentetsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ06"/>
      <designation>
         <language value="en"/>
         <value value="Zilucoplan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zilukoplan"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03XB90"/>
      <designation>
         <language value="en"/>
         <value value="Aglepristone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aglepriston"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA53"/>
      <designation>
         <language value="en"/>
         <value value="Donepezil, memantine and Ginkgo folium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Donepezil, memantin og Ginkgo folium"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA"/>
      <designation>
         <language value="en"/>
         <value value="Electrolyte solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA01"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FC02"/>
      <designation>
         <language value="en"/>
         <value value="Isatuximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isatuksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GA"/>
      <designation>
         <language value="en"/>
         <value value="Sympathomimetics used as decongestants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karkontraherende midler (sympatomimetika)"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB03"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC06"/>
      <designation>
         <language value="en"/>
         <value value="Capecitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kapecitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ05"/>
      <designation>
         <language value="en"/>
         <value value="Avacopan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avakopan"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Oxymetazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksymetazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD10"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and saxagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og saksagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Alprostadil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alprostadil"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC04"/>
      <designation>
         <language value="en"/>
         <value value="Fenoterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoterol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX22"/>
      <designation>
         <language value="en"/>
         <value value="Perampanel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perampanel"/>
      </designation>
   </concept>
   <concept>
      <code value="A07BA"/>
      <designation>
         <language value="en"/>
         <value value="Charcoal preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kullmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AB02"/>
      <designation>
         <language value="en"/>
         <value value="Orphenadrine (chloride)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orfenadrin (klorid)"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX"/>
      <designation>
         <language value="en"/>
         <value value="Other dermatologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD01"/>
      <designation>
         <language value="en"/>
         <value value="Phenformin and sulfonylureas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenformin og sulfonylureaderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL05"/>
      <designation>
         <language value="en"/>
         <value value="Amisulpride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amisulprid"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH05"/>
      <designation>
         <language value="en"/>
         <value value="Etoricoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etorikoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA"/>
      <designation>
         <language value="en"/>
         <value value="Bacterial and viral vaccines, combined"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterie- og virusvaksiner, kombinert"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AG01"/>
      <designation>
         <language value="en"/>
         <value value="Narcobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Narkobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="S01F"/>
      <designation>
         <language value="en"/>
         <value value="Mydriatics and cycloplegics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mydriatika og cykloplegika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ07"/>
      <designation>
         <language value="en"/>
         <value value="Beinaglutide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beinaglutid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04A"/>
      <designation>
         <language value="en"/>
         <value value="Sheep"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Får"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA15"/>
      <designation>
         <language value="en"/>
         <value value="Gemifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Pethidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Petidin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01C"/>
      <designation>
         <language value="en"/>
         <value value="Hypothalamic hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypothalamushormoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH01"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus A, purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk A, renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR07"/>
      <designation>
         <language value="en"/>
         <value value="Stavudine, lamivudine and nevirapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stavudin, lamivudin og nevirapin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH55"/>
      <designation>
         <language value="en"/>
         <value value="Panipenem and betamipron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Panipenem og betamipron"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA05"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA09"/>
      <designation>
         <language value="en"/>
         <value value="Noretynodrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretynodrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB"/>
      <designation>
         <language value="en"/>
         <value value="Tumor necrosis factor alpha (TNF-alpha) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tumornekrosefaktor alfa (TNF-alfa)-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB16"/>
      <designation>
         <language value="en"/>
         <value value="Peginterferon alfacon-2"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peginterferon alfakon-2"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC12"/>
      <designation>
         <language value="en"/>
         <value value="Halometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halometason"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Tetracosactide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakosaktid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC12"/>
      <designation>
         <language value="en"/>
         <value value="Brodalumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brodalumab"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF"/>
      <designation>
         <language value="en"/>
         <value value="Artemisinin and derivatives, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemisinin og derivater, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA54"/>
      <designation>
         <language value="en"/>
         <value value="Theophylline, combinations excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllin, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A03"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for functional gastrointestinal disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot funksjonelle gastrointestinale lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XA02"/>
      <designation>
         <language value="en"/>
         <value value="Teicoplanin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teikoplanin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01RA94"/>
      <designation>
         <language value="en"/>
         <value value="Lincosamides, combinations with other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkosamider, kombinasjoner med andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA03"/>
      <designation>
         <language value="en"/>
         <value value="Pravastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pravastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD07"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01XX91"/>
      <designation>
         <language value="en"/>
         <value value="Tigilanol tiglate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tigilanoltiglat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CE04"/>
      <designation>
         <language value="en"/>
         <value value="Belotecan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belotekan"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BB02"/>
      <designation>
         <language value="en"/>
         <value value="Mexiletine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meksiletin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX11"/>
      <designation>
         <language value="en"/>
         <value value="Bermekimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bermekimab"/>
      </designation>
   </concept>
   <concept>
      <code value="V09GA"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CH03"/>
      <designation>
         <language value="en"/>
         <value value="Tasimelteon"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tasimelteon"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA08"/>
      <designation>
         <language value="en"/>
         <value value="Pitavastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pitavastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CH"/>
      <designation>
         <language value="en"/>
         <value value="Melatonin receptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melatonin reseptor agonister"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BC"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides (heterocyclic)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, derivater av heterosykliske forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09CA"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II antagonists, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II antagonister, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, weak, combinations with antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, milde, kombinasjoner med antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA07"/>
      <designation>
         <language value="en"/>
         <value value="Ambutonium and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ambuton og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC02"/>
      <designation>
         <language value="en"/>
         <value value="Histapyrrodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Histapyrrodin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX01"/>
      <designation>
         <language value="en"/>
         <value value="Amsacrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amsakrin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA25"/>
      <designation>
         <language value="en"/>
         <value value="Lifitegrast"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lifitegrast"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA11"/>
      <designation>
         <language value="en"/>
         <value value="Protriptyline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protriptylin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AD01"/>
      <designation>
         <language value="en"/>
         <value value="Pentazocine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentazocin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AG"/>
      <designation>
         <language value="en"/>
         <value value="Iodine products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jodmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QG52"/>
      <designation>
         <language value="en"/>
         <value value="Products for teats and udder"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler for jur og brystvorter"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA07"/>
      <designation>
         <language value="en"/>
         <value value="Calcium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB03"/>
      <designation>
         <language value="en"/>
         <value value="Piromidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piromidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA02"/>
      <designation>
         <language value="en"/>
         <value value="Clidinium and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klidin og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AF04"/>
      <designation>
         <language value="en"/>
         <value value="Betrixaban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betriksaban"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of different antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av ulike antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA01"/>
      <designation>
         <language value="en"/>
         <value value="Cisplatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cisplatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01BA90"/>
      <designation>
         <language value="en"/>
         <value value="Florfenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Florfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA06"/>
      <designation>
         <language value="en"/>
         <value value="Calcium lactate gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumlaktoglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK10"/>
      <designation>
         <language value="en"/>
         <value value="Vilanterol and fluticasone furoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vilanterol og flutikasonfuroat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BC01"/>
      <designation>
         <language value="en"/>
         <value value="Mannitol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mannitol"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA12"/>
      <designation>
         <language value="en"/>
         <value value="Clorexolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloreksolon"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD06"/>
      <designation>
         <language value="en"/>
         <value value="Trifarotene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trifaroten"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC14"/>
      <designation>
         <language value="en"/>
         <value value="Clenbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klenbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="C08DA02"/>
      <designation>
         <language value="en"/>
         <value value="Gallopamil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gallopamil"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of tetracyclines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av tetrasykliner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Warfarin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Warfarin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CX02"/>
      <designation>
         <language value="en"/>
         <value value="Clonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM06"/>
      <designation>
         <language value="en"/>
         <value value="Rifampicin, pyrazinamide, ethambutol and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifampicin, pyrazinamid, etambutol og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB25"/>
      <designation>
         <language value="en"/>
         <value value="Flumazenil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumazenil"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AE02"/>
      <designation>
         <language value="en"/>
         <value value="Leuprorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leuprorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA21"/>
      <designation>
         <language value="en"/>
         <value value="Maprotiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Maprotilin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC05"/>
      <designation>
         <language value="en"/>
         <value value="Hexafluronium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksafluronium"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AD03"/>
      <designation>
         <language value="en"/>
         <value value="Pentoxifylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentoksyfyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB04"/>
      <designation>
         <language value="en"/>
         <value value="Agalsidase beta"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Agalsidase beta"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA02"/>
      <designation>
         <language value="en"/>
         <value value="Oxprenolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksprenolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD01"/>
      <designation>
         <language value="en"/>
         <value value="Scopolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Skopolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB04"/>
      <designation>
         <language value="en"/>
         <value value="Amphotericin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfotericin B"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX03"/>
      <designation>
         <language value="en"/>
         <value value="Sultiame"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sultiam"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02A"/>
      <designation>
         <language value="en"/>
         <value value="Cattle"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kveg"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CD06"/>
      <designation>
         <language value="en"/>
         <value value="Macimorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Macimorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA15"/>
      <designation>
         <language value="en"/>
         <value value="Talampicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talampicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="R05FA"/>
      <designation>
         <language value="en"/>
         <value value="Opium derivatives and expectorants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiumsderivater og ekspektorantia"/>
      </designation>
   </concept>
   <concept>
      <code value="B05CB04"/>
      <designation>
         <language value="en"/>
         <value value="Sodium bicarbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumhydrogenkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DB02"/>
      <designation>
         <language value="en"/>
         <value value="Hydralazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydralazin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05X"/>
      <designation>
         <language value="en"/>
         <value value="I.v. solution additives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infusjonskonsentrater"/>
      </designation>
   </concept>
   <concept>
      <code value="M05"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of bone diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av bensykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="J02"/>
      <designation>
         <language value="en"/>
         <value value="Antimycotics for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antimykotika til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LC05"/>
      <designation>
         <language value="en"/>
         <value value="Moxonidine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksonidin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX18"/>
      <designation>
         <language value="en"/>
         <value value="Lacosamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lakosamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA04"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB01"/>
      <designation>
         <language value="en"/>
         <value value="Glibenclamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glibenklamid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD02"/>
      <designation>
         <language value="en"/>
         <value value="Bretylium tosilate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bretyliumtosilat"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12AA"/>
      <designation>
         <language value="en"/>
         <value value="Calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH07"/>
      <designation>
         <language value="en"/>
         <value value="Tralokinumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tralokinumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AX"/>
      <designation>
         <language value="en"/>
         <value value="Other anthelmintic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre anthelminitka"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB10"/>
      <designation>
         <language value="en"/>
         <value value="Epanolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epanolol"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD59"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB05"/>
      <designation>
         <language value="en"/>
         <value value="Laronidase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laronidase"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC04"/>
      <designation>
         <language value="en"/>
         <value value="Carmofur"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karmofur"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Desogestrel and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desogestrel og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BX08"/>
      <designation>
         <language value="en"/>
         <value value="Mitiglinide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitiglinid"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AD03"/>
      <designation>
         <language value="en"/>
         <value value="Ethionamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etionamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02"/>
      <designation>
         <language value="en"/>
         <value value="Topical products for joint and muscular pain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topikale midler ved muskel- og leddsmerter"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA12"/>
      <designation>
         <language value="en"/>
         <value value="Lorajmine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorajmin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX14"/>
      <designation>
         <language value="en"/>
         <value value="Entrectinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Entrektinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51"/>
      <designation>
         <language value="en"/>
         <value value="Antiprotozoals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protozomidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EA"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QV"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varia"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BB03"/>
      <designation>
         <language value="en"/>
         <value value="Chlorzoxazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorzoksason"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA71"/>
      <designation>
         <language value="en"/>
         <value value="Quinidine, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinidin, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX20"/>
      <designation>
         <language value="en"/>
         <value value="Lonafarnib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lonafarnib"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE51"/>
      <designation>
         <language value="en"/>
         <value value="Buclizine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buklizin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AB72"/>
      <designation>
         <language value="en"/>
         <value value="Pethidine, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Petidin, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX07"/>
      <designation>
         <language value="en"/>
         <value value="Irbesartan, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Irbesartan, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX53"/>
      <designation>
         <language value="en"/>
         <value value="Thenalidine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenalidin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG02"/>
      <designation>
         <language value="en"/>
         <value value="Delavirdine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Delavirdin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR11"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine, tenofovir disoproxil and efavirenz"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin, tenofovirdisoproksil og efavirenz"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Bamipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bamipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA12"/>
      <designation>
         <language value="en"/>
         <value value="Rokitamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rokitamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX13"/>
      <designation>
         <language value="en"/>
         <value value="Evolocumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Evolokumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CR04"/>
      <designation>
         <language value="en"/>
         <value value="Sultamicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sultamicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BA"/>
      <designation>
         <language value="en"/>
         <value value="Aminoquinolines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminokinoliner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DC"/>
      <designation>
         <language value="en"/>
         <value value="Other cytotoxic antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre cytotoksiske antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Raltitrexed"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Raltitreksed"/>
      </designation>
   </concept>
   <concept>
      <code value="D06B"/>
      <designation>
         <language value="en"/>
         <value value="Chemotherapeutics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kjemoterapeutika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BX"/>
      <designation>
         <language value="en"/>
         <value value="Other anti-parathyroid agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiparathyroidea midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12AA03"/>
      <designation>
         <language value="en"/>
         <value value="Calcium gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA17"/>
      <designation>
         <language value="en"/>
         <value value="Drospirenone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Drospirenon og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA24"/>
      <designation>
         <language value="en"/>
         <value value="Abatacept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abatacept"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD12"/>
      <designation>
         <language value="en"/>
         <value value="Cefoperazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefoperazon"/>
      </designation>
   </concept>
   <concept>
      <code value="H02CA03"/>
      <designation>
         <language value="en"/>
         <value value="Ketoconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketokonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA05"/>
      <designation>
         <language value="en"/>
         <value value="Ponatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ponatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CC01"/>
      <designation>
         <language value="en"/>
         <value value="Etacrynic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etakrynsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH"/>
      <designation>
         <language value="en"/>
         <value value="Carbapenems"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbapenemer"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BC"/>
      <designation>
         <language value="en"/>
         <value value="Bone morphogenetic proteins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beninduserende proteiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51B"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols for intramammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler til intrammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EM"/>
      <designation>
         <language value="en"/>
         <value value="Phosphatidylinositol-3-kinase (Pi3K) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfatidylinositol-3-kinasehemmere (Pi3K)"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB07"/>
      <designation>
         <language value="en"/>
         <value value="Methantheline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metantelin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11E"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, incl. combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks, inkl. kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05"/>
      <designation>
         <language value="en"/>
         <value value="Psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN04B"/>
      <designation>
         <language value="en"/>
         <value value="Dopaminergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopaminerge midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02CA01"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolone and antiinfectives"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD15"/>
      <designation>
         <language value="en"/>
         <value value="Avian infectious bursal disease virus (Gumboro disease) + Avian herpes virus (Marek’s disease)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fuglebursalsykdomsvirus (Gumboro), infeksiøs + fugleherpesvirus (Mareks sykdom)"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AC02"/>
      <designation>
         <language value="en"/>
         <value value="Nicotinyl alcohol (pyridylcarbinol)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikotinylalkohol (pyridylkarbinol)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX23"/>
      <designation>
         <language value="en"/>
         <value value="Pralsetinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pralsetinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC08"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinonid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EA03"/>
      <designation>
         <language value="en"/>
         <value value="Iclaprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iklaprim"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CB04"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC08"/>
      <designation>
         <language value="en"/>
         <value value="Ketoconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketokonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB09"/>
      <designation>
         <language value="en"/>
         <value value="Esmolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Esmolol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antipsychotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antipsykotika"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA13"/>
      <designation>
         <language value="en"/>
         <value value="Rifamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB07"/>
      <designation>
         <language value="en"/>
         <value value="Interferon beta-1a"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon beta-1a"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA14"/>
      <designation>
         <language value="en"/>
         <value value="Sarecycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Saresyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="B02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Alfa1 antitrypsin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa-1-antitrypsin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07DA06"/>
      <designation>
         <language value="en"/>
         <value value="Timolol, thiazides and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timolol, tiazider og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AX"/>
      <designation>
         <language value="en"/>
         <value value="Other parasympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre parasympatika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA04"/>
      <designation>
         <language value="en"/>
         <value value="Digitoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digitoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE03"/>
      <designation>
         <language value="en"/>
         <value value="Ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED"/>
      <designation>
         <language value="en"/>
         <value value="Long-acting sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider med lang virketid"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC24"/>
      <designation>
         <language value="en"/>
         <value value="Ticagrelor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tikagrelor"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA05"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-hepatitis B-pertussis-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-hepatitt B-kikhoste-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EH03"/>
      <designation>
         <language value="en"/>
         <value value="Tucatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tukatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BB"/>
      <designation>
         <language value="en"/>
         <value value="Fibrinogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fibrinogen"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB"/>
      <designation>
         <language value="en"/>
         <value value="Halogenated hydrocarbons"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halogenerte hydrokarboner"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01X"/>
      <designation>
         <language value="en"/>
         <value value="Other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF07"/>
      <designation>
         <language value="en"/>
         <value value="Tenofovir disoproxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenofovirdisoproksil"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10AC01"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (human)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin, human"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH06"/>
      <designation>
         <language value="en"/>
         <value value="Lumiracoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lumirakoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG04"/>
      <designation>
         <language value="en"/>
         <value value="Vigabatrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vigabatrin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AH"/>
      <designation>
         <language value="en"/>
         <value value="Quinoline derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF09"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate, sulfadoxine and pyrimethamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat, sulfadoksin og pyrimetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK15"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol and budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol og budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA07"/>
      <designation>
         <language value="en"/>
         <value value="Dobutamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dobutamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA05"/>
      <designation>
         <language value="en"/>
         <value value="Alizapride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alisaprid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG13"/>
      <designation>
         <language value="en"/>
         <value value="Teprotumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teprotumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Ferric oxide polymaltose complexes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferrioksypolymaltosekomplekser"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CC02"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD65"/>
      <designation>
         <language value="en"/>
         <value value="Macrogol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrogol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB12"/>
      <designation>
         <language value="en"/>
         <value value="Difenpiramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenpiramid"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AD"/>
      <designation>
         <language value="en"/>
         <value value="Papaverine and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papaverin og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antibiotics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibiotika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QA14A"/>
      <designation>
         <language value="en"/>
         <value value="Anabolic steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anabole steroider"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XA06"/>
      <designation>
         <language value="en"/>
         <value value="Potassium phosphate, incl. comb. with other potassium salts"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumfosfat, inkl. kombinasjoner med andre kalium-salter"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA04"/>
      <designation>
         <language value="en"/>
         <value value="Acepromazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acepromazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA15"/>
      <designation>
         <language value="en"/>
         <value value="Telithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01C"/>
      <designation>
         <language value="en"/>
         <value value="Cardiac stimulants excl. cardiac glycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjertestimulerende midler ekskl. hjerteglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AA01"/>
      <designation>
         <language value="en"/>
         <value value="Equine influenza virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesteinfluensavirus"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA04"/>
      <designation>
         <language value="en"/>
         <value value="Doxazosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksazosin"/>
      </designation>
   </concept>
   <concept>
      <code value="J06"/>
      <designation>
         <language value="en"/>
         <value value="Immune sera and immunoglobulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsera og immunoglobuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX08"/>
      <designation>
         <language value="en"/>
         <value value="Lenvatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lenvatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB10"/>
      <designation>
         <language value="en"/>
         <value value="Alclometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alklometason"/>
      </designation>
   </concept>
   <concept>
      <code value="P01B"/>
      <designation>
         <language value="en"/>
         <value value="Antimalarials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Malariamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA26"/>
      <designation>
         <language value="en"/>
         <value value="Ephedrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efedrin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB04"/>
      <designation>
         <language value="en"/>
         <value value="Aclarubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aklarubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA03"/>
      <designation>
         <language value="en"/>
         <value value="Vindesine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vindesin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA05"/>
      <designation>
         <language value="en"/>
         <value value="Pemoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pemolin"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AC20"/>
      <designation>
         <language value="en"/>
         <value value="Imidazoles/triazoles in combination with corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazol/triazolderivater i kombinasjon med kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="J07X"/>
      <designation>
         <language value="en"/>
         <value value="Other vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XB"/>
      <designation>
         <language value="en"/>
         <value value="Polymyxins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polymyksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA10"/>
      <designation>
         <language value="en"/>
         <value value="Calcium glucoheptonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglukoheptonat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC06"/>
      <designation>
         <language value="en"/>
         <value value="Isoetarine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoetarin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC"/>
      <designation>
         <language value="en"/>
         <value value="Proton pump inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protonpumpehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C09CA07"/>
      <designation>
         <language value="en"/>
         <value value="Telmisartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telmisartan"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="QM05BA02"/>
      <designation>
         <language value="en"/>
         <value value="Clodronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klodronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BD01"/>
      <designation>
         <language value="en"/>
         <value value="Amiodarone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amiodaron"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB30"/>
      <designation>
         <language value="en"/>
         <value value="Capreomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kapreomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EC20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD08"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor VIIa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor VIIa"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BK02"/>
      <designation>
         <language value="en"/>
         <value value="Zoster, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zoster, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51BA"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH"/>
      <designation>
         <language value="en"/>
         <value value="Opioid anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opioidanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="QD08AG02"/>
      <designation>
         <language value="en"/>
         <value value="Povidone-iodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Povidon, jodert"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AJ02"/>
      <designation>
         <language value="en"/>
         <value value="Ravulizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ravulizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AG05"/>
      <designation>
         <language value="en"/>
         <value value="Rilpivirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rilpivirin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB21"/>
      <designation>
         <language value="en"/>
         <value value="Fenpiverinium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenpiverin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA16"/>
      <designation>
         <language value="en"/>
         <value value="Clevidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klevidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BX"/>
      <designation>
         <language value="en"/>
         <value value="Other hormone antagonists and related agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hormonantagonister og beslektede substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD16"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and canagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og kanagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA11"/>
      <designation>
         <language value="en"/>
         <value value="Gentamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gentamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CB"/>
      <designation>
         <language value="en"/>
         <value value="Testosterone-5-alpha reductase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Testosteron-5-alfareduktasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="QA05"/>
      <designation>
         <language value="en"/>
         <value value="Bile and liver therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Galle- og leverterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA07"/>
      <designation>
         <language value="en"/>
         <value value="Tobacco"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tobakk"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EE"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of sulfonamides and trimethoprim, incl. derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av sulfonamider og trimetoprim, inkl. derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA05"/>
      <designation>
         <language value="en"/>
         <value value="Profenamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Profenamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05C"/>
      <designation>
         <language value="en"/>
         <value value="Hypnotics and sedatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypnotika og sedativa"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AN"/>
      <designation>
         <language value="en"/>
         <value value="Live parasitic vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parasittvaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DB04"/>
      <designation>
         <language value="en"/>
         <value value="Cadralazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kadralazin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA05"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)klorid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BX"/>
      <designation>
         <language value="en"/>
         <value value="Other dopaminergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre dopaminerge midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EQ"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AD51"/>
      <designation>
         <language value="en"/>
         <value value="Ethosuximide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etosuksimid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CA"/>
      <designation>
         <language value="en"/>
         <value value="Alpha- and beta-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa- og betaagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CF01"/>
      <designation>
         <language value="en"/>
         <value value="Tuberculin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tuberkulin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EJ"/>
      <designation>
         <language value="en"/>
         <value value="Janus associated kinase (JAK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Janus assosierte kinasehemmere (JAK)"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA15"/>
      <designation>
         <language value="en"/>
         <value value="Alefacept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alefacept"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA03"/>
      <designation>
         <language value="en"/>
         <value value="House dust mites"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Husstøvmidd"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK08"/>
      <designation>
         <language value="en"/>
         <value value="Beksagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bexagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ02"/>
      <designation>
         <language value="en"/>
         <value value="Dihydrocodeine and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydrokodein og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for constipation"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot forstoppelse"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA24"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA03"/>
      <designation>
         <language value="en"/>
         <value value="Cefuroxime and metronodazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefuroksim og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED02"/>
      <designation>
         <language value="en"/>
         <value value="Sulfalene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfalen"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE18"/>
      <designation>
         <language value="en"/>
         <value value="Naproxcinod"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naprokscinod"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Quingestanol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kingestanol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EB"/>
      <designation>
         <language value="en"/>
         <value value="Short-acting sulfonamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider med kort virketid"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AB"/>
      <designation>
         <language value="en"/>
         <value value="Choline esters"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolinestere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AD03"/>
      <designation>
         <language value="en"/>
         <value value="Avian herpes virus (Marek's disease)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fugleherpesvirus (Mareks sykdom)"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH03"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus A,C, bivalent purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk A,C, divalent renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AC01"/>
      <designation>
         <language value="en"/>
         <value value="Colestyramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolestyramin"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA"/>
      <designation>
         <language value="en"/>
         <value value="Parathyroid hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parathyreoideahormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AE"/>
      <designation>
         <language value="en"/>
         <value value="Live bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="C09B"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QD11"/>
      <designation>
         <language value="en"/>
         <value value="Other dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03D"/>
      <designation>
         <language value="en"/>
         <value value="Potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S02BA01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA17"/>
      <designation>
         <language value="en"/>
         <value value="Prulifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prulifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB14"/>
      <designation>
         <language value="en"/>
         <value value="Landiolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Landiolol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD06"/>
      <designation>
         <language value="en"/>
         <value value="Bromperidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromperidol"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA12"/>
      <designation>
         <language value="en"/>
         <value value="Alprazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alprazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03AC"/>
      <designation>
         <language value="en"/>
         <value value="Iron, parenteral preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern, injeksjonsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B05XX"/>
      <designation>
         <language value="en"/>
         <value value="Other i.v. solution additives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre infusjonskonsentrater"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC04"/>
      <designation>
         <language value="en"/>
         <value value="Insulin lispro"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin lispro"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB16"/>
      <designation>
         <language value="en"/>
         <value value="Ethanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etanol"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EQ10"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX28"/>
      <designation>
         <language value="en"/>
         <value value="Rupatadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rupatadin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BE04"/>
      <designation>
         <language value="en"/>
         <value value="Lotilaner"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lotilaner"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AD02"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AH04"/>
      <designation>
         <language value="en"/>
         <value value="Phenoperidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoperidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CB"/>
      <designation>
         <language value="en"/>
         <value value="Prolactine inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prolaktinhemmende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH51"/>
      <designation>
         <language value="en"/>
         <value value="Sitagliptin and simvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitagliptin og simvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="S02BA08"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DX"/>
      <designation>
         <language value="en"/>
         <value value="Other anti-dementia drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot demens"/>
      </designation>
   </concept>
   <concept>
      <code value="QC05"/>
      <designation>
         <language value="en"/>
         <value value="Vasoprotectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vasoprotektorer"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AJ05"/>
      <designation>
         <language value="en"/>
         <value value="Live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia + feline leukaemia recombinant live canarypox virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus, levende + kattecalicivirusantigen, inaktivert + kattepanleukopenivirus / parvovirus, levende + klamydia, levende + katteleukemi, kanarikoppervirus, rekombinant, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03C"/>
      <designation>
         <language value="en"/>
         <value value="Estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="C03C"/>
      <designation>
         <language value="en"/>
         <value value="High-ceiling diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="High-ceiling diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AE"/>
      <designation>
         <language value="en"/>
         <value value="Carbamide products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbamidmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FB02"/>
      <designation>
         <language value="en"/>
         <value value="Moxetumomab pasudotox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksetumomabpasudotoks"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AH01"/>
      <designation>
         <language value="en"/>
         <value value="Diazoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diazoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DX"/>
      <designation>
         <language value="en"/>
         <value value="Other vasodilators used in cardiac diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kardilaterende midler ved hjertesykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AL52"/>
      <designation>
         <language value="en"/>
         <value value="Pneumococcus purified polysaccharides antigen and haemophilius influenzae, conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pneumokokk, renset polysakkarid antigen og haemophilus influenzae, konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CC"/>
      <designation>
         <language value="en"/>
         <value value="Aryloxyacetic acid derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aryloksyeddiksyrederivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51BA90"/>
      <designation>
         <language value="en"/>
         <value value="Florfenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Florfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE03"/>
      <designation>
         <language value="en"/>
         <value value="Ketoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AA02"/>
      <designation>
         <language value="en"/>
         <value value="Salmon pancreas disease (SPD), protein coding plasmid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laksepankreassykdom, (SPD), proteinkodende plasmid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AP01"/>
      <designation>
         <language value="en"/>
         <value value="Trichophyton"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trikofyton"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF07"/>
      <designation>
         <language value="en"/>
         <value value="Rasburicase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rasburikase"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX06"/>
      <designation>
         <language value="en"/>
         <value value="Candesartan, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kandesartan, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AC"/>
      <designation>
         <language value="en"/>
         <value value="Phenothiazines with piperidine structure"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiaziner med piperidinring i sidekjeden"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA02"/>
      <designation>
         <language value="en"/>
         <value value="Trichlormethiazide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triklormetiazid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF13"/>
      <designation>
         <language value="en"/>
         <value value="Tenofovir alafenamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenofoviralafenamid"/>
      </designation>
   </concept>
   <concept>
      <code value="B01"/>
      <designation>
         <language value="en"/>
         <value value="Antithrombotic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitrombotiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C05BB02"/>
      <designation>
         <language value="en"/>
         <value value="Polidocanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polidokanol"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Pamidronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pamidronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA02"/>
      <designation>
         <language value="en"/>
         <value value="Carboplatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karboplatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QH03B"/>
      <designation>
         <language value="en"/>
         <value value="Antithyroid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antithyreoideamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX07"/>
      <designation>
         <language value="en"/>
         <value value="Etomidate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etomidat"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC05"/>
      <designation>
         <language value="en"/>
         <value value="Esomeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Esomeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA05"/>
      <designation>
         <language value="en"/>
         <value value="Vinflunine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinflunin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20C"/>
      <designation>
         <language value="en"/>
         <value value="Mink"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mink"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AB06"/>
      <designation>
         <language value="en"/>
         <value value="Bevantolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bevantolol"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA02"/>
      <designation>
         <language value="en"/>
         <value value="Budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="QD04AB"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anestetika til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AA03"/>
      <designation>
         <language value="en"/>
         <value value="Pepsin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pepsin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CX"/>
      <designation>
         <language value="en"/>
         <value value="Other plant alkaloids and natural products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre plantealkaloider og naturprodukter"/>
      </designation>
   </concept>
   <concept>
      <code value="R05CB13"/>
      <designation>
         <language value="en"/>
         <value value="Dornase alfa (desoxyribonuclease)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dornase alfa (desoksyribonuklease)"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD03"/>
      <designation>
         <language value="en"/>
         <value value="Paclitaxel poliglumex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paklitakselpoliglumeks"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD01"/>
      <designation>
         <language value="en"/>
         <value value="Omeprazole, amoxicillin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omeprazol, amoksicillin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DA02"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BA"/>
      <designation>
         <language value="en"/>
         <value value="Solutions for parenteral nutrition"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Løsninger for parenteral ernæring"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA03"/>
      <designation>
         <language value="en"/>
         <value value="Lisinopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisinopril"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BA01"/>
      <designation>
         <language value="en"/>
         <value value="Phenformin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenformin"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous glycine sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)glycinsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA51"/>
      <designation>
         <language value="en"/>
         <value value="Ampicillin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ampicillin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX53"/>
      <designation>
         <language value="en"/>
         <value value="Vosaroxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vosaroksin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AL02"/>
      <designation>
         <language value="en"/>
         <value value="IPN virus + aeromonas + moritella + vibrio"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="IPN virus + aeromonas + moritella + vibrio"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA02"/>
      <designation>
         <language value="en"/>
         <value value="Opium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opium"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC06"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium lactate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumlaktat"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH01"/>
      <designation>
         <language value="en"/>
         <value value="Tacrolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Takrolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51FF"/>
      <designation>
         <language value="en"/>
         <value value="Lincosamides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkosamider"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AR01"/>
      <designation>
         <language value="en"/>
         <value value="Bovine tuberculin PPD"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bovint tuberkulin PPD"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent, combinations with antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke, kombinasjoner med antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01BA"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC06"/>
      <designation>
         <language value="en"/>
         <value value="Cabergoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabergolin"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF55"/>
      <designation>
         <language value="en"/>
         <value value="Econazole, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekonazol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AE05"/>
      <designation>
         <language value="en"/>
         <value value="Levofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AX01"/>
      <designation>
         <language value="en"/>
         <value value="Parapox ovis virus, inactivated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parakopper ovisvirus, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD25"/>
      <designation>
         <language value="en"/>
         <value value="Metformin, saxagliptin and dapagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin, saksagliptin og dapagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BB"/>
      <designation>
         <language value="en"/>
         <value value="Specific immunoglobulins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spesifikke immunglobuliner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BA"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna alkaloids, tertiary amines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonnaalkaloider, tertiære aminer"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA14"/>
      <designation>
         <language value="en"/>
         <value value="Temocapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temokapril"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Acenocoumarol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acenokumarol"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, potent (group III)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, sterke (gruppe III)"/>
      </designation>
   </concept>
   <concept>
      <code value="V08DA06"/>
      <designation>
         <language value="en"/>
         <value value="Perflubutane, phospholipid microspheres"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perflubutan, fosfolipidmikrosfærer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA10"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="B03XA03"/>
      <designation>
         <language value="en"/>
         <value value="Methoxy polyethylene glycol-epoetin beta"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoksipolyetylenglykolepoetin beta"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AX01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrogen peroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrogenperoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02C"/>
      <designation>
         <language value="en"/>
         <value value="Other gynecologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre gynekologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="P01CX01"/>
      <designation>
         <language value="en"/>
         <value value="Pentamidine isethionate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentamidinisetionat"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD06"/>
      <designation>
         <language value="en"/>
         <value value="Esomeprazole, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Esomeprazol, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD"/>
      <designation>
         <language value="en"/>
         <value value="Osmotically acting laxatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Osmotisk virkende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QL03"/>
      <designation>
         <language value="en"/>
         <value value="Immunostimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA07"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous fumarate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)fumarat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MB06"/>
      <designation>
         <language value="en"/>
         <value value="Cinoxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinoksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BC07"/>
      <designation>
         <language value="en"/>
         <value value="Lorcainide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorkainid"/>
      </designation>
   </concept>
   <concept>
      <code value="V10X"/>
      <designation>
         <language value="en"/>
         <value value="Other therapeutic radiopharmaceuticals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre radiofarmaka til terapeutisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02AB06"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH04"/>
      <designation>
         <language value="en"/>
         <value value="Parecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="N06D"/>
      <designation>
         <language value="en"/>
         <value value="Anti-dementia drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot demens"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11DA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B1, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B1, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="V04C"/>
      <designation>
         <language value="en"/>
         <value value="Other diagnostic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre diagnostika"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA03"/>
      <designation>
         <language value="en"/>
         <value value="Natamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="S02AA15"/>
      <designation>
         <language value="en"/>
         <value value="Ciprofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciprofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AA01"/>
      <designation>
         <language value="en"/>
         <value value="Simvastatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simvastatin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AX05"/>
      <designation>
         <language value="en"/>
         <value value="Meptazinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meptazinol"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Estriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østriol"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB32"/>
      <designation>
         <language value="en"/>
         <value value="Glutathione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glutation"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD10"/>
      <designation>
         <language value="en"/>
         <value value="Cefetamet"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefetamet"/>
      </designation>
   </concept>
   <concept>
      <code value="M03CA"/>
      <designation>
         <language value="en"/>
         <value value="Dantrolene and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dantrolen og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA05"/>
      <designation>
         <language value="en"/>
         <value value="Nifedipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nifedipin"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AL"/>
      <designation>
         <language value="en"/>
         <value value="Silver compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sølvforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AA07"/>
      <designation>
         <language value="en"/>
         <value value="Dicycloverine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dicykloverin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA13"/>
      <designation>
         <language value="en"/>
         <value value="Bendroflumethiazide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bendroflumetiazid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG04"/>
      <designation>
         <language value="en"/>
         <value value="Glycerol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glyserol"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01A"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory and antirheumatic products, non-steroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske og antireumatiske midler,  ikke-steroide"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01"/>
      <designation>
         <language value="en"/>
         <value value="Pituitary and hypothalamic hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofyse- og hypothalamushormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX25"/>
      <designation>
         <language value="en"/>
         <value value="Cenobamate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Senobamat"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AD"/>
      <designation>
         <language value="en"/>
         <value value="Other agents for local oral treatment"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler til lokal behandling i munnen"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD07"/>
      <designation>
         <language value="en"/>
         <value value="Coagulation factor XIII"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koagulasjonsfaktor XIII"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AB04"/>
      <designation>
         <language value="en"/>
         <value value="Enflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enfluran"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AA01"/>
      <designation>
         <language value="en"/>
         <value value="Trihexyphenidyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triheksylfenidyl"/>
      </designation>
   </concept>
   <concept>
      <code value="S01B"/>
      <designation>
         <language value="en"/>
         <value value="Antiinflammatory agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiinflammatoriske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AC90"/>
      <designation>
         <language value="en"/>
         <value value="Methadone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metadon"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA51"/>
      <designation>
         <language value="en"/>
         <value value="Etilefrine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etilefrin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD15"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and dapagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og dapagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA14"/>
      <designation>
         <language value="en"/>
         <value value="Nomegestrol and estradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nomegestrol og østradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CC"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX01"/>
      <designation>
         <language value="en"/>
         <value value="Fosfomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosfomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AB"/>
      <designation>
         <language value="en"/>
         <value value="Zinc products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BC02"/>
      <designation>
         <language value="en"/>
         <value value="Methadone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metadon"/>
      </designation>
   </concept>
   <concept>
      <code value="M03C"/>
      <designation>
         <language value="en"/>
         <value value="Muscle relaxants, directly acting agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Direkte virkende muskelrelakserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA05"/>
      <designation>
         <language value="en"/>
         <value value="Ajmaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ajmalin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ23"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocodone and ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokodon og ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FG02"/>
      <designation>
         <language value="en"/>
         <value value="Quinupristin/dalfopristin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinupristin/dalfopristin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BF"/>
      <designation>
         <language value="en"/>
         <value value="Alpha glucosidase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa glukosidasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51CE01"/>
      <designation>
         <language value="en"/>
         <value value="Benzylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03D"/>
      <designation>
         <language value="en"/>
         <value value="Other systemic drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre systemiske midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH01"/>
      <designation>
         <language value="en"/>
         <value value="Vorinostat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vorinostat"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB02"/>
      <designation>
         <language value="en"/>
         <value value="Camphora"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kamfer"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA23"/>
      <designation>
         <language value="en"/>
         <value value="Quinupramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinupramin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA10"/>
      <designation>
         <language value="en"/>
         <value value="Trandolapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trandolapril"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AC"/>
      <designation>
         <language value="en"/>
         <value value="Quinoline derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB"/>
      <designation>
         <language value="en"/>
         <value value="Prolactine inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prolaktinhemmende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03"/>
      <designation>
         <language value="en"/>
         <value value="Antiepileptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiepileptika"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AX01"/>
      <designation>
         <language value="en"/>
         <value value="Botulinum toxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Botulinumtoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG02"/>
      <designation>
         <language value="en"/>
         <value value="Valpromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valpromid"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP55"/>
      <designation>
         <language value="en"/>
         <value value="Sofosbuvir and velpatasvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sofosbuvir og velpatasvir"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX02"/>
      <designation>
         <language value="en"/>
         <value value="Tryptophan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tryptofan"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AA"/>
      <designation>
         <language value="en"/>
         <value value="Phenothiazines with aliphatic side-chain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentiaziner med alifatisk sidekjede"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01G"/>
      <designation>
         <language value="en"/>
         <value value="Aminoglycoside antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminoglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX02"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and aliskiren"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og aliskiren"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA14"/>
      <designation>
         <language value="en"/>
         <value value="Mepindolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepindolol"/>
      </designation>
   </concept>
   <concept>
      <code value="QR02AD"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics, local"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AC01"/>
      <designation>
         <language value="en"/>
         <value value="Isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA10"/>
      <designation>
         <language value="en"/>
         <value value="Ketazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other alkylating agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre alkyleringsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in hereditary angioedema"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler ved hereditært angioødem"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12A"/>
      <designation>
         <language value="en"/>
         <value value="Calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI"/>
      <designation>
         <language value="en"/>
         <value value="Other cephalosporins and penems"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre cefalosporiner og penemer"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA11"/>
      <designation>
         <language value="en"/>
         <value value="Pravastatin and ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pravastatin og ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD03"/>
      <designation>
         <language value="en"/>
         <value value="Nicofuranose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikofuranose"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP53"/>
      <designation>
         <language value="en"/>
         <value value="Ombitasvir, paritaprevir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ombitasvir, paritaprevir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA"/>
      <designation>
         <language value="en"/>
         <value value="Allergen extracts"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allergenekstrakter"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AA03"/>
      <designation>
         <language value="en"/>
         <value value="Oxytetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksytetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD05"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxyethylpromethazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksyetylprometazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB20"/>
      <designation>
         <language value="en"/>
         <value value="Pegunigalsidase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pegunigalsidase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AA62"/>
      <designation>
         <language value="en"/>
         <value value="Bupropion and naltrexone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bupropion og naltrekson"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for suidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for svin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH52"/>
      <designation>
         <language value="en"/>
         <value value="Meropenem and vaborbactam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meropenem og vaborbaktam"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK08"/>
      <designation>
         <language value="en"/>
         <value value="Pretomanid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pretomanid"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AC02"/>
      <designation>
         <language value="en"/>
         <value value="Itraconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Itrakonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP07"/>
      <designation>
         <language value="en"/>
         <value value="Daclatasvir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daklatasvir"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01R"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF08"/>
      <designation>
         <language value="en"/>
         <value value="Prolgolimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prolgolimab"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53BC02"/>
      <designation>
         <language value="en"/>
         <value value="Diflubenzuron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflubenzuron"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BG91"/>
      <designation>
         <language value="en"/>
         <value value="Bedinvetmab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bedinvetmab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA"/>
      <designation>
         <language value="en"/>
         <value value="Platinum compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Platinaforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AN"/>
      <designation>
         <language value="en"/>
         <value value="Live parasitic vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parasittvaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH01"/>
      <designation>
         <language value="en"/>
         <value value="Sitagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Antithrombin III"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antitrombin III"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01BA"/>
      <designation>
         <language value="en"/>
         <value value="Esters of aminobenzoic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminobenzosyreestre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB09"/>
      <designation>
         <language value="en"/>
         <value value="Valrubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valrubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB05"/>
      <designation>
         <language value="en"/>
         <value value="Mefruside and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mefrusid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AD"/>
      <designation>
         <language value="en"/>
         <value value="Psoralens for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Psoralener til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB10"/>
      <designation>
         <language value="en"/>
         <value value="Perazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perazin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA51"/>
      <designation>
         <language value="en"/>
         <value value="Morphine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Morfin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD03"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and rosiglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og rosiglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC03"/>
      <designation>
         <language value="en"/>
         <value value="Guanoxan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanoksan"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA07"/>
      <designation>
         <language value="en"/>
         <value value="Levonorgestrel and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levonorgestrel og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AG01"/>
      <designation>
         <language value="en"/>
         <value value="Labetalol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Labetalol"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX16"/>
      <designation>
         <language value="en"/>
         <value value="Tiopronin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiopronin"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX11"/>
      <designation>
         <language value="en"/>
         <value value="Rifaximin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifaksimin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Dimethylaminopropionylphenothiazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetylaminopropionylfentiazin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for felidae"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for katt"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03CA04"/>
      <designation>
         <language value="en"/>
         <value value="Torasemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Torasemid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AF01"/>
      <designation>
         <language value="en"/>
         <value value="Butorphanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butorfanol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB53"/>
      <designation>
         <language value="en"/>
         <value value="Oxyphenonium, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyfenon, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AE"/>
      <designation>
         <language value="en"/>
         <value value="Oripavine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oripavinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX08"/>
      <designation>
         <language value="en"/>
         <value value="Linezolid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linezolid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GB"/>
      <designation>
         <language value="en"/>
         <value value="Ovulation stimulants, synthetic"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ovulasjonsstimulerende syntetiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CE01"/>
      <designation>
         <language value="en"/>
         <value value="Benzylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA02"/>
      <designation>
         <language value="en"/>
         <value value="Dexamfetamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksamfetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Temozolomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temozolomid"/>
      </designation>
   </concept>
   <concept>
      <code value="H05B"/>
      <designation>
         <language value="en"/>
         <value value="Anti-parathyroid agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiparathyreoideamidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE06"/>
      <designation>
         <language value="en"/>
         <value value="Penamecillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penamecillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AX"/>
      <designation>
         <language value="en"/>
         <value value="Thiazides, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazider i kombinasjon med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX24"/>
      <designation>
         <language value="en"/>
         <value value="Cannabidiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cannabidiol"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB08"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Polythiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polytiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD10"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, amoxicillin and levofloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, amoksicillin og levofloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XA04"/>
      <designation>
         <language value="en"/>
         <value value="Satraplatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Satraplatin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX94"/>
      <designation>
         <language value="en"/>
         <value value="Isoeugenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoeugenol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE05"/>
      <designation>
         <language value="en"/>
         <value value="Meclozine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meklozin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD53"/>
      <designation>
         <language value="en"/>
         <value value="Adapalene, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adapalen, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB"/>
      <designation>
         <language value="en"/>
         <value value="Acetic acid derivatives and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eddiksyrederivater og lignende substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX19"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin, amlodipine and candesartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin, amlodipin og kandesartan"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA48"/>
      <designation>
         <language value="en"/>
         <value value="Belumosudil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belumosudil"/>
      </designation>
   </concept>
   <concept>
      <code value="C05AA04"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA15"/>
      <designation>
         <language value="en"/>
         <value value="Carteolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karteolol"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA03"/>
      <designation>
         <language value="en"/>
         <value value="Potassium hydrogentartrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumhydrogentartrat"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Dimethyltubocurarine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetyltubokurarin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB"/>
      <designation>
         <language value="en"/>
         <value value="Other aminoglycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre aminoglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA57"/>
      <designation>
         <language value="en"/>
         <value value="Theobromine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teobromin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N01"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FF"/>
      <designation>
         <language value="en"/>
         <value value="PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) hemmere"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="PD-1/PDL-1 (Programmert celledødprotein 1/celledødligand 1) hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CA14"/>
      <designation>
         <language value="en"/>
         <value value="Dopexamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopeksamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX03"/>
      <designation>
         <language value="en"/>
         <value value="Olmesartan medoxomil, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olmesartanmedoksomil, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB06"/>
      <designation>
         <language value="en"/>
         <value value="Cefazedone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefazedon"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA52"/>
      <designation>
         <language value="en"/>
         <value value="Acetyldigoxin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetyldigoksin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX04"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and sacubitril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og sakubitril"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Natamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC03"/>
      <designation>
         <language value="en"/>
         <value value="Vecuronium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vekuronium"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX23"/>
      <designation>
         <language value="en"/>
         <value value="Tisotumab vedotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tisotumabvedotin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03BA06"/>
      <designation>
         <language value="en"/>
         <value value="Triamcinolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triamcinolon"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AE09"/>
      <designation>
         <language value="en"/>
         <value value="Tipranavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tipranavir"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH08"/>
      <designation>
         <language value="en"/>
         <value value="Abrocitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abrocitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for disorders of the musculo-skeletal system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot muskel- og skjelettsykdommer"/>
      </designation>
   </concept>
   <concept>
      <code value="QI10AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02BC"/>
      <designation>
         <language value="en"/>
         <value value="Local hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokale hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04AC30"/>
      <designation>
         <language value="en"/>
         <value value="Etybenzatropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etybenztropin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA23"/>
      <designation>
         <language value="en"/>
         <value value="Indometacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indometacin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ22"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocodone and paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokodon og paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB"/>
      <designation>
         <language value="en"/>
         <value value="Purine analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Purinanaloger"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA"/>
      <designation>
         <language value="en"/>
         <value value="Anticholinesterases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikolinesteraser"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EA01"/>
      <designation>
         <language value="en"/>
         <value value="Fendiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fendilin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC03"/>
      <designation>
         <language value="en"/>
         <value value="Desoximetasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desoksymetason"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA03"/>
      <designation>
         <language value="en"/>
         <value value="Pefloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pefloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB10"/>
      <designation>
         <language value="en"/>
         <value value="Clofibride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofibrid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03BB"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna alkaloids, semisynthetic, quaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonnaalkaloider halvsyntetiske, kvartære ammonium forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="D07CA03"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone and antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon og antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC13"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX25"/>
      <designation>
         <language value="en"/>
         <value value="Baloxavir marboxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Baloksavirmarboksil"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CA72"/>
      <designation>
         <language value="en"/>
         <value value="Ergotamine, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ergotamin, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD11"/>
      <designation>
         <language value="en"/>
         <value value="Lactulose"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Laktulose"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CE90"/>
      <designation>
         <language value="en"/>
         <value value="Penethamate hydroiodide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penetamathydrojodid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG11"/>
      <designation>
         <language value="en"/>
         <value value="Anifrolumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anifrolumab"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA10"/>
      <designation>
         <language value="en"/>
         <value value="Follitropin delta"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Follitropin delta"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD64"/>
      <designation>
         <language value="en"/>
         <value value="Cefpodoxime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefpodoksim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD09"/>
      <designation>
         <language value="en"/>
         <value value="Isothipendyl"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isotipendyl"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA"/>
      <designation>
         <language value="en"/>
         <value value="Androstan derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Androstanderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC07"/>
      <designation>
         <language value="en"/>
         <value value="Fludroxycortide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fludroksykortid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ18"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone and acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon og acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX07"/>
      <designation>
         <language value="en"/>
         <value value="Nitroxoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitroksolin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA20"/>
      <designation>
         <language value="en"/>
         <value value="Calcium (different salts in combination)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium, blanding av salter"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB02"/>
      <designation>
         <language value="en"/>
         <value value="Hydrogen peroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrogenperoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC16"/>
      <designation>
         <language value="en"/>
         <value value="Guselkumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guselkumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB12"/>
      <designation>
         <language value="en"/>
         <value value="Arbekacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Arbekacin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB07"/>
      <designation>
         <language value="en"/>
         <value value="Glipizide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glipizid"/>
      </designation>
   </concept>
   <concept>
      <code value="C02N"/>
      <designation>
         <language value="en"/>
         <value value="COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antihypertensiva i ATC-gr. C02"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09BX90"/>
      <designation>
         <language value="en"/>
         <value value="Benazepril and pimobendan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benazepril og pimobendan"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AC01"/>
      <designation>
         <language value="en"/>
         <value value="Calcium carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB11"/>
      <designation>
         <language value="en"/>
         <value value="Isepamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isepamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX09"/>
      <designation>
         <language value="en"/>
         <value value="Ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FG"/>
      <designation>
         <language value="en"/>
         <value value="Streptogramins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptograminer"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AL"/>
      <designation>
         <language value="en"/>
         <value value="Pneumococcal vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pneumokokkvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AB06"/>
      <designation>
         <language value="en"/>
         <value value="Isoflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isofluran"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BG"/>
      <designation>
         <language value="en"/>
         <value value="Alpha and beta blocking agents and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa- og betablokkere og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA15"/>
      <designation>
         <language value="en"/>
         <value value="Butriptyline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butriptylin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB07"/>
      <designation>
         <language value="en"/>
         <value value="Bumadizone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bumadizon"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Levocabastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levokabastin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BX02"/>
      <designation>
         <language value="en"/>
         <value value="Tizanidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tizanidin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC07"/>
      <designation>
         <language value="en"/>
         <value value="Tocilizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tocilizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01DB01"/>
      <designation>
         <language value="en"/>
         <value value="Cefalexin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefaleksin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BC01"/>
      <designation>
         <language value="en"/>
         <value value="Caffeine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Koffein"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA09"/>
      <designation>
         <language value="en"/>
         <value value="Clobazam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klobazam"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12"/>
      <designation>
         <language value="en"/>
         <value value="Mineral supplements"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mineraltilskudd"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX10"/>
      <designation>
         <language value="en"/>
         <value value="Virginiamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virginiamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Glycopyrronium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykopyrroniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE"/>
      <designation>
         <language value="en"/>
         <value value="Other antifungals for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre fungicider til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX31"/>
      <designation>
         <language value="en"/>
         <value value="Ivacaftor and tezacaftor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivakaftor og tezakaftor"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG52"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B, combinations with pertussis and toxoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B, kombinasjoner med pertussis og toksoider"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE"/>
      <designation>
         <language value="en"/>
         <value value="Direct thrombin inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Direkte trombininhibitorer"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG01"/>
      <designation>
         <language value="en"/>
         <value value="Aminogluthetimide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminoglutetimid"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydroflumethiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroflumetiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA08"/>
      <designation>
         <language value="en"/>
         <value value="Pivmecillinam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pivmecillinam"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC26"/>
      <designation>
         <language value="en"/>
         <value value="Vorapaxar"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vorapaksar"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XB02"/>
      <designation>
         <language value="en"/>
         <value value="Polymyxin B"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polymyksin B"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05BA"/>
      <designation>
         <language value="en"/>
         <value value="Solutions for parenteral nutrition"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Løsninger for parenteral ernæring"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA05"/>
      <designation>
         <language value="en"/>
         <value value="Ramipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ramipril"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB01"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium hydroxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumhydroksid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC02"/>
      <designation>
         <language value="en"/>
         <value value="Pantoprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pantoprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ06"/>
      <designation>
         <language value="en"/>
         <value value="Codeine and paracetamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein og paracetamol"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB"/>
      <designation>
         <language value="en"/>
         <value value="Watersoluble, nephrotropic, low osmolar X-ray contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vannløselige, nefrotrope, lavosmolære røntgenkontrastmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA63"/>
      <designation>
         <language value="en"/>
         <value value="Eritrityl tetranitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytritoltetranitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A02B"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot ulcus og gastroøsofageal reflukssykdom (GERD)"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EA06"/>
      <designation>
         <language value="en"/>
         <value value="Budesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Budesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX13"/>
      <designation>
         <language value="en"/>
         <value value="Retapamulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retapamulin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD"/>
      <designation>
         <language value="en"/>
         <value value="Taxanes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Taksaner"/>
      </designation>
   </concept>
   <concept>
      <code value="C07A"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX04"/>
      <designation>
         <language value="en"/>
         <value value="Vandetanib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vandetanib"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC08"/>
      <designation>
         <language value="en"/>
         <value value="Procaterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokaterol"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AH04"/>
      <designation>
         <language value="en"/>
         <value value="Alitretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alitretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA01"/>
      <designation>
         <language value="en"/>
         <value value="Metoclopramide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoklopramid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB08"/>
      <designation>
         <language value="en"/>
         <value value="Sisomicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sisomicin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB01"/>
      <designation>
         <language value="en"/>
         <value value="Clofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE02"/>
      <designation>
         <language value="en"/>
         <value value="Lepirudin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lepirudin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Methotrexate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metotreksat"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AB01"/>
      <designation>
         <language value="en"/>
         <value value="Probenecid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Probenecid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EA"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LB01"/>
      <designation>
         <language value="en"/>
         <value value="Methyldopa (levorotatory) and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyldopa (venstredreiende) og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB03"/>
      <designation>
         <language value="en"/>
         <value value="Chlorhexidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorheksidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20CL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC08"/>
      <designation>
         <language value="en"/>
         <value value="Cypermethrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cypermetrin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AX11"/>
      <designation>
         <language value="en"/>
         <value value="Mirtazapine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mirtazapin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB10"/>
      <designation>
         <language value="en"/>
         <value value="Amrubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amrubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA08"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="QM03BX90"/>
      <designation>
         <language value="en"/>
         <value value="Guaifenesin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guaifenesin"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AB"/>
      <designation>
         <language value="en"/>
         <value value="Capsaicin and similar agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Capsaicin og lignende stoffer"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02AC02"/>
      <designation>
         <language value="en"/>
         <value value="Itraconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Itrakonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CX01"/>
      <designation>
         <language value="en"/>
         <value value="Mibefradil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mibefradil"/>
      </designation>
   </concept>
   <concept>
      <code value="QA12AX"/>
      <designation>
         <language value="en"/>
         <value value="Calcium, combinations with vitamin D and/or other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsium, kombinasjoner med vitamin D og/eller andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QC05B"/>
      <designation>
         <language value="en"/>
         <value value="Antivaricose therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varicemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EC03"/>
      <designation>
         <language value="en"/>
         <value value="Olsalazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olsalazin"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AA01"/>
      <designation>
         <language value="en"/>
         <value value="Demeclocycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Demeklosyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CG"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactamase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AH"/>
      <designation>
         <language value="en"/>
         <value value="Live and inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende og inaktiverte"/>
      </designation>
   </concept>
   <concept>
      <code value="M02AA15"/>
      <designation>
         <language value="en"/>
         <value value="Diclofenac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diklofenak"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CG"/>
      <designation>
         <language value="en"/>
         <value value="Tests for gastric secretion"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til undersøkelse av ventrikkelsekresjon"/>
      </designation>
   </concept>
   <concept>
      <code value="A03BA04"/>
      <designation>
         <language value="en"/>
         <value value="Belladonna total alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belladonna, totalalkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC02"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium sulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumsulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CB01"/>
      <designation>
         <language value="en"/>
         <value value="Etoposide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etoposid"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA05"/>
      <designation>
         <language value="en"/>
         <value value="Palonosetron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palonosetron"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA59"/>
      <designation>
         <language value="en"/>
         <value value="Trolnitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trolnitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE01"/>
      <designation>
         <language value="en"/>
         <value value="Oxypertine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksypertin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA25"/>
      <designation>
         <language value="en"/>
         <value value="Mexazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meksazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BA"/>
      <designation>
         <language value="en"/>
         <value value="Anti-estrogens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiøstrogener"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX06"/>
      <designation>
         <language value="en"/>
         <value value="Enterovirus 71 vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enterovirus 71-vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN51AA"/>
      <designation>
         <language value="en"/>
         <value value="Barbiturates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barbiturater"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Cyclothiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyklotiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EG01"/>
      <designation>
         <language value="en"/>
         <value value="Temsirolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Temsirolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EA01"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA01"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="C07C"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA74"/>
      <designation>
         <language value="en"/>
         <value value="Theophylline, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teofyllin, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BF02"/>
      <designation>
         <language value="en"/>
         <value value="Pregabalin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pregabalin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CA"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, non-selective, and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, ikke-selektive, og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA41"/>
      <designation>
         <language value="en"/>
         <value value="Imlifidase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imlifidase"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ14"/>
      <designation>
         <language value="en"/>
         <value value="Tramadol and dexketoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tramadol og deksketoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XE"/>
      <designation>
         <language value="en"/>
         <value value="Nitrofuran derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrofuranderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB05"/>
      <designation>
         <language value="en"/>
         <value value="Certolizumab pegol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Certolizumab pegol"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD06"/>
      <designation>
         <language value="en"/>
         <value value="Brinase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brinase"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA06"/>
      <designation>
         <language value="en"/>
         <value value="Trichlormethiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triklormetiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC53"/>
      <designation>
         <language value="en"/>
         <value value="Chloropyramine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorpyramin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH05"/>
      <designation>
         <language value="en"/>
         <value value="Linagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AA06"/>
      <designation>
         <language value="en"/>
         <value value="Canine herpesvirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundeherpesvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CX08"/>
      <designation>
         <language value="en"/>
         <value value="Levosimendan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levosimendan"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX16"/>
      <designation>
         <language value="en"/>
         <value value="Venlafaxine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Venlafaksin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Tetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD14"/>
      <designation>
         <language value="en"/>
         <value value="Ceftibuten"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftibuten"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC19"/>
      <designation>
         <language value="en"/>
         <value value="Difluprednate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difluprednat"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AM07"/>
      <designation>
         <language value="en"/>
         <value value="Rifampicin, ethambutol and isoniazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifampicin, etambutol og isoniazid"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AK"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antihistamines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antihistaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CA"/>
      <designation>
         <language value="en"/>
         <value value="Sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natrium"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09AA"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC03"/>
      <designation>
         <language value="en"/>
         <value value="Methallenestril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metallenøstrol"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02AD90"/>
      <designation>
         <language value="en"/>
         <value value="Cloprostenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloprostenol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01ED01"/>
      <designation>
         <language value="en"/>
         <value value="Timolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timolol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DC01"/>
      <designation>
         <language value="en"/>
         <value value="Minoxidil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Minoksidil"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AB01"/>
      <designation>
         <language value="en"/>
         <value value="Leptospira"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leptospira"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC"/>
      <designation>
         <language value="en"/>
         <value value="Imidazoline receptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolinreseptoragonister"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CG05"/>
      <designation>
         <language value="en"/>
         <value value="Methylthioninium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyltioninklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB26"/>
      <designation>
         <language value="en"/>
         <value value="Methionine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metionin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC05"/>
      <designation>
         <language value="en"/>
         <value value="Methapyrilene"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metapyrilen"/>
      </designation>
   </concept>
   <concept>
      <code value="QA14"/>
      <designation>
         <language value="en"/>
         <value value="Anabolic agents for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anabole midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA20"/>
      <designation>
         <language value="en"/>
         <value value="Artificial tears and other indifferent preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indifferente midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03GA"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09A"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Glucosamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukosamin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE07"/>
      <designation>
         <language value="en"/>
         <value value="Apomorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Apomorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="P02BX04"/>
      <designation>
         <language value="en"/>
         <value value="Triclabendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triklabendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QI08AA01"/>
      <designation>
         <language value="en"/>
         <value value="Rabbit haemorrhagic disease virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanin hemoragisk sykdomsvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BA11"/>
      <designation>
         <language value="en"/>
         <value value="Diflunisal"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflunisal"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EC04"/>
      <designation>
         <language value="en"/>
         <value value="Balsalazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Balsalazid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA01"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BA04"/>
      <designation>
         <language value="en"/>
         <value value="Pemetrexed"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pemetreksed"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BD51"/>
      <designation>
         <language value="en"/>
         <value value="Pyrimethamine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrimetamin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AR"/>
      <designation>
         <language value="en"/>
         <value value="In vivo diagnostic preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="In vivo diagnostiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CM01"/>
      <designation>
         <language value="en"/>
         <value value="Gonadorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08GA02"/>
      <designation>
         <language value="en"/>
         <value value="Amlodipine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amlodipin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Fondaparinux"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fondaparinuks"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DC"/>
      <designation>
         <language value="en"/>
         <value value="Estren derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Estrenderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B03X"/>
      <designation>
         <language value="en"/>
         <value value="Other antianemic preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot anemi"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11EC"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, with minerals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks med mineraler"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AX02"/>
      <designation>
         <language value="en"/>
         <value value="Calcipotriol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsipotriol"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB05"/>
      <designation>
         <language value="en"/>
         <value value="Demegestone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Demegeston"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB07"/>
      <designation>
         <language value="en"/>
         <value value="Talastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talastin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07EA02"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortison"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB02"/>
      <designation>
         <language value="en"/>
         <value value="Fluphenazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flufenazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BD01"/>
      <designation>
         <language value="en"/>
         <value value="Palivizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Palivizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ02AC"/>
      <designation>
         <language value="en"/>
         <value value="Triazole and tetrazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triazol- og tetrazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AA03"/>
      <designation>
         <language value="en"/>
         <value value="Hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI08AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AB10"/>
      <designation>
         <language value="en"/>
         <value value="Ferric maltol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(III)maltol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CA06"/>
      <designation>
         <language value="en"/>
         <value value="Vintafolide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vintafolid"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AH30"/>
      <designation>
         <language value="en"/>
         <value value="Clioquinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kliokinol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BH"/>
      <designation>
         <language value="en"/>
         <value value="Rota virus diarrhea vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rotavirusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01DB"/>
      <designation>
         <language value="en"/>
         <value value="First-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Første generasjon cefalosporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11H"/>
      <designation>
         <language value="en"/>
         <value value="Other plain vitamin preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre usammensatte vitaminmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK04"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol and sodium cromoglicate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol og natriumkromoglikat"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02BA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD05"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous gluconate and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)glukonat og folinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QM05BA05"/>
      <designation>
         <language value="en"/>
         <value value="Tiludronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiludronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CE"/>
      <designation>
         <language value="en"/>
         <value value="Topoisomerase 1 inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topoisomerase 1 hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C01CX09"/>
      <designation>
         <language value="en"/>
         <value value="Angiotensin II"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Angiotensin II"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG09"/>
      <designation>
         <language value="en"/>
         <value value="Emapalumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emapalumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A12B"/>
      <designation>
         <language value="en"/>
         <value value="Potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FG01"/>
      <designation>
         <language value="en"/>
         <value value="Bevacizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bevacizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01JA01"/>
      <designation>
         <language value="en"/>
         <value value="Fluorescein"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorescein"/>
      </designation>
   </concept>
   <concept>
      <code value="QH02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AN01"/>
      <designation>
         <language value="en"/>
         <value value="Coccidia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Coccidia"/>
      </designation>
   </concept>
   <concept>
      <code value="N07CA52"/>
      <designation>
         <language value="en"/>
         <value value="Cinnarizine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinnarizin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC10"/>
      <designation>
         <language value="en"/>
         <value value="Diflorasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diflorason"/>
      </designation>
   </concept>
   <concept>
      <code value="H04AA"/>
      <designation>
         <language value="en"/>
         <value value="Glycogenolytic hormones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glykogenolytisk hormon"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BD02"/>
      <designation>
         <language value="en"/>
         <value value="Rasagiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rasagilin"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IA"/>
      <designation>
         <language value="en"/>
         <value value="Technetium (99mTc) compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teknesium (99mTc) forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AD02"/>
      <designation>
         <language value="en"/>
         <value value="Canine distemper virus + canine adenovirus + canine parvovirus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hundedistempervirus + hundeadenovirus + hundeparvovirus"/>
      </designation>
   </concept>
   <concept>
      <code value="J04A"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for treatment of tuberculosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til behandling av tuberkulose"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AB09"/>
      <designation>
         <language value="en"/>
         <value value="Norgestimate and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestimat og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB11"/>
      <designation>
         <language value="en"/>
         <value value="Iobitridol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jobitridol"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA09"/>
      <designation>
         <language value="en"/>
         <value value="Opiates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiater"/>
      </designation>
   </concept>
   <concept>
      <code value="G03G"/>
      <designation>
         <language value="en"/>
         <value value="Gonadotropins and other ovulation stimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gonadotropiner og andre ovulasjonsstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD03"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, amoxicillin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, amoksicillin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DB08"/>
      <designation>
         <language value="en"/>
         <value value="Valsartan and lercanidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Valsartan og lerkanidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01ED05"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamethoxypyridazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfametoksypyridazin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of oral blood glucose lowering drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av blodglukosesenkende midler til oralt bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QC09BA"/>
      <designation>
         <language value="en"/>
         <value value="ACE inhibitors and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACE-hemmere og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC01"/>
      <designation>
         <language value="en"/>
         <value value="Cefoxitin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefoksitin"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC09"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium orotate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumorotat"/>
      </designation>
   </concept>
   <concept>
      <code value="A04"/>
      <designation>
         <language value="en"/>
         <value value="Antiemetics and antinauseants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC09"/>
      <designation>
         <language value="en"/>
         <value value="Cefmetazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefmetazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE53"/>
      <designation>
         <language value="en"/>
         <value value="Cyclizine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syklizin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AC04"/>
      <designation>
         <language value="en"/>
         <value value="Nicofetamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nikofetamid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BX04"/>
      <designation>
         <language value="en"/>
         <value value="Opicapone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opikapon"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA10"/>
      <designation>
         <language value="en"/>
         <value value="Xipamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xipamid"/>
      </designation>
   </concept>
   <concept>
      <code value="D10BA"/>
      <designation>
         <language value="en"/>
         <value value="Retinoids for treatment of acne"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retinoider til behandling av akne"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EK01"/>
      <designation>
         <language value="en"/>
         <value value="Axitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aksitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL12"/>
      <designation>
         <language value="en"/>
         <value value="Indacaterol, glycopyrroinium bromide and mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indakaterol, glykopyrroniumbromid og mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="A03C"/>
      <designation>
         <language value="en"/>
         <value value="Antispasmodics in combination with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spasmolytika i kombinasjon med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA"/>
      <designation>
         <language value="en"/>
         <value value="Dopa and dopa derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopa og dopaderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX10"/>
      <designation>
         <language value="en"/>
         <value value="Alipogene tiparvovec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alipogentiparvovek"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA05"/>
      <designation>
         <language value="en"/>
         <value value="Mefruside"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mefrusid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BM03"/>
      <designation>
         <language value="en"/>
         <value value="Papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papillomavirus (human typer 6, 11, 16, 18, 31, 33, 45, 52, 58)"/>
      </designation>
   </concept>
   <concept>
      <code value="N02C"/>
      <designation>
         <language value="en"/>
         <value value="Antimigraine preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Migrenemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF04"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate, sulfalene and pyrimethamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat, sulfalen og pyrimetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC02"/>
      <designation>
         <language value="en"/>
         <value value="Basiliximab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Basiliksimab"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for treatment of tuberculosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler til behandling av tuberkulose"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC19"/>
      <designation>
         <language value="en"/>
         <value value="Satralizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Satralizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AB"/>
      <designation>
         <language value="en"/>
         <value value="Estren derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Estrenderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BX05"/>
      <designation>
         <language value="en"/>
         <value value="Respiratory syncytial virus vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Respiratoriske syncytialvirusvaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BF01"/>
      <designation>
         <language value="en"/>
         <value value="Gabapentin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gabapentin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EA06"/>
      <designation>
         <language value="en"/>
         <value value="Asciminib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Askiminib"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE08"/>
      <designation>
         <language value="en"/>
         <value value="Pirprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pirprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01DD"/>
      <designation>
         <language value="en"/>
         <value value="Third-generation cephalosporins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tredje generasjon cefalosporiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE05"/>
      <designation>
         <language value="en"/>
         <value value="Pheneticillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Feneticillin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CA01"/>
      <designation>
         <language value="en"/>
         <value value="Retinol (vit A)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Retinol (Vit A)"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Propantheline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propantelin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AE01"/>
      <designation>
         <language value="en"/>
         <value value="Buprenorphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Buprenorfin"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA03"/>
      <designation>
         <language value="en"/>
         <value value="Terazosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terazosin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD54"/>
      <designation>
         <language value="en"/>
         <value value="Isotretinoin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isotretinoin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD52"/>
      <designation>
         <language value="en"/>
         <value value="Ceftazidime and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftazidim og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CA"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA04"/>
      <designation>
         <language value="en"/>
         <value value="Gadoteridol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadoteridol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EF03"/>
      <designation>
         <language value="en"/>
         <value value="Abemaciclib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abemasiklib"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02B"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin K and other hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin K og andre hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02BC09"/>
      <designation>
         <language value="en"/>
         <value value="Epinephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC18"/>
      <designation>
         <language value="en"/>
         <value value="Indacaterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Indakaterol"/>
      </designation>
   </concept>
   <concept>
      <code value="P02BA"/>
      <designation>
         <language value="en"/>
         <value value="Quinoline derivatives and related substances"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinolinderivater og lignende substanser"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CX"/>
      <designation>
         <language value="en"/>
         <value value="Other mineral products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse mineralmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AB"/>
      <designation>
         <language value="en"/>
         <value value="Nitroimidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitroimidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BX03"/>
      <designation>
         <language value="en"/>
         <value value="Cicletanine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sikletanin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51B"/>
      <designation>
         <language value="en"/>
         <value value="Agents against coccidiosis - optional classification"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot koksidose - valgfri klassifisering"/>
      </designation>
   </concept>
   <concept>
      <code value="C05B"/>
      <designation>
         <language value="en"/>
         <value value="Antivaricose therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varicemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05A"/>
      <designation>
         <language value="en"/>
         <value value="Horse"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hest"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD05"/>
      <designation>
         <language value="en"/>
         <value value="Insulin aspart"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin aspart"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF"/>
      <designation>
         <language value="en"/>
         <value value="Thioxanthene derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tioksantenderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX01"/>
      <designation>
         <language value="en"/>
         <value value="Sunitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sunitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA"/>
      <designation>
         <language value="en"/>
         <value value="Local anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lokalanestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AD06"/>
      <designation>
         <language value="en"/>
         <value value="Acipimox"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acipimoks"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC05"/>
      <designation>
         <language value="en"/>
         <value value="Methazolamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metazolamid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED05"/>
      <designation>
         <language value="en"/>
         <value value="Lorlatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lorlatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX27"/>
      <designation>
         <language value="en"/>
         <value value="Ganaxolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ganaksolon"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02AC"/>
      <designation>
         <language value="en"/>
         <value value="Diphenylpropylamine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difenylpropylaminderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QN04BC"/>
      <designation>
         <language value="en"/>
         <value value="Dopamine agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopaminagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC07"/>
      <designation>
         <language value="en"/>
         <value value="Isoetarine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isoetarin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Phenazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenazon"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA12"/>
      <designation>
         <language value="en"/>
         <value value="Barnidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Barnidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM"/>
      <designation>
         <language value="en"/>
         <value value="Other hypnotics and sedatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hypnotika og sedativa"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XG03"/>
      <designation>
         <language value="en"/>
         <value value="Ixazomib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Iksazomib"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA02"/>
      <designation>
         <language value="en"/>
         <value value="Cyanocobalamin tannin complex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cyanokobalamintanninkompleks"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AE01"/>
      <designation>
         <language value="en"/>
         <value value="Carbamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbamid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FB01"/>
      <designation>
         <language value="en"/>
         <value value="Inotuzumab ozogamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inotuzumabozogamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP56"/>
      <designation>
         <language value="en"/>
         <value value="Sofosbuvir, velpatasvir and voxilaprevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sofosbuvir, velpatasvir og voksilaprevir"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX33"/>
      <designation>
         <language value="en"/>
         <value value="Celecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Celekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="QM02AC99"/>
      <designation>
         <language value="en"/>
         <value value="Preparations with salicylic acid derivatives, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler med innhold av salisyrederivater, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="P02CB"/>
      <designation>
         <language value="en"/>
         <value value="Piperazine and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piperazin og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BA06"/>
      <designation>
         <language value="en"/>
         <value value="Etilevodopa and decarboxylase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etilevodopa og dekarboksylasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AE12"/>
      <designation>
         <language value="en"/>
         <value value="Salicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC13"/>
      <designation>
         <language value="en"/>
         <value value="Fenbendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenbendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF05"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03DB04"/>
      <designation>
         <language value="en"/>
         <value value="Butylscopolamine and analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butylskopolamin og analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="D03B"/>
      <designation>
         <language value="en"/>
         <value value="Enzymes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymer"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DX"/>
      <designation>
         <language value="en"/>
         <value value="Other systemic drugs for obstructive airway diseases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre systemiske midler ved obstruktiv lungesykdom"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD05"/>
      <designation>
         <language value="en"/>
         <value value="Triazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Deslanoside"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deslanosid"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BE71"/>
      <designation>
         <language value="en"/>
         <value value="Paracetamol, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paracetamol, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Insects"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insekter"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01CE09"/>
      <designation>
         <language value="en"/>
         <value value="Procaine penicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prokainpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BB05"/>
      <designation>
         <language value="en"/>
         <value value="Rabies immunoglobulin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin mot hundegalskap"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03X"/>
      <designation>
         <language value="en"/>
         <value value="Other sex hormones and modulators of the genital system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre kjønnshormoner og midler med effekt på genitalia"/>
      </designation>
   </concept>
   <concept>
      <code value="G04CA02"/>
      <designation>
         <language value="en"/>
         <value value="Tamsulosin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tamsulosin"/>
      </designation>
   </concept>
   <concept>
      <code value="A07DA05"/>
      <designation>
         <language value="en"/>
         <value value="Loperamide oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Loperamidoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Clindamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klindamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AF05"/>
      <designation>
         <language value="en"/>
         <value value="Zuclopenthixol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zuklopentiksol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL02"/>
      <designation>
         <language value="en"/>
         <value value="Talimogene laherparepvec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talimogenlaherparepvek"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FA03"/>
      <designation>
         <language value="en"/>
         <value value="Obinutuzumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Obinutuzumab"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD01"/>
      <designation>
         <language value="en"/>
         <value value="Tretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="QC03C"/>
      <designation>
         <language value="en"/>
         <value value="High-ceiling diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="High-ceiling diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DB"/>
      <designation>
         <language value="en"/>
         <value value="Xanthines and adrenergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xantiner og adrenergika"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CH01"/>
      <designation>
         <language value="en"/>
         <value value="Melatonin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melatonin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01BA99"/>
      <designation>
         <language value="en"/>
         <value value="Amphenicols, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amfenikoler, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FE03"/>
      <designation>
         <language value="en"/>
         <value value="Necitumumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Necitumumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EH"/>
      <designation>
         <language value="en"/>
         <value value="Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Human epidermal vekstfaktorreseptor 2 (HER2) tyrosinkinasehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AB"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated bacterial vaccines (including Mycoplasma, Toxoid and Chlamydia vaccines)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, inaktivert (inkludert Mykoplasma-, Toksoid- og Klamydiavaksiner)"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other hematological agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hematologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03DB04"/>
      <designation>
         <language value="en"/>
         <value value="Nomegestrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nomegestrol"/>
      </designation>
   </concept>
   <concept>
      <code value="D02BA"/>
      <designation>
         <language value="en"/>
         <value value="Protectives against UV-radiation for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beskyttelsesmidler ved UV-bestråling, til topikal bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EJ02"/>
      <designation>
         <language value="en"/>
         <value value="Fedratinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fedratinib"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AG06"/>
      <designation>
         <language value="en"/>
         <value value="Tiagabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiagabin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Phenobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB17"/>
      <designation>
         <language value="en"/>
         <value value="Methylthioninium chloride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metyltioninklorid"/>
      </designation>
   </concept>
   <concept>
      <code value="QR02AD02"/>
      <designation>
         <language value="en"/>
         <value value="Lidocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lidokain"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Liothyronine sodium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Liotyroninnatrium"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CF06"/>
      <designation>
         <language value="en"/>
         <value value="Nafcillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nafcillin"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51DX07"/>
      <designation>
         <language value="en"/>
         <value value="Miltefosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Miltefosin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB07"/>
      <designation>
         <language value="en"/>
         <value value="Parnaparin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parnaparin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG06"/>
      <designation>
         <language value="en"/>
         <value value="Exemestane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eksemestan"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11J"/>
      <designation>
         <language value="en"/>
         <value value="Other vitamin products, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre sammensatte vitaminmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AB"/>
      <designation>
         <language value="en"/>
         <value value="Acid preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective, and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, selektive, og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB03"/>
      <designation>
         <language value="en"/>
         <value value="Fluoxetine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluoksetin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD07"/>
      <designation>
         <language value="en"/>
         <value value="Ranimustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ranimustin"/>
      </designation>
   </concept>
   <concept>
      <code value="A11EX"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="A07AA54"/>
      <designation>
         <language value="en"/>
         <value value="Streptomycin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptomycin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Hydroflumethiazide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroflumetiazid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="D"/>
      <designation>
         <language value="en"/>
         <value value="Dermatologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BB05"/>
      <designation>
         <language value="en"/>
         <value value="Fludarabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fludarabin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AD17"/>
      <designation>
         <language value="en"/>
         <value value="Sodium phosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05Z"/>
      <designation>
         <language value="en"/>
         <value value="Hemodialytics and hemofiltrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hemodialysekonsentrater og hemofiltrasjonsvæsker"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EN02"/>
      <designation>
         <language value="en"/>
         <value value="Pemigatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pemigatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC18"/>
      <designation>
         <language value="en"/>
         <value value="Prednicarbate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednikarbat"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB06"/>
      <designation>
         <language value="en"/>
         <value value="Insulin glulisine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin glulisin"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC02"/>
      <designation>
         <language value="en"/>
         <value value="Gallamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gallamin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA14"/>
      <designation>
         <language value="en"/>
         <value value="Solriamfetol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Solriamfetol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK07"/>
      <designation>
         <language value="en"/>
         <value value="Luseogliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Luseogliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="S02CA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids and antiinfectives in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider og antiinfektiva i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AB01"/>
      <designation>
         <language value="en"/>
         <value value="Dixyrazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diksyrazin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX05"/>
      <designation>
         <language value="en"/>
         <value value="Brentuximab vedotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brentuksimabvedotin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB53"/>
      <designation>
         <language value="en"/>
         <value value="Orciprenaline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Orciprenalin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AX04"/>
      <designation>
         <language value="en"/>
         <value value="Difelikefalin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difelikefalin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Xylometazoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xylometazolin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07FX01"/>
      <designation>
         <language value="en"/>
         <value value="Propranolol and other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propranolol og andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03B"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for obstructive airway diseases, inhalants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler ved obstruktiv lungesykdom, til inhalasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR03"/>
      <designation>
         <language value="en"/>
         <value value="Tenofovir disoproxil and emtricitabine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenofovirdisoproksil og emtricitabin"/>
      </designation>
   </concept>
   <concept>
      <code value="V09IX"/>
      <designation>
         <language value="en"/>
         <value value="Other diagnostic radiopharmaceuticals for tumour detection"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre diagnostiske radiofarmaka for tumordeteksjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AE04"/>
      <designation>
         <language value="en"/>
         <value value="Lawsonia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lawsonia"/>
      </designation>
   </concept>
   <concept>
      <code value="J01GB06"/>
      <designation>
         <language value="en"/>
         <value value="Amikacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amikacin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AL"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral and inactivated bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale og inaktiverte bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AF01"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria toxoid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteritoksoid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB04"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="D04"/>
      <designation>
         <language value="en"/>
         <value value="Antipruritics, incl. antihistamines, anesthetics,  etc."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kløemidler, inkl. antihistaminer, anestetika, etc."/>
      </designation>
   </concept>
   <concept>
      <code value="QA12CE"/>
      <designation>
         <language value="en"/>
         <value value="Selenium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX09"/>
      <designation>
         <language value="en"/>
         <value value="Mogamulizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mogamulizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA05"/>
      <designation>
         <language value="en"/>
         <value value="Carindacillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karindacillin"/>
      </designation>
   </concept>
   <concept>
      <code value="D03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Bromelains"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromelener"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA09"/>
      <designation>
         <language value="en"/>
         <value value="Clorindione"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorindion"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE09"/>
      <designation>
         <language value="en"/>
         <value value="Levocetirizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levocetirizin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB02"/>
      <designation>
         <language value="en"/>
         <value value="Lynestrenol and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lynestrenol og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CX01"/>
      <designation>
         <language value="en"/>
         <value value="Trabectedin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trabektedin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BA05"/>
      <designation>
         <language value="en"/>
         <value value="Ornipressin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ornipressin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BB02"/>
      <designation>
         <language value="en"/>
         <value value="Desonide and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desonid og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="J02AX04"/>
      <designation>
         <language value="en"/>
         <value value="Caspofungin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaspofungin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CB"/>
      <designation>
         <language value="en"/>
         <value value="Sulfonamides and potassium in combination"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfonamider og kalium i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02BX"/>
      <designation>
         <language value="en"/>
         <value value="Other systemic hemostatics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre systemiske hemostatika"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AJ52"/>
      <designation>
         <language value="en"/>
         <value value="Pertussis, purified antigen, combinations with toxoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kikhoste, renset antigen, kombinasjoner med toksoider"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AC05"/>
      <designation>
         <language value="en"/>
         <value value="Moxonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moksonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AH10"/>
      <designation>
         <language value="en"/>
         <value value="Live feline rhinotracheitis virus + live feline panleucopenia virus / parvovirus + inactivated feline calicivirus + feline leukaemia recombinant live canarypox virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus, levende + kattepanleukopenivirus / parvovirus, levende + kattecalicivirus, inaktivert + katteleukemi, kanarikoppervirus, rekombinant, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51RV01"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterials and corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle midler og kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CB"/>
      <designation>
         <language value="en"/>
         <value value="Synthetic estrogens, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Syntetiske østrogener, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BG08"/>
      <designation>
         <language value="en"/>
         <value value="Ziconotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zikonotid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD05"/>
      <designation>
         <language value="en"/>
         <value value="Omeprazole, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omeprazol, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC08"/>
      <designation>
         <language value="en"/>
         <value value="Piribedil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Piribedil"/>
      </designation>
   </concept>
   <concept>
      <code value="QA04AD"/>
      <designation>
         <language value="en"/>
         <value value="Other antiemetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antiemetika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB"/>
      <designation>
         <language value="en"/>
         <value value="Heparin group"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heparingruppen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FD05"/>
      <designation>
         <language value="en"/>
         <value value="Trastuzumab duocarmazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trastuzumabduokarmazin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD03"/>
      <designation>
         <language value="en"/>
         <value value="Cefsulodin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefsulodin"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB12"/>
      <designation>
         <language value="en"/>
         <value value="Ioxilan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Joksilan"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin K antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin K-antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB17"/>
      <designation>
         <language value="en"/>
         <value value="Bufexamac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bufeksamak"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07A"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, usammensatte midler"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53A"/>
      <designation>
         <language value="en"/>
         <value value="Ectoparasiticides for topical use, incl. insecticides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ektoparasittmidler for topikal bruk, inkl. insektisider"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX20"/>
      <designation>
         <language value="en"/>
         <value value="Rosuvastatin and telmisartan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rosuvastatin og telmisartan"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX05"/>
      <designation>
         <language value="en"/>
         <value value="Zinc acetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sinkacetat"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AC04"/>
      <designation>
         <language value="en"/>
         <value value="Quingestanol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kingestanol"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BD03"/>
      <designation>
         <language value="en"/>
         <value value="Factor VIII inhibitor bypassing activity"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Faktor VIII-inhibitor bypass-aktivitet"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AE01"/>
      <designation>
         <language value="en"/>
         <value value="Cholera, inactivated, whole cell"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolera, inaktivert, helcelle"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF05"/>
      <designation>
         <language value="en"/>
         <value value="Itacitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Itakitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB12"/>
      <designation>
         <language value="en"/>
         <value value="Albinterferon alfa-2b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Albinterferon alfa-2b"/>
      </designation>
   </concept>
   <concept>
      <code value="QA05AX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for bile therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Annen galleterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD28"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and teneligliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og teneligliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA07"/>
      <designation>
         <language value="en"/>
         <value value="Bietaserpine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bietaserpin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN03AA02"/>
      <designation>
         <language value="en"/>
         <value value="Phenobarbital"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenobarbital"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AC03"/>
      <designation>
         <language value="en"/>
         <value value="Mesoridazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mesoridazin"/>
      </designation>
   </concept>
   <concept>
      <code value="G02AD04"/>
      <designation>
         <language value="en"/>
         <value value="Carboprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karboprost"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB04"/>
      <designation>
         <language value="en"/>
         <value value="Chlorphenamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorfenamin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE01"/>
      <designation>
         <language value="en"/>
         <value value="Desirudin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desirudin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD04"/>
      <designation>
         <language value="en"/>
         <value value="Pantoprazole, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pantoprazol, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AC"/>
      <designation>
         <language value="en"/>
         <value value="Substituted ethylene diamines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etylendiaminer, substituerte"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BK06"/>
      <designation>
         <language value="en"/>
         <value value="Sotagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sotagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01BA03"/>
      <designation>
         <language value="en"/>
         <value value="Phenylephrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylefrin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB06"/>
      <designation>
         <language value="en"/>
         <value value="Ganciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ganciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="QM09AX01"/>
      <designation>
         <language value="en"/>
         <value value="Hyaluronic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hyaluronsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AE"/>
      <designation>
         <language value="en"/>
         <value value="Live bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bakterielle vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Acetyldigoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetyldigoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LF01"/>
      <designation>
         <language value="en"/>
         <value value="Guanethidine and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Guanetidin og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AX04"/>
      <designation>
         <language value="en"/>
         <value value="Mitapivat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mitapivat"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH02"/>
      <designation>
         <language value="en"/>
         <value value="Vildagliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vildagliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03GA03"/>
      <designation>
         <language value="en"/>
         <value value="Serum gonadotrophin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Serumgonadotropin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB03"/>
      <designation>
         <language value="en"/>
         <value value="Auranofin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Auranofin"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AB03"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (pork)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (svin)"/>
      </designation>
   </concept>
   <concept>
      <code value="G03CC04"/>
      <designation>
         <language value="en"/>
         <value value="Estrone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Østron"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB51"/>
      <designation>
         <language value="en"/>
         <value value="Heparin, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heparin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05CM92"/>
      <designation>
         <language value="en"/>
         <value value="Xylazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xylazine"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL07"/>
      <designation>
         <language value="en"/>
         <value value="Idecabtagene vicleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idekabtagenvikleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX15"/>
      <designation>
         <language value="en"/>
         <value value="Cariprazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kariprazin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX10"/>
      <designation>
         <language value="en"/>
         <value value="Propofol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propofol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XD"/>
      <designation>
         <language value="en"/>
         <value value="Imidazole derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Imidazolderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX16"/>
      <designation>
         <language value="en"/>
         <value value="Givosiran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Givosiran"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD"/>
      <designation>
         <language value="en"/>
         <value value="Drugs for urinary frequency and incontinence"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot hyppig vannlatning og inkontinens"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA07"/>
      <designation>
         <language value="en"/>
         <value value="Bietaserpine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bietaserpin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA04"/>
      <designation>
         <language value="en"/>
         <value value="Clomipramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klomipramin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA04"/>
      <designation>
         <language value="en"/>
         <value value="Simvastatin and fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simvastatin og fenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AF01"/>
      <designation>
         <language value="en"/>
         <value value="Isocarboxazid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isokarboksazid"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BC07"/>
      <designation>
         <language value="en"/>
         <value value="Dexrabeprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksrabeprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="V08CA08"/>
      <designation>
         <language value="en"/>
         <value value="Gadobenic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gadobensyre"/>
      </designation>
   </concept>
   <concept>
      <code value="A08"/>
      <designation>
         <language value="en"/>
         <value value="Antiobesity preparations, excl. diet products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot fedme, ekskl. diettmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AG02"/>
      <designation>
         <language value="en"/>
         <value value="Efalizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efalizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="QP54AA01"/>
      <designation>
         <language value="en"/>
         <value value="Ivermectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivermektin"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA"/>
      <designation>
         <language value="en"/>
         <value value="Dihydropyridine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydropyridinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BN04"/>
      <designation>
         <language value="en"/>
         <value value="Covid-19, protein subunit"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Covid-19, proteinsubenhet"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC07"/>
      <designation>
         <language value="en"/>
         <value value="Frovatriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Frovatriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BA02"/>
      <designation>
         <language value="en"/>
         <value value="Methoxsalen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoksalen"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD"/>
      <designation>
         <language value="en"/>
         <value value="Butyrophenone derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butyrofenonderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX03"/>
      <designation>
         <language value="en"/>
         <value value="Thenalidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenalidin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05BA23"/>
      <designation>
         <language value="en"/>
         <value value="Tofisopam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tofisopam"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB04"/>
      <designation>
         <language value="en"/>
         <value value="Rifabutin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifabutin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA04"/>
      <designation>
         <language value="en"/>
         <value value="Irbesartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Irbesartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51BC"/>
      <designation>
         <language value="en"/>
         <value value="Triazines against coccidiosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Triaziner mot koksidiose"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB15"/>
      <designation>
         <language value="en"/>
         <value value="Diphemanil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difemanil"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FY03"/>
      <designation>
         <language value="en"/>
         <value value="Prolgolimab and nurulimab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prolgolimab og nurulimab"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD04"/>
      <designation>
         <language value="en"/>
         <value value="Hydrotalcite"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrotalcit"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD63"/>
      <designation>
         <language value="en"/>
         <value value="Ceftriaxone and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftriakson og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AB03"/>
      <designation>
         <language value="en"/>
         <value value="Benzbromarone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzbromaron"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB35"/>
      <designation>
         <language value="en"/>
         <value value="Sugammadex"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sugammadeks"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CG02"/>
      <designation>
         <language value="en"/>
         <value value="Tazobactam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tazobaktam"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AF01"/>
      <designation>
         <language value="en"/>
         <value value="Mesna"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mesna"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AA07"/>
      <designation>
         <language value="en"/>
         <value value="Trofosfamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trofosfamid"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA58"/>
      <designation>
         <language value="en"/>
         <value value="Efgartigimod alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efgartigimod alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AX"/>
      <designation>
         <language value="en"/>
         <value value="Other drugs for functional gastrointestinal disorders"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot funksjonelle gastrointestinale lidelser"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC05"/>
      <designation>
         <language value="en"/>
         <value value="Flumethrin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flumetrin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA05"/>
      <designation>
         <language value="en"/>
         <value value="Mebutizide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mebutizid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AB11"/>
      <designation>
         <language value="en"/>
         <value value="Sulodexide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulodeksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QB02BX01"/>
      <designation>
         <language value="en"/>
         <value value="Etamsylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etamsylat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC10"/>
      <designation>
         <language value="en"/>
         <value value="Cefprozil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefprozil"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BD"/>
      <designation>
         <language value="en"/>
         <value value="Diaminopyrimidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diaminopyrimidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX27"/>
      <designation>
         <language value="en"/>
         <value value="Favipiravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Favipiravir"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA12"/>
      <designation>
         <language value="en"/>
         <value value="Acetyldihydrocodeine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetyldihydrokodein"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA07"/>
      <designation>
         <language value="en"/>
         <value value="Lomefloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lomefloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB03"/>
      <designation>
         <language value="en"/>
         <value value="Epirubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epirubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AG04"/>
      <designation>
         <language value="en"/>
         <value value="Meclofenamic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meklofenamsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX06"/>
      <designation>
         <language value="en"/>
         <value value="Omega-3-triglycerides incl. other esters and acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omega-3-triglycerider inkl. andre estere og syrer"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB08"/>
      <designation>
         <language value="en"/>
         <value value="Interferon beta-1b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon beta-1b"/>
      </designation>
   </concept>
   <concept>
      <code value="V09I"/>
      <designation>
         <language value="en"/>
         <value value="Tumor detection"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tumor deteksjon"/>
      </designation>
   </concept>
   <concept>
      <code value="QP"/>
      <designation>
         <language value="en"/>
         <value value="Antiparasitic products, insecticides and repellents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiparasitære midler, insekticider og insektmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR21"/>
      <designation>
         <language value="en"/>
         <value value="Dolutegravir and rilpivirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dolutegravir og rilpivirin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AX06"/>
      <designation>
         <language value="en"/>
         <value value="Atovaquone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atovakvon"/>
      </designation>
   </concept>
   <concept>
      <code value="D06BB04"/>
      <designation>
         <language value="en"/>
         <value value="Podophyllotoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Podofyllotoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="C04AD"/>
      <designation>
         <language value="en"/>
         <value value="Purine derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Purinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC04"/>
      <designation>
         <language value="en"/>
         <value value="Clopidogrel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klopidogrel"/>
      </designation>
   </concept>
   <concept>
      <code value="QS02CA90"/>
      <designation>
         <language value="en"/>
         <value value="Betamethasone and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betametason og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="C08EX02"/>
      <designation>
         <language value="en"/>
         <value value="Perhexiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perheksilin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51G"/>
      <designation>
         <language value="en"/>
         <value value="Aminoglycoside antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminoglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="L01CD51"/>
      <designation>
         <language value="en"/>
         <value value="Paclitaxel and encequidar"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Paklitaksel og encekidar"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AD01"/>
      <designation>
         <language value="en"/>
         <value value="Clobetasol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klobetasol"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX14"/>
      <designation>
         <language value="en"/>
         <value value="Levetiracetam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levetiracetam"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC09"/>
      <designation>
         <language value="en"/>
         <value value="Tretoquinol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tretokinol"/>
      </designation>
   </concept>
   <concept>
      <code value="J06BA02"/>
      <designation>
         <language value="en"/>
         <value value="Immunoglobulins, normal human, for intravascular adm."/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunglobulin, normal human, til intravaskulær adm."/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH06"/>
      <designation>
         <language value="en"/>
         <value value="Gemigliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gemigliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CA"/>
      <designation>
         <language value="en"/>
         <value value="Alpha-adrenoreceptor antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfablokkere"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DI54"/>
      <designation>
         <language value="en"/>
         <value value="Ceftolozane and beta-lactamase inhibitor"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ceftolozan og beta-laktamasehemmer"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA01"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-poliomyelitis-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-poliomyelitt-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="QA10A"/>
      <designation>
         <language value="en"/>
         <value value="Insuliner og analoger"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="D07XD"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, very potent, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, ekstra sterke, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N"/>
      <designation>
         <language value="en"/>
         <value value="Nervous system"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nervesystemet"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD02"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and sulfonylureas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og sulfonylureaderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD09"/>
      <designation>
         <language value="en"/>
         <value value="Mometasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mometason"/>
      </designation>
   </concept>
   <concept>
      <code value="C05CA01"/>
      <designation>
         <language value="en"/>
         <value value="Rutoside"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rutosid"/>
      </designation>
   </concept>
   <concept>
      <code value="P01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Mepacrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepakrin"/>
      </designation>
   </concept>
   <concept>
      <code value="QB03B"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B12 and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B12 og folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB01"/>
      <designation>
         <language value="en"/>
         <value value="Flutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01EC03"/>
      <designation>
         <language value="en"/>
         <value value="Sulfamoxole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfamoksol"/>
      </designation>
   </concept>
   <concept>
      <code value="L04A"/>
      <designation>
         <language value="en"/>
         <value value="Immunosuppressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunsuppressive midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A07BA01"/>
      <designation>
         <language value="en"/>
         <value value="Medicinal charcoal"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinsk kull"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AD01"/>
      <designation>
         <language value="en"/>
         <value value="Ethosuximide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etosuksimid"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01MA"/>
      <designation>
         <language value="en"/>
         <value value="Fluoroquinolones"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorokinoloner"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC08"/>
      <designation>
         <language value="en"/>
         <value value="Carbasalate calcium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbasalatkalsium"/>
      </designation>
   </concept>
   <concept>
      <code value="A12BA04"/>
      <designation>
         <language value="en"/>
         <value value="Potassium hydrogencarbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaliumhydrogenkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AX"/>
      <designation>
         <language value="en"/>
         <value value="Other lipid modifying agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre lipidmodifiserende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA06"/>
      <designation>
         <language value="en"/>
         <value value="Norgestrel and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestrel og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01MA16"/>
      <designation>
         <language value="en"/>
         <value value="Gatifloxacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gatifloksacin"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC09"/>
      <designation>
         <language value="en"/>
         <value value="Rotigotine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rotigotin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB10"/>
      <designation>
         <language value="en"/>
         <value value="Adenosine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adenosin"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AG06"/>
      <designation>
         <language value="en"/>
         <value value="Oil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olje"/>
      </designation>
   </concept>
   <concept>
      <code value="C01"/>
      <designation>
         <language value="en"/>
         <value value="Cardiac therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hjerteterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AH08"/>
      <designation>
         <language value="en"/>
         <value value="Live feline rhinotracheitis virus + inactivated feline calicivirus antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus, levende + kattecalicivirusantigen, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF01"/>
      <designation>
         <language value="en"/>
         <value value="Zidovudine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zidovudin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DD01"/>
      <designation>
         <language value="en"/>
         <value value="Cefotaxime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefotaksim"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA13"/>
      <designation>
         <language value="en"/>
         <value value="Norfloxacin and tinidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norfloksacin og tinidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA79"/>
      <designation>
         <language value="en"/>
         <value value="Codeine, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kodein, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB01"/>
      <designation>
         <language value="en"/>
         <value value="Ethotoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etotoin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AC52"/>
      <designation>
         <language value="en"/>
         <value value="Methadone, comb. excl. psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metadon, kombinasjoner ekskl. psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QP51DX"/>
      <designation>
         <language value="en"/>
         <value value="Other agents against leishmaniosis and trypanosomosis"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler mot leishmaniose og trypanosomose"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB10"/>
      <designation>
         <language value="en"/>
         <value value="Cortisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortison"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA10"/>
      <designation>
         <language value="en"/>
         <value value="Milk"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Melk"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD01"/>
      <designation>
         <language value="en"/>
         <value value="Flurazepam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flurazepam"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BF"/>
      <designation>
         <language value="en"/>
         <value value="Gabapentinoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gabapentinoider"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX40"/>
      <designation>
         <language value="en"/>
         <value value="Omacetaxine mepesuccinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Omacetaksinmepesuksinat"/>
      </designation>
   </concept>
   <concept>
      <code value="A11"/>
      <designation>
         <language value="en"/>
         <value value="Vitamins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BX04"/>
      <designation>
         <language value="en"/>
         <value value="Perindopril, bisoprolol and amlodipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perindopril, bisoprolol og amlodipin"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BG05"/>
      <designation>
         <language value="en"/>
         <value value="Vorozole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vorozol"/>
      </designation>
   </concept>
   <concept>
      <code value="D08AC"/>
      <designation>
         <language value="en"/>
         <value value="Biguanides and amidines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biguanider og amidiner"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA05"/>
      <designation>
         <language value="en"/>
         <value value="Tree pollen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trepollen"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX79"/>
      <designation>
         <language value="en"/>
         <value value="Eflornithine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Eflornitin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03BB01"/>
      <designation>
         <language value="en"/>
         <value value="Butylscopolamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butylscopolamin"/>
      </designation>
   </concept>
   <concept>
      <code value="A09AC"/>
      <designation>
         <language value="en"/>
         <value value="Enzyme and acid preparations, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzymmidler i kombinasjon med syremidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA12"/>
      <designation>
         <language value="en"/>
         <value value="Nadolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nadolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AD03"/>
      <designation>
         <language value="en"/>
         <value value="Insulin (pork)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insulin (svin)"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Vinyl ether"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vinyleter"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX25"/>
      <designation>
         <language value="en"/>
         <value value="Mizolastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mizolastin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA26"/>
      <designation>
         <language value="en"/>
         <value value="Azithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azitromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC10"/>
      <designation>
         <language value="en"/>
         <value value="Carbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA16"/>
      <designation>
         <language value="en"/>
         <value value="Tertatolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tertatolol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA08"/>
      <designation>
         <language value="en"/>
         <value value="Troleandomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Troleandomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AC17"/>
      <designation>
         <language value="en"/>
         <value value="Fluticasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Flutikason"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX03"/>
      <designation>
         <language value="en"/>
         <value value="Methacholine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metakolin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB10"/>
      <designation>
         <language value="en"/>
         <value value="Desogestrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desogestrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="B05AA02"/>
      <designation>
         <language value="en"/>
         <value value="Other plasma protein fractions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre plasmaproteinfraksjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AF"/>
      <designation>
         <language value="en"/>
         <value value="Janus associated kinase (JAK) inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Janus assosierte kinasehemmere (JAK)"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AL"/>
      <designation>
         <language value="en"/>
         <value value="Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Adrenergika i kombinasjon med antikolinergika inkludert trippelkombinasjoner med kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DA01"/>
      <designation>
         <language value="en"/>
         <value value="Diazoxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diazoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="N04BC03"/>
      <designation>
         <language value="en"/>
         <value value="Dihydroergocryptine mesylate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dihydroergokryptinmesylat"/>
      </designation>
   </concept>
   <concept>
      <code value="B05D"/>
      <designation>
         <language value="en"/>
         <value value="Peritoneal dialytics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Peritonealdialysevæsker"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BB03"/>
      <designation>
         <language value="en"/>
         <value value="Mepivacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mepivakain"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AB01"/>
      <designation>
         <language value="en"/>
         <value value="Streptococcus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptokokk"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BB51"/>
      <designation>
         <language value="en"/>
         <value value="Folic acid, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Folsyre, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N01BA05"/>
      <designation>
         <language value="en"/>
         <value value="Benzocaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzokain"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BD52"/>
      <designation>
         <language value="en"/>
         <value value="Measles, combinations with mumps and rubella, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meslinger, kombinasjoner med kusma og rubella, levende svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AB03"/>
      <designation>
         <language value="en"/>
         <value value="Clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="D11"/>
      <designation>
         <language value="en"/>
         <value value="Other dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre dermatologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S02CA05"/>
      <designation>
         <language value="en"/>
         <value value="Fluocinolone acetonide and antiinfectives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluocinolonacetonid og antiinfektiva"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF05"/>
      <designation>
         <language value="en"/>
         <value value="Econazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ekonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA71"/>
      <designation>
         <language value="en"/>
         <value value="Reserpine and diuretics, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reserpin og diuretika, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QI04AN01"/>
      <designation>
         <language value="en"/>
         <value value="Toxoplasma"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Toksoplasma"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA03"/>
      <designation>
         <language value="en"/>
         <value value="Oxyphenbutazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksyfenbutazon"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AD04"/>
      <designation>
         <language value="en"/>
         <value value="Ferric oxide polymaltose complexes and folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ferrioksypolymaltosekomplekser og folinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD06"/>
      <designation>
         <language value="en"/>
         <value value="Nimustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nimustin"/>
      </designation>
   </concept>
   <concept>
      <code value="R01AD"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AA01"/>
      <designation>
         <language value="en"/>
         <value value="Praziquantel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazikvantel"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AE02"/>
      <designation>
         <language value="en"/>
         <value value="Cholera, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolera, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA07"/>
      <designation>
         <language value="en"/>
         <value value="Propatylnitrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propatylnitrat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XG01"/>
      <designation>
         <language value="en"/>
         <value value="Bortezomib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bortezomib"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BA04"/>
      <designation>
         <language value="en"/>
         <value value="Sparteine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spartein"/>
      </designation>
   </concept>
   <concept>
      <code value="C10B"/>
      <designation>
         <language value="en"/>
         <value value="Lipid modifying agents, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lipidmodifiserende midler, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AH02"/>
      <designation>
         <language value="en"/>
         <value value="Everolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Everolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="V07AB"/>
      <designation>
         <language value="en"/>
         <value value="Solvents and diluting agents, incl. irrigating solutions"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oppløsnings-og fortynningsvæsker, inkl. skyllemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB19"/>
      <designation>
         <language value="en"/>
         <value value="Dexamethasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksametason"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA06"/>
      <designation>
         <language value="en"/>
         <value value="Timolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Timolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA15"/>
      <designation>
         <language value="en"/>
         <value value="Cefixime and ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefiksim og ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA"/>
      <designation>
         <language value="en"/>
         <value value="Other ophthalmologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre øyemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH08"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk A,C,Y,W-135, tetravalent renset polysakkarid antigen konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="QA02BC"/>
      <designation>
         <language value="en"/>
         <value value="Proton pump inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Protonpumpehemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AB05"/>
      <designation>
         <language value="en"/>
         <value value="Rifapentine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rifapentin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA13"/>
      <designation>
         <language value="en"/>
         <value value="Ticarcillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tikarcillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC17"/>
      <designation>
         <language value="en"/>
         <value value="Tildrakizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tildrakizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XB"/>
      <designation>
         <language value="en"/>
         <value value="Methylhydrazines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylhydraziner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Alfaxalone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfaksalon"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BB02"/>
      <designation>
         <language value="en"/>
         <value value="Enalapril and lercanidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enalapril og lerkanidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="V10XX"/>
      <designation>
         <language value="en"/>
         <value value="Various therapeutic radiopharmaceuticals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diverse radiofarmaka til terapeutisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="QG51AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AX04"/>
      <designation>
         <language value="en"/>
         <value value="Linaclotide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linaklotid"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX05"/>
      <designation>
         <language value="en"/>
         <value value="Riociguat"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Riociguat"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02BG"/>
      <designation>
         <language value="en"/>
         <value value="Other analgesics and antipyretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre analgetika og antipyretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB02"/>
      <designation>
         <language value="en"/>
         <value value="Erlotinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erlotinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01AA"/>
      <designation>
         <language value="en"/>
         <value value="Inactivated viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Inaktiverte virale vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC06"/>
      <designation>
         <language value="en"/>
         <value value="Hexoprenaline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Heksoprenalin"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD12"/>
      <designation>
         <language value="en"/>
         <value value="Rabeprazole, amoxicillin and clarithromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabeprazol, amoksicillin og klaritromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03CA06"/>
      <designation>
         <language value="en"/>
         <value value="Bevonium and psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bevon og psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AX"/>
      <designation>
         <language value="en"/>
         <value value="Other antidepressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antidepressiva"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01F"/>
      <designation>
         <language value="en"/>
         <value value="Macrolides, lincosamides and streptogramins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makrolider, linkosamider og streptograminer"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AF02"/>
      <designation>
         <language value="en"/>
         <value value="Clotrimazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klotrimazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XD03"/>
      <designation>
         <language value="en"/>
         <value value="Ornidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ornidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AE07"/>
      <designation>
         <language value="en"/>
         <value value="Cetirizine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cetirizin"/>
      </designation>
   </concept>
   <concept>
      <code value="H03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Tiratricol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiratrikol"/>
      </designation>
   </concept>
   <concept>
      <code value="H05BX01"/>
      <designation>
         <language value="en"/>
         <value value="Cinacalcet"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cinakalset"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC09"/>
      <designation>
         <language value="en"/>
         <value value="Floxuridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Floksuridin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DA10"/>
      <designation>
         <language value="en"/>
         <value value="Fimasartan and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fimasartan og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX21"/>
      <designation>
         <language value="en"/>
         <value value="Pentanedioic acid imidazolyl ethanamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentandioinsyreimidazolyletanamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AC"/>
      <designation>
         <language value="en"/>
         <value value="Pyrethrins and pyrethroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyretriner og pyretroider"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AD03"/>
      <designation>
         <language value="en"/>
         <value value="Voclosporin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Voklosporin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA02"/>
      <designation>
         <language value="en"/>
         <value value="Potassium canrenoate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kanrenoatkalium"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD04"/>
      <designation>
         <language value="en"/>
         <value value="Glimepiride and rosiglitazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glimepirid og rosiglitazon"/>
      </designation>
   </concept>
   <concept>
      <code value="A12CC08"/>
      <designation>
         <language value="en"/>
         <value value="Magnesium pidolate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Magnesiumpidolat"/>
      </designation>
   </concept>
   <concept>
      <code value="D05AC01"/>
      <designation>
         <language value="en"/>
         <value value="Dithranol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ditranol"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BB02"/>
      <designation>
         <language value="en"/>
         <value value="Chlorpropamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klorpropamid"/>
      </designation>
   </concept>
   <concept>
      <code value="D07"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, dermatological preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til dermatologisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD05"/>
      <designation>
         <language value="en"/>
         <value value="Almasilate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Almasilat"/>
      </designation>
   </concept>
   <concept>
      <code value="C02DD"/>
      <designation>
         <language value="en"/>
         <value value="Nitroferricyanide derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitroferricyanidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A14AA02"/>
      <designation>
         <language value="en"/>
         <value value="Stanozolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Stanozolol"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA09"/>
      <designation>
         <language value="en"/>
         <value value="Meticrane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metikran"/>
      </designation>
   </concept>
   <concept>
      <code value="C08C"/>
      <designation>
         <language value="en"/>
         <value value="Selective calcium channel blockers with mainly vascular effects"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive kalsiumantagonister med primært vaskulær virkning"/>
      </designation>
   </concept>
   <concept>
      <code value="G03BA"/>
      <designation>
         <language value="en"/>
         <value value="3-oxoandrosten (4) derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="3-oksoandrosten (4) derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB04"/>
      <designation>
         <language value="en"/>
         <value value="Penthienate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pentienat"/>
      </designation>
   </concept>
   <concept>
      <code value="B03A"/>
      <designation>
         <language value="en"/>
         <value value="Iron preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jernmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC21"/>
      <designation>
         <language value="en"/>
         <value value="Bimekizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bimekizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EC03"/>
      <designation>
         <language value="en"/>
         <value value="Encorafenib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enkorafenib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX"/>
      <designation>
         <language value="en"/>
         <value value="Other antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C08CA09"/>
      <designation>
         <language value="en"/>
         <value value="Lacidipine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lacidipin"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BA02"/>
      <designation>
         <language value="en"/>
         <value value="Simvastatin and ezetimibe"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Simvastatin og ezetimib"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX09"/>
      <designation>
         <language value="en"/>
         <value value="Maraviroc"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Maravirok"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01C"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactam antibacterials, penicillins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktam antibakterielle midler, penicilliner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD07"/>
      <designation>
         <language value="en"/>
         <value value="Benperidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benperidol"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA53"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of rauwolfia alkoloids, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider i blanding, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XE01"/>
      <designation>
         <language value="en"/>
         <value value="Nitrofurantoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrofurantoin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA02"/>
      <designation>
         <language value="en"/>
         <value value="Spiramycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spiramycin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EQ13"/>
      <designation>
         <language value="en"/>
         <value value="Sulfadoxine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sulfadoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CF"/>
      <designation>
         <language value="en"/>
         <value value="Tuberculosis diagnostics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til tuberkuloseundersøkelse"/>
      </designation>
   </concept>
   <concept>
      <code value="V08DA01"/>
      <designation>
         <language value="en"/>
         <value value="Perflutren, human albumin microspheres"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perflutren, mikrosfærer av humant albumin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK52"/>
      <designation>
         <language value="en"/>
         <value value="Niraparib and abiraterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Niraparib og abirateron"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX54"/>
      <designation>
         <language value="en"/>
         <value value="Macitentan and tadalafil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Makitentan og tadalafil"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BJ"/>
      <designation>
         <language value="en"/>
         <value value="Glucagon-like peptide-1 (GLP-1) analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glukagonlignende peptid-1 (GLP-1)-analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06A"/>
      <designation>
         <language value="en"/>
         <value value="ANTIBIOTICS FOR TOPICAL USE"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ANTIBIOTICS FOR TOPICAL USE"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AC11"/>
      <designation>
         <language value="en"/>
         <value value="Albendazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Albendazol"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01GB03"/>
      <designation>
         <language value="en"/>
         <value value="Gentamicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gentamicin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AX"/>
      <designation>
         <language value="en"/>
         <value value="Other anti-acne preparations for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler til topikal behandling av akne"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EE01"/>
      <designation>
         <language value="en"/>
         <value value="Latanoprost"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Latanoprost"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DH06"/>
      <designation>
         <language value="en"/>
         <value value="Tebipenem pivoxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tebipenempivoksil"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB15"/>
      <designation>
         <language value="en"/>
         <value value="Velmanase alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Velmanase alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX26"/>
      <designation>
         <language value="en"/>
         <value value="Fenfluramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenfluramin"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51R"/>
      <designation>
         <language value="en"/>
         <value value="Combination of antibacterials for intrammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjon av antibakterielle midler for intramammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="C07D"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, selective, thiazides and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere, tiazider og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AB03"/>
      <designation>
         <language value="en"/>
         <value value="Aluminium phosphate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aluminiumfosfat"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC06"/>
      <designation>
         <language value="en"/>
         <value value="Tesamorelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tesamorelin"/>
      </designation>
   </concept>
   <concept>
      <code value="H03BC"/>
      <designation>
         <language value="en"/>
         <value value="Perchlorates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perklorater"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AE03"/>
      <designation>
         <language value="en"/>
         <value value="Lanthanum carbonate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lantanumkarbonat"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK03"/>
      <designation>
         <language value="en"/>
         <value value="Rucaparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rukaparib"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01A"/>
      <designation>
         <language value="en"/>
         <value value="Anterior pituitary lobe hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hypofyseforlapphormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX05"/>
      <designation>
         <language value="en"/>
         <value value="13C-urea"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="13C-urea"/>
      </designation>
   </concept>
   <concept>
      <code value="V06DC"/>
      <designation>
         <language value="en"/>
         <value value="Carbohydrates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbohydrater"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC04"/>
      <designation>
         <language value="en"/>
         <value value="Debrisoquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Debrisokin"/>
      </designation>
   </concept>
   <concept>
      <code value="B02BX09"/>
      <designation>
         <language value="en"/>
         <value value="Fostamatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fostamatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01RA"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA54"/>
      <designation>
         <language value="en"/>
         <value value="Methylpropylpropanediol dinitrate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylpropylpropandioldinitrat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N06BA12"/>
      <designation>
         <language value="en"/>
         <value value="Lisdexamfetamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisdeksamfetamin"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AH90"/>
      <designation>
         <language value="en"/>
         <value value="Firocoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Firokoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="N06DA02"/>
      <designation>
         <language value="en"/>
         <value value="Donepezil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Donepezil"/>
      </designation>
   </concept>
   <concept>
      <code value="QP53AF"/>
      <designation>
         <language value="en"/>
         <value value="Organophosphorous compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Organofosfater"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA04"/>
      <designation>
         <language value="en"/>
         <value value="Amoxicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amoksicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AD04"/>
      <designation>
         <language value="en"/>
         <value value="Isotretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isotretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF01"/>
      <designation>
         <language value="en"/>
         <value value="Artemether and lumefantrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemeter og lumefantrin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC03"/>
      <designation>
         <language value="en"/>
         <value value="Picotamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pikotamid"/>
      </designation>
   </concept>
   <concept>
      <code value="D10AX03"/>
      <designation>
         <language value="en"/>
         <value value="Azelaic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azelainsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="QM01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Phenylbutazone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenylbutazon"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX04"/>
      <designation>
         <language value="en"/>
         <value value="Lenalidomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lenalidomid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB03"/>
      <designation>
         <language value="en"/>
         <value value="Erysipelothrix"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erysipelotriks"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AB"/>
      <designation>
         <language value="en"/>
         <value value="Respiratory stimulants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Respirasjonsstimulerende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L02BB04"/>
      <designation>
         <language value="en"/>
         <value value="Enzalutamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Enzalutamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A11HA05"/>
      <designation>
         <language value="en"/>
         <value value="Biotin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biotin"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BC01"/>
      <designation>
         <language value="en"/>
         <value value="Dibotermin alfa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dibotermin alfa"/>
      </designation>
   </concept>
   <concept>
      <code value="C02B"/>
      <designation>
         <language value="en"/>
         <value value="Antiadrenergic agents, ganglion-blocking"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiadrenergika, ganglieblokkerende"/>
      </designation>
   </concept>
   <concept>
      <code value="R07AX01"/>
      <designation>
         <language value="en"/>
         <value value="Nitric oxide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nitrogenoksid"/>
      </designation>
   </concept>
   <concept>
      <code value="QH01AA"/>
      <designation>
         <language value="en"/>
         <value value="ACTH"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="ACTH"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AA"/>
      <designation>
         <language value="en"/>
         <value value="Antibiotics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibiotika"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AX03"/>
      <designation>
         <language value="en"/>
         <value value="Sodium phenylbutyrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumfenylbutyrat"/>
      </designation>
   </concept>
   <concept>
      <code value="H02AB15"/>
      <designation>
         <language value="en"/>
         <value value="Meprednisone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meprednison"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AA01"/>
      <designation>
         <language value="en"/>
         <value value="Alcuronium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alkuron"/>
      </designation>
   </concept>
   <concept>
      <code value="C03AH"/>
      <designation>
         <language value="en"/>
         <value value="Thiazides, combinations with psycholeptics and/or analgesics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiazider, kombinasjoner med psykoleptika og/eller analgetika"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of xanthines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xantiner i kombinasjon"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA"/>
      <designation>
         <language value="en"/>
         <value value="Aldosterone antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldosteronantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11HA30"/>
      <designation>
         <language value="en"/>
         <value value="Dexpanthenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dekspantenol"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XL04"/>
      <designation>
         <language value="en"/>
         <value value="Tisagenlecleucel"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tisagenlekleucel"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD55"/>
      <designation>
         <language value="en"/>
         <value value="Hydroxyethylpromethazine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroksyetylprometazin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK01"/>
      <designation>
         <language value="en"/>
         <value value="Pyrazinamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pyrazinamid"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BD11"/>
      <designation>
         <language value="en"/>
         <value value="Fesoterodine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fesoterodin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DF"/>
      <designation>
         <language value="en"/>
         <value value="Monobactams"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Monobaktamer"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AD01"/>
      <designation>
         <language value="en"/>
         <value value="Streptokinase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Streptokinase"/>
      </designation>
   </concept>
   <concept>
      <code value="QI09AB04"/>
      <designation>
         <language value="en"/>
         <value value="Bordetella + pasteurella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bordetella + pasteurella"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA09"/>
      <designation>
         <language value="en"/>
         <value value="Fosinopril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fosinopril"/>
      </designation>
   </concept>
   <concept>
      <code value="QB05X"/>
      <designation>
         <language value="en"/>
         <value value="I.v. solution additives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Infusjonskonsentrater"/>
      </designation>
   </concept>
   <concept>
      <code value="S01XA03"/>
      <designation>
         <language value="en"/>
         <value value="Sodium chloride, hypertonic"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumklorid, hyperton"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB02"/>
      <designation>
         <language value="en"/>
         <value value="Daunorubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Daunorubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="C09AA08"/>
      <designation>
         <language value="en"/>
         <value value="Cilazapril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cilazapril"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX16"/>
      <designation>
         <language value="en"/>
         <value value="Brexpiprazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brekspiprazol"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG53"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B, combinations with meningococcus C, conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B, kombinasjoner med meningokokk C, konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA04"/>
      <designation>
         <language value="en"/>
         <value value="Megestrol and ethinylestradiol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Megestrol og etinyløstradiol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01"/>
      <designation>
         <language value="en"/>
         <value value="Antibacterials for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antibakterielle midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB04"/>
      <designation>
         <language value="en"/>
         <value value="Zomepirac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zomepirak"/>
      </designation>
   </concept>
   <concept>
      <code value="B06AC05"/>
      <designation>
         <language value="en"/>
         <value value="Lanadelumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lanadelumab"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AX07"/>
      <designation>
         <language value="en"/>
         <value value="Caplacizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kaplacizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC07"/>
      <designation>
         <language value="en"/>
         <value value="Pirbuterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pirbuterol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EB09"/>
      <designation>
         <language value="en"/>
         <value value="Acetylcholine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylkolin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA06"/>
      <designation>
         <language value="en"/>
         <value value="Etamiphylline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etamifyllin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC06"/>
      <designation>
         <language value="en"/>
         <value value="Acetylsalicylic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetylsalisylsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="H05AA04"/>
      <designation>
         <language value="en"/>
         <value value="Abaloparatide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Abaloparatid"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX"/>
      <designation>
         <language value="en"/>
         <value value="Antihypertensives for pulmonary arterial hypertension"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihypertensiva for pulmonal arteriell hypertensjon"/>
      </designation>
   </concept>
   <concept>
      <code value="L02AB02"/>
      <designation>
         <language value="en"/>
         <value value="Medroxyprogesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medroksyprogesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BM"/>
      <designation>
         <language value="en"/>
         <value value="Papillomavirus vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Papillomavirus vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BC"/>
      <designation>
         <language value="en"/>
         <value value="Mercurial diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kvikksølvdiuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX04"/>
      <designation>
         <language value="en"/>
         <value value="Sodium oxybate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumoksybat"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BF05"/>
      <designation>
         <language value="en"/>
         <value value="Artenimol and piperaquine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artenimol og piperakin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA12"/>
      <designation>
         <language value="en"/>
         <value value="Tigecycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tigesyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DB05"/>
      <designation>
         <language value="en"/>
         <value value="Cefadroxil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefadroksil"/>
      </designation>
   </concept>
   <concept>
      <code value="A10AC"/>
      <designation>
         <language value="en"/>
         <value value="Insulins and analogues for injection, intermediate-acting"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Insuliner og analoger til injeksjon, middels lang virketid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20CL01"/>
      <designation>
         <language value="en"/>
         <value value="Mink enteritisvirus /parvovirus + inactivated clostridium + inactivated pseudomonas"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Minkenteritittvirus /parvovirus + klostridium + Pseudomona, inaktivert"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB09"/>
      <designation>
         <language value="en"/>
         <value value="Etofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="A12AA03"/>
      <designation>
         <language value="en"/>
         <value value="Calcium gluconate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kalsiumglukonat"/>
      </designation>
   </concept>
   <concept>
      <code value="M03BA72"/>
      <designation>
         <language value="en"/>
         <value value="Carisoprodol, combinations with psycholeptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karisoprodol, kombinasjoner med psykoleptika"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AA01"/>
      <designation>
         <language value="en"/>
         <value value="Ondansetron"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ondansetron"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH09"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus B, multicomponent vaccine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk B, mulitkomponent vaksine"/>
      </designation>
   </concept>
   <concept>
      <code value="QD11AH91"/>
      <designation>
         <language value="en"/>
         <value value="lokivetmab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="lokivetmab"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA03"/>
      <designation>
         <language value="en"/>
         <value value="Tetracaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrakain"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AK05"/>
      <designation>
         <language value="en"/>
         <value value="Bedaquiline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bedakvilin"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CH"/>
      <designation>
         <language value="en"/>
         <value value="Tests for renal function and ureteral injuries"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler til test av nyrefunksjon og skader i urinveiene"/>
      </designation>
   </concept>
   <concept>
      <code value="C10AB11"/>
      <designation>
         <language value="en"/>
         <value value="Choline fenofibrate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolinfenofibrat"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA52"/>
      <designation>
         <language value="en"/>
         <value value="Rescinnamine and diuretics, combinations with other drugs"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Reskinnamin og diuretika, kombinasjoner med andre midler"/>
      </designation>
   </concept>
   <concept>
      <code value="M03AC11"/>
      <designation>
         <language value="en"/>
         <value value="Cisatracurium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cisatrakurium"/>
      </designation>
   </concept>
   <concept>
      <code value="H03BA02"/>
      <designation>
         <language value="en"/>
         <value value="Propylthiouracil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propyltiouracil"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FF01"/>
      <designation>
         <language value="en"/>
         <value value="Clindamycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klindamycin"/>
      </designation>
   </concept>
   <concept>
      <code value="G03XB"/>
      <designation>
         <language value="en"/>
         <value value="Progesterone receptor modulators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progesteron reseptormodulatorer"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DC"/>
      <designation>
         <language value="en"/>
         <value value="Leukotriene receptor antagonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Leukotrienreseptor antagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EA05"/>
      <designation>
         <language value="en"/>
         <value value="Brimonidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brimonidin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI07AB03"/>
      <designation>
         <language value="en"/>
         <value value="Bordetella"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bordetella"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX17"/>
      <designation>
         <language value="en"/>
         <value value="Capmatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kapmatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BX01"/>
      <designation>
         <language value="en"/>
         <value value="Halofantrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Halofantrin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01DB01"/>
      <designation>
         <language value="en"/>
         <value value="Doxorubicin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksorubicin"/>
      </designation>
   </concept>
   <concept>
      <code value="V"/>
      <designation>
         <language value="en"/>
         <value value="Various"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varia"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC02"/>
      <designation>
         <language value="en"/>
         <value value="Salbutamol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Salbutamol"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CC54"/>
      <designation>
         <language value="en"/>
         <value value="Relugolix, estradiol and norethisterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Relugoliks, østradiol og noretisteron"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR27"/>
      <designation>
         <language value="en"/>
         <value value="Lamivudine, tenofovir disoproxil and dolutegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lamivudin, tenofovirdisoproksil og dolutegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="QL01EX90"/>
      <designation>
         <language value="en"/>
         <value value="Toceranib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tokeranib"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AH01"/>
      <designation>
         <language value="en"/>
         <value value="Sirolimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sirolimus"/>
      </designation>
   </concept>
   <concept>
      <code value="A11CC05"/>
      <designation>
         <language value="en"/>
         <value value="Colecalciferol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolekalsiferol"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA02"/>
      <designation>
         <language value="en"/>
         <value value="Cisapride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cisaprid"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FA15"/>
      <designation>
         <language value="en"/>
         <value value="Dienogest and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dienogest og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CC01"/>
      <designation>
         <language value="en"/>
         <value value="Sumatriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sumatriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AB58"/>
      <designation>
         <language value="en"/>
         <value value="Sodium picosulfate, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumpikosulfat, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP02"/>
      <designation>
         <language value="en"/>
         <value value="Telaprevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telaprevir"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AC23"/>
      <designation>
         <language value="en"/>
         <value value="Olokizumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olokizumab"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA12"/>
      <designation>
         <language value="en"/>
         <value value="Nadolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nadolol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD02"/>
      <designation>
         <language value="en"/>
         <value value="Lansoprazole, tetracycline and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lansoprazol, tetrasyklin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="R02AX03"/>
      <designation>
         <language value="en"/>
         <value value="Benzydamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Benzydamin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA03"/>
      <designation>
         <language value="en"/>
         <value value="Antilymphocyte immunoglobulin (horse)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antilymfocyttimmunglobulin (hest)"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BK"/>
      <designation>
         <language value="en"/>
         <value value="Varicella zoster vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Varicella zoster vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AF"/>
      <designation>
         <language value="en"/>
         <value value="Carboxamide derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karboksamidderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Oxitriptan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksitriptan"/>
      </designation>
   </concept>
   <concept>
      <code value="G03AA18"/>
      <designation>
         <language value="en"/>
         <value value="Drospirenone and estetrol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Drospirenon og estetrol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BX13"/>
      <designation>
         <language value="en"/>
         <value value="Alginic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alginsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX07"/>
      <designation>
         <language value="en"/>
         <value value="Phenacemide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenacemid"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX07"/>
      <designation>
         <language value="en"/>
         <value value="Fampridine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fampridin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BA04"/>
      <designation>
         <language value="en"/>
         <value value="Cytisincline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cytisinklin"/>
      </designation>
   </concept>
   <concept>
      <code value="S01FA"/>
      <designation>
         <language value="en"/>
         <value value="Anticholinergics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikolinergika"/>
      </designation>
   </concept>
   <concept>
      <code value="A11EA"/>
      <designation>
         <language value="en"/>
         <value value="Vitamin B-complex, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitamin B-kompleks, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FF02"/>
      <designation>
         <language value="en"/>
         <value value="Lincomycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Linkomycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AJ01"/>
      <designation>
         <language value="en"/>
         <value value="Raltegravir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Raltegravir"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BB03"/>
      <designation>
         <language value="en"/>
         <value value="Atenolol and thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atenolol og tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="A07FA"/>
      <designation>
         <language value="en"/>
         <value value="Antidiarrheal microorganisms"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidiarroiske mikroorganismer"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AC07"/>
      <designation>
         <language value="en"/>
         <value value="Somapacitan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Somapacitan"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB22"/>
      <designation>
         <language value="en"/>
         <value value="Doxycycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Doksysyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AF02"/>
      <designation>
         <language value="en"/>
         <value value="Nalbuphine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nalbufin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01FX22"/>
      <designation>
         <language value="en"/>
         <value value="Loncastuximab tesirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lonkastuksimabtesirin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AE05"/>
      <designation>
         <language value="en"/>
         <value value="Lurasidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lurasidon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC"/>
      <designation>
         <language value="en"/>
         <value value="Selective beta-2-adrenoreceptor agonists"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Selektive beta-2-agonister"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BB02"/>
      <designation>
         <language value="en"/>
         <value value="Quinethazone and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kinetazon og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="N07BB01"/>
      <designation>
         <language value="en"/>
         <value value="Disulfiram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Disulfiram"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX04"/>
      <designation>
         <language value="en"/>
         <value value="Propanidid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propanidid"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA03"/>
      <designation>
         <language value="en"/>
         <value value="Smoking"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Røyking"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB15"/>
      <designation>
         <language value="en"/>
         <value value="Ropeginterferon alfa-2b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ropeginterferon alfa-2b"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH04"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk A,C,Y,W-135, tetravalent renset polysakkarid antigen"/>
      </designation>
   </concept>
   <concept>
      <code value="A11JA"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of vitamins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CA01"/>
      <designation>
         <language value="en"/>
         <value value="Ampicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ampicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="C02BB"/>
      <designation>
         <language value="en"/>
         <value value="Secondary and tertiary amines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sekundære og tertiære aminer"/>
      </designation>
   </concept>
   <concept>
      <code value="A03AB18"/>
      <designation>
         <language value="en"/>
         <value value="Prifinium bromide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prifiniumbromid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EB07"/>
      <designation>
         <language value="en"/>
         <value value="Dacomitinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dakomitinib"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX01"/>
      <designation>
         <language value="en"/>
         <value value="Fusidic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fusidinsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AD10"/>
      <designation>
         <language value="en"/>
         <value value="Lumateperone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lumateperon"/>
      </designation>
   </concept>
   <concept>
      <code value="V08BA01"/>
      <designation>
         <language value="en"/>
         <value value="Barium sulfate with suspending agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bariumsulfat med suspensjonsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX12"/>
      <designation>
         <language value="en"/>
         <value value="Larotrectinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Larotrektinib"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DA04"/>
      <designation>
         <language value="en"/>
         <value value="Progesterone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Progesteron"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX02"/>
      <designation>
         <language value="en"/>
         <value value="Asparaginase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Asparaginase"/>
      </designation>
   </concept>
   <concept>
      <code value="H03CA"/>
      <designation>
         <language value="en"/>
         <value value="Iodine therapy"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jodterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="G03HA"/>
      <designation>
         <language value="en"/>
         <value value="Antiandrogens, plain"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiandrogener, usammensatte"/>
      </designation>
   </concept>
   <concept>
      <code value="B03AA10"/>
      <designation>
         <language value="en"/>
         <value value="Ferrous ascorbate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jern(II)askorbat"/>
      </designation>
   </concept>
   <concept>
      <code value="N04B"/>
      <designation>
         <language value="en"/>
         <value value="Dopaminergic agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dopaminerge midler"/>
      </designation>
   </concept>
   <concept>
      <code value="S01GX08"/>
      <designation>
         <language value="en"/>
         <value value="Ketotifen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ketotifen"/>
      </designation>
   </concept>
   <concept>
      <code value="QG02CB03"/>
      <designation>
         <language value="en"/>
         <value value="Cabergoline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kabergolin"/>
      </designation>
   </concept>
   <concept>
      <code value="N07AA"/>
      <designation>
         <language value="en"/>
         <value value="Anticholinesterases"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antikolinesteraser"/>
      </designation>
   </concept>
   <concept>
      <code value="C09XA02"/>
      <designation>
         <language value="en"/>
         <value value="Aliskiren"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aliskiren"/>
      </designation>
   </concept>
   <concept>
      <code value="C02KX03"/>
      <designation>
         <language value="en"/>
         <value value="Sitaxentan"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sitaksentan"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC09"/>
      <designation>
         <language value="en"/>
         <value value="Epoprostenol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Epoprostenol"/>
      </designation>
   </concept>
   <concept>
      <code value="J01A"/>
      <designation>
         <language value="en"/>
         <value value="Tetracyclines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasykliner"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BA"/>
      <designation>
         <language value="en"/>
         <value value="Bisphosphonates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bisfosfonater"/>
      </designation>
   </concept>
   <concept>
      <code value="A02BD13"/>
      <designation>
         <language value="en"/>
         <value value="Rabeprazole, amoxicillin and metronidazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rabeprazol, amoksicillin og metronidazol"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA18"/>
      <designation>
         <language value="en"/>
         <value value="Dimetacrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dimetakrin"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AA03"/>
      <designation>
         <language value="en"/>
         <value value="Glutamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glutamin"/>
      </designation>
   </concept>
   <concept>
      <code value="C04A"/>
      <designation>
         <language value="en"/>
         <value value="Peripheral vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Perifere kardilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51C"/>
      <designation>
         <language value="en"/>
         <value value="Beta-lactam antibacterials, penicillins, for intramammary use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beta-laktamantibakterielle midler, penicilliner, for intramammær bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="V09"/>
      <designation>
         <language value="en"/>
         <value value="Diagnostic radiopharmaceuticals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Radiofarmaka til diagnostisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AF"/>
      <designation>
         <language value="en"/>
         <value value="Nucleoside and nucleotide reverse transcriptase inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nukleosid og nukleotid reverstranskriptase-hemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="QN02B"/>
      <designation>
         <language value="en"/>
         <value value="Other analgesics and antipyretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre analgetika og antipyretika"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA12"/>
      <designation>
         <language value="en"/>
         <value value="Tobramycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tobramycin"/>
      </designation>
   </concept>
   <concept>
      <code value="A03FA03"/>
      <designation>
         <language value="en"/>
         <value value="Domperidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Domperidon"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR04"/>
      <designation>
         <language value="en"/>
         <value value="Zidovudine, lamivudine and abacavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Zidovudin, lamivudin og abakavir"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AA02"/>
      <designation>
         <language value="en"/>
         <value value="Oxprenolol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksprenolol"/>
      </designation>
   </concept>
   <concept>
      <code value="C01E"/>
      <designation>
         <language value="en"/>
         <value value="Other cardiac preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre midler for hjerteterapi"/>
      </designation>
   </concept>
   <concept>
      <code value="QG03DX90"/>
      <designation>
         <language value="en"/>
         <value value="Altrenogest"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Altrenogest"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE05"/>
      <designation>
         <language value="en"/>
         <value value="Fenbufen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenbufen"/>
      </designation>
   </concept>
   <concept>
      <code value="C01EB16"/>
      <designation>
         <language value="en"/>
         <value value="Ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="M04AC01"/>
      <designation>
         <language value="en"/>
         <value value="Colchicine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kolkisin"/>
      </designation>
   </concept>
   <concept>
      <code value="A04AD14"/>
      <designation>
         <language value="en"/>
         <value value="Rolapitant"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rolapitant"/>
      </designation>
   </concept>
   <concept>
      <code value="C03CB02"/>
      <designation>
         <language value="en"/>
         <value value="Bumetanide and potassium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bumetanid og kalium"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AA06"/>
      <designation>
         <language value="en"/>
         <value value="Kebuzone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kebuzon"/>
      </designation>
   </concept>
   <concept>
      <code value="QI05AI01"/>
      <designation>
         <language value="en"/>
         <value value="Equine influenza virus + clostridium"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hesteinfluensavirus + klostridium"/>
      </designation>
   </concept>
   <concept>
      <code value="C02AA"/>
      <designation>
         <language value="en"/>
         <value value="Rauwolfia alkaloids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaloider"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE02"/>
      <designation>
         <language value="en"/>
         <value value="Phenoxymethylpenicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoksymetylpenicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Interferon beta natural"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naturlig interferon beta"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06AA"/>
      <designation>
         <language value="en"/>
         <value value="Non-selective monoamine reuptake inhibitors"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-selektive monoaminreopptakshemmere"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA03"/>
      <designation>
         <language value="en"/>
         <value value="Clopamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klopamid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DC07"/>
      <designation>
         <language value="en"/>
         <value value="Cefotiam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefotiam"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AK11"/>
      <designation>
         <language value="en"/>
         <value value="Formoterol and fluticasone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Formoterol og flutikason"/>
      </designation>
   </concept>
   <concept>
      <code value="A06AB08"/>
      <designation>
         <language value="en"/>
         <value value="Sodium picosulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumpikosulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CB02"/>
      <designation>
         <language value="en"/>
         <value value="Methoxyphenamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoksyfenamin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01BA52"/>
      <designation>
         <language value="en"/>
         <value value="Thiamphenicol, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiamfenikol, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="D11AX22"/>
      <designation>
         <language value="en"/>
         <value value="Ivermectin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ivermektin"/>
      </designation>
   </concept>
   <concept>
      <code value="H02BX01"/>
      <designation>
         <language value="en"/>
         <value value="Methylprednisolone, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metylprednisolon, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BX"/>
      <designation>
         <language value="en"/>
         <value value="Other urologicals"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre urologiske midler"/>
      </designation>
   </concept>
   <concept>
      <code value="N07XX06"/>
      <designation>
         <language value="en"/>
         <value value="Tetrabenazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrabenazin"/>
      </designation>
   </concept>
   <concept>
      <code value="H01CA02"/>
      <designation>
         <language value="en"/>
         <value value="Nafarelin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nafarelin"/>
      </designation>
   </concept>
   <concept>
      <code value="B05BB01"/>
      <designation>
         <language value="en"/>
         <value value="Electrolytes"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Elektrolytter"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB52"/>
      <designation>
         <language value="en"/>
         <value value="Dexchlorpheniramine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deksklorfeniramin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB05"/>
      <designation>
         <language value="en"/>
         <value value="Norethisterone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Noretisteron og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07XB"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, moderately potent, other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, middels sterke, andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02BC"/>
      <designation>
         <language value="en"/>
         <value value="Bisquaternary ammonium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Biskvartære ammoniumforbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BA01"/>
      <designation>
         <language value="en"/>
         <value value="Encephalitis, tick borne, inactivated, whole virus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Encefalitt, skogflåttbåren, inaktivert helvirus"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB01"/>
      <designation>
         <language value="en"/>
         <value value="Norgestrel and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Norgestrel og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="C09DX08"/>
      <designation>
         <language value="en"/>
         <value value="Telmisartan, amlodipine and hydrochlorothiazide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Telmisartan, amlodipin og hydroklortiazid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01EX18"/>
      <designation>
         <language value="en"/>
         <value value="Avapritinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Avapritinib"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DE03"/>
      <designation>
         <language value="en"/>
         <value value="Cefozopran"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefozopran"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA04"/>
      <designation>
         <language value="en"/>
         <value value="Smoking, cigarette"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sigarettrøyking"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AL02"/>
      <designation>
         <language value="en"/>
         <value value="Sultopride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sultoprid"/>
      </designation>
   </concept>
   <concept>
      <code value="C02CC01"/>
      <designation>
         <language value="en"/>
         <value value="Betanidine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betanidin"/>
      </designation>
   </concept>
   <concept>
      <code value="C01DA38"/>
      <designation>
         <language value="en"/>
         <value value="Tenitramine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tenitramin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01CE03"/>
      <designation>
         <language value="en"/>
         <value value="Propicillin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Propicillin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AF02"/>
      <designation>
         <language value="en"/>
         <value value="Oxcarbazepine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Okskarbazepin"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AX11"/>
      <designation>
         <language value="en"/>
         <value value="Topiramate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Topiramat"/>
      </designation>
   </concept>
   <concept>
      <code value="G02CB02"/>
      <designation>
         <language value="en"/>
         <value value="Lisuride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Lisurid"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD05"/>
      <designation>
         <language value="en"/>
         <value value="Fotemustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fotemustin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AH07"/>
      <designation>
         <language value="en"/>
         <value value="Meningococcus C, purified polysaccharides antigen conjugated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Meningokokk C, renset polysakkarid antigen konjugert"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AJ03"/>
      <designation>
         <language value="en"/>
         <value value="Live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Katterhinotrakeitittvirus, levende + kattecalicivirusantigen, inaktivert + kattepanleukopenivirus / parvovirus, levende + klamydia, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="V01A"/>
      <designation>
         <language value="en"/>
         <value value="Allergens"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Allergener"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AB09"/>
      <designation>
         <language value="en"/>
         <value value="Famciclovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Famciklovir"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA28"/>
      <designation>
         <language value="en"/>
         <value value="Belatacept"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Belatacept"/>
      </designation>
   </concept>
   <concept>
      <code value="L01BC52"/>
      <designation>
         <language value="en"/>
         <value value="Fluorouracil, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fluorouracil, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QS01AA02"/>
      <designation>
         <language value="en"/>
         <value value="Chlortetracycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortetrasyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CC01"/>
      <designation>
         <language value="en"/>
         <value value="Penicillamine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penicillamin"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CC53"/>
      <designation>
         <language value="en"/>
         <value value="Terbutaline, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Terbutalin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Nystatin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Nystatin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01DE01"/>
      <designation>
         <language value="en"/>
         <value value="Cefepime"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Cefepim"/>
      </designation>
   </concept>
   <concept>
      <code value="QN05AD90"/>
      <designation>
         <language value="en"/>
         <value value="Azaperone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Azaperon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AC01"/>
      <designation>
         <language value="en"/>
         <value value="Thiotepa"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiotepa"/>
      </designation>
   </concept>
   <concept>
      <code value="N03AB02"/>
      <designation>
         <language value="en"/>
         <value value="Phenytoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenytoin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD07AA"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids, weak (group I)"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider, milde (gruppe I)"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AB08"/>
      <designation>
         <language value="en"/>
         <value value="Etodolac"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etodolak"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AB09"/>
      <designation>
         <language value="en"/>
         <value value="Miconazole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Mikonazol"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AE03"/>
      <designation>
         <language value="en"/>
         <value value="Argatroban"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Argatroban"/>
      </designation>
   </concept>
   <concept>
      <code value="C07CG"/>
      <designation>
         <language value="en"/>
         <value value="Alpha and beta blocking agents and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfa- og betablokkere og andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XK01"/>
      <designation>
         <language value="en"/>
         <value value="Olaparib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Olaparib"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AA10"/>
      <designation>
         <language value="en"/>
         <value value="Trimethobenzamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetobenzamid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD13"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and alogliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og alogliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="N01AX05"/>
      <designation>
         <language value="en"/>
         <value value="Alfaxalone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alfaksalon"/>
      </designation>
   </concept>
   <concept>
      <code value="R03CA02"/>
      <designation>
         <language value="en"/>
         <value value="Ephedrine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Efedrin"/>
      </designation>
   </concept>
   <concept>
      <code value="D03AX16"/>
      <designation>
         <language value="en"/>
         <value value="Beremagene geperpavec"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Beremagenegeperpavek"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA01"/>
      <designation>
         <language value="en"/>
         <value value="Spironolactone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Spironolakton"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED04"/>
      <designation>
         <language value="en"/>
         <value value="Brigatinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brigatinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AX13"/>
      <designation>
         <language value="en"/>
         <value value="Glatiramer acetate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Glatirameracetat"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ05"/>
      <designation>
         <language value="en"/>
         <value value="Antivirals for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antivirale midler til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="D10BA01"/>
      <designation>
         <language value="en"/>
         <value value="Isotretinoin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Isotretinoin"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XH02"/>
      <designation>
         <language value="en"/>
         <value value="Romidepsin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Romidepsin"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX06"/>
      <designation>
         <language value="en"/>
         <value value="Pomalidomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Pomalidomid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD22"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and evogliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og evogliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC02"/>
      <designation>
         <language value="en"/>
         <value value="Cloricromen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloricromen"/>
      </designation>
   </concept>
   <concept>
      <code value="D09A"/>
      <designation>
         <language value="en"/>
         <value value="Medicated dressings"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medisinsk forbindingsmateriale"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE01"/>
      <designation>
         <language value="en"/>
         <value value="Artemisinin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artemisinin"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AA05"/>
      <designation>
         <language value="en"/>
         <value value="Opipramol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opipramol"/>
      </designation>
   </concept>
   <concept>
      <code value="L03AB05"/>
      <designation>
         <language value="en"/>
         <value value="Interferon alfa-2b"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Interferon alfa-2b"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA12"/>
      <designation>
         <language value="en"/>
         <value value="Metolazone and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metolazon og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC30"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="R03AC04"/>
      <designation>
         <language value="en"/>
         <value value="Fenoterol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoterol"/>
      </designation>
   </concept>
   <concept>
      <code value="A07FA03"/>
      <designation>
         <language value="en"/>
         <value value="Escherichia coli"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Escherichia coli"/>
      </designation>
   </concept>
   <concept>
      <code value="QI02AD"/>
      <designation>
         <language value="en"/>
         <value value="Live viral vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Virale vaksiner, levende"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XJ02"/>
      <designation>
         <language value="en"/>
         <value value="Sonidegib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sonidegib"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE"/>
      <designation>
         <language value="en"/>
         <value value="Drugs used in erectile dysfunction"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Midler mot erektil dysfunksjon"/>
      </designation>
   </concept>
   <concept>
      <code value="L01ED01"/>
      <designation>
         <language value="en"/>
         <value value="Crizotinib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Krizotinib"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX11"/>
      <designation>
         <language value="en"/>
         <value value="Estramustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Estramustin"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AX08"/>
      <designation>
         <language value="en"/>
         <value value="Risperidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Risperidon"/>
      </designation>
   </concept>
   <concept>
      <code value="C10BX18"/>
      <designation>
         <language value="en"/>
         <value value="Atorvastatin, amlodipine and ramipril"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Atorvastatin, amlodipin og ramipril"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AG51"/>
      <designation>
         <language value="en"/>
         <value value="Haemophilus influenzae B, combinations with toxoids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Haemophilus influenzae B, kombinasjoner med toksoider"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CC"/>
      <designation>
         <language value="en"/>
         <value value="Aldehydes and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aldehyder og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="B03BA04"/>
      <designation>
         <language value="en"/>
         <value value="Cobamamide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kobamamid"/>
      </designation>
   </concept>
   <concept>
      <code value="QA03F"/>
      <designation>
         <language value="en"/>
         <value value="Propulsives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Motilitetsregulerende midle"/>
      </designation>
   </concept>
   <concept>
      <code value="G04BE01"/>
      <designation>
         <language value="en"/>
         <value value="Alprostadil"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Alprostadil"/>
      </designation>
   </concept>
   <concept>
      <code value="A05BA03"/>
      <designation>
         <language value="en"/>
         <value value="Silymarin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Silymarin"/>
      </designation>
   </concept>
   <concept>
      <code value="QI01"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for aves"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for fugl"/>
      </designation>
   </concept>
   <concept>
      <code value="D07BB04"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone butyrate and antiseptics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortisonbutyrat og antiseptika"/>
      </designation>
   </concept>
   <concept>
      <code value="C01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Acetyldigitoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Acetyldigitoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01"/>
      <designation>
         <language value="en"/>
         <value value="Anesthetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anestetika"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AP03"/>
      <designation>
         <language value="en"/>
         <value value="Boceprevir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Boceprevir"/>
      </designation>
   </concept>
   <concept>
      <code value="J07AM51"/>
      <designation>
         <language value="en"/>
         <value value="Tetanus toxoid, combinations with diphtheria toxoid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetanustoksoid, kombinasjoner med difteritoksoid"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XX03"/>
      <designation>
         <language value="en"/>
         <value value="Clofoctol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klofoktol"/>
      </designation>
   </concept>
   <concept>
      <code value="QN06A"/>
      <designation>
         <language value="en"/>
         <value value="Antidepressants"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antidepressiva"/>
      </designation>
   </concept>
   <concept>
      <code value="M05BB01"/>
      <designation>
         <language value="en"/>
         <value value="Etidronic acid and calcium, sequential"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etidronsyre og kalsium, sekvensielle"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA05"/>
      <designation>
         <language value="en"/>
         <value value="Cigarette"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sigaretter"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD08"/>
      <designation>
         <language value="en"/>
         <value value="Oxomemazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksomemazin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX18"/>
      <designation>
         <language value="en"/>
         <value value="Acrivastine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Akrivastin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02BG09"/>
      <designation>
         <language value="en"/>
         <value value="Methoxyflurane"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metoksyfluran"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR26"/>
      <designation>
         <language value="en"/>
         <value value="Darunavir and ritonavir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Darunavir og ritonavir"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AR08"/>
      <designation>
         <language value="en"/>
         <value value="Emtricitabine, tenofovir disoproxil and rilpivirine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Emtricitabin, tenofovirdisoproksil og rilpivirin"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AX13"/>
      <designation>
         <language value="en"/>
         <value value="Umifenovir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Umifenovir"/>
      </designation>
   </concept>
   <concept>
      <code value="N07A"/>
      <designation>
         <language value="en"/>
         <value value="Parasympathomimetics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Parasympatomimetika"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA"/>
      <designation>
         <language value="en"/>
         <value value="Opium alkaloids and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Opiumsalkaloider og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD03"/>
      <designation>
         <language value="en"/>
         <value value="Almagate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Almagat"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ51EA01"/>
      <designation>
         <language value="en"/>
         <value value="Trimethoprim"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trimetoprim"/>
      </designation>
   </concept>
   <concept>
      <code value="V08D"/>
      <designation>
         <language value="en"/>
         <value value="Ultrasound contrast media"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kontrastmidler for ultralyd"/>
      </designation>
   </concept>
   <concept>
      <code value="N06AB04"/>
      <designation>
         <language value="en"/>
         <value value="Citalopram"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Citalopram"/>
      </designation>
   </concept>
   <concept>
      <code value="A01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Sodium fluoride"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumfluorid"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BD20"/>
      <designation>
         <language value="en"/>
         <value value="Metformin and empagliflozin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metformin og empagliflozin"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AB51"/>
      <designation>
         <language value="en"/>
         <value value="Brompheniramine, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bromfeniramin, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="N05CD04"/>
      <designation>
         <language value="en"/>
         <value value="Estazolam"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Estazolam"/>
      </designation>
   </concept>
   <concept>
      <code value="M01CB02"/>
      <designation>
         <language value="en"/>
         <value value="Sodium aurotiosulfate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Natriumaurotiosulfat"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AH02"/>
      <designation>
         <language value="en"/>
         <value value="Rofecoxib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rofekoksib"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BX"/>
      <designation>
         <language value="en"/>
         <value value="Other low-ceiling diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="G03FB07"/>
      <designation>
         <language value="en"/>
         <value value="Medrogestone and estrogen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Medrogeston og østrogen"/>
      </designation>
   </concept>
   <concept>
      <code value="C07AG02"/>
      <designation>
         <language value="en"/>
         <value value="Carvedilol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karvedilol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01EC54"/>
      <designation>
         <language value="en"/>
         <value value="Brinzolamide, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Brinzolamid, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="V04CX02"/>
      <designation>
         <language value="en"/>
         <value value="Folic acid"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Folsyre"/>
      </designation>
   </concept>
   <concept>
      <code value="D05BB01"/>
      <designation>
         <language value="en"/>
         <value value="Etretinate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Etretinat"/>
      </designation>
   </concept>
   <concept>
      <code value="D02AC"/>
      <designation>
         <language value="en"/>
         <value value="Soft paraffin and fat products"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vaselin og fettprodukter"/>
      </designation>
   </concept>
   <concept>
      <code value="L01AD03"/>
      <designation>
         <language value="en"/>
         <value value="Semustine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Semustin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07E"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents and vasodilators"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokkere og vasodilaterende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="B02AA"/>
      <designation>
         <language value="en"/>
         <value value="Amino acids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminosyrer"/>
      </designation>
   </concept>
   <concept>
      <code value="C03BA04"/>
      <designation>
         <language value="en"/>
         <value value="Chlortalidone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Klortalidon"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AX02"/>
      <designation>
         <language value="en"/>
         <value value="Thalidomide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Talidomid"/>
      </designation>
   </concept>
   <concept>
      <code value="J07BF02"/>
      <designation>
         <language value="en"/>
         <value value="Poliomyelitis oral, trivalent, live attenuated"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Poliomyelitt oral, trivalent, levende, svekket"/>
      </designation>
   </concept>
   <concept>
      <code value="C09BA13"/>
      <designation>
         <language value="en"/>
         <value value="Moexipril and diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Moeksipril og diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="QG01A"/>
      <designation>
         <language value="en"/>
         <value value="With corticosteroids"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Med kortikosteroider"/>
      </designation>
   </concept>
   <concept>
      <code value="QI06AJ"/>
      <designation>
         <language value="en"/>
         <value value="Live and inactivated viral and bacterial vaccines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Levende og inaktiverte virale og bakterielle vaksiner"/>
      </designation>
   </concept>
   <concept>
      <code value="V01AA08"/>
      <designation>
         <language value="en"/>
         <value value="Food"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Næringsmidler"/>
      </designation>
   </concept>
   <concept>
      <code value="C07DA"/>
      <designation>
         <language value="en"/>
         <value value="Beta blocking agents, non-selective, thiazides and other diuretics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Betablokker, ikke-selektiv, tiazider andre diuretika"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BC"/>
      <designation>
         <language value="en"/>
         <value value="Methanolquinolines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metanolkinoliner"/>
      </designation>
   </concept>
   <concept>
      <code value="H01BB03"/>
      <designation>
         <language value="en"/>
         <value value="Carbetocin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Karbetocin"/>
      </designation>
   </concept>
   <concept>
      <code value="C03DA05"/>
      <designation>
         <language value="en"/>
         <value value="Finerenone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Finerenon"/>
      </designation>
   </concept>
   <concept>
      <code value="B02"/>
      <designation>
         <language value="en"/>
         <value value="Antihemorrhagics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antihemoragika"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH07"/>
      <designation>
         <language value="en"/>
         <value value="Evogliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Evogliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="C07BA68"/>
      <designation>
         <language value="en"/>
         <value value="Metipranolol and thiazides, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Metipranolol og tiazider, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="H02"/>
      <designation>
         <language value="en"/>
         <value value="Corticosteroids for systemic use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kortikosteroider til systemisk bruk"/>
      </designation>
   </concept>
   <concept>
      <code value="A10BH08"/>
      <designation>
         <language value="en"/>
         <value value="Teneligliptin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Teneligliptin"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AJ19"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone and ibuprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon og ibuprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="J04AD02"/>
      <designation>
         <language value="en"/>
         <value value="Tiocarlide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tiokarlid"/>
      </designation>
   </concept>
   <concept>
      <code value="QI20"/>
      <designation>
         <language value="en"/>
         <value value="Immunologicals for other species"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Immunologiske midler for andre arter"/>
      </designation>
   </concept>
   <concept>
      <code value="D01AE16"/>
      <designation>
         <language value="en"/>
         <value value="Amorolfine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amorolfin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE04"/>
      <designation>
         <language value="en"/>
         <value value="Fenoprofen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fenoprofen"/>
      </designation>
   </concept>
   <concept>
      <code value="R01A"/>
      <designation>
         <language value="en"/>
         <value value="Decongestants and other nasal preparations for topical use"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rhinologika og andre midler til topikal bruk i nesen"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AA19"/>
      <designation>
         <language value="en"/>
         <value value="Gusperimus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Gusperimus"/>
      </designation>
   </concept>
   <concept>
      <code value="N02AA56"/>
      <designation>
         <language value="en"/>
         <value value="Oxycodone and naltrexone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oksykodon og naltrekson"/>
      </designation>
   </concept>
   <concept>
      <code value="C08E"/>
      <designation>
         <language value="en"/>
         <value value="Non-selective calcium channel blockers"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ikke-selektive kalsiumantagonister"/>
      </designation>
   </concept>
   <concept>
      <code value="H01AX"/>
      <designation>
         <language value="en"/>
         <value value="Other anterior pituitary lobe hormones and analogues"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre hypofyseforlapphormoner og analoger"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AD03"/>
      <designation>
         <language value="en"/>
         <value value="Thiethylperazine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tietylperazin"/>
      </designation>
   </concept>
   <concept>
      <code value="M01AE02"/>
      <designation>
         <language value="en"/>
         <value value="Naproxen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Naproksen"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB24"/>
      <designation>
         <language value="en"/>
         <value value="Digitalis antitoxin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Digitalisantitoksin"/>
      </designation>
   </concept>
   <concept>
      <code value="V08AB04"/>
      <designation>
         <language value="en"/>
         <value value="Iopamidol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Jopamidol"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA14"/>
      <designation>
         <language value="en"/>
         <value value="Butizide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Butizid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="V03AB03"/>
      <designation>
         <language value="en"/>
         <value value="Edetates"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Edetater"/>
      </designation>
   </concept>
   <concept>
      <code value="J05AH02"/>
      <designation>
         <language value="en"/>
         <value value="Oseltamivir"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Oseltamivir"/>
      </designation>
   </concept>
   <concept>
      <code value="P01BE03"/>
      <designation>
         <language value="en"/>
         <value value="Artesunate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Artesunat"/>
      </designation>
   </concept>
   <concept>
      <code value="D06AX12"/>
      <designation>
         <language value="en"/>
         <value value="Amikacin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Amikacin"/>
      </designation>
   </concept>
   <concept>
      <code value="J07CA06"/>
      <designation>
         <language value="en"/>
         <value value="Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Difteri-haemophilus influenzae B-kikhoste-poliomyelitt-tetanus"/>
      </designation>
   </concept>
   <concept>
      <code value="S01AA01"/>
      <designation>
         <language value="en"/>
         <value value="Chloramphenicol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kloramfenikol"/>
      </designation>
   </concept>
   <concept>
      <code value="S01HA04"/>
      <designation>
         <language value="en"/>
         <value value="Proxymetacaine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Proksymetakain"/>
      </designation>
   </concept>
   <concept>
      <code value="N05AH"/>
      <designation>
         <language value="en"/>
         <value value="Diazepines, oxazepines, thiazepines and oxepines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Diazepiner, oksazepiner, tiazepiner og oksepiner"/>
      </designation>
   </concept>
   <concept>
      <code value="C02LA50"/>
      <designation>
         <language value="en"/>
         <value value="Comb. of rauwolfia alkaloids and diuretics incl. other combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Rauwolfiaalkaolider i blanding og diuretika inkl. andre kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="L04AB06"/>
      <designation>
         <language value="en"/>
         <value value="Golimumab"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Golimumab"/>
      </designation>
   </concept>
   <concept>
      <code value="J01G"/>
      <designation>
         <language value="en"/>
         <value value="Aminoglycoside antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Aminoglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="QD06AA"/>
      <designation>
         <language value="en"/>
         <value value="Tetracycline and derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Tetrasyklin og derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="QR03BA08"/>
      <designation>
         <language value="en"/>
         <value value="Ciclesonide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Ciklesonid"/>
      </designation>
   </concept>
   <concept>
      <code value="D07AB11"/>
      <designation>
         <language value="en"/>
         <value value="Hydrocortisone buteprate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydrokortisonbuteprat"/>
      </designation>
   </concept>
   <concept>
      <code value="J01FA01"/>
      <designation>
         <language value="en"/>
         <value value="Erythromycin"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Erytromycin"/>
      </designation>
   </concept>
   <concept>
      <code value="J01D"/>
      <designation>
         <language value="en"/>
         <value value="Other beta-lactam antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre beta-laktam antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="R03DA"/>
      <designation>
         <language value="en"/>
         <value value="Xanthines"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Xantinderivater"/>
      </designation>
   </concept>
   <concept>
      <code value="R05DA20"/>
      <designation>
         <language value="en"/>
         <value value="Combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="QN01AX93"/>
      <designation>
         <language value="en"/>
         <value value="Tricaine mesilate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Trikainmesilat"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX27"/>
      <designation>
         <language value="en"/>
         <value value="Desloratadine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Desloratadin"/>
      </designation>
   </concept>
   <concept>
      <code value="Z80AA02"/>
      <designation>
         <language value="en"/>
         <value value="Cigarette smoke"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Sigarettrøyk"/>
      </designation>
   </concept>
   <concept>
      <code value="C03B"/>
      <designation>
         <language value="en"/>
         <value value="Low-ceiling diuretics, excl. thiazides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Low-ceiling diuretika, ekskl. tiazider"/>
      </designation>
   </concept>
   <concept>
      <code value="N02CX"/>
      <designation>
         <language value="en"/>
         <value value="Other antimigraine preparations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre migrenemidler"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52AA51"/>
      <designation>
         <language value="en"/>
         <value value="Praziquantel, combinations"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prazikvantel, kombinasjoner"/>
      </designation>
   </concept>
   <concept>
      <code value="J01AA10"/>
      <designation>
         <language value="en"/>
         <value value="Penimepicycline"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Penimepisyklin"/>
      </designation>
   </concept>
   <concept>
      <code value="QA11"/>
      <designation>
         <language value="en"/>
         <value value="Vitamins"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Vitaminer"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01EW"/>
      <designation>
         <language value="en"/>
         <value value="Combinations of sulfonamides and trimethoprim, incl. derivatives"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner av sulfonamider og trimetoprim, inkudert derivater"/>
      </designation>
   </concept>
   <concept>
      <code value="C01BB"/>
      <designation>
         <language value="en"/>
         <value value="Antiarrhythmics, class Ib"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Antiarytmika, klasse Ib"/>
      </designation>
   </concept>
   <concept>
      <code value="C03EA01"/>
      <designation>
         <language value="en"/>
         <value value="Hydrochlorothiazide and potassium-sparing agents"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Hydroklortiazid og kaliumsparende midler"/>
      </designation>
   </concept>
   <concept>
      <code value="J01XC"/>
      <designation>
         <language value="en"/>
         <value value="Steroid antibacterials"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Steroid antibakterielle midler"/>
      </designation>
   </concept>
   <concept>
      <code value="L01XX35"/>
      <designation>
         <language value="en"/>
         <value value="Anagrelide"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anagrelid"/>
      </designation>
   </concept>
   <concept>
      <code value="A08AA51"/>
      <designation>
         <language value="en"/>
         <value value="Phentermine and topiramate"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Fentermin og topiramat"/>
      </designation>
   </concept>
   <concept>
      <code value="R06AX16"/>
      <designation>
         <language value="en"/>
         <value value="Deptropine"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Deptropin"/>
      </designation>
   </concept>
   <concept>
      <code value="QD01AE91"/>
      <designation>
         <language value="en"/>
         <value value="Bronopol"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Bronopol"/>
      </designation>
   </concept>
   <concept>
      <code value="A02AD"/>
      <designation>
         <language value="en"/>
         <value value="Combinations and complexes of aluminium, calcium and magnesium compounds"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Kombinasjoner og komplekser av aluminium, kalsium og magnesium forbindelser"/>
      </designation>
   </concept>
   <concept>
      <code value="A16AB09"/>
      <designation>
         <language value="en"/>
         <value value="Idursulfase"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Idursulfase"/>
      </designation>
   </concept>
   <concept>
      <code value="QJ01GB"/>
      <designation>
         <language value="en"/>
         <value value="Other aminoglycosides"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Andre aminoglykosider"/>
      </designation>
   </concept>
   <concept>
      <code value="S01BA04"/>
      <designation>
         <language value="en"/>
         <value value="Prednisolone"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Prednisolon"/>
      </designation>
   </concept>
   <concept>
      <code value="G01AX03"/>
      <designation>
         <language value="en"/>
         <value value="Policresulen"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Polikresulen"/>
      </designation>
   </concept>
   <concept>
      <code value="QP52"/>
      <designation>
         <language value="en"/>
         <value value="Anthelminitics"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Anthelmintika"/>
      </designation>
   </concept>
   <concept>
      <code value="B01AC07"/>
      <designation>
         <language value="en"/>
         <value value="Dipyridamole"/>
      </designation>
      <designation>
         <language value="no"/>
         <value value="Dipyridamol"/>
      </designation>
   </concept>
</CodeSystem>
